Sentence,class,file
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/let-7e and MMP9 in ASC differentiation M Ventayol et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/5b/8f/cddis20142a.PMC3944246.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)BRCA1 and p63 coregulate S100A2 to modulate mutant p53 stability NE Buckley et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/9b/22/cddis201431a.PMC3944248.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/Regulation of EMT by BAG3 via ZEB1 X Meng et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/ae/a9/cddis201432a.PMC3944249.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Nonthermal plasma induced apoptosis in HNSCC SU Kang et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/73/21/cddis201433a.PMC3944250.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Survivin-2B promoted autophagy in NB4 cells K Shi et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/62/be/cddis201434a.PMC3944251.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Thioridazine sensitizes TRAIL-induced apoptosis K-J Min et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/e8/6e/cddis201435a.PMC3944252.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/Metabolism and pancreatic cancer R Blum and Y Kloog 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/76/ff/cddis201438a.PMC3944253.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Hypoxia induces complete antifolate resistance S Raz et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/99/98/cddis201439a.PMC3944254.pdf
Versteeg R. R2: microarray analysis and visualization platform (http://r2.amc.nl).29.,OADS,/arxiv_data1/oa_pdf/89/a2/cddis201440a.PMC3944256.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Spliceosome regulates Mcl1 activity TW Laetsch et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/89/a2/cddis201440a.PMC3944256.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)MYCN increase precedes neuronal differentiation L Guglielmi et al 14 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/cb/22/cddis201442a.PMC3944258.pdf
Images were processed with Zen 2009 imagesoftware (Carl Zeiss) and analyses were performed using ImageJ software(downloaded from http://www.embl-heidelberg.de/eamnet/).,OADS,/arxiv_data1/oa_pdf/3f/b1/cddis201444a.PMC3944259.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)p66Shc inhibits B-cell chemotaxis L Patrussi et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/3f/b1/cddis201444a.PMC3944259.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/Ethanol alters proteolytic pathways via TLR4 A Pla et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/ef/3f/cddis201446a.PMC3944260.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/MiR-21 regulates apoptosis through Tipe2 Q Ruan et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/51/f8/cddis201447a.PMC3944261.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)HMGB1–LPS complex promotes SF transformation Y Qin et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/95/7b/cddis201448a.PMC3944262.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Smad7 sustains colon cancer growth C Stolﬁ et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/97/36/cddis201449a.PMC3944263.pdf
"Target prediction tools TargetScan (http://www.targetscan.org), PicTar ( http://pictar.md c-berlin.de/) and microRNA.org (http://www.microrna.org) were utilized inorder to ﬁnd out possible target genes for miR-542-3p.",OADS,/arxiv_data1/oa_pdf/93/f6/cddis20144a.PMC3944264.pdf
"Target prediction tools Target Scan (http://www.targetscan.org), PicTar (http://pictar.bio.nyu.edu) and miRanda(http://www.microrna.org) were utilized in order to ﬁnd out possible target genesfor the differentially expressed miRNAs.",OADS,/arxiv_data1/oa_pdf/93/f6/cddis20144a.PMC3944264.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)miR-542-3p inhibits bone formation J Kureel et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/93/f6/cddis20144a.PMC3944264.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/Editorial 2 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/fb/25/cddis201450a.PMC3944265.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)p-AKT inhibits apoptosis via binding DRAM in HCC K Liu et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/0f/f6/cddis201451a.PMC3944266.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)UBE2N inhibition in neuroblastoma J Cheng et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/5f/19/cddis201454a.PMC3944268.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)GSK3 brepresses MYOGENIN function in ARMS MG Dionyssiou et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/94/94/cddis201458a.PMC3944270.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Metformin on esophageal carcinoma Y Feng et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/3a/92/cddis201459a.PMC3944271.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)MiRNA-210 modulates an energy metabolism shift MH e et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/2b/41/cddis201460a.PMC3944272.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Impact of HPV on anti-EGFR antibody response M Pogorzelski et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/84/8e/cddis201462a.PMC3944273.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Glucose metabolism and senescence D Gitenay et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/cc/71/cddis201463a.PMC3944274.pdf
ELISA standardcurves and values were calculated with ReaderFit (http://www.readerﬁt.com).,OADS,/arxiv_data1/oa_pdf/18/2a/cddis201467a.PMC3944275.pdf
Microarray data have been deposited in NCBI’s Gene Expression Omnibus and are accessible through GEO Series accession number GSE43112 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE43112).,OADS,/arxiv_data1/oa_pdf/18/2a/cddis201467a.PMC3944275.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Dkk-1 increases malignancy of cancer cells U Krause et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/18/2a/cddis201467a.PMC3944275.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Akt and mTOR in necroptosis Q Liu et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/ad/ff/cddis201469a.PMC3944276.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Noxa determines ABT-737 sensitivity through MCL-1 W Nakajima et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/b3/af/cddis20146a.PMC3944277.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)TGF- bupregulates Par-4 during EMT P Chaudhry et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/ef/ce/cddis20147a.PMC3944278.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)FOXC1 dysfunction contributes to earlier-onset glaucoma YA Ito et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/c2/72/cddis20148a.PMC3944279.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/DRUGSURV: drug repositioning using patient survival data I Amelio et al 5 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/11/5f/cddis20149a.PMC3944280.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/74/e5/jpts-167.PMC3944281.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/db/c9/jpts-171.PMC3944282.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/5d/6c/jpts-179.PMC3944283.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/b8/c8/jpts-183.PMC3944284.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/7d/fa/jpts-187.PMC3944285.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/84/15/jpts-191.PMC3944286.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/27/27/jpts-195.PMC3944287.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/88/28/jpts-199.PMC3944288.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/6b/d2/jpts-203.PMC3944289.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/67/6a/jpts-209.PMC3944290.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/jpts-215.PMC3944291.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/e1/bf/jpts-219.PMC3944292.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/53/07/jpts-223.PMC3944293.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/b7/06/jpts-229.PMC3944294.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/e9/da/jpts-235.PMC3944295.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c3/ad/jpts-239.PMC3944296.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ca/25/jpts-243.PMC3944297.pdf
": Effects of circuit training as alternative to usual physiotherapy after stroke: randomised controlled  trial, 2012, 344 doi: http://dx.doi.org/ 10.1136/bmj.e2672 .",Non-OADS,/arxiv_data1/oa_pdf/ca/25/jpts-243.PMC3944297.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/32/5f/jpts-247.PMC3944298.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/49/6e/jpts-251.PMC3944299.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/0c/64/jpts-255.PMC3944300.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/14/2a/jpts-259.PMC3944301.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/3e/79/jpts-263.PMC3944302.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/64/e0/jpts-269.PMC3944303.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/6a/d1/jpts-271.PMC3944304.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/2b/05/jpts-275.PMC3944305.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ec/72/jpts-281.PMC3944306.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/86/03/jpts-285.PMC3944307.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/54/0a/jpts-291.PMC3944308.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/24/73/jpts-295.PMC3944309.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/64/77/jpts-301.PMC3944310.pdf
"http://www.mhlw.go.jp/topics/kaigo/osirase/jigyo/11/index.html (Ac - cessed May 18, 2013) 2) Ministry of Health, General condition of national life base investigation  in 2010. http://www.mhlw.go.jp/toukei/saikin/hw/k-kyosa/k-kyosa10/4–3.",OADS,/arxiv_data1/oa_pdf/64/77/jpts-301.PMC3944310.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/jpts-305.PMC3944311.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/b4/0e/jpts-309.PMC3944312.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/36/e6/jpts-313.PMC3944313.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/9d/84/jpts-319.PMC3944314.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/00/c1/jpts-321.PMC3944315.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4287 | DOI: 10.1038/srep04287 6",Non-OADS,/arxiv_data1/oa_pdf/85/a4/srep04287.PMC3944317.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3b/19/srep04229.PMC3944319.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4229 | DOI: 10.1038/srep04229 6",Non-OADS,/arxiv_data1/oa_pdf/3b/19/srep04229.PMC3944319.pdf
http://www.pdf.org/ en/parkinson_statistics.,OADS,/arxiv_data1/oa_pdf/bf/df/mt2013281a.PMC3944322.pdf
FoxFeed Blog: http://www.michaeljfox.org/foundation/news-detail.php?novel-partnership-between-academia-and-industry-drives-forward-gene-therapy-approach-to-treat-parkinson.,Non-OADS,/arxiv_data1/oa_pdf/bf/df/mt2013281a.PMC3944322.pdf
http://www.ceregene.com/press_041913.asp.,Non-OADS,/arxiv_data1/oa_pdf/bf/df/mt2013281a.PMC3944322.pdf
"The Lancet,   http://dx.doi.org/10.1016/S0140-6736(13)61939-X.",Non-OADS,/arxiv_data1/oa_pdf/bf/df/mt2013281a.PMC3944322.pdf
"To view a copy of this license,  visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Molecular Therapy vol.",Non-OADS,/arxiv_data1/oa_pdf/bf/df/mt2013281a.PMC3944322.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Molecular Therapy vol.",Non-OADS,/arxiv_data1/oa_pdf/fe/50/mt2013250a.PMC3944324.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ 674 www.moleculartherapy.org vol.",Non-OADS,/arxiv_data1/oa_pdf/ee/db/mt2013284a.PMC3944330.pdf
"To view a copy of this license,  visit http://creativecommons.org/licenses/by-nc-sa/3.0/ 510 www.moleculartherapy.org vol.",Non-OADS,/arxiv_data1/oa_pdf/ce/39/mt2013239a.PMC3944333.pdf
Then the retainedreads were mapped to the chicken reference genome downloaded from Ensembl genome browser (ftp://ftp.ensembl.org/pub/release-63/fasta/gallus_gallus/dna/) using the software SOAPaligner v 2.21 (http://soap.genomics.org.cn/) 57.,OADS,/arxiv_data1/oa_pdf/3c/b9/srep04299.PMC3944351.pdf
Gene information was also obtained from the public FTP site of Ensembl (ftp://ftp.ensembl.org/pub/release-63/gtf/gallus_gallus/).,OADS,/arxiv_data1/oa_pdf/3c/b9/srep04299.PMC3944351.pdf
Repeatannotations were downloaded from the UCSC database (http://hgdownload.cse.ucsc.edu/goldenPath/rn4/bigZips/chromOut.tar.gz) and reads distribution on repetitiveelements was analyzed by the software RepeatMasker (http://www.repeatmasker.org/).,OADS,/arxiv_data1/oa_pdf/3c/b9/srep04299.PMC3944351.pdf
The CGIs were scanned by CpGPlot (https://gcg.gwdg.de/emboss/cpgplot.html) inthis study.,OADS,/arxiv_data1/oa_pdf/3c/b9/srep04299.PMC3944351.pdf
The peak detection was carried out with the software MACS V 1.4.2 (http://liulab.dfci.harvard.edu/MACS/) 58.,Non-OADS,/arxiv_data1/oa_pdf/3c/b9/srep04299.PMC3944351.pdf
"Integration of gene expression analysis .For the raw reads obtained from RNA-Seq, the sequencing adaptors, reads with unknown nucleotides larger than 5%, and lowquality bases (more than half of the bases’ qualities were less than 10) were trimmed.Then all the clean data was mapped to the chicken genome with no more than 5 bpmismatches using SOAPaligner v 2.21 (http://soap.genomics.org.cn/) 57.",OADS,/arxiv_data1/oa_pdf/3c/b9/srep04299.PMC3944351.pdf
"Additionally, genes of which expression levels changed inaccordance with DNA methylation changes were used for gene network andbiological processes enrichment analysis with Ingenuity Pathways Analysis (IPA)(Ingenuity Systems; http://www.ingenuity.com).",OADS,/arxiv_data1/oa_pdf/3c/b9/srep04299.PMC3944351.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3c/b9/srep04299.PMC3944351.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4299 | DOI: 10.1038/srep04299 9",Non-OADS,/arxiv_data1/oa_pdf/3c/b9/srep04299.PMC3944351.pdf
"Two types of specific siRNA (siRNA-1 and siRNA-2) were respec- tively designed using siRNA design software, Enhanced siDirect  (http://design.RNAi.jp/) and BLOCK-iT RNAi Designer (http://rnaidesigner.invitrogen.com/rnaiexpress/).",OADS,/arxiv_data1/oa_pdf/99/c3/jrd-59-353.PMC3944357.pdf
The standard classification of lipid  droplet distribution was performed by using the public domain ImageJ program (developed at the U.S. National Institutes of Health and available on the Internet at http://rsb.info.nih.gov/ij).,OADS,/arxiv_data1/oa_pdf/dc/93/jrd-59-405.PMC3944360.pdf
"The	primers	were	chosen	using	Primer3,	 an	online	software	package	(http://primer3.sourceforge.net/).",OADS,/arxiv_data1/oa_pdf/24/b0/jrd-59-346.PMC3944365.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/82/00/srep04290.PMC3944369.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4290 | DOI: 10.1038/srep04290 10",Non-OADS,/arxiv_data1/oa_pdf/82/00/srep04290.PMC3944369.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/40/a2/srep04295.PMC3944386.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4295 | DOI: 10.1038/srep04295 7",Non-OADS,/arxiv_data1/oa_pdf/40/a2/srep04295.PMC3944386.pdf
The scales are accessible at http://www.telecarecorp.com/page3-61/RCMAvailability .,Non-OADS,/arxiv_data1/oa_pdf/8d/49/11414_2013_Article_9348.PMC3944429.pdf
Available online http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219905/ .,Non-OADS,/arxiv_data1/oa_pdf/8d/49/11414_2013_Article_9348.PMC3944429.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License (http://creativecommons.org/licenses/   by-nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/7f/TOCMJ-8-6.PMC3944431.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Experiment al & Molecular Medicine website (http://www.nature.com/emm)VOR enhances DOX via acetylated p53 S-J Lee et al 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/d3/8f/emm2013149a.PMC3944441.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on Experiment al & Molecular Medicine website (http://www.nature.com/emm)Knockdown of 14-3-3 zenhances radiosensitivity and apoptosis in CD133þcells YK Lee et al 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/c8/d1/emm2013151a.PMC3944442.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/LR11 shedding is modulated by CD9 ST s u k a m o t o et al 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/bd/ac/emm2013161a.PMC3944444.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Recent advance in brown adipose physiology Y-H Lee et al 7 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/2f/69/emm2013163a.PMC3944445.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Heptachlor induced PD-related neurotoxicity SH o n g et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/71/d7/emm201412a.PMC3944446.pdf
Available at: http://www.who.int/immunization_monitoring/burden/pneumo_hib_estimates/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/71/53/inf-33-S140.PMC3944478.pdf
Available at: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/71/53/inf-33-S140.PMC3944478.pdf
Available at: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/71/53/inf-33-S140.PMC3944478.pdf
"‡United Nations “Composition of macro geographical (continental) regions, geographical sub-regions, and selected economic and other groupings” from http://unstats.un.org/unsd/ methods/m49/m49regin.htm.",Non-OADS,/arxiv_data1/oa_pdf/3c/b4/inf-33-S109.PMC3944481.pdf
"When information on pCV dosing schedules within national immunization programs was not reported, we obtained it through data reported by World Health Organization (http://apps.who.int/immunization_monitoring/en/globalsummary/countryprofilesel- ect.cfm) or the Vaccine Information management System (http:// www.jhsph.edu/ivac/vims).",Non-OADS,/arxiv_data1/oa_pdf/3c/b4/inf-33-S109.PMC3944481.pdf
http://www.sportsci.org/resource/stats/  effectmag.html (accessed 5 Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/ce/47/JBS-30-1077551.PMC3944542.pdf
Available at: http://www.fda.gov/ RegulatoryInformation/Guidances/ ucm129335.html 13.,Non-OADS,/arxiv_data1/oa_pdf/6e/75/JBS-30-1077547.PMC3944544.pdf
"Available at http://www.wtf.org/wtf_eng/ site/rules/competition.html, accessed on  May 30, 2012.REFERENCES  Acknowledgements This study was supported by the projects 2012-007-001 and 2013- 158-001 of the Catholic University of Valencia.",Non-OADS,/arxiv_data1/oa_pdf/ce/8d/JBS-30-1077553.PMC3944546.pdf
2005  [cited 2009 November 25];  Available from: http://www.lifesaving.org/ download/SLSAHighPerformance  TestingProtocols.pdf.,OADS,/arxiv_data1/oa_pdf/f4/57/JBS-30-1077550.PMC3944549.pdf
http://www.kukkiwon.or.kr/ eng/index.action.,Non-OADS,/arxiv_data1/oa_pdf/6a/23/JBS-30-1029822.PMC3944553.pdf
2007;S645  http://dx.doi.org/10.1016/S0021- 9290(07)70603-6.,OADS,/arxiv_data1/oa_pdf/6a/23/JBS-30-1029822.PMC3944553.pdf
"World Taekwondo Federation About WTF  – Introduction http://www.wtf.org/wtf_ eng/site/about_wtf/intro.html accessed  on February 12, 2012 15.",Non-OADS,/arxiv_data1/oa_pdf/6a/23/JBS-30-1029822.PMC3944553.pdf
Available at: http://figdocs.lx2.,Non-OADS,/arxiv_data1/oa_pdf/f1/ba/JBS-30-1029818.PMC3944558.pdf
"Retrieved June  8th, 2006, from http://coachesinfo.com/ category/gymnastics/75/.",Non-OADS,/arxiv_data1/oa_pdf/f1/ba/JBS-30-1029818.PMC3944558.pdf
"All calculations were performed  using STATISTICA data analysis software system, version 10 (StatSoft,  Inc., 2011; www.statsoft.com), except Hardy-Weinberg equilibrium,  which was tested with the programming language and environment  R (http://www.r-project.org).",OADS,/arxiv_data1/oa_pdf/e6/18/JBS-30-1029823.PMC3944561.pdf
"In the years 2004-2007 the WADA coordinated 21 projects in  the areas of genomics, transcriptomics, proteomics, metabolomics,  virology and bioinformatics [http://www.wada-ama.org/] aimed at  identifying genes and their variants that might be of potential interest  to athletes.",Non-OADS,/arxiv_data1/oa_pdf/9d/ec/JBS-30-1059606.PMC3944571.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/af/19/IJPI-4-15.PMC3944612.pdf
Available from: http://www.drugbank.ca/drugs/DB00758.,Non-OADS,/arxiv_data1/oa_pdf/a1/40/IJPI-4-19.PMC3944613.pdf
26 International Journal of Pharmaceutical Investigation | January 2014 | Vol 4 | Issue 1Rao and Lakshmi: Clopidogrel ﬂ oating tablets Available from: http://www.pharmacopeia.cn/v29240/usp29nf24s0_ c1151s56.html.,Non-OADS,/arxiv_data1/oa_pdf/a1/40/IJPI-4-19.PMC3944613.pdf
Available from: http://www.pharmacopeia.cn/v29240/usp29nf24s0_m18680.html.,Non-OADS,/arxiv_data1/oa_pdf/a1/40/IJPI-4-19.PMC3944613.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/IJPI-4-38.PMC3944616.pdf
Editor: Hassane Mchaourab./C2112014 The Authors 0006-3495/14/02/0834/9 $2.00 http://dx.doi.org/10.1016/j.bpj.2014.01.008 834 Biophysical Journal Volume 106 February 2014 834–842,Non-OADS,/arxiv_data1/oa_pdf/c4/de/main.PMC3944623.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Dopamine risk genes promote prefrontal hypoactivity A Vercammen et al 7 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –7",Non-OADS,/arxiv_data1/oa_pdf/2c/f1/tp2013125a.PMC3944629.pdf
MRI-based quanti ﬁcation of cerebral volumes was performed using Freesurfer (v.4.05) software package (http://surfer.nmr.,OADS,/arxiv_data1/oa_pdf/98/1d/tp2013126a.PMC3944630.pdf
The FreeSurfer software and its documentation can be down-loaded from http://surfer.nmr.mgh.harvard.edu.,OADS,/arxiv_data1/oa_pdf/98/1d/tp2013126a.PMC3944630.pdf
"As described in the PsychiatricGenomics Consortium guidelines regarding polygenic risk pro ﬁle analyses (http://pgc.unc.edu), all SNPs in the extended major histocompatibilitycomplex region were removed at this stage, except one representing the best hit in this region.",Non-OADS,/arxiv_data1/oa_pdf/98/1d/tp2013126a.PMC3944630.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Polygenic determinants derived from GWAS lack reproducibility S Papiol et al 4 Translational Psychiatry (2014), 1 –4 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/98/1d/tp2013126a.PMC3944630.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Epigenetic rescue of extreme anxiety via Crhr1 SV Sotnikov et al 8 Translational Psychiatry (2014), 1 –8 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/fd/89/tp2013127a.PMC3944631.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Maternal immune activation and depression D Khan et al 8 Translational Psychiatry (2014), 1 –8 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/1f/e0/tp2013132a.PMC3944633.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Correspondence 2 Translational Psychiatry (2014), 1 –2 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/97/ee/tp20141a.PMC3944634.pdf
"Statistical analysis Genetic association analyses and calculation of allelic frequencies and Hardy –Weinberg equilibrium were conducted using the online tool at the TUM Helmholtz Center (Munich, Germany; http://ihg.gsf.de/cgi-bin/hw/ hwa1.pl).",OADS,/arxiv_data1/oa_pdf/8b/1c/tp20142a.PMC3944635.pdf
All results were doubled-checked using Ken Rothman ’s Episheet spreadsheet and PLINK (for details see http://pngu.mgh.harvard.edu/~purcell/plink/; http://krothman.hostbyet2.com/episheet.xls).,OADS,/arxiv_data1/oa_pdf/8b/1c/tp20142a.PMC3944635.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)TRIP4 as a novel Alzheimer risk gene A Ruiz et al 4 Translational Psychiatry (2014), 1 –4 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/8b/1c/tp20142a.PMC3944635.pdf
Available at http://www.atsdr.cdc.gov/hac/pha/pha.asp?docid = 380&pg = 0 (accessed 2 November 2013).,OADS,/arxiv_data1/oa_pdf/a6/e2/tp20144a.PMC3944636.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Environmental toxicants and ASD DA Rossignol et al 23 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –23",Non-OADS,/arxiv_data1/oa_pdf/a6/e2/tp20144a.PMC3944636.pdf
"Microarray meta-analysis Microarray Analysis Suite 5.0 (Affymetrix, Santa Clara, CA, USA) -normalized data from the Stanley microarray collection was downloaded from fourstudies using the Array collection group from dorsolateral prefrontal cortex(DLPFC) of individuals with schizophrenia, bipolar disorder and healthycontrols (http://www.stanleygenomics.org, AltarA, Bahn, Dobrin and Kato 44 ).",OADS,/arxiv_data1/oa_pdf/3d/aa/tp20148a.PMC3944638.pdf
Pathway analysis Genes that were signi ﬁcantly changed between the high in ﬂammation/ stress in both schizophrenia as well as bipolar disorder and low inﬂammation/stress controls (false discovery rate Po0.05) were isolated and ingenuity pathway analysis (http://www.ingenuity.com) was used toidentify other genes that may be part of an extended alteredinﬂammatory –stress pathway dysregulation.,Non-OADS,/arxiv_data1/oa_pdf/3d/aa/tp20148a.PMC3944638.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Inﬂammation and stress in disorders with psychosis SG Fillman et al 10 Translational Psychiatry (2014), 1 –10 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/3d/aa/tp20148a.PMC3944638.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJune 2013 |  76  | e3921 | Page 1 of 10Video Article Retrograde Fluorescent Labeling Allows for Targeted Extracellular Single-unit Recording from Identified Neurons In vivo Ariel M. Lyons-Warren1, Tsunehiko Kohashi1,2, Steven Mennerick3, Bruce A. Carlson1 1Department of Biology, Washington University in St. Louis 2Division of Biological Science, Graduate School of Science, Nagoya University 3Department of Psychiatry, Washington University in St. Louis Correspondence to: Ariel M. Lyons-Warren at warrena@wusm.wustl.edu URL: http://www.jove.com/video/3921 DOI: doi:10.3791/3921 Keywords: Neuroscience, Issue 76, Neurobiology, Physiology, Cellular Biology, Molecular Biology, Fluorescent imaging, weakly electric fish, sensory processing, tract-tracing, electrophysiology, neuron, individual axons, labeling, injection, surgery, recording, mormyrids, animal model Date Published: 6/26/2013 Citation: Lyons-Warren, A.M., Kohashi, T., Mennerick, S., Carlson, B.A.",Non-OADS,/arxiv_data1/oa_pdf/e1/54/jove-76-3921.PMC3944651.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/3921/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/e1/54/jove-76-3921.PMC3944651.pdf
"18As expression and/or activity of PRMT and DDAH are regulated by reactivebasic research http://www.kidney-international.org &2013 International Society of Nephrology Correspondence: Yosuke Nakayama, Division of Nephrology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.",Non-OADS,/arxiv_data1/oa_pdf/01/81/ki2013398a.PMC3944656.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ 578 Kidney International (2014) 85,5 7 0 – 5 7 8basic research Y Nakayama et al.",Non-OADS,/arxiv_data1/oa_pdf/01/81/ki2013398a.PMC3944656.pdf
Data were analyzed by the R-program software (http://www.r-project.org).,OADS,/arxiv_data1/oa_pdf/43/9f/bcj201410a.PMC3944658.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Cytogenetics and survival in AML V Lazarevic et al 7 &2014 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/43/9f/bcj201410a.PMC3944658.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)CD19-targeting liposomal rapamycin for lymphoma K Ono et al 6 Blood Cancer Journal &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/8f/79/bcj20142a.PMC3944660.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Treatment of hairy cell leukemia V Maevis et al 11 &2014 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/f8/7c/bcj20143a.PMC3944661.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Letter to the Editor 4 Blood Cancer Journal &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/2e/53/bcj20145a.PMC3944663.pdf
"These were PONDR- FIT (http://www.disprot.org/pondr-ﬁt.php) 5and RONN (http:// www.app.strubi.ox.ac.uk/RONN/?p=RONN&HTTP_VARS).6As shown in Figure 1, both predictors conﬁrmed the structurally disordered C terminus of the wild-type CALR.",OADS,/arxiv_data1/oa_pdf/70/bd/bcj20147a.PMC3944664.pdf
"Calculations were performed using the Scripps Institute’s on-line Protein Calculator v.3.3 (http://www.scripps.edu/ Bcdputnam/protcalc.html) Designation Sequence pI Wild-type QDEEQRLKEEEEDKKRKEEEEAEDKEDDEDKDEDEEDEEDKEEDEEEDVPGQAKDEL 3.98a Deletions L367fs*46 QDEEQRTRRMMRTKMRMRRMRRTRRKMRRKMSPARPRTSCREACLQGWTEA 12E370fs*43 QDEEQRLKEVMRTKMRMRRMRRTRRKMRRKMSPARPRTSCREACLQGWTEA 11.76E370fs*48 QDEEQRLKEQRTRRMMRTKMRMRRMRRTRRKMRRKMSPARPRTSCREACLQGWTEA 11.96L367fs*48 QDEEQRQRTRRMMRTKMRMRRMRRTRRKMRRKMSPARPRTSCREACLQGWTEA 12.05L367fs*44 QDEERRMMRTKMRMRRMRRTRRKMRRKMSPARPRTSCREACLQGWTEA 11.95 K368fs*51 QDEEQRLRRRQRTRRMMRTKMRMRRMRRTRRKMRRKMSPARPRTSCREACLQGWTEA 12.18 L367fs*52 QDEEQRRRRRQRTRRMMRTKMRMRRMRRTRRKMRRKMSPARPRTSCREACLQGWTEA 12.21R366fs*53 QDEEQKRRRRQRTRRMMRTKMRMRRMRRTRRKMRRKMSPARPRTSCREACLQGWTEA 12.8E371fs*49 QDEEQRLKEERQRTRRMMRTKMRMRRMRRTRRKMRRKMSPARPRTSCREACLQGWTEA 11.91K368fs*43 QDEEQRLMMRTKMRMRRMRRTRRKMRRKMSPARPRTSCREACLQGWTEA 11.88E370fs*37 QDEEQRLKERMRRMRRTRRKMRRKMSPARPRTSCREACLQGWTEA 11.66D373fs*47 QDEEQRLKEEEERTRRMMRTKMRMRRMRRTRRKMRRKMSPARPRTSCREACLQGWTEA 11.63 K374fs*53 QDEEQRLKEEEEDKRRRRQRTRRMMRTKMRMRRMRRTRRKMRRKMSPARPRTSCREACLQGWTEA 11.79 E371fs*49 QDEEQRLKEERTRRMMRTKMRMRRMRRTRRKMRRKMSPARPRTSCREACLQGWTEA 11.85Mean 11.97 b,c Insertions K385fs*47 QDEEQRLKEEEEDKKRKEEEEAEDNCRRMMRTKMRMRRMRRTRRKMRRKMSPARPRTSCREACLQGWTEA 10.09K385fs*47 QDEEQRLKEEEEDKKRKEEEEAEDLCRRMMRTKMRMRRMRRTRRKMRRKMSPARPRTSCREACLQGWTEA 10.09 Mean 10.09d Complex R376fs*55 QDEEQRLKEEEEDKKLCKRRRRQRTRRMMRTKMRMRRMRRTRRKMRRKMSPARPRTSCREACLQGWTEA 11.71K385fs*47 QDEEQRLKEEEEDKKRKEEEEAEDSCRRMMRTKMRMRRMRRTRRKMRRKMSPARPRTSCREACLQGWTEA 10.09E381fs*48 QDEEQRLKEEEEDKKRKEEEDPCRRMMRTKMRMRRMRRTRRKMRRKMSPARPRTSCREACLQGWTEA 10.54Mean 10.78 aP¼0.0001 vs all mutants.bP¼0.03 vs mutants with insertions.cP¼0.01 vs mutants with complex rearrangements.dP¼0.33 vs mutants with complex rearrangements.Letter to the Editor 2 Blood Cancer Journal &2014 Macmillan Publishers Limited",OADS,/arxiv_data1/oa_pdf/70/bd/bcj20147a.PMC3944664.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Letter to the Editor 3 &2014 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/70/bd/bcj20147a.PMC3944664.pdf
"20–26Several activators of the NQO1 enzyme have been identified, of which b-lapachone (3,4-dihydro-2,2- dimethyl-2 H-naphto[1,2-b]pyran-5,6-dione; bL) is the best known.27,28bL was first isolated from the bark of the lapacho tree and reported to inhibit tumor growth.29However, recent reports indicate that the enzymatic activation of NQO1 by bLhttp://www.kidney-international.org basic research &2013 International Society of Nephrology Correspondence: Hong-Seob So, Center for Metabolic Function Regulation, Department of Microbiology, Wonkwang University School of Medicine, 344-2 Shinyong-dong, Iksan, Jeonbuk 570-749, Republic of Korea.E-mail: jeanso@wku.ac.kr 6These authors contributed equally to this work as first authors.",Non-OADS,/arxiv_data1/oa_pdf/c9/23/ki2013330a.PMC3944666.pdf
Supplementary material is linked to the online version of the paper at http://www.nature.com/ki REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c9/23/ki2013330a.PMC3944666.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ 560 Kidney International (2014) 85,5 4 7 – 5 6 0basic research G-S Oh et al.",Non-OADS,/arxiv_data1/oa_pdf/c9/23/ki2013330a.PMC3944666.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/50/bc/srep04296.PMC3944672.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4296 | DOI: 10.1038/srep04296 5",Non-OADS,/arxiv_data1/oa_pdf/50/bc/srep04296.PMC3944672.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2013 |  73  | e50180 | Page 1 of 11Video Article Biochemical and High Throughput Microscopic Assessment of Fat Mass in Caenorhabditis Elegans Elizabeth C. Pino1, Christopher M. Webster1, Christopher E. Carr2, Alexander A. Soukas1 1Center for Human Genetic Research and Department of Medicine, Massachusetts General Hospital and Harvard Medical School 2Department of Earth, Atmospheric, and Planetary Sciences, Massachusetts Institute of Technology Correspondence to: Alexander A. Soukas at asoukas@chgr.mgh.harvard.edu URL: http://www.jove.com/video/50180 DOI: doi:10.3791/50180 Keywords: Genetics, Issue 73, Biochemistry, Cellular Biology, Molecular Biology, Developmental Biology, Physiology, Anatomy, Caenorhabditis elegans , Obesity, Energy Metabolism, Lipid Metabolism, C. elegans , fluorescent lipid staining, lipids, Nile red, fat, high throughput screening, obesity, gas chromatography, mass spectrometry, GC/MS, animal model Date Published: 3/30/2013 Citation: Pino, E.C., Webster, C.M., Carr, C.E., Soukas, A.A. Biochemical and High Throughput Microscopic Assessment of Fat Mass in Caenorhabditis Elegans .",Non-OADS,/arxiv_data1/oa_pdf/9d/40/jove-73-50180.PMC3944676.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50180/ Introduction Conservation of metabolic pathways between humans and the nematode Caenorhabditis elegans  makes it a powerful model organism for the study of obesity.,Non-OADS,/arxiv_data1/oa_pdf/9d/40/jove-73-50180.PMC3944676.pdf
"Secondary structures of family S46 peptidases were predicted using Jpred37(http:// www.compbio.dundee.ac.uk/www-jpred/), while secondary structures for knownClan PA peptidases were deduced from tertiary structures deposited in the ProteinData Bank (PDB; http://www.rcsb.org/pdb/home); i.e.",OADS,/arxiv_data1/oa_pdf/dd/30/srep04292.PMC3944710.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/dd/30/srep04292.PMC3944710.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4292 | DOI: 10.1038/srep04292 10",Non-OADS,/arxiv_data1/oa_pdf/dd/30/srep04292.PMC3944710.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Wessling, M., Morcillo, L.G.",Non-OADS,/arxiv_data1/oa_pdf/c9/11/srep04294.PMC3944711.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4294 | DOI: 10.1038/srep04294 5",Non-OADS,/arxiv_data1/oa_pdf/c9/11/srep04294.PMC3944711.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/db/03/srep04286.PMC3944721.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4286 | DOI: 10.1038/srep04286 4",Non-OADS,/arxiv_data1/oa_pdf/db/03/srep04286.PMC3944721.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4291 | DOI: 10.1038/srep04291 5",Non-OADS,/arxiv_data1/oa_pdf/03/33/srep04291.PMC3944728.pdf
"The M1 and M2 paradigm of macrophage activation: time for reassessment Fernando O. Martinez 1 * and Siamon Gordon 2 * Addresses: 1 Botnar Research Center, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Windmill Road, OX3 7LD, Oxford, UK; 2 Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE, UK * Corresponding authors: Fernando O. Martinez (fernando.martinezestrada@kennedy.ox.ac.uk); Siamon Gordon (siamon.gordon@path.ox.ac.uk) F1000Prime Reports 2014, 6:13 (doi:10.12703/P6-13) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/e7/biolrep-06-13.PMC3944738.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/6/13 Abstract Macrophages are endowed with a variety of receptors for lineage-determining growth factors, T helper (Th) cell cytokines, and B cell, host, and microbial products.",Non-OADS,/arxiv_data1/oa_pdf/cc/e7/biolrep-06-13.PMC3944738.pdf
"Grouping of M1 and M2 stimuli: need for immunological contextualization The definition of M1 and M2 macrophage polarity derives from the pre-genomic era, when a few markers Page 2 of 13 (page number not for citation purposes) F1000Prime Reports 2014, 6:13 http://f1000.com/prime/reports/b/6/13",Non-OADS,/arxiv_data1/oa_pdf/cc/e7/biolrep-06-13.PMC3944738.pdf
"Page 3 of 13 (page number not for citation purposes) F1000Prime Reports 2014, 6:13 http://f1000.com/prime/reports/b/6/13",Non-OADS,/arxiv_data1/oa_pdf/cc/e7/biolrep-06-13.PMC3944738.pdf
"The GM-CSF receptor Page 4 of 13 (page number not for citation purposes) F1000Prime Reports 2014, 6:13 http://f1000.com/prime/reports/b/6/13",Non-OADS,/arxiv_data1/oa_pdf/cc/e7/biolrep-06-13.PMC3944738.pdf
"Long-term exposure drives different gene expression prog rams that interact with LPS and IFN- gpathways in a complex and non-exclusively Page 5 of 13 (page number not for citation purposes) F1000Prime Reports 2014, 6:13 http://f1000.com/prime/reports/b/6/13",Non-OADS,/arxiv_data1/oa_pdf/cc/e7/biolrep-06-13.PMC3944738.pdf
"Page 6 of 13 (page number not for citation purposes) F1000Prime Reports 2014, 6:13 http://f1000.com/prime/reports/b/6/13",Non-OADS,/arxiv_data1/oa_pdf/cc/e7/biolrep-06-13.PMC3944738.pdf
"Page 7 of 13 (page number not for citation purposes) F1000Prime Reports 2014, 6:13 http://f1000.com/prime/reports/b/6/13",Non-OADS,/arxiv_data1/oa_pdf/cc/e7/biolrep-06-13.PMC3944738.pdf
"Page 8 of 13 (page number not for citation purposes) F1000Prime Reports 2014, 6:13 http://f1000.com/prime/reports/b/6/13",Non-OADS,/arxiv_data1/oa_pdf/cc/e7/biolrep-06-13.PMC3944738.pdf
"Page 9 of 13 (page number not for citation purposes) F1000Prime Reports 2014, 6:13 http://f1000.com/prime/reports/b/6/13",Non-OADS,/arxiv_data1/oa_pdf/cc/e7/biolrep-06-13.PMC3944738.pdf
"Martinez FO, Helming L, Milde R, Varin A, Melgert BN, Draijer C, Thomas B, Fabbri M, Crawshaw A, Ho LP, Hacken NH ten, Cobos Jiménez V, Kootstra NA, Hamann J, Greaves DR, Locati M, Mantovani A, Gordon S: Genetic programs expressed in resting Page 10 of 13 (page number not for citation purposes) F1000Prime Reports 2014, 6:13 http://f1000.com/prime/reports/b/6/13",Non-OADS,/arxiv_data1/oa_pdf/cc/e7/biolrep-06-13.PMC3944738.pdf
"Mildner A, Chapnik E, Manor O, Yona S, Kim K, Aychek T, Varol D, Beck G, Itzhaki ZB, Feldmesser E, Amit I, Hornstein E, Jung S: Mononuclear phagocyte miRNome analysis identifies miR-142 Page 11 of 13 (page number not for citation purposes)F1000Prime Reports 2014, 6:13 http://f1000.com/prime/reports/b/6/13",Non-OADS,/arxiv_data1/oa_pdf/cc/e7/biolrep-06-13.PMC3944738.pdf
"Page 12 of 13 (page number not for citation purposes)F1000Prime Reports 2014, 6:13 http://f1000.com/prime/reports/b/6/13",Non-OADS,/arxiv_data1/oa_pdf/cc/e7/biolrep-06-13.PMC3944738.pdf
"Page 13 of 13 (page number not for citation purposes)F1000Prime Reports 2014, 6:13 http://f1000.com/prime/reports/b/6/13",Non-OADS,/arxiv_data1/oa_pdf/cc/e7/biolrep-06-13.PMC3944738.pdf
"Quality control in mitochondria: use it, break it, fix it, trash it Benoît Kornmann Address: Institute of Biochemistry HPM G16, Otto-Stern-Weg 3, 8093 Zürich, Switzerland Email: benoit.kornmann@bc.biol.ethz.ch F1000Prime Reports 2014, 6:15 (doi:10.12703/P6-15) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/3d/biolrep-06-15.PMC3944741.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/6/15 Abstract Repairing or disposing of a malfunctioning object is an everyday dilemma.,Non-OADS,/arxiv_data1/oa_pdf/5b/3d/biolrep-06-15.PMC3944741.pdf
"The mechanismsunderlying these various phenomena are actually verysimilar and relate to the fact that the electrochemical potential of the IMM is crucial for the translocation of Page 2 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:15 http://f1000.com/prime/reports/b/6/15",Non-OADS,/arxiv_data1/oa_pdf/5b/3d/biolrep-06-15.PMC3944741.pdf
"Page 3of6 (page number notforcitation purposes)F1000Prime Reports 2014, 6:15 http://f1000.com/prime/reports/b/6/15",Non-OADS,/arxiv_data1/oa_pdf/5b/3d/biolrep-06-15.PMC3944741.pdf
"Page 4of6 (page number notforcitation purposes) F1000Prime Reports 2014, 6:15 http://f1000.com/prime/reports/b/6/15 association study found that longevity was associated with variations in genes encoding mitochondrial proteins",Non-OADS,/arxiv_data1/oa_pdf/5b/3d/biolrep-06-15.PMC3944741.pdf
"Page 5 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:15 http://f1000.com/prime/reports/b/6/15",Non-OADS,/arxiv_data1/oa_pdf/5b/3d/biolrep-06-15.PMC3944741.pdf
"Page 6 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:15 http://f1000.com/prime/reports/b/6/15",Non-OADS,/arxiv_data1/oa_pdf/5b/3d/biolrep-06-15.PMC3944741.pdf
"The treatment of idiopathic pulmonary fibrosis Hannah V. Woodcock1,2and Toby M. Maher1-3* Addresses:1NIHR Respiratory Biomedical Research Unit, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK;2Centre for Inflammation and Tissue Repair, University College London, Rayne Institute, 5 University Road, London, WC1E 6JJ, UK;3Centre for Leucocyte Biology, Imperial College London, Sir Alexander Fleming Building, London, SW3, UK * Corresponding author: Toby M. Maher (t.maher@rbht.nhs.uk) F1000Prime Reports 2014, 6:16 (doi:10.12703/P6-16) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/89/medrep-06-16.PMC3944742.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/16 Abstract Idiopathic pulmonary fibrosis (IPF) is a progressive and invariably fatal disease with a median survival of less than three years from diagnosis.,Non-OADS,/arxiv_data1/oa_pdf/e2/89/medrep-06-16.PMC3944742.pdf
"Page 2of9 (page number notforcitation purposes)F1000Prime Reports 2014, 6:16 http://f1000.com/prime/reports/m/6/16",Non-OADS,/arxiv_data1/oa_pdf/e2/89/medrep-06-16.PMC3944742.pdf
"(Continued ) Page 3 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:16 http://f1000.com/prime/reports/m/6/16",Non-OADS,/arxiv_data1/oa_pdf/e2/89/medrep-06-16.PMC3944742.pdf
"Page 4of9 (page number notforcitation purposes)F1000Prime Reports 2014, 6:16 http://f1000.com/prime/reports/m/6/16",Non-OADS,/arxiv_data1/oa_pdf/e2/89/medrep-06-16.PMC3944742.pdf
"Page 5 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:16 http://f1000.com/prime/reports/m/6/16",Non-OADS,/arxiv_data1/oa_pdf/e2/89/medrep-06-16.PMC3944742.pdf
"Page 6 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:16 http://f1000.com/prime/reports/m/6/16",Non-OADS,/arxiv_data1/oa_pdf/e2/89/medrep-06-16.PMC3944742.pdf
"Page 7of9 (page number notforcitation purposes)F1000Prime Reports 2014, 6:16 http://f1000.com/prime/reports/m/6/16",Non-OADS,/arxiv_data1/oa_pdf/e2/89/medrep-06-16.PMC3944742.pdf
"Page 8 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:16 http://f1000.com/prime/reports/m/6/16",Non-OADS,/arxiv_data1/oa_pdf/e2/89/medrep-06-16.PMC3944742.pdf
"Page 9 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:16 http://f1000.com/prime/reports/m/6/16",Non-OADS,/arxiv_data1/oa_pdf/e2/89/medrep-06-16.PMC3944742.pdf
"Treatment of dyslipidemia Andrew Tonkin* and Allison Byrnes Address: School of Public Health and Preventive Medicine, Department of Epidemiology and Preventive Medicine, 99 Commercial Road, Melbourne, Vic 3004, Australia * Corresponding author: Andrew Tonkin (andrew.tonkin@monash.edu) F1000Prime Reports 2014, 6:17 (doi:10.12703/P6-17) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/25/medrep-06-17.PMC3944745.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/17 Abstract Atherosclerotic cardiovascular disease (including coronary heart disease, stroke and peripheral arterial disease) is the leading cause of death globally.",Non-OADS,/arxiv_data1/oa_pdf/b5/25/medrep-06-17.PMC3944745.pdf
"In addition to lowering LDL cholesterol and triglycerides by about 15% and 40%, respectively,HDL-cholesterol concentrations are increased by 20%-25% and lipoprotein(a) (Lp[a]) decreased by 25%.However, side effects, particularly flushing, have limited Page 2 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:17 http://f1000.com/prime/reports/m/6/17",Non-OADS,/arxiv_data1/oa_pdf/b5/25/medrep-06-17.PMC3944745.pdf
"This class of Page 3 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:17 http://f1000.com/prime/reports/m/6/17",Non-OADS,/arxiv_data1/oa_pdf/b5/25/medrep-06-17.PMC3944745.pdf
"In dal-OUTCOMES, dalcetrapib also Page 4 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:17 http://f1000.com/prime/reports/m/6/17",OADS,/arxiv_data1/oa_pdf/b5/25/medrep-06-17.PMC3944745.pdf
"Studies to date show Page 5 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:17 http://f1000.com/prime/reports/m/6/17",Non-OADS,/arxiv_data1/oa_pdf/b5/25/medrep-06-17.PMC3944745.pdf
"Adherence to a healthy lifestyle, extending beyond nutrition alone, has been shown to improve outcomes whether or notdrug therapies, including those targeting dyslipidemia, Page 6 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:17 http://f1000.com/prime/reports/m/6/17",Non-OADS,/arxiv_data1/oa_pdf/b5/25/medrep-06-17.PMC3944745.pdf
"Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Page 7 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:17 http://f1000.com/prime/reports/m/6/17",Non-OADS,/arxiv_data1/oa_pdf/b5/25/medrep-06-17.PMC3944745.pdf
"Safety of treatment, changes in Page 8 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:17 http://f1000.com/prime/reports/m/6/17",Non-OADS,/arxiv_data1/oa_pdf/b5/25/medrep-06-17.PMC3944745.pdf
[http://clinicaltrials.gov/show/NCT01687998].,Non-OADS,/arxiv_data1/oa_pdf/b5/25/medrep-06-17.PMC3944745.pdf
[http://www.athero.org/IASPositionPaper.asp].,Non-OADS,/arxiv_data1/oa_pdf/b5/25/medrep-06-17.PMC3944745.pdf
"Levantesi G, Marfisi R, Mozaffarian D, Franzosi MG, Maggioni A, Nicolosi GL, Schweiger C, Silletta M, Tavazzi L, Tognoni G, Page 9 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:17 http://f1000.com/prime/reports/m/6/17",Non-OADS,/arxiv_data1/oa_pdf/b5/25/medrep-06-17.PMC3944745.pdf
"Page 10 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:17 http://f1000.com/prime/reports/m/6/17",Non-OADS,/arxiv_data1/oa_pdf/b5/25/medrep-06-17.PMC3944745.pdf
"Recent advances in the medical treatment of Cushing ’s disease Maria Fleseriu Address: Northwest Pituitary Center, and Departments of Medicine and Neurological Surgery, Oregon Health & Science University, 3181 SW Sam Jackson Park Road (BTE 472), Portland, Oregon 97239, USA Email: fleseriu@ohsu.edu F1000Prime Reports 2014, 6:18 (doi:10.12703/P6-18) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/73/medrep-06-18.PMC3944746.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/18 Abstract Cushing ’s disease is a condition of hypercortisolism caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary adenoma.,Non-OADS,/arxiv_data1/oa_pdf/f8/73/medrep-06-18.PMC3944746.pdf
"Twenty patients (out of the 36 patients who Page 2 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:18 http://f1000.com/prime/reports/m/6/18",Non-OADS,/arxiv_data1/oa_pdf/f8/73/medrep-06-18.PMC3944746.pdf
"Page 3 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:18 http://f1000.com/prime/reports/m/6/18",Non-OADS,/arxiv_data1/oa_pdf/f8/73/medrep-06-18.PMC3944746.pdf
"Page 4 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:18 http://f1000.com/prime/reports/m/6/18",Non-OADS,/arxiv_data1/oa_pdf/f8/73/medrep-06-18.PMC3944746.pdf
"Recommended monitoring should include measure- ment of serum potassium, clinical assessment of adrenal Page 5 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:18 http://f1000.com/prime/reports/m/6/18",Non-OADS,/arxiv_data1/oa_pdf/f8/73/medrep-06-18.PMC3944746.pdf
"Five patients experienced ACTH Page 6 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:18 http://f1000.com/prime/reports/m/6/18",Non-OADS,/arxiv_data1/oa_pdf/f8/73/medrep-06-18.PMC3944746.pdf
"Abbreviations ACTH, adrenocorticotropic hormone; DA, dopamineagonist; EGFR, epidermal growth factor receptor; FDA, US Food and Drug Administration; HbA1c, glycated Page 7 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:18 http://f1000.com/prime/reports/m/6/18",Non-OADS,/arxiv_data1/oa_pdf/f8/73/medrep-06-18.PMC3944746.pdf
"Page 8 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:18 http://f1000.com/prime/reports/m/6/18",Non-OADS,/arxiv_data1/oa_pdf/f8/73/medrep-06-18.PMC3944746.pdf
"Page 9 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:18 http://f1000.com/prime/reports/m/6/18",Non-OADS,/arxiv_data1/oa_pdf/f8/73/medrep-06-18.PMC3944746.pdf
"Philip N. Ainslie 1 * and Patrice Brassard 2,3 Addresses: 1 Center for Heart, Lung and Vascular Health, School of Health and Exercise Sciences, University of British Columbia –Okanagan, Kelowna, British Columbia, Canada; 2 Department of Kinesiology, Faculty of Medicine, Université Laval, Québec, Canada; 3 Research Center of the Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Canada * Corresponding author: Philip N. Ainslie (philip.ainslie@ubc.ca) F1000Prime Reports 2014, 6:14 (doi:10.12703/P6-14) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/5a/biolrep-06-14.PMC3944747.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/6/14 Abstract Cerebral autoregulation refers to the mechanisms that act to keep cerebral blood flow (CBF) constant during changes in blood pressure.,Non-OADS,/arxiv_data1/oa_pdf/c9/5a/biolrep-06-14.PMC3944747.pdf
"Clearly, the mechanisms underpinning cerebral autoregu- lation are multifactorial and likely reflect many redundant Page 2 of 6 (page number not for citation purposes) F1000Prime Reports 2014, 6:14 http://f1000.com/prime/reports/b/6/14",Non-OADS,/arxiv_data1/oa_pdf/c9/5a/biolrep-06-14.PMC3944747.pdf
"This consideration is particularly important in comparing studies conducted Page 3 of 6 (page number not for citation purposes) F1000Prime Reports 2014, 6:14 http://f1000.com/prime/reports/b/6/14",Non-OADS,/arxiv_data1/oa_pdf/c9/5a/biolrep-06-14.PMC3944747.pdf
"Cassaglia PA, Griffiths RI, Walker AM: Sympathetic nerve activity in the superior cervical ganglia increases in response to Page 4 of 6 (page number not for citation purposes) F1000Prime Reports 2014, 6:14 http://f1000.com/prime/reports/b/6/14",Non-OADS,/arxiv_data1/oa_pdf/c9/5a/biolrep-06-14.PMC3944747.pdf
"Page 5 of 6 (page number not for citation purposes) F1000Prime Reports 2014, 6:14 http://f1000.com/prime/reports/b/6/14",Non-OADS,/arxiv_data1/oa_pdf/c9/5a/biolrep-06-14.PMC3944747.pdf
"Page 6 of 6 (page number not for citation purposes) F1000Prime Reports 2014, 6:14 http://f1000.com/prime/reports/b/6/14",Non-OADS,/arxiv_data1/oa_pdf/c9/5a/biolrep-06-14.PMC3944747.pdf
http://dx.doi.org/10.1007/978-3-7643-7567-6_6 .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
http://dx.doi.org/10.1074/jbc.M110.185629 .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
http://dx.doi.org/10.1128/JB.02002-12 .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
16:849 – 861. http://dx.doi.org/10.1016/j.chembiol.2009.07.006 .,OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
J. Bacteriol.184:6906 – 6917. http://dx.doi.org/10.1128/JB.184.24.6906-6917.2002 .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
http://dx.doi.org/10.1074/jbc.M800694200 .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
http://dx.doi.org/10.1002/jcp.22419 .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
http://dx.doi.org/10.1186/gb-2007-8- 5-r89 .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
http://dx.doi.org/ 10.1126/science.1106753 .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
Science 339:130. http://dx.doi.org/10.1126/science.339.6116.130 .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
Nature 432: 622– 625. http://dx.doi.org/10.1038/nature03131 .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
http://dx.doi.org/10.1371/ journal.pone.0039115 .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
http://dx.doi.org/10.1021/jm100377f .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
http://dx.doi.org/ 10.1016/j.bmcl.2009.02.034 .,OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
11:617– 625. http://dx.doi.org/ 10.1021/cc9000357 .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
http://dx.doi.org/10.1021/jm030003x .,OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
http://dx.doi.org/10.1371/journal.ppat.1002251 .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
http://dx.doi.org/10.1016/ j.resmic.2004.08.011 .,OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
http://dx.doi.org/10.1016/S1046- 5928(02)00041-4 .,OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
16:421– 429. http://dx.doi.org/10.1038/nsmb.1567 .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
http://dx.doi.org/10.1093/ nar/gki866 .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
http://dx.doi.org/10.1128/AAC.34.8.1473 .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
http://dx.doi.org/10.1074/ jbc.M300073200 .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
Chem.286:42626 – 42634. http://dx.doi.org/10.1074/jbc.M111.282046 .,OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
http://dx.doi.org/10.1074/jbc.M110.211649 .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
http://dx.doi.org/10.1111/j.1365-2958.2010.07099.x .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
12: 672– 693. http://dx.doi.org/10.2174/156802612799984535 .,Non-OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
http://dx.doi.org/10.1016/j.tim.2011.07.009 .,OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
http://dx.doi.org/10.1073/ pnas.0900589106 .Genetic Validation of NadD and NadE Drug Targets January/February 2014 Volume 5 Issue 1 e00747-13®mbio.asm.org 9,OADS,/arxiv_data1/oa_pdf/28/f4/mBio.00747-13.PMC3944813.pdf
167:603– 662. http://dx.doi.org/10.1164/rccm.167.4.603 .,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
http://dx.doi.org/10.1016/S0140-6736(10)60410-2 .,OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
194:479 – 485. http://dx.doi.org/10.1086/505877 .,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
Chest 136: 420 – 425. http://dx.doi.org/ 10.1378/chest.08-2427 .,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
http://dx.doi.org/ 10.1073/pnas.1009261108 .,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
http://dx.doi.org/10.1016/j.chom.2012.01.009 .,OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
http://www.jimmunol.org/content/174/3/1491.long .,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
http://dx.doi.org/10.1074/ jbc.M109.070201 .,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
3:60 – 68. http://dx.doi.org/10.1038/nchembio844 .,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
http://dx.doi.org/10.1111/ j.1365-2958.2010.07273.x .,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
http://dx.doi.org/10.1126/ science.1091176 .,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
http://dx.doi.org/10.1111/j.1365- 2958.2010.07276.x .,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
4:609 – 616. http://dx.doi.org/ 10.1038/nchembio.109 .,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
http://dx.doi.org/10.1128/JB.01597-06 .17.,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
http://dx.doi.org/10.1128/JB.00546-13 .,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
22:439 – 458. http://dx.doi.org/10.1146/ annurev.nutr.22.012502.114457 .,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
http://dx.doi.org/ 10.1007/s00018-004-5076-x .,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
http://dx.doi.org/10.1046/j.1365- 2958.2003.03368.x .,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
http://dx.doi.org/10.1046/ j.1365-2958.2002.03132.x .,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
http://dx.doi.org/10.1016/ j.micinf.2008.01.011 .,OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
183: 4866 – 4875. http://dx.doi.org/10.1128/ JB.183.16.4866-4875.2001 .,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
http://dx.doi.org/10.1007/s00775-009-0590-9 .,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
168: 407– 414. http://dx.doi.org/10.1016/j.micres.2013.02.007 .,OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
http://dx.doi.org/10.1111/j.1365-2958.2004.04403.x .,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
http://mic.sgmjournals .org/content/148/10/3007.long .,Non-OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
http://dx.doi.org/10.1128/JB.00166-10 .,OADS,/arxiv_data1/oa_pdf/62/e8/mBio.00876-13.PMC3944814.pdf
Segmentation and 3D visu- alization were performed with Amira ( http://amira.zib.de ).,OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1128/JVI.01370-13 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1042/ BC20040058 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1111/ cmi.12029 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1074/ jbc.M201107200 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1099/0022-1317-45-1-161 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
78:8732– 8745. http://dx.doi.org/10.1128/ JVI.78.16.8732-8745.2004 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/ 10.1073/pnas.0605835103 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/ 10.1016/0022-2836(68)90223-4 .,OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/ 10.1016/0042-6822(92)90478-8 .,OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1016/ 0042-6822(65)90199-6 .,OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1016/0042-6822(74)90465-6 .,OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
Virology 68: 455– 466. http://dx.doi.org/10.1016/0042-6822(75)90286-X .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1016/ 0042-6822(62)90125-3 .,OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
Virology 73: 442– 453. http://dx.doi.org/10.1016/0042-6822(76)90405-0 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1128/JVI.75.3.1459- 1475.2001 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
76:8285– 8297. http://dx.doi.org/10.1128/JVI.76.16.8285- 8297.2002 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1128/ JVI.77.10.5948-5963.2003 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1128/JVI.78.4.1882-1892.2004 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1073/ pnas.50.2.268 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
285:41604 – 41613. http://dx.doi.org/10.1074/ jbc.M110.176255 .Reovirus Inclusions Contain Cell Membranes January/February 2014 Volume 5 Issue 1 e00931-13®mbio.asm.org 9,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1016/j.tcb.2010.04.001 .,OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1006/viro.2000.0652 .,OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1016/0042-6822(69)90362-6 .,OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
Release of bluetongue virus-like particles from insect cells is mediated by BTV nonstructural protein NS3/NS3A.Virology 193:592– 603. http://dx.doi.org/10.1006/viro.1993.1167 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1111/ j.1462-5822.2008.01184.x .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
76: 4483– 4496. http://dx.doi.org/10.1128/JVI.76.9.4483-4496.2002 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1016/j.virol.2010.06.043 .,OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1371/ journal.pone.0047947 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/ 10.1128/JVI.06997-11 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
75: 4029 – 4039. http://dx.doi.org/10.1128/JVI.75.9.4029-4039.2001 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1128/mBio.00049-13 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1128/JVI.80.8.3935-3946.2006 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
81:4892– 4894. http://dx.doi.org/ 10.1128/JVI.02698-06 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1128/ JVI.76.4.1839-1855.2002 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
9:875– 890. http://dx.doi.org/10.1111/ j.1462-5822.2006.00837.x .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1371/journal.pone.0065526 .,Non-OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
218: 52– 61. http://dx.doi.org/10.1111/j.1365- 2818.2005.01466.x .Fernández de Castro et al.,OADS,/arxiv_data1/oa_pdf/93/b3/mBio.00931-13.PMC3944815.pdf
http://dx.doi.org/10.1038/nature05762 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/10.1126/science.1211057 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/ 10.1126/science.1210718 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/ 10.1126/science.1190333 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
10: 811– 813. http://dx.doi.org/10.1038/nm1077 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/10.1056/NEJMoa003364 .,OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
Thorax 61:611– 615. http://dx.doi.org/10.1136/thx.2005.048397 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm5838a4.htm .,OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/ 10.1128/CMR.00058-05 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/10.1093/cid/ciq022 .,OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/10.1086/656333 .Mina et al.,OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
Pediatrics 122: 805– 811. http://dx.doi.org/10.1542/ peds.2008-1336 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
121: 616 – 621. http://dx.doi.org/10.1016/S0194-5998(99)70068-9 .,OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/10.1172/JCI35412 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/10.4049/ jimmunol.1002194 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/10.1038/nm1765 .,OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/10.1038/nri2629 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/10.1016/ j.immuni.2010.10.002 .,OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/10.1016/ S0042-6822(02)00035-1 .,OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/ 10.1111/j.1750-2659.2008.00056.x .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/10.1093/infdis/jit317 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/10.1016/j.vaccine.2008.12.023 .,OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
Laryngoscope 110:651– 654. http://dx.doi.org/ 10.1097/00005537-200004000-00021 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
84: 4105– 4108. http://dx.doi.org/10.1128/JVI.02621-09 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/ 10.1016/j.vaccine.2011.07.093 .,OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
85:76 – 85. http://dx.doi.org/10.1128/JVI.01564-10 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
71:4289 – 4296. http://dx.doi.org/10.1128/ IAI.71.8.4289-4296.2003 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/10.1002/jmv.1045 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
81:645– 652. http://dx.doi.org/ 10.1128/IAI.01278-12 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
81:625– 628. http://dx.doi.org/10.1128/IAI.01460-12 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/10.1056/NEJMoa035060 .,OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/10.1001/jama.2012.194139 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/10.1086/341462 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/10.3201/ eid1802.110714 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/10.1096/fj.09-146779 .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
356:685– 696. http://dx.doi.org/ 10.1056/NEJMoa065368 .,OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/10.1016/S0140-6736(04)16357-5 .53.FDA.,OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://www.fda.gov/ohrms/dockets/ac/07 /brieﬁng/2007-4292B1-02.pdf .,Non-OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
http://dx.doi.org/10.1016/j.vaccine.2013.01.055 .Mina et al.,OADS,/arxiv_data1/oa_pdf/62/b9/mBio.01040-13.PMC3944816.pdf
"1), ﬁrst observed with Buraidah_1_2013, has now ex-panded to include a virus from Ta’if, two viruses from KhamisMushait in the southern province of Asir, and the UAE_DubaiFIG 1 Bayesian-inferred phylogeny of the 32 new MERS-CoV sequences combined with the 33 previously available genomes (EMC/2012 [JX869059], Jordan_N3 [KC776174], Munich_AbuDhabi_2013 [KF192507], England-Qatar_2012 [KC667074], Al-Hasa_1_2013 [KF186567], Al-Hasa_2_2013 [KF186566], Al-Hasa_3_2013 [KF186565], Al-Hasa_4_2013 [KF186564, plus all previously published MERS-CoV sequences 17], England2-HPA [http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/MERSCoV/respPartialgeneticsequenceofnovelcoronavirus/], France_UAE_2013 [KF 745068], Qatar_3_2013 [KF961221], and Qatar_4_2013 [KF961222]).",Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
"TABLE 1 Summary of all MERS-CoV genomic sequences used in this study GenomeSample collection dateGenome fractiona GenBank accession number or source Jordan_N3_2012 15 April 2012 1 KC776174 Bisha_1_2012 19 June 2012 1 KF600620England-Qatar_2012 19 September 2012 1 KC667074Riyadh_1_2012 23 October 2012 1 KF600612Riyadh_2_2012 30 October 2012 1 KF600652Riyadh_3_2013 5 February 2013 1 KF600613England2-HPA_2013 10 February 2013 1 http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/MERSCoV /respPartialgeneticsequenceofnovelcoronavirus/ Riyadh_4_2013 1 March 2013 1 KJ156952 Munich_AbuDhabi_2013 22 March 2013 1 KF192507Al_Hasa_2_2013 21 April 2013 1 KF186566Al_Hasa_3_2013 22 Apr 2013 1 KF186565Al-Hasa_24_2013 1 May 2013 0.41 KJ156867, KJ156919, KJ156875, KJ156885, KJ156870, KJ156892, KJ156902 Al_Hasa_4_2013 1 May 2013 1 KF186564Al-Hasa_7_2013 1 May 2013 0.93 KF600623, KF600655Al-Hasa_8_2013 1 May 2013 0.74 KF600618, KF600626, KF600635, KF600638Al-Hasa_9_2013 1 May 2013 0.46 KF600622, KF600639, KF600648, KF600649, KF600654Al-Hasa_25_2013 2 May 2013 1 KJ156866Al-Hasa_10_2013 2 May 2013 0.32 KF600614, KF600624, KF600629, KF600636, KF600641, KF600642, KF600646, KF600653 Al-Hasa_11_2013 3 May 2013 0.9 KF600629, KF600636, KF600646Al-Hasa_12_2013 7 May 2013 1 KF600627Al-Hasa_13_2013 7 May 2013 0.37 KF600616, KF600637, KF600640, KF600650, KF600656France_UAE_2013 7 May 2013 0.99 KF745068Al-Hasa_14_2013 8 May 2013 0.75 KF600615, KF600643Al_Hasa_1_2013 9 May 2013 1 KF186567Al-Hasa_22_2013 9 May 2013 0.47 KF600617, KF600619, KF600621, KF600625, KF600631, KF600633Al-Hasa_15_2013 11 May 2013 1 KF600645Al-Hasa_16_2013 12 May 2013 1 KF600644Al-Hasa_23_2013 13 May 2013 0.76 KJ156860, KJ156894, KJ156929, KJ156923, KJ156862Buraidah_1_2013 13 May 2013 1 KF600630Al-Hasa_17_2013 15 May 2013 1 KF600647Al-Hasa_19_2013 23 May 2013 1 KF600632Al-Hasa_18_2013 23 May 2013 1 KF600651Al-Hasa_21_2013 30 May 2013 1 KF600634Hafr-Al-Batin_1_2013 4 June 2013 1 KF600628Taif_1_2013 12 June 2013 1 KJ156949Wadi-Ad-Dawasir_1_2013 12 June 2013 1 KJ156881Taif_2_2013 12 June 2013 0.94 KJ156896, KJ156876Taif_3_2013 13 Jun 2013 0.62 KJ156938, KJ156897, KJ156922, KJ156868, KJ156921, KJ156915, KJ156906 Taif_4_2013 13 June 2013 0.27 KJ156886, KJ156871Al-Hasa_26_2013 18 June 2013 0.99 KJ156882, KJ156941, KJ156872Al-Hasa_27_2013 19 June 2013 0.94 KJ156943, KJ156939Al-Hasa_28_2013 22 June 2013 0.71 KJ156887, KJ156940, KJ156889, KJ156893, KJ156884, KJ156930, KJ156928, KJ156909 Riyadh_5_2013 2 July 2013 1 KJ156944Riyadh_6_2013 2 July 2013 0.73 KJ156879, KJ156947, KJ156890, KJ156908, KJ156927Asir_1_2013 2 July 2013 0.44 KJ156948, KJ156925, KJ156903, KJ156883Riyadh_7_2013 15 July 2013 0.97 KJ156937, KJ156905Riyadh_9_2013 17 July 2013 1 KJ156869Riyadh_8_2013 17 July 2013 0.99 KJ156880, KJ156942Hafr-Al-Batin_2_2013 5 August 2013 1 KJ156910Riyadh_10_2013 5 August 2013 0.95 KJ156891, KJ156936, KJ156907Asir_2_2013 5 August 2013 0.65 KJ156863, KJ156899, KJ156912, KJ156900, KJ156898, KJ156945, KJ156932 Riyadh_11_2013 6 August 2013 0.94 KJ156946, KJ156911Riyadh_12_2013 8 August 2013 0.95 KJ156926, KJ156901Riyadh_13_2013 13 August 2013 0.97 KJ156888, KJ156873Riyadh_14_2013 15 August 2013 1 KJ156934Riyadh_15_2013 19 August 2013 0.49 KJ156914, KJ156877, KJ156878, KJ156859, KJ156933, KJ156953Hafr-Al-Batin_5_2013 25 August 2013 0.63 KJ156951, KJ156924, KJ156954, KJ156913 (Continued on following page)Cotten et al.",Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1056/ NEJMoa1211721 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1128/mBio.00473-12 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1056/ NEJMoa1303729 .,OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://www.who.int/csr/don/2014_01_27mers/en/index.html .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1126/ science.1087139 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
Dis.13:859 – 866. http://dx.doi.org/10.1016/S1473-3099(13)70164-6 .,OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.3201/eid1911.131172 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1016/S1473- 3099(13)70690-X .,OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
Lancet 382: 694 – 699. http://dx.doi.org/10.1016/S0140- 6736(13)61492-0 .,OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1016/S1473-3099(13)70304-9 .,OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1093/infdis/jit589 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
J. Med.369:407– 416. http://dx.doi.org/10.1056/NEJMoa1306742 .,OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/ 10.3201/eid1905.130057 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1016/S0140- 6736(1013)61887-61885 .,OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1093/ molbev/msn090 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/ 10.1016/S0140-6736(13)60982-4 .,OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1128/ JVI.02433-13 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1038/nature12328 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1128/JVI.01674- 07.,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/ 10.1038/sj.emboj.7600640 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1128/JVI.02041-07 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1128/JVI.01394-09 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
83:6689 – 6705. http://dx.doi.org/10.1128/ JVI.02220-08 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://www.promedmail.org/direct.php?id /H110052051424 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
368: 20120205. http://dx.doi.org/10.1098/ rstb.2012.0205 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
19:455– 477. http://dx.doi.org/10.1089/ cmb.2012.0021 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1093/molbev/msr121 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1093/ bioinformatics/17.8.754 .Cotten et al.,OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1093/molbev/mss075 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1371/currents.RRN1031 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1093/molbev/mss084 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
Bioinformatics 21:676 – 679. http://dx.doi.org/10.1093/ bioinformatics/bti079 .,OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1371/ journal.pgen.1002764 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
77:8801– 8811. http://dx.doi.org/10.1128/JVI.77.16.8801-8811.2003 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
http://dx.doi.org/10.1371/ journal.pone.0049566 .,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
"http://dx.doi.org/10.1038/ cr.2013.92 .Spread, Circulation, and Evolution of MERS-CoV January/February 2014 Volume 5 Issue 1 e01062-13®mbio.asm.org 11",OADS,/arxiv_data1/oa_pdf/c8/02/mBio.01062-13.PMC3944817.pdf
Probabilities were recalculated using the “negenes”R-package ( http://www.biostat.wisc.edu/~kbroman/software/ ) from cur- rent data available from the Tuberculosis Animal Research and GeneEvaluation Taskforce (TARGET) ( http://webhost.nts.jhu.edu/target/ ).,OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
48: 77– 84. http://dx.doi.org/10.1046/j.1365-2958.2003.03425.x .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
102:8327– 8332. http://dx.doi.org/10.1073/ pnas.0503272102 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1086/592447 .,OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1086/517526 .,OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1086/589515 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1086/652497 .,OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
6:422. http://dx.doi.org/ 10.1038/msb.2010.68 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
1:26.http://dx.doi.org/ 10.1186/1752-0509-1-26 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
"3:88. http://dx.doi.org/10.1038/ msb4100129 .16.Raman K, Chandra N. 2008.",Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
BMC Microbiol.8:234. http://dx.doi.org/10.1186/1471-2180-8-234 .,OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/ 10.1101/gr.077693.108 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
4:95. http://dx.doi.org/10.1186/1752-0509-4-95 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1016/j.ajhg.2008.02.013 .,OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1371/ journal.pcbi.1000641 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1101/gr.3610305 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1186/1471-2105-8-S10-S6 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/ 10.1371/journal.pcbi.1000054 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
69:6660 – 6667. http://dx.doi.org/10.1158/0008- 5472.CAN-09-1133 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
BMC Bioinformatics 11:213. http://dx.doi.org/10.1186/ 1471-2105-11-213 .,OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1093/ nar/gkn760 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1371/journal.ppat.1002251 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1371/journal.pone.0075913 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1371/journal.ppat.1002946 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
Dis.198:877– 885. http://dx.doi.org/10.1086/591098 .,OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
101: 4602– 4607. http://dx.doi.org/10.1073/ pnas.0306023101 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
182:4889 – 4898. http://dx.doi.org/ 10.1128/JB.182.17.4889-4898.2000 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1046/j.1365-2958.2002.02779.x .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1086/605700 .,OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1039/b616817p .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1046/j.1365-2958.1999.01593.x .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
Nature 402:79 – 83. http://dx.doi.org/10.1038/47042 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1086/380413 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/ 10.1128/JB.185.10.2999-3008.2003 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1099/mic.0.26278-0 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1128/ IAI.73.6.3492-3501.2005 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1371/journal.pgen.1000767 .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
9:6665– 6677. http://dx.doi.org/10.1021/pr100808n .,Non-OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1016/ j.tube.2010.09.008 .,OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1016/j.tube.2010.03.010 .,OADS,/arxiv_data1/oa_pdf/93/30/mBio.01066-13.PMC3944818.pdf
http://dx.doi.org/10.1007/BF01311063 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1016/ j.virusres.2011.09.017 .,OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1006/ viro.1996.0305 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1038/ nrmicro3066 .,OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.2217/fvl.11.138 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1159/000149714 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1099/vir.0.042218-0 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
84:4832– 4839. http://dx.doi.org/10.1128/JVI.02405-09 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1128/ JVI.00576-10 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1073/ pnas.0406743102 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1128/JVI.02397-07 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1128/JVI.01013-09 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1128/ JVI.00508-06 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1128/JVI.00290-08 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
85:4752– 4760. http://dx.doi.org/10.1128/ JVI.01945-10 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
2012:524024. http://dx.doi.org/10.1155/2012/ 524024 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1128/JVI.02402-06 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1074/ jbc.R700002200 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/ 10.1016/j.celrep.2013.01.033 .,OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
Immunol.4:491– 496. http://dx.doi.org/10.1038/ni921 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
6:644 – 658. http://dx.doi.org/10.1038/nri1900 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
Oncogene 30:631– 641. http://dx.doi.org/10.1038/onc.2010.493 .,OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1016/j.sbi.2007.12.002 .,OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1128/JVI.02647-13 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1128/JVI.05356-11 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1006/viro.2001.1133 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1006/viro.1997.8976 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/ 10.1016/j.virol.2004.05.018 .,OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
18:6694 – 6704. http://dx.doi.org/10.1093/emboj/ 18.23.6694 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1128/JVI.06223-11 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
81:4991– 4999. http://dx.doi.org/10.1128/ JVI.01933-06 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1126/science.1237568 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1111/ j.1749-6632.2009.05049.x .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1016/j.virol.2010.02.018 .,OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1128/JVI.00986-08 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
76:33– 45. http://dx.doi.org/ 10.1128/MMBR.05012-11 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1074/jbc.M111.267567 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
21:421– 429. http://dx.doi.org/10.1016/j.tim.2013.06.006 .,OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1371/ journal.pone.0053717 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1038/43206 .,Non-OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/10.1128/JVI.01658-10 .Cimica et al.,OADS,/arxiv_data1/oa_pdf/bc/f4/mBio.01088-13.PMC3944819.pdf
http://dx.doi.org/ 10.1146/annurev-cellbio-101011-155745 .,OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/ 10.1111/j.1600-065X.2012.01167.x .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
27: 487– 495. http://dx.doi.org/10.1016/j.pt.2011.08.001 .,OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/ 10.1073/pnas.94.25.13955 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1084/jem.185.7.1261 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1385/IR: 27:2-3:521 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1126/science.3128869 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1016/j.immuni.2008.05.019 .,OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1084/jem.20050054 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/ 10.1146/annurev.immunol.021908.132715 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1038/gene.2010.31 .,OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/ 10.1128/IAI.00898-10 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1128/ mBio.00255-13 .Gorfu et al.,OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.4049/ jimmunol.1000012 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
Cell Host Microbe 8:471– 483. http://dx.doi.org/10.1016/j.chom.2010.11.007 .,OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1084/jem.20100717 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
BMCGenomics 14:188. http://dx.doi.org/10.1186/1471-2164-14-188 .,OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1038/nature10558 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
13:397– 411. http://dx.doi.org/10.1038/ nri3452 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
68:6932– 6938. http://dx.doi.org/10.1128/IAI.68.12.6932-6938.2000 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1038/378088a0 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1073/ pnas.96.5.2256 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
Nature 386:619 – 623. http://dx.doi.org/10.1038/386619a0 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1126/ science.275.5297.206 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.4049/jimmunol.1202121 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
"14:414 – 421. http://dx.doi.org/10.1016/ j.mib.2011.07.002 .37.Hunn JP, Feng CG, Sher A, Howard JC.",OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
7:837– 848. http://dx.doi.org/ 10.1111/j.1462-5822.2005.00517.x .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/ 10.1073/pnas.0506643103 .,OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1038/ni.1960 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1189/jlb.1011527 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1016/ j.micinf.2010.03.004 .,OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1016/ j.ijpara.2010.10.001 .,OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1084/jem.20101660 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1371/ journal.ppat.1003320 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1016/j.ijpara.2007.05.010 .,OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1371/journal.ppat.1002638 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/ 10.1371/journal.ppat.1000906 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1111/j.1600-0854.2004.00244.x .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
712:49 – 61. http://dx.doi.org/10.1007/978-1-4419- 8414-2_4 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1074/jbc.M112.443697 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
91:69 – 81. http://dx.doi.org/10.1016/ j.actatropica.2003.11.016 .,OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1111/j.1600- 0854.2007.00589.x .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1038/nature10394 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
Nature 477: 596 – 600. http://dx.doi.org/10.1038/ nature10510 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1016/j.immuni.2006.02.004 .,OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.4049/ jimmunol.1201065 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1016/j.immuni.2012.08.027 .,OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1038/nature04515 .,Non-OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1128/IAI.73.2.695-702.2005 .,OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
Cell Host Microbe 9:472– 483. http://dx.doi.org/ 10.1016/j.chom.2011.04.015 .,OADS,/arxiv_data1/oa_pdf/ad/af/mBio.01117-13.PMC3944820.pdf
http://dx.doi.org/10.1371/journal.pone.0033229 .,Non-OADS,/arxiv_data1/oa_pdf/2f/fa/main.PMC3944822.pdf
"Keywords The Gambia, immunization, socio-demographic, determinants, childThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/9d/czt004.PMC3944881.pdf
"Table 4 Unadjusted and adjusted analysis of association between vaccination coverage and predictor variables Variable Category Unadjusted OR Adjusted OR ( n¼6350) OR CI P-value OR CI P-value Full immunization Area Rural (ref) 1.00 1.00 Urban 0.72 0.65–0.79 <0.001 0.73 0.64–0.84 <0.001a Peri-urban 0.72 0.62–0.83 <0.001 0.72 0.61–0.85 <0.001a Sex Male (ref) 1.00 Female 1.03 0.94–1.13 0.57 – – – Ethnic group Mandinka(ref) 1.00 1.00 Fula 1.14 1.00–1.29 0.046 1.15 1.00–1.32 0.060Wolof 1.16 1.04–1.29 0.008 1.14 1.01–1.28 0.032 a Other 0.90 0.70–1.16 0.418 1.10 0.82–1.46 0.537 WealthbQuintile 1: lowest (ref) 1.00 1.00 Quintile 2 0.79 0.68–0.92 0.003 0.82 0.70–0.95 0.010a Quintile 3 0.89 0.76–1.05 0.164 0.97 0.82–1.14 0.705Quintile 4 0.81 0.69–0.94 0.007 0.92 0.78–1.09 0.330 Quintile 5 0.70 0.59–0.83 <0.001 0.89 0.72–1.09 0.251 Mothers age (years) – 1.00 0.99–1.01 0.272 – – – BCG Area Rural (ref) 1.00 1.00 Urban 0.79 0.68–0.91 0.001 0.54 0.44–0.66 <0.001 a Peri-urban 0.88 0.72–1.09 0.255 0.69 0.54–0.88 0.003a Sex Male (ref) 1.00 Female 1.03 0.90–1.18 0.659 – – – Ethnic group Mandinka (ref) 1.00 1.00 Fula 1.36 1.13–1.63 0.001 1.50 1.21–1.86 <0.001a Wolof 1.42 1.22–1.65 <0.001 1.52 1.28–1.81 <0.001a Other 1.05 0.74–1.48 0.790 1.21 0.80–1.82 0.364 (continued)Table 3 Percentage of children who received vaccination by area of residence for each vaccine and national estimate comparators Vaccine All areas (n¼7363)Rural (n¼3989)Urban (n¼2472)Peri-urban (n¼902)WHO 2009aMICS3% bFHDSS 2008c (n¼662) % coverage95% CI % coverage95% CI % coverage95% CI % coverage95% CI BCG 86 (86–87) 88 (86–88) 85 (83–86) 86 (84–88) 94 98.7 94 DTP3 (at least three doses) 79 (78–80) 82 (80–83) 76 (74–77) 79 (77–82) 98 86.8 67 Polio (at least three doses) 88 (87–89) 89 (88–90) 86 (84–87) 89 (87–91) 97 87.6 81 Measles 73 (72–74) 75 (73–76) 70 (68–71) 72 (69–75) 96 92.4 67 Yellow fever 72 (71–73) 74 (73–75) 69 (67–71) 72 (69–75) 96 83.5 67 Full immunizationd52 (51–53) 56 (54–57) 47 (45–49) 47 (44–51) – 55.3 48 Vitamin A (at least one dose) 43 (41–44) 39 (37–40) 47 (45–49) 47 (43–50) – – 68 Hepatitis B (at least one dose) 92 (92–93) 92 (91–93) 93 (92–94) 92 (90–94) – – 95 Hepatitis B (three doses) 69 (68–70) 70 (69–72) 68 (66–69) 68 (65–71) 98 – 51 aData source: WHO Gambia Immunization profile: http://apps.who.int/immunization_monitoring/en/globalsummary/countryprofileresult.cfm?C ¼gmb, accessed 12 November 2012. bMICS 3 measures percentage of children aged 12–23 months having received specified vaccine at the time of the survey.",Non-OADS,/arxiv_data1/oa_pdf/87/9d/czt004.PMC3944881.pdf
"http://www.who.int/gho/countries/gmb.pdf, accessed 8 November 2011.WHO.",Non-OADS,/arxiv_data1/oa_pdf/87/9d/czt004.PMC3944881.pdf
"http://apps.who.int/immunization_monitoring/en/globalsummary/timeseries/ TSWUcoverageByCountry.cfm?country ¼GMB, accessed 22 August 2011. WHO, UNICEF.",Non-OADS,/arxiv_data1/oa_pdf/87/9d/czt004.PMC3944881.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/36/8e/ndt-10-427.PMC3944998.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 427–432Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  427OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5801 9comparison of predictive equations   for resting energy expenditure among   patients with schizophrenia in Japan Norio sugawara1 Norio Yasui-Furukori1 T etsu T omita1,2 hanako Furukori3 Kazutoshi Kubo1,4 Taku Nakagami1,4 sunao Kaneko1 1Department of Neuropsychiatry,   hirosaki University school of  Medicine, hirosaki, 2Department of  Psychiatry, hirosaki-aiseikai hospital,   hirosaki, 3Department of Psychiatry,   Kuroishi-akebono hospital, Kuroishi,   4Department of Psychiatry, Odate  Municipal general hospital, Odate,   Japan correspondence: Norio sugawara   Department of Neuropsychiatry,   hirosaki University school of Medicine,   5 Zaifucho, hirosaki city, aomori,   036-8562, Japan   Tel +81 172 39 5066   Fax +81 172 39 5067   email nsuga3@yahoo.co.j pBackground:  Recently, a relationship between obesity and schizophrenia has been reported.",Non-OADS,/arxiv_data1/oa_pdf/36/8e/ndt-10-427.PMC3944998.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/36/8e/ndt-10-427.PMC3944998.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/36/8e/ndt-10-427.PMC3944998.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/15/ba/dmso-7-073.PMC3944999.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 73–84Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  73Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S5692 4inhibition of the methionine aminopeptidase 2  enzyme for the treatment of obesity Amit A Joharapurkar Nirav A Dhanesha Mukul R Jain Department of Pharmacology  and Toxicology, Zydus Research  Centre, Cadila Healthcare Limited,   Ahmedabad, india Correspondence: Amit A Joharapurkar   Department of Pharmacology   and T oxicology, Zydus Research   Centre, Cadila Healthcare Limited,   Sarkhej Bavla NH 8A, Moraiya,   Ahmedabad 382210, india   Tel + 91 271 766 5555   Fax + 91 271 766 5155   email amitjoharapurkar@zyduscadila.co mAbstract:  Worldwide prevalence of obesity has nearly doubled since 1980.",Non-OADS,/arxiv_data1/oa_pdf/15/ba/dmso-7-073.PMC3944999.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs311/ en/index.html .,Non-OADS,/arxiv_data1/oa_pdf/15/ba/dmso-7-073.PMC3944999.pdf
Available  from: http://zafgen.com/zafgen/our-approach/the-science .,Non-OADS,/arxiv_data1/oa_pdf/15/ba/dmso-7-073.PMC3944999.pdf
Available from: http://zafgen.com/zafgen/newsroom/press- releases .,Non-OADS,/arxiv_data1/oa_pdf/15/ba/dmso-7-073.PMC3944999.pdf
Available from: http://www.fda.gov/downloads/drugs/developme nt  approvalprocess/developmentresources/ucm163348.pdf .,Non-OADS,/arxiv_data1/oa_pdf/15/ba/dmso-7-073.PMC3944999.pdf
Available from: http://www.drugs.com/monograph/ phentermine .html.,Non-OADS,/arxiv_data1/oa_pdf/15/ba/dmso-7-073.PMC3944999.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/15/ba/dmso-7-073.PMC3944999.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/15/ba/dmso-7-073.PMC3944999.pdf
Available from: http://www.drugs.,Non-OADS,/arxiv_data1/oa_pdf/15/ba/dmso-7-073.PMC3944999.pdf
Available from: http://www.zealandpharma.com/product- pipeline/cardio-metabolic-diseases/drug-candidates-for-diabetes-and- metabolic-diseases/zp2929 .,Non-OADS,/arxiv_data1/oa_pdf/15/ba/dmso-7-073.PMC3944999.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2f/19/opth-8-477.PMC3945045.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 477–481Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  477Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S5970 0intraoperative endoscopic observation   of sclerotomy site after cannula removal   for 23-gauge vitrectomy Taiichi Hikichi Hirokuni Kitamei shoko Kosaka shoko shioya Kimitaka Takami Ohtsuka eye Hospital, sapporo, Japan Correspondence: Taiichi Hikichi   Ohtsuka eye Hospital, Kita-16 Nishi-4,  Kita-ku, sapporo 001-0016, Japan   Tel +811 1747 5211   Fax +811 1757 5223   email taiichi-hikichi@hokkaido.med.or.j pBackground:  The purpose of this study was to determine the incidence of vitreous incarceration  in sclerotomy after cannula removal during 23-gauge vitrectomy.",Non-OADS,/arxiv_data1/oa_pdf/2f/19/opth-8-477.PMC3945045.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/2f/19/opth-8-477.PMC3945045.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/19/opth-8-477.PMC3945045.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/74/45/oajsm-5-013.PMC3945046.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOpen Access Journal of Sports Medicine 2014:5 13–24Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  13Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/OAJSM.S3664 6Optimal management of shoulder   impingement syndrome Rafael F escamilla1,2 T odd R Hooks3 Kevin e wilk4 1Department of Physical Therapy,   California State University,   Sacramento, CA, USA; 2Andrews  Research and education institute,   Gulf Breeze, FL, USA; 3Drayer Physical  Therapy institute, Columbus, MS,   USA; 4Champion Sports Medicine,   Birmingham, AL, USA Correspondence: Rafael F escamilla   Department of Physical Therapy,   California State University, 6000 J St,   Sacramento, CA 95819-6096, USA   Tel +1 916 278 6930   email rescamil@csus.ed uAbstract:  Shoulder impingement is a progressive orthopedic condition that occurs as a result  of altered biomechanics and/or structural abnormalities.",Non-OADS,/arxiv_data1/oa_pdf/74/45/oajsm-5-013.PMC3945046.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/74/45/oajsm-5-013.PMC3945046.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/74/45/oajsm-5-013.PMC3945046.pdf
Available from:  http://www.ncbi.nlm.nih.gov/pubmed/2229377 2” \o “The Physician  and sportsmedicine.” Phys Sportsmed.,Non-OADS,/arxiv_data1/oa_pdf/74/45/oajsm-5-013.PMC3945046.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/73/c3/sccaa-7-045.PMC3945047.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpStem Cells and Cloning: Advances and Applications 2014:7 45–52Stem Cells and Cloning: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  45Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/SCCAA.S3750 6Adult human mesenchymal stromal cells and   the treatment of graft versus host disease Richard P Herrmann Marian J Sturm Cell and Tissue Therapies, western  Australia, Royal Perth Hospital,   wellington Street, Perth, wA,   Australia Correspondence: Marian Sturm   CTTwA, Level 2, North Block, Royal  Perth Hospital, wellington Street,   Perth, wA, 6000, Australia   email marian.sturm@health.wa.gov.a uAbstract:  Graft versus host disease is a difficult and potentially lethal complication of  hematopoietic stem cell transplantation.",Non-OADS,/arxiv_data1/oa_pdf/73/c3/sccaa-7-045.PMC3945047.pdf
"Stem Cells and Cloning: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/stem-cells-and-cloning-advances-and-applications-journa lStem Cells and Cloning: Advances and Applications is an international,  peer-reviewed, open access journal.",Non-OADS,/arxiv_data1/oa_pdf/73/c3/sccaa-7-045.PMC3945047.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/73/c3/sccaa-7-045.PMC3945047.pdf
Available from: http://www.clinicaltrials.gov/ct2/ show/NCT00366145?term =mesenchymal +stem+cells+AND+bone+m arrow+transplantation&rank =16.,Non-OADS,/arxiv_data1/oa_pdf/73/c3/sccaa-7-045.PMC3945047.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/84/78/ppa-8-275.PMC3945048.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 275–282Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  275OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5628 0systematic review and meta-analysis   for thrombolysis treatment in patients   with acute submassive pulmonary embolism Yaoqian cao* haiyan Zhao* Wanpeng gao Yan Wang Jie cao  respiratory Department, Tianjin  Medical University general hospital,   Tianjin 300052, People’s republic of  china *These two authors contributed  equally to this work correspondence: Jie cao   respiratory Department, Tianjin Medical  University general hospital, Tianjin  300052, People’s republic of china   email tjcaojie@sina.co mPurpose:  The aim of this systematic review was to evaluate the efficacy and safety of  thrombolytic treatment in patients with submassive pulmonary embolism (PE).",Non-OADS,/arxiv_data1/oa_pdf/84/78/ppa-8-275.PMC3945048.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/84/78/ppa-8-275.PMC3945048.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/78/ppa-8-275.PMC3945048.pdf
Available from http://clinicaltrials.go v/ct2/ show/NCT00639743?term =PEITHO +pulmonary +embogov/ct2/ show/NCT00639743?term =PEITHO+pulmonary +embolism +thro mbolysis+study&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/84/78/ppa-8-275.PMC3945048.pdf
Taxonomic trees were illustrated manually using FigTree (v.1.4.0; http://tree.bio.ed.ac.uk/software/figtree) based on MEGAN4 results.,OADS,/arxiv_data1/oa_pdf/b4/bd/srep04245.PMC3945050.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b4/bd/srep04245.PMC3945050.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 Figure 5 |HTS rarefaction analysis.",Non-OADS,/arxiv_data1/oa_pdf/b4/bd/srep04245.PMC3945050.pdf
Base map provided by ReefBase (http://www.reefbase.org).,OADS,/arxiv_data1/oa_pdf/56/2d/srep04250.PMC3945051.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/56/2d/srep04250.PMC3945051.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4250 | DOI: 10.1038/srep04250 4",Non-OADS,/arxiv_data1/oa_pdf/56/2d/srep04250.PMC3945051.pdf
Editor: Godfrey Smith./C2112014 The Authors 0006-3495/14/02/0824/10 $2.00 http://dx.doi.org/10.1016/j.bpj.2013.12.041 824 Biophysical Journal Volume 106 February 2014 824–833,Non-OADS,/arxiv_data1/oa_pdf/0e/04/main.PMC3945099.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357What Does the Korean Medical Association Need to Talk About?",Non-OADS,/arxiv_data1/oa_pdf/22/46/jkms-29-309.PMC3945122.pdf
"Hyoung Wook Park Department of Social Medicine, College of Medicine, Dankook University, Cheonan, Koreahttp://dx.doi.org/10.3346/jkms.2014.29.3.309  • J Korean Med Sci 2014; 29: 309-310 The Korean Medical Association (KMA) vowed on January 12,  2014 to go on an all-out strike on March 3 to protest the govern - ment’s proposals to allow telemedicine and for-profit medical  subsidiaries.",Non-OADS,/arxiv_data1/oa_pdf/22/46/jkms-29-309.PMC3945122.pdf
"310  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.309cal care institutions, coercive medical care benefit costs, coer - cive deduction of medical care benefit costs, and prohibition of  unprescribed medical care.",Non-OADS,/arxiv_data1/oa_pdf/22/46/jkms-29-309.PMC3945122.pdf
Available at http://www.nhis.or.kr/portal/site/main/MENU_WB - DCC01 [accessed on 2 February 2014].,Non-OADS,/arxiv_data1/oa_pdf/22/46/jkms-29-309.PMC3945122.pdf
Available at http://www.mw.go.kr/front_new/al/sal0301vw.jsp?PAR_ MENU_ID=04&MENU_ID=0403&page=4&CONT_SEQ=295097 [ac - cessed on 2 February 2014].,Non-OADS,/arxiv_data1/oa_pdf/22/46/jkms-29-309.PMC3945122.pdf
Available at http://www.oxfordmartin.ox.ac.,Non-OADS,/arxiv_data1/oa_pdf/22/46/jkms-29-309.PMC3945122.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Cell Therapy for Wound Healing In covering wounds, efforts should include utilization of the safest and least invasive  methods with goals of achieving optimal functional and cosmetic outcome.",Non-OADS,/arxiv_data1/oa_pdf/5e/c6/jkms-29-311.PMC3945123.pdf
"Keywords:  Cell-and Tissue-based Therapy; Wounds and Injuries; Tissue EngineeringHi-Jin You and Seung-Kyu Han Department of Plastic Surgery,   Korea University College of Medicine,   Seoul, Korea  Received: 29 October 2013 Accepted: 8 January 2014 Address for Correspondence: Seung-Kyu Han, MD Department of Plastic Surgery, Korea University Guro Hospital,  148 Gurodong-ro, Guro-gu, Seoul 152-703, Korea Tel: +82.2-2626-3333, Fax: +82.2-868-6698  E-mail: pshan@kumc.or.krhttp://dx.doi.org/10.3346/jkms.2014.29.3.311  • J Korean Med Sci 2014; 29: 311-319 We all experience our fair share of wounds during the course of  our lives.",Non-OADS,/arxiv_data1/oa_pdf/5e/c6/jkms-29-311.PMC3945123.pdf
"• Cell Therapy for Wound Healing 312  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.311other with sutures (stitches), staples, or adhesive tape (approxi - mated wound), the wound also heals by primary intention.",Non-OADS,/arxiv_data1/oa_pdf/5e/c6/jkms-29-311.PMC3945123.pdf
"• Cell Therapy for Wound Healing http://jkms.org   313 http://dx.doi.org/10.3346/jkms.2014.29.3.311fore, the wound remains open without being cured for long pe - riods of time.",Non-OADS,/arxiv_data1/oa_pdf/5e/c6/jkms-29-311.PMC3945123.pdf
• Cell Therapy for Wound Healing 314  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.311been carried out involving 59 patients with diabetic foot ulcers.,Non-OADS,/arxiv_data1/oa_pdf/5e/c6/jkms-29-311.PMC3945123.pdf
• Cell Therapy for Wound Healing http://jkms.org   315 http://dx.doi.org/10.3346/jkms.2014.29.3.311effect related to fibroblast allograft treatment (Fig.,Non-OADS,/arxiv_data1/oa_pdf/5e/c6/jkms-29-311.PMC3945123.pdf
• Cell Therapy for Wound Healing 316  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.311 A DB EC F Fig.,Non-OADS,/arxiv_data1/oa_pdf/5e/c6/jkms-29-311.PMC3945123.pdf
• Cell Therapy for Wound Healing http://jkms.org   317 http://dx.doi.org/10.3346/jkms.2014.29.3.311Fig.,Non-OADS,/arxiv_data1/oa_pdf/5e/c6/jkms-29-311.PMC3945123.pdf
"• Cell Therapy for Wound Healing 318  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.311endothelial growth factor (VEGF), and epidermal growth factor  (EGF).",Non-OADS,/arxiv_data1/oa_pdf/5e/c6/jkms-29-311.PMC3945123.pdf
ORCID Hi-Jin You http://orcid.org/ 0000-0002-9997-2736 Seung-Kyu Han http://orcid.org/ 0000-0002-2875-9276 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5e/c6/jkms-29-311.PMC3945123.pdf
• Cell Therapy for Wound Healing http://jkms.org   319 http://dx.doi.org/10.3346/jkms.2014.29.3.311flaps.,Non-OADS,/arxiv_data1/oa_pdf/5e/c6/jkms-29-311.PMC3945123.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Long Term Outcomes of Pediatric Liver Transplantation  According to Age Liver transplantation (LT) has been the key therapy for end stage liver diseases.",Non-OADS,/arxiv_data1/oa_pdf/49/02/jkms-29-320.PMC3945124.pdf
"Keywords:  Pediatrics; Liver Transplantation; Survival Rate; Fulminant Hepatitis; Living  Donors; Liver TransplantationJeik Byun,1 Nam-Joon Yi,1   Jeong-Moo Lee,1 Suk-won Suh,1   Tae Yoo,1 YoungRok Choi,1 Jae-Sung Ko,2  Jeong-Kee Seo,2 Hyeyoung Kim,1   Hae Won Lee,1 Hyun-Young Kim,1  Kwang-Woong Lee,1 Sung-Eun Jung,1  Seong-Cheol Lee,1 Kwi-Won Park,1   and Kyung-Suk Suh1 Departments of 1Surgery, and 2Pediatrics, Seoul  National University College of Medicine, Seoul,  Korea Received: 23 September 2013 Accepted: 16 December 2013 Address for Correspondence: Nam-Joon Yi, MD Department of Surgery, Seoul National University College of  Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea Tel: +82.2-2072-2990, Fax: +82.2-766-3975 E-mail: gsleenj@hanmail.nethttp://dx.doi.org/10.3346/jkms.2014.29.3.320  • J Korean Med Sci 2014; 29: 320-327 INTRODUCTION  Liver transplantation (LT) has been a key therapy for end stage  liver diseases in children for over 40 yr.",Non-OADS,/arxiv_data1/oa_pdf/49/02/jkms-29-320.PMC3945124.pdf
• Not Risky Liver Transplantation in Infancy http://jkms.org   321 http://dx.doi.org/10.3346/jkms.2014.29.3.320Assessment of variables We assessed pre-operative and peri-operative characteristics  that are known to be related to survival outcomes of LT.,Non-OADS,/arxiv_data1/oa_pdf/49/02/jkms-29-320.PMC3945124.pdf
"• Not Risky Liver Transplantation in Infancy 322  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.320for Organ Sharing (UNOS) criteria was a model: Status 1, inten - sive care unit-bound with expected survival less than 7 days;  Status 2, continuously hospitalized; and Status 3, at home, but  requiring continuous medical care (7).",Non-OADS,/arxiv_data1/oa_pdf/49/02/jkms-29-320.PMC3945124.pdf
• Not Risky Liver Transplantation in Infancy http://jkms.org   323 http://dx.doi.org/10.3346/jkms.2014.29.3.320Table 1.,Non-OADS,/arxiv_data1/oa_pdf/49/02/jkms-29-320.PMC3945124.pdf
"• Not Risky Liver Transplantation in Infancy 324  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.320been published analyzing recipients in this age group; however,  most of the previous data were obtained from DDLT based cen - ters of western countries.",Non-OADS,/arxiv_data1/oa_pdf/49/02/jkms-29-320.PMC3945124.pdf
• Not Risky Liver Transplantation in Infancy http://jkms.org   325 http://dx.doi.org/10.3346/jkms.2014.29.3.320Table 3.,Non-OADS,/arxiv_data1/oa_pdf/49/02/jkms-29-320.PMC3945124.pdf
• Not Risky Liver Transplantation in Infancy 326  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.320directly affected patient survivals.,Non-OADS,/arxiv_data1/oa_pdf/49/02/jkms-29-320.PMC3945124.pdf
DISCLOSURE None of the authors of this study has any financial interest or  conflict with industries or parties.ORCID Jeik Byun http://orcid.org/0000-0002-3405-5945 Jeong-Moo Lee http://orcid.org/0000-0001-7806-8759 Suk-won Suh http://orcid.org/0000-0001-6111-9601 YoungRok Choi http://orcid.org/0000-0003-2408-7086 Jae-Sung Ko http://orcid.org/0000-0002-3064-2974 Hyeyoung Kim  http://orcid.org/0000-0002-3157-8214 Hae Won Lee http://orcid.org/0000-0002-3312-9295  Hyun-Young Kim http://orcid.org/0000-0003-0106-9969 Kwang-Woong Lee http://orcid.org/0000-0001-6412-1926 Kwi-Won Park http://orcid.org/0000-0002-9857-3709 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/49/02/jkms-29-320.PMC3945124.pdf
Available at  http://www.konos.go.kr/konosis [accessed on 17 July 2013].,Non-OADS,/arxiv_data1/oa_pdf/49/02/jkms-29-320.PMC3945124.pdf
"• Not Risky Liver Transplantation in Infancy http://jkms.org   327 http://dx.doi.org/10.3346/jkms.2014.29.3.320cion W, Hammer GB, So SK.",Non-OADS,/arxiv_data1/oa_pdf/49/02/jkms-29-320.PMC3945124.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Recent Trends of Antigenic Variation in Bordetella pertussis  Isolates in Korea Pertussis is a representative vaccine-preventable disease.",Non-OADS,/arxiv_data1/oa_pdf/1c/0d/jkms-29-328.PMC3945125.pdf
4800-4845-300 and  4800-4851-300) of the Korea National Institute of Health.http://dx.doi.org/10.3346/jkms.2014.29.3.328  • J Korean Med Sci 2014; 29: 328-333 INTRODUCTION Bordetella pertussis  is the pathogenic organism responsible for  pertussis.,Non-OADS,/arxiv_data1/oa_pdf/1c/0d/jkms-29-328.PMC3945125.pdf
• Antigenic variations in Bordetella pertussis http://jkms.org   329 http://dx.doi.org/10.3346/jkms.2014.29.3.328inoculated on Reagan Lowe medium (10% horse blood) with  cephalexin and incubated in a humid incubator at 37°C for 7  days.,Non-OADS,/arxiv_data1/oa_pdf/1c/0d/jkms-29-328.PMC3945125.pdf
The number of pertussis cases  was obtained from the disease web statistics system (http://stat.cdc.go.kr) establish- ed by the Korea Centers for Disease Control and Prevention.,OADS,/arxiv_data1/oa_pdf/1c/0d/jkms-29-328.PMC3945125.pdf
• Antigenic variations in Bordetella pertussis 330  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.328Fig.,Non-OADS,/arxiv_data1/oa_pdf/1c/0d/jkms-29-328.PMC3945125.pdf
• Antigenic variations in Bordetella pertussis http://jkms.org   331 http://dx.doi.org/10.3346/jkms.2014.29.3.328reported numbers of pertussis cases also increased consider - ably (Fig.,Non-OADS,/arxiv_data1/oa_pdf/1c/0d/jkms-29-328.PMC3945125.pdf
"• Antigenic variations in Bordetella pertussis 332  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.328ptxP3 type in the 2009 isolates was 58.3%, and this increased to  86.6% in the 2011 isolates.",Non-OADS,/arxiv_data1/oa_pdf/1c/0d/jkms-29-328.PMC3945125.pdf
• Antigenic variations in Bordetella pertussis http://jkms.org   333 http://dx.doi.org/10.3346/jkms.2014.29.3.3288.,Non-OADS,/arxiv_data1/oa_pdf/1c/0d/jkms-29-328.PMC3945125.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Reliability and Validity of a Korean Translation of the ASAS  Health Index and Environmental Factors in Korean Patients with  Axial Spondyloarthritis The objective of this study was to develop a Korean version of the Assessment of  Spondyloarthritis International Society-Health Index/Environmental Factor (ASAS HI/EF)  and to evaluate its reliability and validity in Korean patients with axial spondyloarthritis  (SpA).",Non-OADS,/arxiv_data1/oa_pdf/dc/20/jkms-29-334.PMC3945126.pdf
"2011-0008867  and 2011-0011332), and by Chonnam National University, 2011.http://dx.doi.org/10.3346/jkms.2014.29.3.334  • J Korean Med Sci 2014; 29: 334-337 INTRODUCTION  Ankylosing spondylitis (AS) is characterized by inflammation of  the axial skeleton, sacroiliac joints, and, to a lesser degree, pe - ripheral joints and certain extra-articular organs, including the  eyes, skin, and cardiovascular system (1).",Non-OADS,/arxiv_data1/oa_pdf/dc/20/jkms-29-334.PMC3945126.pdf
• Korean Version of ASAS Health Index http://jkms.org   335 http://dx.doi.org/10.3346/jkms.2014.29.3.334in two international cross-sectional studies with the aim of re - ducing the item pool.,Non-OADS,/arxiv_data1/oa_pdf/dc/20/jkms-29-334.PMC3945126.pdf
• Korean Version of ASAS Health Index 336  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.334Table 1.,Non-OADS,/arxiv_data1/oa_pdf/dc/20/jkms-29-334.PMC3945126.pdf
• Korean Version of ASAS Health Index http://jkms.org   337 http://dx.doi.org/10.3346/jkms.2014.29.3.334MI.,Non-OADS,/arxiv_data1/oa_pdf/dc/20/jkms-29-334.PMC3945126.pdf
ORCID Jung-Ho Choi http://orcid.org/0000-0003-1220-5540 Tae-Jong Kim http://orcid.org/0000-0002-2871-1635 Kichul Shin http://orcid.org/0000-0002-6749-7598 Chan-Bum Choi http://orcid.org/0000-0002-4691-5455  Ji-Hyun Kim http://orcid.org/0000-0003-1081-2590 So-Hyun Kim http://orcid.org/0000-0001-9884-9173 Nah-Ihm Kim http://orcid.org/0000-0001-6215-8549 Min-Joo Ahn http://orcid.org/0000-0002-2778-0735 Hyun-Ju Jung http://orcid.org/0000-0003-0425-7180 Kyung-Eun Lee http://orcid.org/0000-0003-1048-9068  Dong-Jin Park http://orcid.org/0000-0002-8709-987X Yong-Wook Park http://orcid.org/0000-0002-6937-7119 Shin-Seok Lee http://orcid.org/0000-0001-6810-7355  Tae-Hwan Kim  http://orcid.org/0000-0002-3542-2276REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/dc/20/jkms-29-334.PMC3945126.pdf
• Korean Version of ASAS Health Index http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.334Appendix 1 날짜:  이름:  I. Korean version _ASAS Health Index (ASAS 건강지표) 다음 설문지의 항목에 대한 답변을 현재 당신의 류마티스 질병 상태에 근거하여 한 개만 체크하여 주시기 바랍니다.,Non-OADS,/arxiv_data1/oa_pdf/dc/20/jkms-29-334.PMC3945126.pdf
• Korean Version of ASAS Health Index http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.334 I. Korean version_Environmental Factors related to ASAS Health Index (ASAS 건강지표관련 환경요인) 다음 설문지의 항목에 대한 답변을 현재 당신의 류마티스 질병 상태에 근거하여 한 개만 체크하여 주시기 바랍니다.,Non-OADS,/arxiv_data1/oa_pdf/dc/20/jkms-29-334.PMC3945126.pdf
"• Korean Version of ASAS Health Index http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.334 사용자 매뉴얼 ASAS 건강지표에 대한 설명 ASAS 건강지표는 Assessment of SpondyloArthritis Inernational Society (ASAS)에 의해, 축성 척추관절염 환자들의 건강을 평가하기 위해 만들어졌 습니다.",Non-OADS,/arxiv_data1/oa_pdf/dc/20/jkms-29-334.PMC3945126.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Nomogram for Prediction of Prostate Cancer with Serum Prostate  Specific Antigen Less than 10 ng/mL Although prostate-specific antigen (PSA) is a very useful screening tool, prostate biopsy is  still necessary to confirm prostate cancer (PCA).",Non-OADS,/arxiv_data1/oa_pdf/f6/59/jkms-29-338.PMC3945127.pdf
"Keywords:  Biopsy; Nomograms; Prostate; Prostatic NeoplasmsJae Hyun Ahn, Jeong Zoo Lee,   Moon Kee Chung, and Hong Koo Ha Department of Urology and Biomedical Research  Institute, Pusan National University Hospital, Busan,  Korea Received: 7 January 2013 Accepted: 8 January 2014 Address for Correspondence: Hong Koo Ha, MD Department of Urology and Biomedical Research Institute,  Pusan National University Hospital, 179 Gudeok-ro,   Seo-gu, Busan 602-739, Korea Tel: +82.51-240-7351, Fax: +82.51-247-5443 E-mail: hongkooha@naver.comhttp://dx.doi.org/10.3346/jkms.2014.29.3.338  • J Korean Med Sci 2014; 29: 338-342 INTRODUCTION Prostate cancer (PCA) is the fifth most common malignancy  worldwide and the second most common in men (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/f6/59/jkms-29-338.PMC3945127.pdf
• Nomogram for PCA with PSA  http://jkms.org   339 http://dx.doi.org/10.3346/jkms.2014.29.3.338Table 1.,Non-OADS,/arxiv_data1/oa_pdf/f6/59/jkms-29-338.PMC3945127.pdf
• Nomogram for PCA with PSA  340  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.338Fig.,OADS,/arxiv_data1/oa_pdf/f6/59/jkms-29-338.PMC3945127.pdf
• Nomogram for PCA with PSA  http://jkms.org   341 http://dx.doi.org/10.3346/jkms.2014.29.3.338to develop a predicting model for PCA and the predictive value  was reached up to 74%.,OADS,/arxiv_data1/oa_pdf/f6/59/jkms-29-338.PMC3945127.pdf
ORCID Hong Koo Ha http://orcid.org/0000-0002-8240-7765   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f6/59/jkms-29-338.PMC3945127.pdf
• Nomogram for PCA with PSA  342  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.338Japanese patients with serum PSA levels less than 10 ng/mL.,Non-OADS,/arxiv_data1/oa_pdf/f6/59/jkms-29-338.PMC3945127.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Establishment of an Orthotopic Mouse Non-Muscle Invasive  Bladder Cancer Model Expressing the Mammalian Target of  Rapamycin Signaling Pathway We established an orthotopic non-muscle invasive bladder cancer (NMIBC) mouse model  expressing the mammalian target of the rapamycin (mTOR) signaling pathway.",Non-OADS,/arxiv_data1/oa_pdf/52/d4/jkms-29-343.PMC3945128.pdf
"This study was also  supported by the Biomedical Science Scholarship Grants,  Department of Medicine, Chung-Ang University in 2013. http://dx.doi.org/10.3346/jkms.2014.29.3.343  • J Korean Med Sci 2014; 29: 343-350 INTRODUCTION Bladder cancer is the fourth most common cancer and the sec - ond most frequently diagnosed urologic cancer in men (1).",Non-OADS,/arxiv_data1/oa_pdf/52/d4/jkms-29-343.PMC3945128.pdf
• Orthotopic Mouse Bladder Cancer Model 344  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.343mice in bladder cancer research has allowed direct implanta - tion of human carcinomas into the corresponding organ of the  animal model.,Non-OADS,/arxiv_data1/oa_pdf/52/d4/jkms-29-343.PMC3945128.pdf
"• Orthotopic Mouse Bladder Cancer Model http://jkms.org   345 http://dx.doi.org/10.3346/jkms.2014.29.3.343In vitro and in vivo BLI of KU-7-luc cells KU-7-luc cells were imaged using an IVIS 200 (Xenogen Corp.,  Alameda, CA, USA).",OADS,/arxiv_data1/oa_pdf/52/d4/jkms-29-343.PMC3945128.pdf
• Orthotopic Mouse Bladder Cancer Model 346  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.343sections using a microtome and stained with H&E for tumor  volume measurements (largest width2× largest length × 0.5).,Non-OADS,/arxiv_data1/oa_pdf/52/d4/jkms-29-343.PMC3945128.pdf
• Orthotopic Mouse Bladder Cancer Model http://jkms.org   347 http://dx.doi.org/10.3346/jkms.2014.29.3.343Table 2.,Non-OADS,/arxiv_data1/oa_pdf/52/d4/jkms-29-343.PMC3945128.pdf
"• Orthotopic Mouse Bladder Cancer Model 348  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.343expression of the KU-7-luc cell line for mTOR, phosphorylated  mTOR (p-mTOR), p70S6K, p-p70S6K, 4E-BP1, p-4E-BP1, eIF4E,  and p-eIF4E were well observed.",Non-OADS,/arxiv_data1/oa_pdf/52/d4/jkms-29-343.PMC3945128.pdf
• Orthotopic Mouse Bladder Cancer Model http://jkms.org   349 http://dx.doi.org/10.3346/jkms.2014.29.3.343signaling pathway activation status.,Non-OADS,/arxiv_data1/oa_pdf/52/d4/jkms-29-343.PMC3945128.pdf
• Orthotopic Mouse Bladder Cancer Model 350  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.343cer Res 1999; 59: 2834-7.,Non-OADS,/arxiv_data1/oa_pdf/52/d4/jkms-29-343.PMC3945128.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Novel Combination Markers for Predicting Survival in Patients  with Muscle Invasive Bladder Cancer: USP18 and DGCR2 We performed gene expression profiling in bladder cancer patients to identify cancer- specific survival-related genes in muscle invasive bladder cancer (MIBC) patients.",Non-OADS,/arxiv_data1/oa_pdf/6b/c2/jkms-29-351.PMC3945129.pdf
"Keywords:  Urinary Bladder Neoplasms; USP18  Protein, Human; DGCR2 ; Survival; Gene  Expression ProfilingYe-Hwan Kim,1 Won Tae Kim,1   Pildu Jeong,1 Yun-Sok Ha,1,4   Ho Won Kang,1 Seok Joong Yun,1   Sung-Kwon Moon,2 Yung Hyun Choi,3  Isaac Yi Kim,4 and Wun-Jae Kim1 1Department of Urology, College of Medicine,  Chungbuk National University, Cheongju;  2Department of Food and Biotechnology, Chung- Ang University, Seoul; 3Department of Biomaterial  Control, Dong-Eui University, Busan, Korea; 4Section  of Urological Oncology, The Cancer Institute of New  Jersey, Robert Wood Johnson Medical School, New  Brunswick, NJ, USA Received: 10 October 2013 Accepted: 16 December 2013 Address for Correspondence: Wun-Jae Kim, MD Department of Urology, Chungbuk National University, College  of Medicine and Institute for Tumor Research, 776 1 Sunhwan- ro, Heungduk-gu, Cheongju 361-763, Korea Tel: +82.43-269-6371, Fax: +82.43-269-6144 E-mail: wjkim@chungbuk.ac.kr This research was supported by Basic Science Research Program  through the National Research Foundation of Korea (NRF)  funded by the Ministry of Education, Science and Technology  (2013R1A1A2004740) and by a grant from the Next-Generation  BioGreen 21 Program (No.PJ009621), Rural Development  Administration, Republic of Korea.http://dx.doi.org/10.3346/jkms.2014.29.3.351  • J Korean Med Sci 2014; 29: 351-356 INTRODUCTION In the USA, more than 70,000 new cases of bladder cancer were  diagnosed and at least 14,000 patients died from bladder can ­ cer (1).",Non-OADS,/arxiv_data1/oa_pdf/6b/c2/jkms-29-351.PMC3945129.pdf
"In a previous study, we investigated gene expression profiling  in bladder cancer patients, and uploaded the full microarray  data set at http://www.ncbi.nlm.nih.gov/geo/ with the data se ­ ries accession number GSE13507.",OADS,/arxiv_data1/oa_pdf/6b/c2/jkms-29-351.PMC3945129.pdf
"• USP18  and DGCR2  in Muscle Invasive Bladder Cancer 352  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.351candidate genes ( USP18, DGCR2, ZNF699 ) and evaluated whe­ ther their identification by microarray­based gene expression  profiling could be associated with cancer ­specific survival in  MIBC patients.",OADS,/arxiv_data1/oa_pdf/6b/c2/jkms-29-351.PMC3945129.pdf
The full microar ­ ray data set is available online at http://www.ncbi.nlm.nih.gov/ geo/ under the data series accession number GSE13507.,OADS,/arxiv_data1/oa_pdf/6b/c2/jkms-29-351.PMC3945129.pdf
"• USP18  and DGCR2  in Muscle Invasive Bladder Cancer http://jkms.org   353 http://dx.doi.org/10.3346/jkms.2014.29.3.351ing to the Kaplan­Meier method, with differences between the  times assessed using log ­rank statistics.",Non-OADS,/arxiv_data1/oa_pdf/6b/c2/jkms-29-351.PMC3945129.pdf
• USP18  and DGCR2  in Muscle Invasive Bladder Cancer 354  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.351Fig.,Non-OADS,/arxiv_data1/oa_pdf/6b/c2/jkms-29-351.PMC3945129.pdf
• USP18  and DGCR2  in Muscle Invasive Bladder Cancer http://jkms.org   355 http://dx.doi.org/10.3346/jkms.2014.29.3.351Table 3.,Non-OADS,/arxiv_data1/oa_pdf/6b/c2/jkms-29-351.PMC3945129.pdf
ORCID Ye­Hwan Kim http://orcid.org/0000-0002-8676-7119 Won Tae Kim http://orcid.org/0000-0002-7482-4550  Pildu Jeong http://orcid.org/0000-0002-5602-5376  Yun­ Sok Ha http://orcid.org/0000-0003-3732-9814  Ho Won Kang http://orcid.org/0000-0002-8164-4427,Non-OADS,/arxiv_data1/oa_pdf/6b/c2/jkms-29-351.PMC3945129.pdf
• USP18  and DGCR2  in Muscle Invasive Bladder Cancer 356  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.351Seok Joong Yun http://orcid.org/0000-0001-7737-4746  Sung­Kwon Moon http://orcid.org/0000-0002-4514-3457  Yung Hyun Choi http://orcid.org/0000-0002-1454-3124 Isaac Yi Kim http://orcid.org/0000-0002-1967-5281  Wun­ Jae Kim  http://orcid.org/0000-0002-8060-8926  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/6b/c2/jkms-29-351.PMC3945129.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Non-Spine Bone Metastasis as an Initial Manifestation of Cancer  in Korea Non-spine bone metastasis accounts for approximately 20% of all skeletal metastases, but  little data have been published that focused on bone metastasis to the pelvis and  extremities as an initial manifestation of cancer.",Non-OADS,/arxiv_data1/oa_pdf/d6/29/jkms-29-357.PMC3945130.pdf
"Keywords:  Neoplasm Metastasis; Neoplasms; Non-Spine; DiagnosisWanlim Kim,1 Ilkyu Han,1,2   Seungcheol Kang,1 Sang A Lee,1   and Han-Soo Kim1,2 1Department of Orthopaedic Surgery and  2Musculoskeletal Tumor Center, Seoul National  University Hospital, Seoul, Korea Received: 12 October 2013 Accepted: 16 December 2013 Address for Correspondence: Ilkyu Han, MD Department of Orthopaedic Surgery, Seoul National University  Hospital, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea  Tel: +82.2-2072-0682, Fax: +82.2-764-2718  E-mail: hik19@snu.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.3.357  • J Korean Med Sci 2014; 29: 357-362 INTRODUCTION The most common sites for metastatic carcinoma are the lung,  liver, and skeleton, respectively (1).",Non-OADS,/arxiv_data1/oa_pdf/d6/29/jkms-29-357.PMC3945130.pdf
"• Extremity Metastasis of Unknown Cancer 358  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.357patients who had a remote history of cancer with bone metas - tasis (n = 22), 2) patients who presented with spinal metastasis  as their initial symptom (n = 226), 3) insufficient information  from the medical record (n = 17), and 4) hematologic malig - nancies (n = 29).",Non-OADS,/arxiv_data1/oa_pdf/d6/29/jkms-29-357.PMC3945130.pdf
• Extremity Metastasis of Unknown Cancer http://jkms.org   359 http://dx.doi.org/10.3346/jkms.2014.29.3.357Table 3.,Non-OADS,/arxiv_data1/oa_pdf/d6/29/jkms-29-357.PMC3945130.pdf
• Extremity Metastasis of Unknown Cancer 360  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.357Fig.,Non-OADS,/arxiv_data1/oa_pdf/d6/29/jkms-29-357.PMC3945130.pdf
"• Extremity Metastasis of Unknown Cancer http://jkms.org   361 http://dx.doi.org/10.3346/jkms.2014.29.3.357vious history of cancer was evident, the lung was the most com - mon site of primary cancer, as reported previously (3-5, 7-11).",Non-OADS,/arxiv_data1/oa_pdf/d6/29/jkms-29-357.PMC3945130.pdf
ORCID Wanlim Kim http://orcid.org/0000-0003-1544-7211 Ilkyu Han http://orcid.org/0000-0001-9841-3775 Seungcheol Kang http://orcid.org/0000-0002-0172-2721  Sang A Lee http://orcid.org/0000-0001-9006-4152  Han-Soo Kim http://orcid.org/0000-0002-6543-2598 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d6/29/jkms-29-357.PMC3945130.pdf
• Extremity Metastasis of Unknown Cancer 362  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.357bone disease from occult carcinoma: a profile.,Non-OADS,/arxiv_data1/oa_pdf/d6/29/jkms-29-357.PMC3945130.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Intimal Hyperplasia in Loop-Injured Carotid Arteries Is  Attenuated in Transglutaminase 2-Null Mice Arterial restenosis frequently develops after open or endovascular surgery due to intimal  hyperplasia.",Non-OADS,/arxiv_data1/oa_pdf/60/8b/jkms-29-363.PMC3945131.pdf
"A100190) and National Research Foundation of Korea (2010- 0019472).http://dx.doi.org/10.3346/jkms.2014.29.3.363  • J Korean Med Sci 2014; 29: 363-369 INTRODUCTION Arterial restenosis is the major complication in vascular recon - structive procedures such as bypass graft, endarterectomy, bal - loon angioplasty and stent angioplasty.",Non-OADS,/arxiv_data1/oa_pdf/60/8b/jkms-29-363.PMC3945131.pdf
• Attenuation of Intimal Hyperplasia in TG2-null Mice 364  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.363of TG2 prevented inward remodeling induced by endothelin-1.,Non-OADS,/arxiv_data1/oa_pdf/60/8b/jkms-29-363.PMC3945131.pdf
"• Attenuation of Intimal Hyperplasia in TG2-null Mice http://jkms.org   365 http://dx.doi.org/10.3346/jkms.2014.29.3.363RESULTS Intimal hyperplasia in loop-injured carotid arteries and in  ligated arteries in TG2-null mice  TG2 is implicated in apoptosis, cell adhesion and extracellular  matrix formation under stressed conditions.",Non-OADS,/arxiv_data1/oa_pdf/60/8b/jkms-29-363.PMC3945131.pdf
"• Attenuation of Intimal Hyperplasia in TG2-null Mice 366  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.363but not medial changes, in response to vascular injury.",Non-OADS,/arxiv_data1/oa_pdf/60/8b/jkms-29-363.PMC3945131.pdf
• Attenuation of Intimal Hyperplasia in TG2-null Mice http://jkms.org   367 http://dx.doi.org/10.3346/jkms.2014.29.3.363Fig.,Non-OADS,/arxiv_data1/oa_pdf/60/8b/jkms-29-363.PMC3945131.pdf
• Attenuation of Intimal Hyperplasia in TG2-null Mice 368  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.363tive cells between two groups (data not shown).,Non-OADS,/arxiv_data1/oa_pdf/60/8b/jkms-29-363.PMC3945131.pdf
"• Attenuation of Intimal Hyperplasia in TG2-null Mice http://jkms.org   369 http://dx.doi.org/10.3346/jkms.2014.29.3.363reduced in TG2-null mice, suggesting that TG2 plays a critical role  in the development of intimal hyperplasia after vascular injury.",Non-OADS,/arxiv_data1/oa_pdf/60/8b/jkms-29-363.PMC3945131.pdf
ORCID Seung-Kee Min http://orcid.org/0000-0001-6849-3786  Eui Man Jeong http://orcid.org/0000-0003-0692-2033 Sung-Yup Cho http://orcid.org/0000-0002-2720-6952 In-Gyu Kim http://orcid.org/0000-0002-0751-4288 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/60/8b/jkms-29-363.PMC3945131.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Relationship among Complex Fractionated Electrograms,  Wavebreak, Phase Singularity, and Local Dominant Frequency in  Fibrillation Wave-Dynamics: a Modeling Comparison Study  Although complex fractionated electrogram (CFE) is known to be a target for catheter  ablation of fibrillation, its physiological meaning in fibrillation wave-dynamics remains to  be clarified.",Non-OADS,/arxiv_data1/oa_pdf/8f/b3/jkms-29-370.PMC3945132.pdf
"2012027176).http://dx.doi.org/10.3346/jkms.2014.29.3.370  • J Korean Med Sci 2014; 29: 370-377 INTRODUCTION In 2004, Nademanee et al.",OADS,/arxiv_data1/oa_pdf/8f/b3/jkms-29-370.PMC3945132.pdf
• CFE in Fibrillation Wave-Dynamics http://jkms.org   371 http://dx.doi.org/10.3346/jkms.2014.29.3.370ablation targeting CFE and LDF .,OADS,/arxiv_data1/oa_pdf/8f/b3/jkms-29-370.PMC3945132.pdf
• CFE in Fibrillation Wave-Dynamics 372  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.370and averaging inter-deflection time intervals.,OADS,/arxiv_data1/oa_pdf/8f/b3/jkms-29-370.PMC3945132.pdf
• CFE in Fibrillation Wave-Dynamics http://jkms.org   373 http://dx.doi.org/10.3346/jkms.2014.29.3.370Fig.,OADS,/arxiv_data1/oa_pdf/8f/b3/jkms-29-370.PMC3945132.pdf
• CFE in Fibrillation Wave-Dynamics 374  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.370Table 1.,OADS,/arxiv_data1/oa_pdf/8f/b3/jkms-29-370.PMC3945132.pdf
• CFE in Fibrillation Wave-Dynamics http://jkms.org   375 http://dx.doi.org/10.3346/jkms.2014.29.3.370Fig.,OADS,/arxiv_data1/oa_pdf/8f/b3/jkms-29-370.PMC3945132.pdf
• CFE in Fibrillation Wave-Dynamics 376  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.370namics.,OADS,/arxiv_data1/oa_pdf/8f/b3/jkms-29-370.PMC3945132.pdf
ORCID Yonghyeon Yun http://orcid.org/0000-0001-5497-452X Minki Hwang http://orcid.org/0000-0001-7404-3052 Jae Hyung Park http://orcid.org/0000-0002-3198-1134 Hangsik Shin http://orcid.org/0000-0002-3353-0310 Eun Bo Shim http://orcid.org/0000-0003-2657-0389 Hui-Nam Pak http://orcid.org/0000-0002-3256-3620 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8f/b3/jkms-29-370.PMC3945132.pdf
• CFE in Fibrillation Wave-Dynamics http://jkms.org   377 http://dx.doi.org/10.3346/jkms.2014.29.3.370trogram in the electroanatomically remodeled left atrium of patients with  atrial fibrillation.,OADS,/arxiv_data1/oa_pdf/8f/b3/jkms-29-370.PMC3945132.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Simulation of Oral Glucose Tolerance Tests and the  Corresponding Isoglycemic Intravenous Glucose Infusion  Studies for Calculation of the Incretin Effect  The incretin effect, which is a unique stimulus of insulin secretion in response to oral  ingestion of nutrients, is calculated by the difference in insulin secretory responses from an  oral glucose tolerance test (OGTT) and a corresponding isoglycemic intravenous glucose  infusion (IIGI) study.",Non-OADS,/arxiv_data1/oa_pdf/a0/dc/jkms-29-378.PMC3945133.pdf
"Received: 3 September 2013 Accepted: 4 December 2013 Address for Correspondence: Sungwan Kim, PhD Department of Biomedical Engineering, Seoul National  University College of Medicine, 101 Daehak-ro, Jongno-gu,  Seoul 110-744, Korea Tel: +82.2-2072-3126, Fax: +82.2-745-7870 E-mail: sungwan@snu.ac.kr This work was partially supported by the Research Settlement  Fund for the new faculty of Seoul National University (800- 20100161), and by the National Research Foundation of Korea  funded by the Korean Government (Grant 2010-0024462 and  2011-0009127).http://dx.doi.org/10.3346/jkms.2014.29.3.378  • J Korean Med Sci 2014; 29: 378-385 INTRODUCTION  Incretins are hormones that are secreted from the gastrointestinal tract in response to  nutrient ingestion; the glucose-dependent insulinotropic polypeptide (GIP) and glu - cagon-like peptide-1 (GLP-1) are the two incretin hormones that have been identified  (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/a0/dc/jkms-29-378.PMC3945133.pdf
"• Simulation of OGTT and IIGI Study for Incretin Effect http://jkms.org   379 http://dx.doi.org/10.3346/jkms.2014.29.3.378originated mainly from limited clinical data on incretin hor - mones, they encompass the relationships among incretin hor - mones, insulin, and the rate of the gastric emptying (10, 13, 15).",OADS,/arxiv_data1/oa_pdf/a0/dc/jkms-29-378.PMC3945133.pdf
• Simulation of OGTT and IIGI Study for Incretin Effect 380  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.378 The hepatic glucose balance (Hepbal G; mM/min) reflects the  sum of glucose production in the liver and glucose uptake from  the mesenteric circulation described in Eq.,OADS,/arxiv_data1/oa_pdf/a0/dc/jkms-29-378.PMC3945133.pdf
• Simulation of OGTT and IIGI Study for Incretin Effect http://jkms.org   381 http://dx.doi.org/10.3346/jkms.2014.29.3.378in several ways.,Non-OADS,/arxiv_data1/oa_pdf/a0/dc/jkms-29-378.PMC3945133.pdf
• Simulation of OGTT and IIGI Study for Incretin Effect 382  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.378Table 3.,Non-OADS,/arxiv_data1/oa_pdf/a0/dc/jkms-29-378.PMC3945133.pdf
• Simulation of OGTT and IIGI Study for Incretin Effect http://jkms.org   383 http://dx.doi.org/10.3346/jkms.2014.29.3.378the mathematical model.,OADS,/arxiv_data1/oa_pdf/a0/dc/jkms-29-378.PMC3945133.pdf
• Simulation of OGTT and IIGI Study for Incretin Effect 384  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.378obtained.,OADS,/arxiv_data1/oa_pdf/a0/dc/jkms-29-378.PMC3945133.pdf
ORCID Myeungseon Kim  http://orcid.org/0000-0002-5554-2363 Tae Jung Oh  http://orcid.org/0000-0002-5078-6123 Jung Chan Lee  http://orcid.org/0000-0002-4546-0962  Karam Choi  http://orcid.org/0000-0001-6781-7435 Min Young Kim  http://orcid.org/0000-0002-1016-8056 Hee Chan Kim  http://orcid.org/0000-0002-2112-426X Young Min Cho  http://orcid.org/0000-0002-2331-6126 Sungwan Kim  http://orcid.org/0000-0002-9318-849X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a0/dc/jkms-29-378.PMC3945133.pdf
• Simulation of OGTT and IIGI Study for Incretin Effect http://jkms.org   385 http://dx.doi.org/10.3346/jkms.2014.29.3.378docrinol Metab 2006; 291: E1144-50.,OADS,/arxiv_data1/oa_pdf/a0/dc/jkms-29-378.PMC3945133.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-635718F-FDG Positron-Emission Tomography/Computed  Tomography Findings of Radiographic Lesions Suggesting   Old Healed Tuberculosis The presence of radiographic lesions suggesting old healed tuberculosis (TB) is one of the  strongest risk factors for the subsequent development of active TB.",Non-OADS,/arxiv_data1/oa_pdf/f1/d9/jkms-29-386.PMC3945134.pdf
"Keywords:  Positron-Emission Tomography; Tomography, X-Ray Computed; Tuberculosis,  Pulmonary; Latent Tuberculosis; Interferon-gamma Release TestsYun-Jeong Jeong,1 Jin Chul Paeng,2  Hyun-Yeol Nam,2* Ji Sun Lee,3   Sang-Min Lee,3 Chul-Gyu Yoo,3   Young Whan Kim,3 Sung Koo Han,3   and Jae-Joon Yim3 1Department of Internal Medicine, Dongguk  University Ilsan Hospital, Dongguk University  College of Medicine, Goyang; 2Department of  Nuclear Medicine, 3Division of Pulmonary and  Critical Care Medicine, Department of Internal  Medicine and Lung Institute of Medical Research  Center, Seoul National University College of  Medicine, Seoul, Korea *Current Address: Department of Nuclear Medicine,  Samsung Changwon Hospital, Sungkyunkwan  University School of Medicine, Changwon, Korea  Received: 17 October 2013 Accepted: 8 January 2014 Address for Correspondence: Jae-Joon Yim, MD  Division of Pulmonary and Critical Care Medicine, Department  of Internal Medicine and Lung Institute, Seoul National  University College of Medicine, 103 Daehak-ro, Jongno-gu,  Seoul 110-744, Korea Tel: +82.2-2072-2059, Fax: +82.2-2072-9662 E-mail: yimjj@snu.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.3.386  • J Korean Med Sci 2014; 29: 386-391 INTRODUCTION Old healed tuberculosis (TB) can be defined as radiographic le - sions suggesting TB sequelae without clinical or microbiologi - cal evidence of active pulmonary TB.",Non-OADS,/arxiv_data1/oa_pdf/f1/d9/jkms-29-386.PMC3945134.pdf
• PET/CT Findings of Old Healed Tuberculosis http://jkms.org   387 http://dx.doi.org/10.3346/jkms.2014.29.3.386graphic lesions suggesting old healed TB.,Non-OADS,/arxiv_data1/oa_pdf/f1/d9/jkms-29-386.PMC3945134.pdf
• PET/CT Findings of Old Healed Tuberculosis 388  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.386Table 1.,Non-OADS,/arxiv_data1/oa_pdf/f1/d9/jkms-29-386.PMC3945134.pdf
• PET/CT Findings of Old Healed Tuberculosis http://jkms.org   389 http://dx.doi.org/10.3346/jkms.2014.29.3.386Fig.,Non-OADS,/arxiv_data1/oa_pdf/f1/d9/jkms-29-386.PMC3945134.pdf
• PET/CT Findings of Old Healed Tuberculosis 390  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.386previously (32).,Non-OADS,/arxiv_data1/oa_pdf/f1/d9/jkms-29-386.PMC3945134.pdf
ORCID Yun-Jeong Jeong http://orcid.org/0000-0001-9144-7403 Jin Chul Paeng http://orcid.org/0000-0002-7464-9342 Hyun-Yeol Nam http://orcid.org/0000-0003-2995-1961 Ji Sun Lee http://orcid.org/0000-0002-3465-0381   Sang-Min Lee http://orcid.org/0000-0002-1388-9318 Jae-Joon Yim http://orcid.org/0000-0002-9605-0074 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f1/d9/jkms-29-386.PMC3945134.pdf
"• PET/CT Findings of Old Healed Tuberculosis http://jkms.org   391 http://dx.doi.org/10.3346/jkms.2014.29.3.386Control and Prevention (CDC): this statement was endorsed by the  Council of the Infectious Diseases Society of America (IDSA), Septem - ber 1999, and the sections of this statement.",Non-OADS,/arxiv_data1/oa_pdf/f1/d9/jkms-29-386.PMC3945134.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Relationship between Tetrahydrobiopterin and Portal  Hypertension in Patients with Chronic Liver Disease Tetrahydrobiopterin (BH4) is an essential cofactor in NO synthesis by endothelial nitric  oxide synthase (eNOS) enzymes.",Non-OADS,/arxiv_data1/oa_pdf/a4/b3/jkms-29-392.PMC3945135.pdf
"Received: 30 October 2013 Accepted: 8 January 2014 Address for Correspondence: Soon Koo Baik, MD Department of Internal Medicine, Wonju Severance Christian  Hospital, Yonsei University Wonju College of Medicine,   20 Insan-ro, Wonju 220-701, Korea Tel: +82.33-741-1223, Fax: +82.33-741-1228 E-mail: baiksk@yonsei.ac.kr This study was supported by a grant of the Korea Healthcare  technology R&D Project, Ministry of Health and Welfare,  Republic of Korea (HI10C2020).http://dx.doi.org/10.3346/jkms.2014.29.3.392  • J Korean Med Sci 2014; 29: 392-399 INTRODUCTION  Portal hypertension (PHT) is a common clinical consequence  of chronic liver disease that is characterized by a pathological  increase in portal venous pressure and is associated with signif - icant morbidity and mortality (1-3).",Non-OADS,/arxiv_data1/oa_pdf/a4/b3/jkms-29-392.PMC3945135.pdf
"• Tetrahydrobiopterin and Portal Hypertension http://jkms.org   393 http://dx.doi.org/10.3346/jkms.2014.29.3.392tivity of the rate-limiting enzyme in BH4 synthesis, guanosine  triphosphate-cyclohydrolase I (GTPCH), which is associated  with decreased NOS activity and NO availability (14).",Non-OADS,/arxiv_data1/oa_pdf/a4/b3/jkms-29-392.PMC3945135.pdf
"• Tetrahydrobiopterin and Portal Hypertension 394  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.392Transient elastography At the same day of measurement of HVPG, after overnight fast - ing, all patients underwent abdominal ultrasonography.",Non-OADS,/arxiv_data1/oa_pdf/a4/b3/jkms-29-392.PMC3945135.pdf
• Tetrahydrobiopterin and Portal Hypertension http://jkms.org   395 http://dx.doi.org/10.3346/jkms.2014.29.3.392Relationship between BH4 and the Laennec fibrosis  scoring system Fig.,Non-OADS,/arxiv_data1/oa_pdf/a4/b3/jkms-29-392.PMC3945135.pdf
• Tetrahydrobiopterin and Portal Hypertension 396  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.392BH4 (mM/mg) HVPG (mmHg) 0 5 10 15 20 25 301.250 1.000 0.750 0.500 0.250 0.000y = 0.61-8.4×10-3 r2 = 0.023 P = 0.036 Fig.,Non-OADS,/arxiv_data1/oa_pdf/a4/b3/jkms-29-392.PMC3945135.pdf
"• Tetrahydrobiopterin and Portal Hypertension http://jkms.org   397 http://dx.doi.org/10.3346/jkms.2014.29.3.392HVPG in non-cirrhosis (n = 40), stage 1 (n = 39), stage 2 (n =   44), stage 3 (n = 45), and stage 4 (n = 25) cases were 8.2 ± 3.8  (range 2-17), 11.1 ± 3.7 (range 5-19), 14.4 ± 4.9 (range 3-24),  16.8 ± 4.8 (range 5-27), and 15.9 ± 4.0 (range 5-24), respectively  (P< 0.001).",Non-OADS,/arxiv_data1/oa_pdf/a4/b3/jkms-29-392.PMC3945135.pdf
• Tetrahydrobiopterin and Portal Hypertension 398  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.392hydropterin by sepiapterin reductase (SPR).,Non-OADS,/arxiv_data1/oa_pdf/a4/b3/jkms-29-392.PMC3945135.pdf
DISCLOSURE The authors have no conflicts of interest to disclose.ORCID Won Ki Hong http://orcid.org/0000-0002-2229-6936 Kwang Yong Shim http://orcid.org/0000-0001-8064-3898  Soon Koo Baik http://orcid.org/0000-0001-6245-2537 Moon Young Kim http://orcid.org/0000-0002-2501-2206  Mee Yon Cho http://orcid.org/0000-0002-7955-4211 Yoon Ok Jang http://orcid.org/0000-0002-5206-3885 Young Shik Park http://orcid.org/0000-0002-8808-4530 Jin Han http://orcid.org/0000-0003-1859-3425 Gaeun Kim http://orcid.org/0000-0003-1914-8331 Youn Zoo Cho http://orcid.org/0000-0002-1064-290X Hye Won Hwang http://orcid.org/0000-0001-5408-8894 Jin Hyung Lee http://orcid.org/0000-0002-8152-9541  Myeong Hun Chae http://orcid.org/0000-0001-5449-0592 Sang Ok Kwon http://orcid.org/0000-0001-5050-570X  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a4/b3/jkms-29-392.PMC3945135.pdf
• Tetrahydrobiopterin and Portal Hypertension http://jkms.org   399 http://dx.doi.org/10.3346/jkms.2014.29.3.392ogy 2003; 37: 172-81.,Non-OADS,/arxiv_data1/oa_pdf/a4/b3/jkms-29-392.PMC3945135.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Translation and Linguistic Validation of the Korean Version of the  Dysfunctional Voiding Symptom Score Although studies on pediatric dysfunctional voiding are increasing, there have not been  enough efforts to validate the Dysfunctional Voiding Symptom Score (DVSS) questionnaire.",Non-OADS,/arxiv_data1/oa_pdf/b2/18/jkms-29-400.PMC3945136.pdf
"Keywords:  Validation Studies; Questionnaires; Urination DisordersHahn-Ey Lee,1 Walid Farhat,2   and Kwanjin Park1 1Department of Urology, Seoul National University  Hospital, Seoul, Korea; 2The Division of Urology, The  Hospital for Sick Children and University of Toronto,  Toronto, Ontario, Canada Received: 18 December 2013 Accepted: 14 January 2014 Address for Correspondence: Kwanjin Park, MD  Division of Pediatric Urology, Seoul National University  Children’s Hospital, Seoul National University College of  Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea Tel: +82.2-2072-0695, Fax: +82.2-742-4665 E-mail: urodori@naver.comhttp://dx.doi.org/10.3346/jkms.2014.29.3.400  • J Korean Med Sci 2014; 29: 400-404 INTRODUCTION Dysfunctional voiding (DV) is a common clinical problem seen  in approximately 40% patients who visit the pediatric urologist  (1).",Non-OADS,/arxiv_data1/oa_pdf/b2/18/jkms-29-400.PMC3945136.pdf
• Korean Version of Dysfunctional Voiding Symptom Score http://jkms.org   401 http://dx.doi.org/10.3346/jkms.2014.29.3.400The DVSS questionnaire  The DVSS questionnaire consists of a validated symptom scor - ing for wetting and functional disorders in children.,Non-OADS,/arxiv_data1/oa_pdf/b2/18/jkms-29-400.PMC3945136.pdf
• Korean Version of Dysfunctional Voiding Symptom Score 402  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.400National University Hospital (IRB No.,Non-OADS,/arxiv_data1/oa_pdf/b2/18/jkms-29-400.PMC3945136.pdf
"• Korean Version of Dysfunctional Voiding Symptom Score http://jkms.org   403 http://dx.doi.org/10.3346/jkms.2014.29.3.400tors affecting DV showed that question number 7 “When I have  to pee, I cannot wait” showed statistically significant correlation  with self-reported DV symptoms (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/b2/18/jkms-29-400.PMC3945136.pdf
"• Korean Version of Dysfunctional Voiding Symptom Score 404  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.400Park, Sung Yong Cho, Young Jae Im, and Chang Hee Yoo for valu - able help in data acquisition and patient interviewing.",Non-OADS,/arxiv_data1/oa_pdf/b2/18/jkms-29-400.PMC3945136.pdf
ORCID Hahn-Ey Lee http://orcid.org/0000-0003-0686-5622 Walid Farhat http://orcid.org/0000-0002-3298-5604  Kwanjin Park http://orcid.org/0000-0002-8926-3047 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b2/18/jkms-29-400.PMC3945136.pdf
• Korean Version of Dysfunctional Voiding Symptom Score http://jkms.org   http://dx.doi.org/10.3346/jkms.2014.29.3.400Appendix 1.,Non-OADS,/arxiv_data1/oa_pdf/b2/18/jkms-29-400.PMC3945136.pdf
• Korean Version of Dysfunctional Voiding Symptom Score http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.400Appendix 2.,Non-OADS,/arxiv_data1/oa_pdf/b2/18/jkms-29-400.PMC3945136.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Clinicopathologic Analysis of Pituitary Adenoma - A Single  Institute Experience Pituitary adenoma (PA) is a common benign neuroendocrine tumor; however, the  incidence and proportion of hormone-producing PAs in Korean patients remain unknown.",Non-OADS,/arxiv_data1/oa_pdf/d1/2f/jkms-29-405.PMC3945137.pdf
"http://dx.doi.org/10.3346/jkms.2014.29.3.405  • J Korean Med Sci 2014; 29: 405-410 INTRODUCTION Pituitary adenoma (PA), comprising 10%-15% of intracranial  neoplasms, is the most common benign neuroendocrine tu - mor of the central nervous system (1-5).",Non-OADS,/arxiv_data1/oa_pdf/d1/2f/jkms-29-405.PMC3945137.pdf
"• Pituitary Adenoma 406  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.405from 2006-2011 and reviewed the patients’ medical records, pa- thology reports, radiological findings and immunohistochemi - cal studies retrieved from the Seoul National University Hospi - tal (SNUH) archives.",OADS,/arxiv_data1/oa_pdf/d1/2f/jkms-29-405.PMC3945137.pdf
• Pituitary Adenoma http://jkms.org   407 http://dx.doi.org/10.3346/jkms.2014.29.3.405Table 2.,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/jkms-29-405.PMC3945137.pdf
• Pituitary Adenoma 408  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.405with visual problem (71.4%) and one goiter (14.3%) and remain - ing one case (14.3%) was incidentally found.,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/jkms-29-405.PMC3945137.pdf
"• Pituitary Adenoma http://jkms.org   409 http://dx.doi.org/10.3346/jkms.2014.29.3.405ed adverse effects, such as visual field defects, hypopituitarism,  or radiation change (4, 11).",Non-OADS,/arxiv_data1/oa_pdf/d1/2f/jkms-29-405.PMC3945137.pdf
• Pituitary Adenoma 410  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.405specimen bias because we analyzed surgically resected and im - munohistochemistry proven cases only.,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/jkms-29-405.PMC3945137.pdf
ORCID Hwa Jin Cho  http://orcid.org/0000-0002-7613-1942 Jeong Wook Seo  http://orcid.org/0000-0003-0242-1805 Jung Min Yun  http://orcid.org/0000-0002-7141-0440 Sung-Hye Park  http://orcid.org/0000-0002-8681-1597 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/jkms-29-405.PMC3945137.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Validity of the Korean Version of the Fear of Alzheimer’s Disease  Scale for the Assessment of Anticipatory Dementia Anticipatory dementia is related to anxiety, which is a clinical predictor of early conversion  to Alzheimer’s disease.",Non-OADS,/arxiv_data1/oa_pdf/8d/a1/jkms-29-411.PMC3945138.pdf
"Keywords:  Alzheimer Disease; Anticipatory Dementia; Scale; Anxiety; Cognitive  Impairment; KoreaYeonsil Moon,1 Hee-Jin Kim,2   Hojin Choi,3 Seong-il Oh,2   and Seol-Heui Han1,4 1Department of Neurology, Konkuk University  Medical Center, Seoul; 2Department of Neurology,  College of Medicine, Hanyang University, Seoul;  3Department of Neurology, Hanyang University Guri  Hospital, Guri; 4Center for Geriatric Neuroscience  Research, Institute of Biomedical Science, Konkuk  Medical Science Research Center, Konkuk University,  Seoul, Korea Received: 26 September 2013 Accepted: 19 December 2013 Address for Correspondence: Seol-Heui Han, MD Department of Neurology, Konkuk University Medical Center,  120-1 Neungdong-ro, Gwangjin-gu, Seoul 143-729, Korea Tel: +82.2-2030-7460, Fax: +82.2-2030-7469 E-mail: alzdoc@kuh.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.3.411  • J Korean Med Sci 2014; 29: 411-415 INTRODUCTION As Alzheimer’s disease (AD) becomes of increasing interest to  the general population, concerns over developing dementia or  AD also increase.",Non-OADS,/arxiv_data1/oa_pdf/8d/a1/jkms-29-411.PMC3945138.pdf
• The Korean Version of FADS 412  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.411were similar to procedures used for the FADS.,Non-OADS,/arxiv_data1/oa_pdf/8d/a1/jkms-29-411.PMC3945138.pdf
"• The Korean Version of FADS http://jkms.org   413 http://dx.doi.org/10.3346/jkms.2014.29.3.41126, 28, and 29) fell below the recommended level of 0.60.",Non-OADS,/arxiv_data1/oa_pdf/8d/a1/jkms-29-411.PMC3945138.pdf
• The Korean Version of FADS 414  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.411DISCUSSION The present study indicates that the K ­FADS is a reliable and  valid scale to quantify anticipatory dementia.,Non-OADS,/arxiv_data1/oa_pdf/8d/a1/jkms-29-411.PMC3945138.pdf
• The Korean Version of FADS http://jkms.org   415 http://dx.doi.org/10.3346/jkms.2014.29.3.411ORCID Yeonsil Moon http://orcid.org/0000-0001-7770-4127  Hee­ Jin Kim http://orcid.org/0000-0001-7880-690X  Hojin Choi http://orcid.org/0000-0002-9637-4423 Seong­il Oh http://orcid.org/0000-0002-8067-2135  Seol­Heui Han http://orcid.org/0000-0003-3608-2514  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8d/a1/jkms-29-411.PMC3945138.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Prophylactic Effect of Erythropoietin Injection to Prevent Acute  Mountain Sickness: An Open-Label Randomized Controlled  Trial This study was performed to evaluate whether increasing hemoglobin before ascent by  prophylactic erythropoietin injections prevents acute mountain sickness (AMS).",Non-OADS,/arxiv_data1/oa_pdf/36/de/jkms-29-416.PMC3945139.pdf
"Erythropoietin and  sildenafil were provided by CJ Pharmaceutical.http://dx.doi.org/10.3346/jkms.2014.29.3.416  • J Korean Med Sci 2014; 29: 416-422 INTRODUCTION Acute mountain sickness (AMS) is characterized by headache  in an unacclimatized person who recently arrived at an altitude  above 2,500 m, plus one or more of the following: gastrointesti - nal symptoms, weakness, dizziness or lightheadedness, and  difficulty sleeping (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/36/de/jkms-29-416.PMC3945139.pdf
• Erythropoietin and Acute Mountain Sickness http://jkms.org   417 http://dx.doi.org/10.3346/jkms.2014.29.3.41645 subjects with Hb ≤ 15.5 g/dL volunteered to participate.,Non-OADS,/arxiv_data1/oa_pdf/36/de/jkms-29-416.PMC3945139.pdf
• Erythropoietin and Acute Mountain Sickness 418  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.416the Asan Medical Center.,Non-OADS,/arxiv_data1/oa_pdf/36/de/jkms-29-416.PMC3945139.pdf
• Erythropoietin and Acute Mountain Sickness http://jkms.org   419 http://dx.doi.org/10.3346/jkms.2014.29.3.416SaO 2.,Non-OADS,/arxiv_data1/oa_pdf/36/de/jkms-29-416.PMC3945139.pdf
"• Erythropoietin and Acute Mountain Sickness 420  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.416nificantly decreased LLS scores, AMS incidence, and the num - ber of subjects who met immediate descent criteria.",Non-OADS,/arxiv_data1/oa_pdf/36/de/jkms-29-416.PMC3945139.pdf
• Erythropoietin and Acute Mountain Sickness http://jkms.org   421 http://dx.doi.org/10.3346/jkms.2014.29.3.416during their stay at Deurali and ABC.,Non-OADS,/arxiv_data1/oa_pdf/36/de/jkms-29-416.PMC3945139.pdf
ORCID Kyoung Heo  http://orcid.org/0000-0002-0790-9837 Joong Koo Kang http://orcid.org/0000-0003-0941-3824  Chang Min Choi http://orcid.org/0000-0002-2881-4669   Moo Song Lee http://orcid.org/0000-0003-1085-9073  Kyoung Woo Noh http://orcid.org/0000-0001-7149-435X  Soon Bae Kim http://orcid.org/0000-0003-1649-0318 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/36/de/jkms-29-416.PMC3945139.pdf
Available at http://www.usariem.army.mil/assets/docs/partner - ing/TB-Med-505-Sept-2010.pdf [accessed on 22 May 2012].,OADS,/arxiv_data1/oa_pdf/36/de/jkms-29-416.PMC3945139.pdf
• Erythropoietin and Acute Mountain Sickness 422  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.416etin abuse in athletes.,Non-OADS,/arxiv_data1/oa_pdf/36/de/jkms-29-416.PMC3945139.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Extended Rapid Response System: 1-Year Experience in a  University Hospital The rapid response system (RRS) is an innovative system designed for in-hospital, at-risk  patients but underutilization of the RRS generally results in unexpected cardiopulmonary  arrests.",Non-OADS,/arxiv_data1/oa_pdf/01/89/jkms-29-423.PMC3945140.pdf
"Unfortunately, patients who experienced a delayed  RRS call have been shown to have a markedly increased mor -http://dx.doi.org/10.3346/jkms.2014.29.3.423  • J Korean Med Sci 2014; 29: 423-430ORIGINAL ARTICLE Emergency & Critical Care Medicine",Non-OADS,/arxiv_data1/oa_pdf/01/89/jkms-29-423.PMC3945140.pdf
• The Extended Rapid Response System 424  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.423tality rate compared with those who received a timely call (19- 23).,Non-OADS,/arxiv_data1/oa_pdf/01/89/jkms-29-423.PMC3945140.pdf
• The Extended Rapid Response System http://jkms.org   425 http://dx.doi.org/10.3346/jkms.2014.29.3.423in each hospital wards (23 wards) for three times (69 education  sessions over 3 months).,Non-OADS,/arxiv_data1/oa_pdf/01/89/jkms-29-423.PMC3945140.pdf
"• The Extended Rapid Response System 426  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.423Feedback We reviewed all the screened patients every week and held con - ferences each month to report monthly results (incidence of  unexpected arrest and the analysis of related factors) to the chief  of the department of Q.I., the hospital president, head nurses of  the general wards and intensive care units, and the chief of the  ‘Risk Management Team (RMT)’ .",Non-OADS,/arxiv_data1/oa_pdf/01/89/jkms-29-423.PMC3945140.pdf
• The Extended Rapid Response System http://jkms.org   427 http://dx.doi.org/10.3346/jkms.2014.29.3.423Table 4.,Non-OADS,/arxiv_data1/oa_pdf/01/89/jkms-29-423.PMC3945140.pdf
"• The Extended Rapid Response System 428  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.423duced by 15.3%, from 1.63 to 1.38 per 100 discharges (Fig.",OADS,/arxiv_data1/oa_pdf/01/89/jkms-29-423.PMC3945140.pdf
• The Extended Rapid Response System http://jkms.org   429 http://dx.doi.org/10.3346/jkms.2014.29.3.423of screened patients needed only consultation and monitoring  of vital signs.,Non-OADS,/arxiv_data1/oa_pdf/01/89/jkms-29-423.PMC3945140.pdf
ORCID Hyun Jung Kwak http://orcid.org/0000-0001-9540-1357   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/01/89/jkms-29-423.PMC3945140.pdf
• The Extended Rapid Response System 430  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.423istics of preventable iatrogenic cardiac arrests.,Non-OADS,/arxiv_data1/oa_pdf/01/89/jkms-29-423.PMC3945140.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Current Status of Intensive Care Units Registered as Critical Care  Subspecialty Training Hospitals in Korea  There is a lack of information on critical care in Korea.",Non-OADS,/arxiv_data1/oa_pdf/b6/82/jkms-29-431.PMC3945141.pdf
"Keywords:  Critical Care; Intensive Care Units; Organizations; Outcome Assessment;  Personnel Staffing; KoreaSang-Hyun Kwak,1 Cheol-Won Jeong,2  Seong-Heon Lee,1 Hyun-Jeong Lee,1   and Younsuck Koh3* 1Department of Anesthesiology and Pain Medicine,  Chonnam National University Medical School,  2Department of Anesthesiology, Chonnam National  University School of Dentistry, Gwangju;  3Department of Pulmonary and Critical Care  Medicine, Asan Medical Center, University of Ulsan  College of Medicine, Seoul, Korea Received: 1 August 2013 Accepted: 10 December 2013 Address for Correspondence: Younsuck Koh, MD Department of Pulmonary and Critical Care Medicine, Asan  Medical Center, University of Ulsan College of Medicine,   88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea Tel: +82.2-3010-3134, Fax: +82.2-3010-4709 E-mail: yskoh@amc.seoul.kr This study was performed under auspices of the Korean Society  of Critical Care Medicine.http://dx.doi.org/10.3346/jkms.2014.29.3.431  • J Korean Med Sci 2014; 29: 431-437 INTRODUCTION In 1962, two university hospitals in Korea set up intensive care  units (ICUs) as postoperative respiratory care units.",Non-OADS,/arxiv_data1/oa_pdf/b6/82/jkms-29-431.PMC3945141.pdf
"• Status of Intensive Care Units in Korea 432  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.431test, linear by linear association Chi-square test, and logistic re - gression analysis were used to test the significance of differenc - es in responses, where appropriate.",OADS,/arxiv_data1/oa_pdf/b6/82/jkms-29-431.PMC3945141.pdf
"• Status of Intensive Care Units in Korea http://jkms.org   433 http://dx.doi.org/10.3346/jkms.2014.29.3.431time nurse-to-patient ratio averaged 1:2.7, and was greater in  small and medium sized hospitals than in large ones ( P< 0.001).",OADS,/arxiv_data1/oa_pdf/b6/82/jkms-29-431.PMC3945141.pdf
• Status of Intensive Care Units in Korea 434  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.431Fig.,Non-OADS,/arxiv_data1/oa_pdf/b6/82/jkms-29-431.PMC3945141.pdf
• Status of Intensive Care Units in Korea http://jkms.org   435 http://dx.doi.org/10.3346/jkms.2014.29.3.431specialists.,Non-OADS,/arxiv_data1/oa_pdf/b6/82/jkms-29-431.PMC3945141.pdf
• Status of Intensive Care Units in Korea 436  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.431Univ.,Non-OADS,/arxiv_data1/oa_pdf/b6/82/jkms-29-431.PMC3945141.pdf
ORCID Sang-Hyun Kwak http://orcid.org/0000-0001-6077-2086 Cheol-Won Jeong http://orcid.org/0000-0003-0167-2901 Seong-Heon Lee http://orcid.org/0000-0001-5568-6730 Hyun-Jeong Lee http://orcid.org/0000-0001-8373-4381 Younsuck Koh http://orcid.org/0000-0001-5066-2027 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b6/82/jkms-29-431.PMC3945141.pdf
• Status of Intensive Care Units in Korea http://jkms.org   437 http://dx.doi.org/10.3346/jkms.2014.29.3.431Care Clin 2006; 22: 407-23.,Non-OADS,/arxiv_data1/oa_pdf/b6/82/jkms-29-431.PMC3945141.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Intratracheal Administration of Umbilical Cord Blood-Derived  Mesenchymal Stem Cells in a Patient with Acute Respiratory  Distress Syndrome Umbilical cord blood (UCB)-derived mesenchymal stem cells (MSCs) have been introduced  as a possible therapy in acute lung injury and acute respiratory distress syndrome (ARDS).",Non-OADS,/arxiv_data1/oa_pdf/a5/1f/jkms-29-438.PMC3945142.pdf
"Keywords:  Acute Respiratory Distress Syndrome, Acute Lung Injury, Stem Cells, TherapyYoujin Chang, So Hee Park, Jin-Won Huh,  Chae-Man Lim, Younsuck Koh,   and Sang-Bum Hong Department of Pulmonary and Critical Care  Medicine, Asan Medical Center, College of Medicine,  University of Ulsan, Seoul, Korea Received: 10 March 2013 Accepted: 1 September 2013 Address for Correspondence: Sang-Bum Hong, MD Department of Pulmonary and Critical Care Medicine, Asan  Medical Center, College of Medicine, University of Ulsan,   86 Asanbyeongwon-gil, Songpa-gu, Seoul 138-736, Korea Tel: +82.2-3010-3893, Fax: +82.2-3010-6968 E-mail: sbhong@amc.seoul.kr This work was performed at Asan Medical Center, Seoul, Korea.http://dx.doi.org/10.3346/jkms.2014.29.3.438  • J Korean Med Sci 2014; 29: 438-440 INTRODUCTION While the recent strategies of lung-protective ventilation and  proper fluid restriction therapy have reduced mortality in pa - tients with acute lung injury (ALI) and acute respiratory distress  syndrome (ARDS), the mortality rate remains high.",Non-OADS,/arxiv_data1/oa_pdf/a5/1f/jkms-29-438.PMC3945142.pdf
"• Intratracheal Stem Cells Administration in Acute Respiratory Distress Syndrome http://jkms.org   439 http://dx.doi.org/10.3346/jkms.2014.29.3.438 On hospital day (HD) 7, he underwent tracheostomy to en - able early weaning from MV .",Non-OADS,/arxiv_data1/oa_pdf/a5/1f/jkms-29-438.PMC3945142.pdf
• Intratracheal Stem Cells Administration in Acute Respiratory Distress Syndrome 440  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.438Fig.,Non-OADS,/arxiv_data1/oa_pdf/a5/1f/jkms-29-438.PMC3945142.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Living Donor Liver Transplantation for an Infant with  Osteogenesis Imperfecta and Intrahepatic Cholestasis:   Report of a Case Osteogenesis imperfecta (OI) is a group of genetic disorders characterized by bone fragility  and connective tissue manifestations.",Non-OADS,/arxiv_data1/oa_pdf/d6/95/jkms-29-441.PMC3945143.pdf
"Keywords:  Osteogenesis Imperfecta; Liver Transplantation; Cholestatic Liver Disease;  Malignant HyperthermiaYoungRok Choi,1 Nam-Joon Yi,1   Jae Sung Ko,2 Jung Min Ko,2   Ung Sik Jin,3 Hee Soo Kim,4   Kook Hyun Lee,4 Tae-Joon Cho,5   Suk-Won Suh,1 Tae Yoo,1   Kwang-Woong Lee,1 and Kyung-Suk Suh1 Departments of 1Surgery, 2Pediatrics and Adolescent  Medicine, 3Plastic and Reconstructive Surgery,  4Anesthesiology and Pain Medicine, and 5Orthopaedic  Surgery, Seoul National University College of  Medicine, Seoul, Korea Received: 1 June 2013 Accepted: 20 August 2013 Address for Correspondence: Nam-Joon Yi, MD Department of Surgery, Seoul National University College of  Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea Tel: +82.10-8288-7959, Fax: +82.2-766-3975  E-mail: gsleenj@hanmail.nethttp://dx.doi.org/10.3346/jkms.2014.29.3.441  • J Korean Med Sci 2014; 29: 441-444 INTRODUCTION Osteogenesis imperfecta (OI) is a heterogeneous group of dis - eases characterized by congenital bone fragility, low bone mass,  subsequent development of the spine and limb deformities.",Non-OADS,/arxiv_data1/oa_pdf/d6/95/jkms-29-441.PMC3945143.pdf
• Liver Transplantation with Osteogenesis Imperfacta and Cholestasis 442  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.441portal fibrosis and damaged bile ducts without definite cause.,Non-OADS,/arxiv_data1/oa_pdf/d6/95/jkms-29-441.PMC3945143.pdf
• Liver Transplantation with Osteogenesis Imperfacta and Cholestasis http://jkms.org   443 http://dx.doi.org/10.3346/jkms.2014.29.3.441venoplasty.,Non-OADS,/arxiv_data1/oa_pdf/d6/95/jkms-29-441.PMC3945143.pdf
"• Liver Transplantation with Osteogenesis Imperfacta and Cholestasis 444  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.441fragility could be overcome with preoperative pamidronate in - fusion therapy, omission of mechanical retractors replacing with  skin traction, meticulous surgical techniques, and planning the  operation.",Non-OADS,/arxiv_data1/oa_pdf/d6/95/jkms-29-441.PMC3945143.pdf
ORCID YoungRok Choi http://orcid.org/0000-0003-2408-7086  Nam-Joon Yi http://orcid.org/0000-0002-5467-425X Jae Sung Ko http://orcid.org/0000-0002-3064-2974 Jung Min Ko http://orcid.org/0000-0002-0407-7828 Ung Sik Jin http://orcid.org/0000-0001-5096-6207 Tae-Joon Cho http://orcid.org/0000-0001-8514-377X  Suk-Won Suh http://orcid.org/0000-0001-6111-9601  Tae Yoo http://orcid.org/0000-0003-3834-7125 Kwang-Woong Lee http://orcid.org/0000-0001-6412-1926   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d6/95/jkms-29-441.PMC3945143.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Computed Tomography and Magnetic Resonance Images of  Adrenocortical Oncocytoma Cases We present two cases of adrenocortical oncocytomas that were well-delineated on multi- detector computed tomography and magnetic resonance imaging.",Non-OADS,/arxiv_data1/oa_pdf/50/9e/jkms-29-445.PMC3945144.pdf
"Keywords:  Adrenal Glands; Neoplasms-Oncocytoma; Computed Tomography; Magnetic  Resonance ImagingJung-Hee Yoon,1 Seong-Sook Cha,2   and Seong Kuk Yoon3  1Department of Radiology, Inje University Haeundae  Paik Hospital, Busan; 2Department of Radiology, Inje  University Busan Paik Hospital, Busan; 3Department  of Radiology, Dong-A University Hospital, Busan,  Korea Received: 27 July 2013 Accepted: 15 November 2013 Address for Correspondence: Jung-Hee Yoon, MD Department of Radiology, Haeundae Paik Hospital, Inje  University College of Medicine, 875 Haeundae-ro, Haeundae- gu, Busan 612-896, Korea Tel: +82.51-797-0355, Fax: +82.51-797-0397 E-mail: radyjh@hanmail.nethttp://dx.doi.org/10.3346/jkms.2014.29.3.445  • J Korean Med Sci 2014; 29: 445-451 INTRODUCTION Adrenocortical oncocytomas are benign tumors consisting of  oncocytes in which the cytoplasm becomes eosinophilic due to  accumulation of abnormal mitochondria.",Non-OADS,/arxiv_data1/oa_pdf/50/9e/jkms-29-445.PMC3945144.pdf
"• Images of Adrenocortical Oncocytoma 446  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.445washout value ([Enhanced CT HU-Delayed CT HU]/[Enhanced  CT HU-Unenhanc  ed CT HU] × 100) was approximately 70% (a  value of more than 60% indicates adrenal adenoma), and the  relative washout value ([Enhanced CT HU-Delayed CT HU]/ Enhanced CT HU × 100) was 50% (a value of more than 40%  indicates adrenal adenoma) (9).",Non-OADS,/arxiv_data1/oa_pdf/50/9e/jkms-29-445.PMC3945144.pdf
"• Images of Adrenocortical Oncocytoma http://jkms.org   447 http://dx.doi.org/10.3346/jkms.2014.29.3.445T1-weighted gradient echo images (TR/TE: 175.0/5.0), without  a definite signal drop (suggesting a fat component) on the op - posed-phase correlated with the in phase.",Non-OADS,/arxiv_data1/oa_pdf/50/9e/jkms-29-445.PMC3945144.pdf
• Images of Adrenocortical Oncocytoma 448  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.445Fig.,Non-OADS,/arxiv_data1/oa_pdf/50/9e/jkms-29-445.PMC3945144.pdf
• Images of Adrenocortical Oncocytoma http://jkms.org   449 http://dx.doi.org/10.3346/jkms.2014.29.3.445Fig.,Non-OADS,/arxiv_data1/oa_pdf/50/9e/jkms-29-445.PMC3945144.pdf
"• Images of Adrenocortical Oncocytoma 450  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.445acteristic enhancement pattern of small (smaller than 4 cm) re - nal oncocytoma at biphasic multidetector CT (14), but there  was no definite segmental enhancement inversion in our cases.",Non-OADS,/arxiv_data1/oa_pdf/50/9e/jkms-29-445.PMC3945144.pdf
"• Images of Adrenocortical Oncocytoma http://jkms.org   451 http://dx.doi.org/10.3346/jkms.2014.29.3.445ed on its size (i.e., generally > 5 cm), central necrosis, contrast  enhancement, and frequent invasion of local organs and exten - sion into the inferior vena cava (17).",Non-OADS,/arxiv_data1/oa_pdf/50/9e/jkms-29-445.PMC3945144.pdf
ORCID Jung-Hee Yoon http://orcid.org/0000-0001-5152-6668  Seong-Sook Cha http://orcid.org/0000-0002-4753-008X Seong Kuk Yoon http://orcid.org/0000-0001-7182-1701   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/50/9e/jkms-29-445.PMC3945144.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Different Clinical Phenotypes in Familial Severe Congenital  Neutropenia Cases with Same Mutation of the ELANE Gene Severe congenital neutropenia (SCN) is a heterogeneous group of disorders with a defect in  granulopoiesis causing marked neutropenia and severe bacterial infections.",Non-OADS,/arxiv_data1/oa_pdf/ed/58/jkms-29-452.PMC3945145.pdf
"Keywords:  Severe Congenital Neutropenia; Neutrophil Elastase; InfectionHye-Kyung Cho and In Sang Jeon  Department of Pediatrics, Graduate School of  Medicine, Gachon University, Incheon, Korea Received: 11 December 2013 Accepted: 17 December 2013 Address for Correspondence: In Sang Jeon, MD  Department of Pediatrics, Graduate School of Medicine, Gachon  Universtiy, 1198 Guwoldong, Namdong-gu, Incheon 405-706,  Korea  Tel: +82.32-460-8382, Fax: +82.32-460-3224 E-mail: isjeon@gilhospital.comhttp://dx.doi.org/10.3346/jkms.2014.29.3.452  • J Korean Med Sci 2014; 29: 452-455 INTRODUCTION Severe congenital neutropenia (SCN) is a disorder of neutro - phil production predisposed to recurrent and severe bacterial  infection from early infancy.",Non-OADS,/arxiv_data1/oa_pdf/ed/58/jkms-29-452.PMC3945145.pdf
• Phenotypes of Familial Severe Congenital Neutropenia with ELANE Mutation http://jkms.org   453 http://dx.doi.org/10.3346/jkms.2014.29.3.452 Fig.,Non-OADS,/arxiv_data1/oa_pdf/ed/58/jkms-29-452.PMC3945145.pdf
• Phenotypes of Familial Severe Congenital Neutropenia with ELANE Mutation 454  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.452colony stimulating factor (G-CSF).,Non-OADS,/arxiv_data1/oa_pdf/ed/58/jkms-29-452.PMC3945145.pdf
"• Phenotypes of Familial Severe Congenital Neutropenia with ELANE Mutation http://jkms.org   455 http://dx.doi.org/10.3346/jkms.2014.29.3.452 For treatment of SCN, G-CSF is the treatment of choice since  1987.",Non-OADS,/arxiv_data1/oa_pdf/ed/58/jkms-29-452.PMC3945145.pdf
ORCID Hye-Kyung Cho  http://orcid.org/0000-0003-0990-1350 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ed/58/jkms-29-452.PMC3945145.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Characterization of Gp41 Polymorphisms in the Fusion Peptide  Domain and T-20 (Enfuvirtide) Resistance-Associated Regions in  Korean HIV-1 Isolates HIV-1 gp41 is an envelope protein that plays an essential role in virus entry.",Non-OADS,/arxiv_data1/oa_pdf/16/d3/jkms-29-456.PMC3945146.pdf
"Received: 19 August 2013 Accepted: 16 December 2013 Address for Correspondence: Sung Soon Kim, PhD  Division of AIDS, Center for Immunology and Pathology, Korea  National Institute of Health, 187 Osongsaengmyeong 2-ro,  Cheongwon 363-951, Korea Tel: +82.43-719-8410, Fax: +82.43-719-8459 E-mail: Sungskim@gmail.com This work was supported by an intramural grant from the Korea  National Institute of Health (Grant Number: 2013-NG51004-00).http://dx.doi.org/10.3346/jkms.2014.29.3.456  • J Korean Med Sci 2014; 29: 456-459 AIDS is a disease caused by HIV infection, which destroys the  CD4 T cells responsible for cell-mediated immunity in the hu - man body, thereby undermining the immune system.",Non-OADS,/arxiv_data1/oa_pdf/16/d3/jkms-29-456.PMC3945146.pdf
"• Gp41 Polymorphisms in Korean HIV-1 Isolates http://jkms.org   457 http://dx.doi.org/10.3346/jkms.2014.29.3.456tide, which is a homolog of amino acids 127-162 in the HR2 re - gion, was approved as a new class of antiretroviral drug that tar - gets the HR1 domain of gp41 (7).",Non-OADS,/arxiv_data1/oa_pdf/16/d3/jkms-29-456.PMC3945146.pdf
"• Gp41 Polymorphisms in Korean HIV-1 Isolates 458  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.3.456(15.4%), S138A (8.6%), N42S/S137A (0.5%), and N42S/L44M/ E137K (0.5%) in the USA (20).",Non-OADS,/arxiv_data1/oa_pdf/16/d3/jkms-29-456.PMC3945146.pdf
DISCLOSURE The authors declare that they have no competing interests.ORCID Dai-Ho Jang http://orcid.org/0000-0002-0691-9857 Cheol-Hee Yoon http://orcid.org/0000-0002-5696-0567 Byeong-Sun Choi http://orcid.org/0000-0002-6128-7995 Yoon-Seok Chung http://orcid.org/0000-0003-4562-5533 Hye-Young Kim http://orcid.org/0000-0001-9664-2179 Sung-Gil Chi http://orcid.org/0000-0003-4643-9003 Sung Soon Kim http://orcid.org/0000-0003-2774-6710  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/16/d3/jkms-29-456.PMC3945146.pdf
• Gp41 Polymorphisms in Korean HIV-1 Isolates http://jkms.org   459 http://dx.doi.org/10.3346/jkms.2014.29.3.45612.,Non-OADS,/arxiv_data1/oa_pdf/16/d3/jkms-29-456.PMC3945146.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Erratum: Correction of Notes Safe Re-administration of Tumor Necrosis Factor-alpha (TNF α) Inhibitors in  Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed  Active Tuberculosis on Previous Anti-TNF α Therapy Young Sun Suh, Seung-ki Kwok, Ji Hyeon Ju, Kyung-Su Park, Sung-Hwan Park, and Chong-Hyeon Yoon Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea  To the Editor: We found an error in our published article.",Non-OADS,/arxiv_data1/oa_pdf/10/d4/jkms-29-460.PMC3945147.pdf
http://dx.doi.org/10.3346/jkms.2014.29.3.460  • J Korean Med Sci 2014; 29: 460CORRESPONDENCE,Non-OADS,/arxiv_data1/oa_pdf/10/d4/jkms-29-460.PMC3945147.pdf
http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/44/c7/tp-96-774.PMC3945296.pdf
"1 Copyright © 2014 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286Concerns about maintenance of  natural teeth and dental implants Tae-Il Kim Department of Periodontology, Seoul National University School of Dentistry, Seoul, Korea Editorial J Periodontal Implant Sci 2014;44:1-1 http://dx.doi.org/10.5051/jpis.2014.44.1.1 Received:  Feb. 4, 2014 Accepted:  Feb. 4, 2014 *Correspondence:   Tae-Il Kim (Editor-in-Chief) Department of Periodontology, Seoul National  University School of Dentistry, 101 Daehak-ro, Jongno-gu, Seoul 110-749, Korea E-mail: periopf@snu.ac.kr   Tel: +82-2-2072-2642   Fax: +82-2-744-1349Periodontal disease is still prevalent according to the recent report from US Centers for  Disease Control and Prevention (CDC) (doi: 10.1177/0022034512457373).",Non-OADS,/arxiv_data1/oa_pdf/fa/a3/jpis-44-1.PMC3945390.pdf
ORCID Tae-Il Kim  http://orcid.org/0000-0003-4087-8021   This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/fa/a3/jpis-44-1.PMC3945390.pdf
"13 Copyright © 2014 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286Delayed intentional replantation of  periodontally hopeless teeth:   a retrospective study Eun-Ung Lee1, Hyun-Chang Lim1, Jung-Seok Lee1, Ui-Won Jung1,   Ui-Sung Kim2, Seung-Jong Lee2, Seong-Ho Choi1,* 1Department of Periodontology, Research Institute for Periodontal Regeneration, Yonsei University College    of Dentistry, Seoul, Korea   2Microscope Center, Department of Conservative Dentistry and Oral Science Research Center,    Yonsei University College of Dentistry, Seoul, KoreaResearch   Article J Periodontal Implant Sci 2014;44:13-19 http://dx.doi.org/10.5051/jpis.2014.44.1.13 Purpose:  The purpose of this study was to retrospectively evaluate the survival of periodon - tally hopeless teeth that were intentionally extracted and replanted after a delay and to com - pare the radiographic characteristics of the survival group with those of the failure group.",Non-OADS,/arxiv_data1/oa_pdf/d7/35/jpis-44-13.PMC3945391.pdf
"More - over, the increased mobility of a treated tooth can affect the outcome of periodontal  This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/d7/35/jpis-44-13.PMC3945391.pdf
ORCID Hyun-Chang Lim  http://orcid.org/0000-0001-7695-1708  Ui-Won Jung  http://orcid.org/0000-0001-6371-4172 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d7/35/jpis-44-13.PMC3945391.pdf
"Min Zheng1,2,†, Li Li1,2,†, Yaling Tang1,3,*, Xin-Hua Liang1,4,* 1Department of Stomatology, Zhou Shan Hospital, Zhoushan Zhejiang, China   2State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University,    Chengdu Sichuan, China   3Department of Oral Pathology, West China Hospital of Stomatology, Sichuan University,    Chengdu Sichuan, China   4Department of Oral and Maxillofacial Surgery, West China College of Stomatology, Sichuan University,    Chengdu Sichuan, ChinaReview   Article J Periodontal Implant Sci 2014;44:2-7 http://dx.doi.org/10.5051/jpis.2014.44.1.2 Implants have been widely used in restorative treatment for patients who have undergone  head and neck cancer surgery.",Non-OADS,/arxiv_data1/oa_pdf/c3/82/jpis-44-2.PMC3945392.pdf
"This review mainly focuses on the success rate of implants, tissue changes after ra -This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/c3/82/jpis-44-2.PMC3945392.pdf
"20 Copyright © 2014 Korean Academy of PeriodontologyIntentional passive eruption combined  with scaling and root planing of  teeth with moderate chronic  periodontitis and traumatic occlusion Ji-Young Joo, Eun-Young Kwon, Ju-Youn Lee* Department of Periodontology, Pusan National University School of Dentistry, Yangsan, Korea Research   Article J Periodontal Implant Sci 2014;44:20-24 http://dx.doi.org/10.5051/jpis.2014.44.1.20 Purpose:  The aim of this clinical trial was to explore the impact of intentional passive  eruption (IPE) using occlusal reduction on the periodontal parameters of teeth with mod - erate chronic periodontitis and traumatic occlusion.",Non-OADS,/arxiv_data1/oa_pdf/2a/b0/jpis-44-20.PMC3945393.pdf
Occlusal adjustment (OA) does  This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/2a/b0/jpis-44-20.PMC3945393.pdf
ORCID Ju-Youn Lee  http://orcid.org/0000-0002-0772-033X REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/2a/b0/jpis-44-20.PMC3945393.pdf
"25 Copyright © 2014 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286Omega 3 fatty acids as a host  modulator in chronic periodontitis  patients: a randomised, double-blind,  palcebo-controlled, clinical trial Girish D. Deore*, Abhijit N. Gurav, Rahul Patil, Abhijeet R. Shete,   Ritam S. NaikTari, Saurabh P. Inamdar Department of Periodontology, Tatyasaheb Kore Dental College and Research Centre, New Pargaon,  Kolhapur, Maharashtra, India Research   Article J Periodontal Implant Sci 2014;44:25-32 http://dx.doi.org/10.5051/jpis.2014.44.1.25 Purpose:  Periodontitis is an infectious disease caused predominantly by gram-negative an - erobes.",Non-OADS,/arxiv_data1/oa_pdf/1a/d7/jpis-44-25.PMC3945394.pdf
HMT aims to reduce tissue destruction and  This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/d7/jpis-44-25.PMC3945394.pdf
ORCID Girish D. Deore  http://orcid.org/0000-0001-8034-3641 Abhijit N. Gurav  http://orcid.org/0000-0002-1530-5160 Rahul Patil  http://orcid.org/0000-0002-9066-5705 Abhijeet R. Shete  http://orcid.org/0000-0001-6871-9749 Ritam S. NaikTari  http://orcid.org/0000-0002-0923-4829 Saurabh P. Inamdar  http://orcid.org/0000-0003-1584-1403 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1a/d7/jpis-44-25.PMC3945394.pdf
"33 Copyright © 2014 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286Alveolar ridge augmentation with the  perforated and nonperforated bone  grafts Erica Dorigatti de Avila1,*, José Scarso Filho2,   Lizete Toledo de Oliveira Ramalho3, Mario Francisco Real Gabrielli2,   Valfrido Antônio Pereira Filho2 1Department of Dental Materials and Prosthodontics, Araraquara School of Dentistry, UNESP Univ Estadual    Paulista, Campus Araraquara, Araraquara, Brazil   2Department of Diagnosis and Surgery, Araraquara School of Dentistry, UNESP Univ Estadual Paulista,    Campus Araraquara, Araraquara, Brazil   3Department of Morphology, Araraquara School of Dentistry, São Paulo State University, Araraquara, BrazilResearch   Article J Periodontal Implant Sci 2014;44:33-38 http://dx.doi.org/10.5051/jpis.2014.44.1.33 Purpose:  Autogenous bones are frequently used because of their lack of antigenicity, but  good osteoconductive and osteoinductive properties.",Non-OADS,/arxiv_data1/oa_pdf/91/51/jpis-44-33.PMC3945395.pdf
This study  This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/91/51/jpis-44-33.PMC3945395.pdf
ORCID Erica Dorigatti de Avila  http://orcid.org/0000-0001-6681-1269 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/91/51/jpis-44-33.PMC3945395.pdf
"39 Copyright © 2014 Korean Academy of PeriodontologypISSN 2093-2278 eISSN 2093-2286Advanced peri-implantitis cases with  radical surgical treatment  Shane J.J. McCrea* The Dental Implant and Gingival-Plastic Surgery Centre, Bournemouth, UK  Case Report J Periodontal Implant Sci 2014;44:39-47 http://dx.doi.org/10.5051/jpis.2014.44.1.39 Purpose:  Peri-implantitis, a clinical term describing the inflammatory process that affects  the soft and hard tissues around an osseointegrated implant, may lead to peri-implant  pocket formation and loss of supporting bone.",Non-OADS,/arxiv_data1/oa_pdf/fc/80/jpis-44-39.PMC3945396.pdf
"However, the lack   This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/fc/80/jpis-44-39.PMC3945396.pdf
"8 Copyright © 2014 Korean Academy of PeriodontologySurvival of 352 titanium implants  placed in 181 patients: a 4-year  multicenter field study Seung-Il Shin1,†, Jeong-Ho Yun2,†, Sung-Geun Kim3, Byoungkyou Park3,   Yeek Herr1, Jong-Hyuk Chung1,* 1Department of Periodontology, Institute of Oral Biology, Kyung Hee University School of Dentistry, Seoul,    Korea   2Division of Periodontology, Department of Dentistry, Inha University School of Medicine, Incheon, Korea   3Department of Periodontology, Kyung Hee University School of Dentistry, Seoul, KoreaResearch   Article J Periodontal Implant Sci 2014;44:8-12 http://dx.doi.org/10.5051/jpis.2014.44.1.8 Purpose:  The aim of this retrospective chart review was to evaluate the four-year survival  rate of a titanium implant system.",Non-OADS,/arxiv_data1/oa_pdf/41/ab/jpis-44-8.PMC3945397.pdf
"Such an implant system, characterized by a sand-blasted, thermally acid-etched surface,  machined collar, and internal hexagonal implant/abutment connection, was introduced in This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/41/ab/jpis-44-8.PMC3945397.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4308 | DOI: 10.1038/srep04308 8",Non-OADS,/arxiv_data1/oa_pdf/5a/92/srep04308.PMC3945482.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/31/b8/srep04306.PMC3945486.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4306 | DOI: 10.1038/srep04306 6",Non-OADS,/arxiv_data1/oa_pdf/31/b8/srep04306.PMC3945486.pdf
All authors participated in correcting manuscript and gave approval to the final version of the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2f/ed/srep04282.PMC3945487.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4282 | DOI: 10.1038/srep04282 9",Non-OADS,/arxiv_data1/oa_pdf/2f/ed/srep04282.PMC3945487.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/66/aa/srep04257.PMC3945489.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4257 | DOI: 10.1038/srep04257 7",Non-OADS,/arxiv_data1/oa_pdf/66/aa/srep04257.PMC3945489.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4309 | DOI: 10.1038/srep04309 7,Non-OADS,/arxiv_data1/oa_pdf/66/f8/srep04309.PMC3945490.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4309 | DOI: 10.1038/srep04309 8",Non-OADS,/arxiv_data1/oa_pdf/66/f8/srep04309.PMC3945490.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4281 | DOI: 10.1038/srep04281 5",Non-OADS,/arxiv_data1/oa_pdf/6e/37/srep04281.PMC3945491.pdf
"We designed specific primers (forward: TTCTGGATAAAGCACACAGAAA; re- verse: CCAAATTTTACAAACTCCTGAACC), in order to am- plify 150 bp including the V617F codon (NM_004972.3:c.1745- 1895), using the Primer 3 software ( http://www.bioinformatics.",OADS,/arxiv_data1/oa_pdf/0b/21/277_2013_Article_1920.PMC3945640.pdf
"Retrieved February 22, 2013, online at http://www.ncbi.nlm.nih.gov/books/NBK64137/ pdf/TOC.pdf .",Non-OADS,/arxiv_data1/oa_pdf/f3/f7/11292_2013_Article_9187.PMC3945711.pdf
http://amityfoundationpress.org/?p=98 .,Non-OADS,/arxiv_data1/oa_pdf/f3/f7/11292_2013_Article_9187.PMC3945711.pdf
"Retrieved February 27, 2013, online at http://bjs.ojp.usdoj.gov/content/pub/pdf/cpus11.pdf .",OADS,/arxiv_data1/oa_pdf/f3/f7/11292_2013_Article_9187.PMC3945711.pdf
"Retrieved February 25, 2013, online at https://www.slu.edu/Documents/ professional_studies/prison_program/Three-Year%20Reincarceration%20Outcomes%20for%20In-Prison%20Therapeutic%20Community%20Treatment%20in%20Texas.pdf .A computerized intervention for offenders with SUD 123",Non-OADS,/arxiv_data1/oa_pdf/f3/f7/11292_2013_Article_9187.PMC3945711.pdf
"RetrievedFebruary 22, 2013, online at http://bjs.ojp.usdoj.gov/content/pub/pdf/hivp08.pdf .",Non-OADS,/arxiv_data1/oa_pdf/f3/f7/11292_2013_Article_9187.PMC3945711.pdf
"Retrieved February 22, 2013, online at http://bjs.ojp.usdoj.gov/content/pub/pdf/dudsfp04.pdf .",Non-OADS,/arxiv_data1/oa_pdf/f3/f7/11292_2013_Article_9187.PMC3945711.pdf
"Retrieved February 22, 2013, online at http://oas.samhsa.gov/NSDUH/ 2k10NSDUH/2k10Results.pdf .",Non-OADS,/arxiv_data1/oa_pdf/f3/f7/11292_2013_Article_9187.PMC3945711.pdf
"Author manuscript retrieved February 25, 2013, from the NIHMS public access website at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2266078/ .",Non-OADS,/arxiv_data1/oa_pdf/f3/f7/11292_2013_Article_9187.PMC3945711.pdf
"In this article by Xiao Wei Tan and colleagues ( Molecular Vision v18:1402-1410 ), the following corrections were made: In the title, abstract, and introduction, the gene symbol TAZ was corrected to be WW Domain Containing Transcription  Regulator (WWTR1/TAZ).Molecular Vision  2014; 20:284-284 <http://www.molvis.org/molvis/v 20/284> Received 19 January 2014 | Accepted 5 March 2014 | Published 5 March 2014© 2014 Molecular Vision 284Erratum: WW Domain Containing Transcription Regulator  regulates human conjunctiva epithelial cell proliferation via  inhibiting TGFβ signaling pathway Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R.",Non-OADS,/arxiv_data1/oa_pdf/16/ab/mv-v20-284.PMC3945738.pdf
"We also  thank Haibo Qin and colleagues of the microbiology laboratory of Sojo University for their excellent technical assistance.Molecular Vision  2014; 20:283-283 <http://www.molvis.org/molvis/v 20/283> Received 30 December 2013 | Accepted 5 March 2014 | Published 5 March 2014© 2014 Molecular Vision 283Erratum: Protective effect of canolol from oxidative stress- induced cell damage in ARPE-19 cells via an ERK mediated  antioxidative pathway Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R.",Non-OADS,/arxiv_data1/oa_pdf/a8/42/mv-v20-283.PMC3945751.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/79/6e/srep04310.PMC3945784.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4310 | DOI: 10.1038/srep04310 6",Non-OADS,/arxiv_data1/oa_pdf/79/6e/srep04310.PMC3945784.pdf
"The validity of these results, however,  remains unconfirmed, with few of the reported susceptibility  variants having been consistently replicated [ 25].Molecular Vision  2014; 20:200-214 <http://www.molvis.org/molvis/v 20/200> Received 23 February 2013 | Accepted 28 February 2014 | Published 3 March 2014© 2014 Molecular Vision 200Candidate gene association study for diabetic retinopathy in  Chinese patients with type 2 diabetes Xiufen Yang,1,2 Yu Deng,1,3 Hong Gu,1 Xuetao Ren,1,4 Na Li,1 Apiradee Lim,5 Torkel Snellingen,4 Xipu Liu,4  Ningli Wang,1 Ningpu Liu1 1Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences  Key Laboratory, Beijing, China; 2Department of Ophthalmology, the Friendship Hospital, Capital Medical University, Beijing,  China; 3Department of Ophthalmology, Fu Xing Hospital, Capital Medical University, Beijing, China; 4Sekwa Institute of Vision  Science, Beijing, China; 5Department of Mathematics and Computer Science, Faculty of Science and Technology, Prince of  Songkla University, Pattani Campus, Pattani, Thailand Purpose:  To investigate whether variants in a set of eight candidate genes are associated with diabetic retinopathy (DR)  in a cohort of Chinese patients with type 2 diabetes mellitus (T2DM).",Non-OADS,/arxiv_data1/oa_pdf/fa/17/mv-v20-200.PMC3945804.pdf
"Molecular Vision  2014; 20:200-214 <http://www.molvis.org/molvis/v 20/200> © 2014 Molecular Vision  201Kinase insert domain receptor (KDR), also called VEGF  receptor (VEGFR) 2, is believed to be responsible for the  majority of the angiogenic and permeability-enhancing  effects of VEGF [ 32,33].",Non-OADS,/arxiv_data1/oa_pdf/fa/17/mv-v20-200.PMC3945804.pdf
"Molecular Vision  2014; 20:200-214 <http://www.molvis.org/molvis/v 20/200> © 2014 Molecular Vision  202Swab DNA Kit; Tiangen Biotech, Beijing, China).",Non-OADS,/arxiv_data1/oa_pdf/fa/17/mv-v20-200.PMC3945804.pdf
Molecular Vision  2014; 20:200-214 <http://www.molvis.org/molvis/v 20/200> © 2014 Molecular Vision  203Basic information of SNPs analyzed with allelic distri - butions is shown in Table 3.,Non-OADS,/arxiv_data1/oa_pdf/fa/17/mv-v20-200.PMC3945804.pdf
Molecular Vision  2014; 20:200-214 <http://www.molvis.org/molvis/v 20/200> © 2014 Molecular Vision  204show any statistically significant association (Table 6).,Non-OADS,/arxiv_data1/oa_pdf/fa/17/mv-v20-200.PMC3945804.pdf
"Molecular Vision  2014; 20:200-214 <http://www.molvis.org/molvis/v 20/200> © 2014 Molecular Vision  205Table  4. g eno Type frequencies  of polymorphisms  in The sTuDieD groups Gene SNP Sample size genotype DR DWR OR (CI) p-value KDRrs2071559 492 TT 84(39.3) 141(50.7) 0.034 CT 95(44.4) 103(37.1) 1.73 (1,2.98) CC 35(16.4) 34(12.2) 1.57 (1.05,2.28) rs1870377 490 TT 53(24.8) 78(28.3) 0.6 TA 113(52.8) 134(48.6) 1.24 (0.81,1.91) AA 48(22.4) 64(23.2) 1.1 (0.66,1.84) rs1870378 471 GG 54(26.9) 80(29.6) 0.8 GA 97(48.3) 126(46.7) 1.14 (0.74,1.76) AA 50(24.9) 64(23.7) 1.16 (0.7,1.92) rs13109660 490 GG 102(47.9) 127(45.8) 0.9 GA 93(43.7) 125(45.1) 0.93 (0.64,1.35) AA 18(8.5) 25(9) 0.9 (0.46,1.73)",Non-OADS,/arxiv_data1/oa_pdf/fa/17/mv-v20-200.PMC3945804.pdf
"Molecular Vision  2014; 20:200-214 <http://www.molvis.org/molvis/v 20/200> © 2014 Molecular Vision  206Gene SNP Sample size genotype DR DWR OR (CI) p-value VEGFrs699947 495 CC 105(48.6) 162(58.1) <0.001 CA 79(36.6) 104(37.3) 1.17 (0.8,1.72) AA 32(18.4) 13(4.7) 3.80 (1.91,7.57) rs833061 491 TT 104(49.1) 158(56.6) 0.001 CT 78(36.8) 108(38.7) 1.1 (0.75,1.61) CC 30(14.2) 13(4.7) 3.6 (1.79,7.22) rs13207351 491 GG 105(48.8) 158(57.2) <0.001 GA 78(36.3) 105(38) 1.12 (0.76,1.64) AA 32(14.9) 13(4.7) 3.7 (1.86,7.39) rs2146323 490 CC 112(52.3) 167(60.5) 0.006 CA 72(33.6) 93(33.7) 1.15 (0.78,1.7) AA 30(14) 16(5.8) 2.8 (1.46,5.37) rs3025021 491 TT 5(2.4) 9(3.2) 0.21 CT 48(22.6) 81(29) 1.07 (0.34,3.37) CC 159(75) 189(67.7) 1.51 (0.5,4.61) rs833069 497 GG 40(18.6) 58(20.6) 0.82 GA 105(48.8) 138(51.8) 1.1 (0.69,1.78) AA 70(18.6) 86(30.5) 1.18 (0.71,1.97) rs2010963 495 GG 70(32.6) 84(30) 0.47 GC 111(51.6) 140(50) 0.95 (0.64,1.42) CC 34(15.8) 56(20) 0.73 (0.43,1.24) rs3025039 498 CC 137(63.7) 198(70.0) 0.15 CT 69(32.1) 47(28.3) 2.6 (0.85,7.93) TT 9(4.2) 5(1.8) 1.25 (0.85,1.84) ICAM-1rs5498 492 AA 92(42.8) 138(49.8) 0.078 GA 100(46.5) 123(44.4) 1.22 (0.84,1.77) GG 23(10.7) 16(5.8) 2.16 (1.08,4.30)",Non-OADS,/arxiv_data1/oa_pdf/fa/17/mv-v20-200.PMC3945804.pdf
"Molecular Vision  2014; 20:200-214 <http://www.molvis.org/molvis/v 20/200> © 2014 Molecular Vision  207Gene SNP Sample size genotype DR DWR OR (CI) p-value EPOrs507392 496 TT 141(65.3) 181(64.6) 0.68 CT 65(30.1) 81(28.9) 1.03 (0.69,1.53) CC 10(4.6) 18(6.4) 0.71 (0.32,1.59) rs551238 494 AA 141(65.3) 182(65.5) CA 65(30.1) 79(28.4) 1.06 (0.72,1.58) 0.74 CC 10(4.6) 17(6.1) 0.76 (0.34,1.71) rs1617640 491 TT 146(69.2) 182(65) GT 55(26.1) 82(29.3) 0.84 (0.56,1.25) 0.61 GG 10(4.7) 16(5.7) 0.78 (0.34,1.77) AKR1B1759853 471 GG 145(70.7) 167(62.8) GA 54(26.3) 91(34.2) 0.68 (0.46,1.02) 0.18 AA 6(2.9) 8(3.0) 0.86 (0.29,2.55) ACE1800764 494 TT 88(40.9) 98(35.1) 0.31 CT 99(46.0) 134(48) 0.83 (0.56,1.23) CC 28(13) 47(16.8) 0.65 (0.38,1.14) rs9896208 496 CC 79(36.6) 84(30) 0.056 TC 97(44.9) 156(55.7) 0.66 (0.44,0.98) TT 40(18.5) 40(14.3) 1.06 (0.62,1.82) PKC-β3,900,007 496 AA 69(31.9) 99(35.4) 0.36 GA 111(51.4) 126(45) 1.26 (0.85,1.88) GG 36(16.7) 55(19.6) 0.94 (0.56,1.58) 2575390 499 CC 193(89.4) 251(88.7) 0.95 CG 22(10.2) 31(11.0) 0.92 (0.52,1.64) GG 1(0.5) 1(0.4) 1.3 (0.08,20.92) 3760106 492 GG 190(89.2) 248(88.9) 0.97 GA 22(10.3) 30(10.8) 1.31 (0.08,21) AA 1(0.5) 1(0.4) 0.96 (0.54,1.71) Data are expressed as number (%).The p value represents comparison between DR and diabetic without retinopathy (DWR) groups, using χ2 or Fisher ’s exact test.",Non-OADS,/arxiv_data1/oa_pdf/fa/17/mv-v20-200.PMC3945804.pdf
"Molecular Vision  2014; 20:200-214 <http://www.molvis.org/molvis/v 20/200> © 2014 Molecular Vision  208Table  5. a ssocia Tion analysis  of polymorphisms  in mul Tivaria Te moDels Gene SNP genotype Ajusted OR (CI) P value KDRrs2071559 TT 0.05 CT 1.57 (1.01,2.44) CC 1.87 (1.01,3.48) rs1870377 TT 0.64 TA 1.13 (0.69,1.85) AA 0.88 (0.48,1.6) rs1870378 GG 0.79 GA 1.1 (0.66,1.81) AA 0.91 (0.5,1.66) rs13109660 GG 0.93 GA 1.01 (0.48,2.13) AA 1.09 (0.7,1.68)",Non-OADS,/arxiv_data1/oa_pdf/fa/17/mv-v20-200.PMC3945804.pdf
"Molecular Vision  2014; 20:200-214 <http://www.molvis.org/molvis/v 20/200> © 2014 Molecular Vision  209Gene SNP genotype Ajusted OR (CI) P value VEGFrs699947 CC 0.002 CA 1.26 (0.82,1.95) AA 3.74 (1.75,8.00) rs833061 TT 0.004 CT 1.19 (0.77,1.85) CC 3.50 (1.62,7.54) rs13207351 GG 0.002 GA 1.22 (0.79,1.89) AA 3.64 (1.71,7.77) rs2146323 CC 0.014 CA 1.14 (0.73,1.77) AA 2.88 (1.4,5.93) rs3025021 TT CT 0.75 (0.2,2.78) 0.22 CC 1.14 (0.32,4.06 rs833069 GG GA 1.09 (0.63,1.89) 0.63 AA 1.3 (0.73,2.34) rs2010963 GG GC 0.89 (0.56,1.41) 0.51 CC 0.7 (0.38,1.28) rs3025039 CC 0.23 CT 1.23 (0.79,1.92) TT 2.8 (0.76,10.27) ICAM-1rs5498 AA 0.091 GA 1.44 (0.94,2.22) GG 2.04 (0.94,4.44)",Non-OADS,/arxiv_data1/oa_pdf/fa/17/mv-v20-200.PMC3945804.pdf
"Molecular Vision  2014; 20:200-214 <http://www.molvis.org/molvis/v 20/200> © 2014 Molecular Vision  210Gene SNP genotype Ajusted OR (CI) P value EPOrs507392 TT 0.88 CT 1.02 (0.65,1.61) CC 0.8 (0.32,2.02) rs551238 AA 0.94 CA 1.07 (0.67,1.68) CC 0.92 (0.36,2.36) rs1617640 TT GT 0.85 (0.53,1.36) 0.79 GG 0.94 (0.36,2.41) AKR1B1759853 GG 0.11 GA 0.62 (0.39,0.99) AA 0.59 (0.17,2.05) ACE1800764 TT 0.33 CT 0.87 (0.56,1.37) CC 0.62 (0.33,1.16) rs9896208 CC TC 0.62 (0.39,0.97) 0.097 TT 0.88 (0.47,1.63) PKC-β3900007 AA 0.82 GA 1.14 (0.72,1.8) GG 1.17 (0.64,2.14) 2575390 CC 0.78 CG 0.89 (0.46,1.71) GG 2.73 (0.1,73.85) 3760106 GG 0.81 GA 2.67 (0.1,71.35) AA 0.92 (0.48,1.77) Multiple logistic regression analysis was used to calculate odds ratio (OR) and 95% confidence interval (CI) by comparing diabetic retinopathy (DR) group with diabetic without  retinopathy (DWR) group, which include the most significant SNP at kinase insert domain receptor gene (KDR) gene ( rs2071559 ), vascular endothelial growth factor (VEGF)  gene ( rs833061 , rs13207351 , rs699947 , rs2146323 ).",Non-OADS,/arxiv_data1/oa_pdf/fa/17/mv-v20-200.PMC3945804.pdf
"Molecular Vision  2014; 20:200-214 <http://www.molvis.org/molvis/v 20/200> © 2014 Molecular Vision  211them, VEGF has been characterized as a critical angiogenic  and vasopermeability factor that is upregulated in various  retinal ischemic disorders, such as retinopathy of prematurity,  AMD, and DR [ 32], whereas anti-VEGF therapy has been  shown to be effective for patients with AMD [ 42] or diabetic  macular edema [ 43].",Non-OADS,/arxiv_data1/oa_pdf/fa/17/mv-v20-200.PMC3945804.pdf
Molecular Vision  2014; 20:200-214 <http://www.molvis.org/molvis/v 20/200> © 2014 Molecular Vision  212REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fa/17/mv-v20-200.PMC3945804.pdf
Molecular Vision  2014; 20:200-214 <http://www.molvis.org/molvis/v 20/200> © 2014 Molecular Vision  2139.,Non-OADS,/arxiv_data1/oa_pdf/fa/17/mv-v20-200.PMC3945804.pdf
Molecular Vision  2014; 20:200-214 <http://www.molvis.org/molvis/v 20/200> © 2014 Molecular Vision  214retinopathy in Chinese patients with Type 2 diabetes.,Non-OADS,/arxiv_data1/oa_pdf/fa/17/mv-v20-200.PMC3945804.pdf
"These include a mutation R128C in the RED subdomain that Molecular Vision  2014; 20:270-282 <http://www.molvis.org/molvis/v 20/270> Received 20 November 2013 | Accepted 3 March 2014 | Published 6 March 2014© 2014 Molecular Vision 270Gene regulation by PAX6: Structural-functional correlations of  missense mutants and transcriptional control of Trpm3/miR-204 Qing Xie,1 Devina Ung,1 Kamil Khafizov,3,4 Andras Fiser,3,4 Ales Cvekl1,2 1Department of Ophthalmology and Visual Sciences, Albert Einstein College of Medicine, Bronx, NY; 2Department of Genetics,  Albert Einstein College of Medicine, Bronx, NY; 3Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY;  4Department of Systems and Computational Biology, Albert Einstein College of Medicine, Bronx, NY Purpose:  Pax6  is a key regulatory gene for eye, brain, and pancreas development.",Non-OADS,/arxiv_data1/oa_pdf/36/d9/mv-v20-270.PMC3945805.pdf
"Molecular Vision  2014; 20:270-282 <http://www.molvis.org/molvis/v 20/270> © 2014 Molecular Vision  271caused foveal hypoplasia in two unrelated patients [ 27,28].",Non-OADS,/arxiv_data1/oa_pdf/36/d9/mv-v20-270.PMC3945805.pdf
Molecular Vision  2014; 20:270-282 <http://www.molvis.org/molvis/v 20/270> © 2014 Molecular Vision  272from paired Student t tests between reactions with cDNA  vector and wild-type Pax6/Pax6(5a) cDNA for each motif.,Non-OADS,/arxiv_data1/oa_pdf/36/d9/mv-v20-270.PMC3945805.pdf
Molecular Vision  2014; 20:270-282 <http://www.molvis.org/molvis/v 20/270> © 2014 Molecular Vision  273 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/36/d9/mv-v20-270.PMC3945805.pdf
Molecular Vision  2014; 20:270-282 <http://www.molvis.org/molvis/v 20/270> © 2014 Molecular Vision  2744B–D) was strongly reduced activation by PAX6(5a) N50K  using the motif 3–1 reporters (Figure 4B).,Non-OADS,/arxiv_data1/oa_pdf/36/d9/mv-v20-270.PMC3945805.pdf
"Molecular Vision  2014; 20:270-282 <http://www.molvis.org/molvis/v 20/270> © 2014 Molecular Vision  275Previous systematic studies of PAX6  missense mutants  primarily focused on the correlation between their transac - tivation and DNA-binding in in vitro assays [ 43,45,46].",Non-OADS,/arxiv_data1/oa_pdf/36/d9/mv-v20-270.PMC3945805.pdf
Molecular Vision  2014; 20:270-282 <http://www.molvis.org/molvis/v 20/270> © 2014 Molecular Vision  276P6CON [ 47].,Non-OADS,/arxiv_data1/oa_pdf/36/d9/mv-v20-270.PMC3945805.pdf
Molecular Vision  2014; 20:270-282 <http://www.molvis.org/molvis/v 20/270> © 2014 Molecular Vision  277 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/36/d9/mv-v20-270.PMC3945805.pdf
Molecular Vision  2014; 20:270-282 <http://www.molvis.org/molvis/v 20/270> © 2014 Molecular Vision  278proteins bound to the Pax6-binding site evaluated with FoldX  [45].,Non-OADS,/arxiv_data1/oa_pdf/36/d9/mv-v20-270.PMC3945805.pdf
"Molecular Vision  2014; 20:270-282 <http://www.molvis.org/molvis/v 20/270> © 2014 Molecular Vision  279increase cell proliferation, without any apparent impact on  neurogenesis.",Non-OADS,/arxiv_data1/oa_pdf/36/d9/mv-v20-270.PMC3945805.pdf
Molecular Vision  2014; 20:270-282 <http://www.molvis.org/molvis/v 20/270> © 2014 Molecular Vision  2803.,Non-OADS,/arxiv_data1/oa_pdf/36/d9/mv-v20-270.PMC3945805.pdf
Molecular Vision  2014; 20:270-282 <http://www.molvis.org/molvis/v 20/270> © 2014 Molecular Vision  281Pax6(Leca4) missense mutation on eye development.,Non-OADS,/arxiv_data1/oa_pdf/36/d9/mv-v20-270.PMC3945805.pdf
Molecular Vision  2014; 20:270-282 <http://www.molvis.org/molvis/v 20/270> © 2014 Molecular Vision  28253.,Non-OADS,/arxiv_data1/oa_pdf/36/d9/mv-v20-270.PMC3945805.pdf
"In these models [ 12,13], newborn animals that  normally vascularize their retinas postnatally are exposed Molecular Vision  2014; 20:231-241 <http://www.molvis.org/molvis/v 20/231> Received 6 December 2013 | Accepted 28 February 2014 | Published 3 March 2014© 2014 Molecular Vision 231Endothelial NADPH oxidase 4 mediates vascular endothelial  growth factor receptor 2–induced intravitreal neovascularization  in a rat model of retinopathy of prematurity Haibo Wang, Zhihong Yang, Yanchao Jiang, M. Elizabeth Hartnett The John A. Moran Eye Center, University of Utah, Salt Lake City, UT Purpose:  NADPH oxidase–generated reactive oxygen species (ROS) are implicated in angiogenesis.",Non-OADS,/arxiv_data1/oa_pdf/f6/ad/mv-v20-231.PMC3945806.pdf
Molecular Vision  2014; 20:231-241 <http://www.molvis.org/molvis/v 20/231> © 2014 Molecular Vision  232to oxygen stresses that cause intravitreal neovascularization  (IVNV) in which blood vessels grow outside the plane of  the retina into the vitreous.,Non-OADS,/arxiv_data1/oa_pdf/f6/ad/mv-v20-231.PMC3945806.pdf
"Molecular Vision  2014; 20:231-241 <http://www.molvis.org/molvis/v 20/231> © 2014 Molecular Vision  233dilution of Alexa 594-conjugated antibody for isolectin B4  and FITC-conjugated goat anti-rabbit secondary antibody  (Invitrogen, Carlsbad, CA) for NOX4.",Non-OADS,/arxiv_data1/oa_pdf/f6/ad/mv-v20-231.PMC3945806.pdf
Molecular Vision  2014; 20:231-241 <http://www.molvis.org/molvis/v 20/231> © 2014 Molecular Vision  234and Passages 2–5 were used in the experiments.,Non-OADS,/arxiv_data1/oa_pdf/f6/ad/mv-v20-231.PMC3945806.pdf
"Molecular Vision  2014; 20:231-241 <http://www.molvis.org/molvis/v 20/231> © 2014 Molecular Vision  235following primary antibodies: p-VEGFR2, total VEGFR2  (Santa Cruz Biotechnology), NOX4, p-STAT3 (Y705), and  total STAT3 (Cell Signaling Technology, Danvers, MA).",Non-OADS,/arxiv_data1/oa_pdf/f6/ad/mv-v20-231.PMC3945806.pdf
Molecular Vision  2014; 20:231-241 <http://www.molvis.org/molvis/v 20/231> © 2014 Molecular Vision  236 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/f6/ad/mv-v20-231.PMC3945806.pdf
Molecular Vision  2014; 20:231-241 <http://www.molvis.org/molvis/v 20/231> © 2014 Molecular Vision  237for time points.,Non-OADS,/arxiv_data1/oa_pdf/f6/ad/mv-v20-231.PMC3945806.pdf
"Molecular Vision  2014; 20:231-241 <http://www.molvis.org/molvis/v 20/231> © 2014 Molecular Vision  238in retinal ECs was increased in the rat OIR model at the time  point when IVNV occurred, whereas NOX4 was less preva - lent during retinal vascular development.",Non-OADS,/arxiv_data1/oa_pdf/f6/ad/mv-v20-231.PMC3945806.pdf
Molecular Vision  2014; 20:231-241 <http://www.molvis.org/molvis/v 20/231> © 2014 Molecular Vision  239pathways as a means of supporting physiologic angiogenesis  while inhibiting IVNV .,Non-OADS,/arxiv_data1/oa_pdf/f6/ad/mv-v20-231.PMC3945806.pdf
Molecular Vision  2014; 20:231-241 <http://www.molvis.org/molvis/v 20/231> © 2014 Molecular Vision  240rat.,Non-OADS,/arxiv_data1/oa_pdf/f6/ad/mv-v20-231.PMC3945806.pdf
Molecular Vision  2014; 20:231-241 <http://www.molvis.org/molvis/v 20/231> © 2014 Molecular Vision  241neovascularization and does not interfere with vasculariza - tion of avascular retina in an ROP model.,Non-OADS,/arxiv_data1/oa_pdf/f6/ad/mv-v20-231.PMC3945806.pdf
"Several independent studies have Molecular Vision  2014; 20:259-269 <http://www.molvis.org/molvis/v 20/259> Received 10 October 2013 | Accepted 28 February 2014 | Published 3 March 2014© 2014 Molecular Vision 259Adrenomedullin22-52 suppresses high-glucose-induced migration,  proliferation, and tube formation of human retinal endothelial  cells Zhigang Chen,1 Gaoqin Liu,1,2 Yanhui Xiao,1 Peirong Lu1,2 1Department of Ophthalmology, the First Affiliated Hospital of Soochow University, Suzhou, China PR; 2Jiangsu Clinical  Immunology Institute, the First Affiliated Hospital of Soochow University, Suzhou, China PR Purpose:  To investigate the roles of an adrenomedullin receptor antagonist (adrenomedullin22–52) on high-glucose- induced human retinal endothelial cell (HREC) in vitro cell biology.",Non-OADS,/arxiv_data1/oa_pdf/e5/24/mv-v20-259.PMC3945807.pdf
"Molecular Vision  2014; 20:259-269 <http://www.molvis.org/molvis/v 20/259> © 2014 Molecular Vision  260suggested that ADM could significantly promote the prolif - eration, migration and tube formation of human umbilical  vein endothelial cells [ 15-17], while those functions could  be suppressed by adrenomedullin22–52 [16,17].",Non-OADS,/arxiv_data1/oa_pdf/e5/24/mv-v20-259.PMC3945807.pdf
"Molecular Vision  2014; 20:259-269 <http://www.molvis.org/molvis/v 20/259> © 2014 Molecular Vision  261(10 ng/ml-1000 ng/ml) for 24 h, and the proliferative activity  was determined by CCK-8 assay according to the manufac - turer’s instructions.",OADS,/arxiv_data1/oa_pdf/e5/24/mv-v20-259.PMC3945807.pdf
"Molecular Vision  2014; 20:259-269 <http://www.molvis.org/molvis/v 20/259> © 2014 Molecular Vision  262detection reagents (Cell Signing Technology, Danvers, MA),  and the pictures were photographed using the ChemiDocTM  MP Imaging System (BIO-RAD, Hercules, CA).",Non-OADS,/arxiv_data1/oa_pdf/e5/24/mv-v20-259.PMC3945807.pdf
Molecular Vision  2014; 20:259-269 <http://www.molvis.org/molvis/v 20/259> © 2014 Molecular Vision  263(10 ng/ml-1000 ng/ml).,Non-OADS,/arxiv_data1/oa_pdf/e5/24/mv-v20-259.PMC3945807.pdf
"Molecular Vision  2014; 20:259-269 <http://www.molvis.org/molvis/v 20/259> © 2014 Molecular Vision  264glucose treatment markedly increased the VEGF protein  expression, while this increase was significantly blocked by  5 μg/ml adrenomedullin22–52.",Non-OADS,/arxiv_data1/oa_pdf/e5/24/mv-v20-259.PMC3945807.pdf
Molecular Vision  2014; 20:259-269 <http://www.molvis.org/molvis/v 20/259> © 2014 Molecular Vision  265DISCUSSION High glucose is considered to be an important risk factor in  the development of DR.,Non-OADS,/arxiv_data1/oa_pdf/e5/24/mv-v20-259.PMC3945807.pdf
"Molecular Vision  2014; 20:259-269 <http://www.molvis.org/molvis/v 20/259> © 2014 Molecular Vision  266equilibrium is broken, serious consequences may arise [ 22].",Non-OADS,/arxiv_data1/oa_pdf/e5/24/mv-v20-259.PMC3945807.pdf
"Molecular Vision  2014; 20:259-269 <http://www.molvis.org/molvis/v 20/259> © 2014 Molecular Vision  267decreased the phosphorylation of Akt, and treatment with  10−6mol/l partially suppressed the phosphorylation of Akt  [19].",Non-OADS,/arxiv_data1/oa_pdf/e5/24/mv-v20-259.PMC3945807.pdf
Molecular Vision  2014; 20:259-269 <http://www.molvis.org/molvis/v 20/259> © 2014 Molecular Vision  2686.,Non-OADS,/arxiv_data1/oa_pdf/e5/24/mv-v20-259.PMC3945807.pdf
Molecular Vision  2014; 20:259-269 <http://www.molvis.org/molvis/v 20/259> © 2014 Molecular Vision  26930.,Non-OADS,/arxiv_data1/oa_pdf/e5/24/mv-v20-259.PMC3945807.pdf
"The resulting Molecular Vision  2014; 20:215-230 <http://www.molvis.org/molvis/v 20/215> Received 11 November 2013 | Accepted 28 February 2014 | Published 3 March 2014© 2014 Molecular Vision 215Varied manifestations of persistent hyperplastic primary vitreous  with graded somatic mosaic deletion of a single gene Michelle N. Mary-Sinclair,1 XiaoFei Wang,2,3 Douglas J. Swanson,4 Caroline Y. Sung,1 Eneida A. Mendonca,5  Kristen Wroblewski,6 Shannon H. Baumer,7 Dan Goldowitz,4 Monica M. Jablonski,2,3 Stephen X. Skapek1 1Department of Pediatrics, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX;  2Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN; 3Department of Anatomy and  Neurobiology, University of Tennessee Health Science Center, Memphis, TN; 4Department of Medical Genetics, Centre of  Molecular Medicine and Therapeutics, CFRI, University of British Columbia, Vancouver, BC, Canada; 5Department of Pediatrics  and Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI; 6Department of Health Studies, University of  Chicago, Chicago, IL; 7Department of Pediatrics, University of Chicago, Chicago, IL Purpose:  Persistent hyperplastic primary vitreous (PHPV) represents a developmental eye disease known to have diverse  manifestations ranging from a trivial remnant of hyaloid vessels to a dense fibrovascular mass causing lens opacity and  retinal detachment.",Non-OADS,/arxiv_data1/oa_pdf/8c/0c/mv-v20-215.PMC3945809.pdf
"Molecular Vision  2014; 20:215-230 <http://www.molvis.org/molvis/v 20/215> © 2014 Molecular Vision  216hyperplastic perivascular cells provide trophic factors, such  as Vegf, which may impede the HVS involution [ 24].",Non-OADS,/arxiv_data1/oa_pdf/8c/0c/mv-v20-215.PMC3945809.pdf
"Molecular Vision  2014; 20:215-230 <http://www.molvis.org/molvis/v 20/215> © 2014 Molecular Vision  217subsequently, the eyes were scored as having a low, medium,  or high degree of disease independently of knowledge of the  mouse genotype or pathology findings.",Non-OADS,/arxiv_data1/oa_pdf/8c/0c/mv-v20-215.PMC3945809.pdf
"Molecular Vision  2014; 20:215-230 <http://www.molvis.org/molvis/v 20/215> © 2014 Molecular Vision  218Regardless of whether it was based on genomic DNA from the  tail biopsy or the assessment of the RPE, the average Arf −/−  content increased step-wise in mice that were judged to have  mostly white, mixed, or mostly agouti coats (Figure 4A,B).",Non-OADS,/arxiv_data1/oa_pdf/8c/0c/mv-v20-215.PMC3945809.pdf
Molecular Vision  2014; 20:215-230 <http://www.molvis.org/molvis/v 20/215> © 2014 Molecular Vision  219 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/8c/0c/mv-v20-215.PMC3945809.pdf
Molecular Vision  2014; 20:215-230 <http://www.molvis.org/molvis/v 20/215> © 2014 Molecular Vision  220scoring was concordant in both eyes of 11 of 13 (slit-lamp)  and 12 of 13 (fundoscopic) animals.,Non-OADS,/arxiv_data1/oa_pdf/8c/0c/mv-v20-215.PMC3945809.pdf
"Molecular Vision  2014; 20:215-230 <http://www.molvis.org/molvis/v 20/215> © 2014 Molecular Vision  221In the case of Arf loss as a mouse model for PHPV,  Pdgfrß-dependent signals drive excess proliferation of  vascular mural cells enveloping the hyaloid stalk and vasa  hyaloidea propria in the posterior eye [ 23,24].",Non-OADS,/arxiv_data1/oa_pdf/8c/0c/mv-v20-215.PMC3945809.pdf
"Molecular Vision  2014; 20:215-230 <http://www.molvis.org/molvis/v 20/215> © 2014 Molecular Vision  222Second, by varying the number of Arf −/− cells in the  chimeric mouse, we recapitulated the wider spectrum of  disease that occurs in the clinical setting.",Non-OADS,/arxiv_data1/oa_pdf/8c/0c/mv-v20-215.PMC3945809.pdf
Molecular Vision  2014; 20:215-230 <http://www.molvis.org/molvis/v 20/215> © 2014 Molecular Vision  223 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/8c/0c/mv-v20-215.PMC3945809.pdf
Molecular Vision  2014; 20:215-230 <http://www.molvis.org/molvis/v 20/215> © 2014 Molecular Vision  224 Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/8c/0c/mv-v20-215.PMC3945809.pdf
Molecular Vision  2014; 20:215-230 <http://www.molvis.org/molvis/v 20/215> © 2014 Molecular Vision  225 Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/8c/0c/mv-v20-215.PMC3945809.pdf
Molecular Vision  2014; 20:215-230 <http://www.molvis.org/molvis/v 20/215> © 2014 Molecular Vision  226 Figure 8.,Non-OADS,/arxiv_data1/oa_pdf/8c/0c/mv-v20-215.PMC3945809.pdf
"Molecular Vision  2014; 20:215-230 <http://www.molvis.org/molvis/v 20/215> © 2014 Molecular Vision  227However, two important points should be noted.",Non-OADS,/arxiv_data1/oa_pdf/8c/0c/mv-v20-215.PMC3945809.pdf
"Molecular Vision  2014; 20:215-230 <http://www.molvis.org/molvis/v 20/215> © 2014 Molecular Vision  228[42,43].",Non-OADS,/arxiv_data1/oa_pdf/8c/0c/mv-v20-215.PMC3945809.pdf
Molecular Vision  2014; 20:215-230 <http://www.molvis.org/molvis/v 20/215> © 2014 Molecular Vision  229vitreous with retinal detachment.,Non-OADS,/arxiv_data1/oa_pdf/8c/0c/mv-v20-215.PMC3945809.pdf
Molecular Vision  2014; 20:215-230 <http://www.molvis.org/molvis/v 20/215> © 2014 Molecular Vision  230tumour syndrome family.,Non-OADS,/arxiv_data1/oa_pdf/8c/0c/mv-v20-215.PMC3945809.pdf
"Green tea,  EGCG, and other flavonoids such as luteolin, myricetin, and  quercetin, have also been shown to attenuate experimental  retinal neovascularization, ischemic retinal injury, diabetic Molecular Vision  2014; 20:242-258 <http://www.molvis.org/molvis/v 20/242> Received 19 June 2013 | Accepted 28 February 2014 | Published 3 March 2014© 2014 Molecular Vision 242Effects of the vegetable polyphenols epigallocatechin-3-gallate,  luteolin, apigenin, myricetin, quercetin, and cyanidin in primary  cultures of human retinal pigment epithelial cells Rui Chen,1 Margrit Hollborn,1 Antje Grosche,2 Andreas Reichenbach,3 Peter Wiedemann,1 Andreas  Bringmann,1 Leon Kohen1,4 (The first two authors contributed equally to the work.)",Non-OADS,/arxiv_data1/oa_pdf/c8/8f/mv-v20-242.PMC3945811.pdf
"Molecular Vision  2014; 20:242-258 <http://www.molvis.org/molvis/v 20/242> © 2014 Molecular Vision  243retinopathy, and light-induced photoreceptor apoptosis,  respectively [ 11-16].",Non-OADS,/arxiv_data1/oa_pdf/c8/8f/mv-v20-242.PMC3945811.pdf
Molecular Vision  2014; 20:242-258 <http://www.molvis.org/molvis/v 20/242> © 2014 Molecular Vision  244performed according to the Declaration of Helsinki.,Non-OADS,/arxiv_data1/oa_pdf/c8/8f/mv-v20-242.PMC3945811.pdf
Molecular Vision  2014; 20:242-258 <http://www.molvis.org/molvis/v 20/242> © 2014 Molecular Vision  24572 °C for 45 s. This was followed by a melt curve analysis  (81 cycles) to determine the product specificity where the  temperature was gradually increased from 55 °C to 95 °C  (0.5 °C/cycle).,Non-OADS,/arxiv_data1/oa_pdf/c8/8f/mv-v20-242.PMC3945811.pdf
"Molecular Vision  2014; 20:242-258 <http://www.molvis.org/molvis/v 20/242> © 2014 Molecular Vision  246increased chemotaxis of RPE cells under control conditions  (Figure 4B, E), and cyanidin had no effect (Figure 4F).",Non-OADS,/arxiv_data1/oa_pdf/c8/8f/mv-v20-242.PMC3945811.pdf
Molecular Vision  2014; 20:242-258 <http://www.molvis.org/molvis/v 20/242> © 2014 Molecular Vision  247 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/c8/8f/mv-v20-242.PMC3945811.pdf
Molecular Vision  2014; 20:242-258 <http://www.molvis.org/molvis/v 20/242> © 2014 Molecular Vision  248mediated by toxic effects of the compounds.,Non-OADS,/arxiv_data1/oa_pdf/c8/8f/mv-v20-242.PMC3945811.pdf
Molecular Vision  2014; 20:242-258 <http://www.molvis.org/molvis/v 20/242> © 2014 Molecular Vision  249and 100 µM (Figure 7A).,Non-OADS,/arxiv_data1/oa_pdf/c8/8f/mv-v20-242.PMC3945811.pdf
Molecular Vision  2014; 20:242-258 <http://www.molvis.org/molvis/v 20/242> © 2014 Molecular Vision  250in mediating the toxic effect of myricetin.,Non-OADS,/arxiv_data1/oa_pdf/c8/8f/mv-v20-242.PMC3945811.pdf
Molecular Vision  2014; 20:242-258 <http://www.molvis.org/molvis/v 20/242> © 2014 Molecular Vision  251 Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/c8/8f/mv-v20-242.PMC3945811.pdf
"Molecular Vision  2014; 20:242-258 <http://www.molvis.org/molvis/v 20/242> © 2014 Molecular Vision  252is an important step in intracellular signaling that stimulates  the proliferation of RPE cells [ 26,33].",Non-OADS,/arxiv_data1/oa_pdf/c8/8f/mv-v20-242.PMC3945811.pdf
Molecular Vision  2014; 20:242-258 <http://www.molvis.org/molvis/v 20/242> © 2014 Molecular Vision  253 Figure 9.,Non-OADS,/arxiv_data1/oa_pdf/c8/8f/mv-v20-242.PMC3945811.pdf
Molecular Vision  2014; 20:242-258 <http://www.molvis.org/molvis/v 20/242> © 2014 Molecular Vision  254bioflavonoids may have adverse effects that may concern non- transformed cells [ 18].,Non-OADS,/arxiv_data1/oa_pdf/c8/8f/mv-v20-242.PMC3945811.pdf
"Molecular Vision  2014; 20:242-258 <http://www.molvis.org/molvis/v 20/242> © 2014 Molecular Vision  255higher concentrations, the polyphenols (with the exception of  EGCG and cyanidin) have toxic effects on the cells.",Non-OADS,/arxiv_data1/oa_pdf/c8/8f/mv-v20-242.PMC3945811.pdf
"Molecular Vision  2014; 20:242-258 <http://www.molvis.org/molvis/v 20/242> © 2014 Molecular Vision  256and did not induce significant apoptosis or necrosis (Figure  7), we assume that normal and moderate intake of the  compounds as natural food will have no deleterious conse - quences in the RPE, and may have even beneficial effects, for  example, in the cases of EGCG and cyanidin.",Non-OADS,/arxiv_data1/oa_pdf/c8/8f/mv-v20-242.PMC3945811.pdf
Molecular Vision  2014; 20:242-258 <http://www.molvis.org/molvis/v 20/242> © 2014 Molecular Vision  25720.,Non-OADS,/arxiv_data1/oa_pdf/c8/8f/mv-v20-242.PMC3945811.pdf
Molecular Vision  2014; 20:242-258 <http://www.molvis.org/molvis/v 20/242> © 2014 Molecular Vision  258M.,Non-OADS,/arxiv_data1/oa_pdf/c8/8f/mv-v20-242.PMC3945811.pdf
Published  by  Elsevier  B.V.   http://dx.doi.org/10.1016/j.prevetmed.2013.11.011Open access under CC BY-NC-ND license .,OADS,/arxiv_data1/oa_pdf/c1/d1/main.PMC3945821.pdf
NAADSM  technical  papers  (http://www.naadsm.org/documentation/ techpapers).,OADS,/arxiv_data1/oa_pdf/c1/d1/main.PMC3945821.pdf
"http://www.naadsm.org/naadsm/ﬁles/wh/ whDescription-draft121001.pdf Reperant,  L.A.,  van  de  Bildt,  M.W.,  van  Amerongen,  G.,  Buehler,  D.M.,  Oster- haus,  A.D.,  Jenni-Eiermann,  S.,  Piersma,  T.,  Kuiken,  T.,  2011.",Non-OADS,/arxiv_data1/oa_pdf/c1/d1/main.PMC3945821.pdf
"Census  of  Agri- culture http://www.agcensus.usda.gov USDA, 2008a.",Non-OADS,/arxiv_data1/oa_pdf/c1/d1/main.PMC3945821.pdf
"National  Agricultural  Statistics  Service,  http://www.nass.",Non-OADS,/arxiv_data1/oa_pdf/c1/d1/main.PMC3945821.pdf
Preprint at http://www.arxiv.org/abs/cond-mat/0309348 (2003).,Non-OADS,/arxiv_data1/oa_pdf/8b/f5/ncomms3447.PMC3945876.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications.,Non-OADS,/arxiv_data1/oa_pdf/8b/f5/ncomms3447.PMC3945876.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Yuan, Z. et al.",Non-OADS,/arxiv_data1/oa_pdf/8b/f5/ncomms3447.PMC3945876.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3447 ARTICLE NATURE COMMUNICATIONS | 4:2447 | DOI: 10.1038/ncomms3447 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/8b/f5/ncomms3447.PMC3945876.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions How to cite this article: Kuroda, N. et al.",Non-OADS,/arxiv_data1/oa_pdf/f2/32/ncomms4089.PMC3945878.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4089 6 NATURE COMMUNICATIONS | 5:3089 | DOI: 10.1038/ncomms4089 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/f2/32/ncomms4089.PMC3945878.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/95/d0/ncomms3932.PMC3945879.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Sagare, A. P. et al.",Non-OADS,/arxiv_data1/oa_pdf/95/d0/ncomms3932.PMC3945879.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3932 14 NATURE COMMUNICATIONS | 4:2932 | DOI: 10.1038/ncomms3932 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/95/d0/ncomms3932.PMC3945879.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/56/4e/ncomms4036.PMC3945880.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: JayaNandanan, N. et al.",Non-OADS,/arxiv_data1/oa_pdf/56/4e/ncomms4036.PMC3945880.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4036 10 NATURE COMMUNICATIONS | 5:3036 | DOI: 10.1038/ncomms4036 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/56/4e/ncomms4036.PMC3945880.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 Figure 1  Generation of transgenic golden Syrian hamsters.",Non-OADS,/arxiv_data1/oa_pdf/22/ff/cr20142a.PMC3945892.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4314 | DOI: 10.1038/srep04314 6",Non-OADS,/arxiv_data1/oa_pdf/b2/05/srep04314.PMC3945921.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4304 | DOI: 10.1038/srep04304 5",Non-OADS,/arxiv_data1/oa_pdf/61/e9/srep04304.PMC3945922.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4301 | DOI: 10.1038/srep04301 5",Non-OADS,/arxiv_data1/oa_pdf/9d/ab/srep04301.PMC3945923.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: UCL has filed a patent on some of the intellectual property disclosed by this paper.,Non-OADS,/arxiv_data1/oa_pdf/16/4b/srep04315.PMC3945924.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4315 | DOI: 10.1038/srep04315 7",Non-OADS,/arxiv_data1/oa_pdf/16/4b/srep04315.PMC3945924.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4e/36/srep04272.PMC3945925.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4272 | DOI: 10.1038/srep04272 6",Non-OADS,/arxiv_data1/oa_pdf/4e/36/srep04272.PMC3945925.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/dc/df/srep04311.PMC3945926.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4311 | DOI: 10.1038/srep04311 6",Non-OADS,/arxiv_data1/oa_pdf/dc/df/srep04311.PMC3945926.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f4/47/srep04305.PMC3945929.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4305 | DOI: 10.1038/srep04305 11",Non-OADS,/arxiv_data1/oa_pdf/f4/47/srep04305.PMC3945929.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/cf/opth-8-483.PMC3945992.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 483–484Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  483Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S6121 6evaluation of barriers between anterior   and posterior compartments during Nd:YAG   capsulotomy in diabetic patients Pelin Özyol erhan Özyol Department of Ophthalmology,    Ünye State Hospital, Ordu, turkey Correspondence: Pelin Özyol   Ünye State Hospital, Department   of Ophthalmology, Ordu, turkey   email pelingesoglu@yahoo.com.t rDear editor We have read the article by Awan et al1 with great interest.",Non-OADS,/arxiv_data1/oa_pdf/56/cf/opth-8-483.PMC3945992.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/56/cf/opth-8-483.PMC3945992.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/cf/opth-8-483.PMC3945992.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d3/10/ijn-9-1139.PMC3945993.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 1139–1152International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1139OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S3466 8chemotherapeutic potential of curcumin-bearing  microcells against hepatocellular carcinoma   in model animals Mohammad Farazuddin1 Bhavyata Dua2 Qamar Zia1 aijaz ahmad Khan3 Beenu Joshi2 Mohammad Owais1 1Interdisciplinary Biotechnology Unit,   aligarh Muslim University, aligarh,   2Immunology Division, National  JalMa Institute for leprosy and  Other Mycobacterial Diseases (NJIl),   agra, 3Department of anatomy,   Jawaharlal Nehru Medical college,   aligarh Muslim University, aligarh,   India correspondence: Mohammad Owais   Interdisciplinary Biotechnology Unit,  aligarh Muslim University, aligarh  202002, India   Tel +91 571 2720 388   Fax +91 571 2721 776   email owais_lakhnawi@yahoo.co mAbstract:  Curcumin (diferuloylmethane) is found in large quantities in the roots of Cur - cuma longa.",Non-OADS,/arxiv_data1/oa_pdf/d3/10/ijn-9-1139.PMC3945993.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d3/10/ijn-9-1139.PMC3945993.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/10/ijn-9-1139.PMC3945993.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4303 | DOI: 10.1038/srep04303 5",Non-OADS,/arxiv_data1/oa_pdf/77/76/srep04303.PMC3946014.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4246 | DOI: 10.1038/srep04246 9",Non-OADS,/arxiv_data1/oa_pdf/3e/32/srep04246.PMC3946040.pdf
Available at: http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/12/a6/qai-65-072.PMC3946363.pdf
Available at: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?,Non-OADS,/arxiv_data1/oa_pdf/12/a6/qai-65-072.PMC3946363.pdf
http://dx.doi.org/10.1016/j.ihj.2013.12.016,OADS,/arxiv_data1/oa_pdf/1f/7c/main.PMC3946438.pdf
Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.ihj.2013.12.016 .,OADS,/arxiv_data1/oa_pdf/1f/7c/main.PMC3946438.pdf
http://dx.doi.org/10.1016/j.ihj.2013.12.038,OADS,/arxiv_data1/oa_pdf/96/83/main.PMC3946439.pdf
http://dx.doi.org/10.1016/j.ihj.2013.12.041,OADS,/arxiv_data1/oa_pdf/c0/b3/main.PMC3946440.pdf
http://dx.doi.org/10.1016/j.ihj.2013.12.024,OADS,/arxiv_data1/oa_pdf/f4/94/main.PMC3946441.pdf
"E-mail address: khanal.s@rediffmail.com 0019-4832/$ esee front matter http://dx.doi.org/10.1016/j.ihj.2013.12.044Dario Sillano, Chiara Resmini, Emanuele Meliga, Giacomo Boccuzzi, Andrea Zufﬁ, Emanuele Barbato, Julian Gunn, Matthew Price, Fiorenzo Gaita, Imad Sheiban,Retrospective multicenter observational study of the inter-ventional management of coronary disease in the very eld-erly: The NINETY.",Non-OADS,/arxiv_data1/oa_pdf/5b/3f/main.PMC3946443.pdf
"E-mail address: khanal.s@rediffmail.com 0019-4832/$ esee front matter http://dx.doi.org/10.1016/j.ihj.2013.12.045 Stephen G. Worthley, Costas P. Tsiouﬁs, Matthew I. Worthley, Ajay Sinhal, Derek P. Chew, Ian T. Meredith, Yuvi Malaiapan,Vasilios Papademetriou, Safety and efﬁcacy of a multi-electrode renal sympathetic denervation system in resistanthypertension: the EnligHTN I trial.",Non-OADS,/arxiv_data1/oa_pdf/5b/3f/main.PMC3946443.pdf
http://dx.doi.org/10.1016/j.ihj.2013.12.050,OADS,/arxiv_data1/oa_pdf/96/f9/main.PMC3946444.pdf
Available from: http://lifevest.zoll.com/ medical-professionals/patientuse.asp .,Non-OADS,/arxiv_data1/oa_pdf/96/f9/main.PMC3946444.pdf
http://dx.doi.org/10.1016/j.ihj.2013.12.014,OADS,/arxiv_data1/oa_pdf/e0/53/main.PMC3946445.pdf
http://dx.doi.org/10.1016/j.ihj.2013.12.009,OADS,/arxiv_data1/oa_pdf/61/44/main.PMC3946454.pdf
Available at: http://www.who.int/nmh/publications/ncd_ report_full_en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/61/44/main.PMC3946454.pdf
http://dx.doi.org/10.1016/j.ihj.2013.10.006,OADS,/arxiv_data1/oa_pdf/48/22/main.PMC3946458.pdf
http://dx.doi.org/10.1016/j.ihj.2013.12.030,OADS,/arxiv_data1/oa_pdf/15/57/main.PMC3946459.pdf
Kasliwal) 0019-4832/$ esee front matter http://dx.doi.org/10.1016/j.ihj.2013.12.052indian heart journal 66 (2014) 25 e30 30,Non-OADS,/arxiv_data1/oa_pdf/38/ff/main.PMC3946462.pdf
http://dx.doi.org/10.1016/j.ihj.2013.12.011,OADS,/arxiv_data1/oa_pdf/e5/9f/main.PMC3946463.pdf
http://dx.doi.org/10.1016/j.ihj.2013.12.018,OADS,/arxiv_data1/oa_pdf/9f/29/main.PMC3946464.pdf
http://dx.doi.org/10.1016/j.ihj.2013.12.053,OADS,/arxiv_data1/oa_pdf/6f/1f/main.PMC3946465.pdf
http://dx.doi.org/10.1016/j.ihj.2013.12.017,OADS,/arxiv_data1/oa_pdf/f4/be/main.PMC3946466.pdf
http://dx.doi.org/10.1016/j.ihj.2013.12.033,OADS,/arxiv_data1/oa_pdf/66/20/main.PMC3946467.pdf
http://dx.doi.org/10.1016/j.ihj.2013.12.003,OADS,/arxiv_data1/oa_pdf/26/9f/main.PMC3946469.pdf
"To rule out the polymorphism a large database (exome sequencing project) containing more than 10,000 alleles(American and European controls) ( http://evs.gs.washington.",Non-OADS,/arxiv_data1/oa_pdf/26/9f/main.PMC3946469.pdf
edu/EVS/ ) was checked along with 1000 genome project (http://browser.1000genomes.org/index.html ) but no such mutation was found in those controls.,OADS,/arxiv_data1/oa_pdf/26/9f/main.PMC3946469.pdf
http://dx.doi.org/10.1016/j.ihj.2013.10.001,OADS,/arxiv_data1/oa_pdf/c5/21/main.PMC3946470.pdf
http://dx.doi.org/10.1016/j.ihj.2013.12.022,OADS,/arxiv_data1/oa_pdf/ef/e8/main.PMC3946472.pdf
http://dx.doi.org/10.1016/j.ihj.2014.01.003,OADS,/arxiv_data1/oa_pdf/7e/9c/main.PMC3946473.pdf
"E-mail address: khanal.s@rediffmail.com 0019-4832/$ esee front matter http://dx.doi.org/10.1016/j.ihj.2013.12.044 Stephen G. Worthley, Costas P. Tsiouﬁs, Matthew I. Worthley, Ajay Sinhal, Derek P. Chew, Ian T. Meredith, Yuvi Malaiapan,Vasilios Papademetriou, Safety and efﬁcacy of a multi-electrode renal sympathetic denervation system in resistanthypertension: the EnligHTN I trial.",Non-OADS,/arxiv_data1/oa_pdf/f0/61/main.PMC3946475.pdf
E-mail address: khanal.s@rediffmail.com 0019-4832/$ esee front matter http://dx.doi.org/10.1016/j.ihj.2013.12.042indian heart journal 66 (2014) 127 e130 130,Non-OADS,/arxiv_data1/oa_pdf/f0/61/main.PMC3946475.pdf
http://dx.doi.org/10.1016/j.ihj.2013.12.036,OADS,/arxiv_data1/oa_pdf/cc/b9/main.PMC3946495.pdf
Kasliwal) 0019-4832/$ esee front matter http://dx.doi.org/10.1016/j.ihj.2013.12.052indian heart journal 66 (2014) 25 e30 30,Non-OADS,/arxiv_data1/oa_pdf/cc/b9/main.PMC3946495.pdf
http://dx.doi.org/10.1016/j.ihj.2013.12.051,OADS,/arxiv_data1/oa_pdf/6d/8c/main.PMC3946507.pdf
Avail- able at: http://www.imia-medinfo.org.,Non-OADS,/arxiv_data1/oa_pdf/61/7f/AIM-22-1-71.PMC3947936.pdf
"Available at: http://www.ifip.or.at/ Accessed: on January 13, 2014.",Non-OADS,/arxiv_data1/oa_pdf/61/7f/AIM-22-1-71.PMC3947936.pdf
Available at: http://www.efmi.org.,Non-OADS,/arxiv_data1/oa_pdf/61/7f/AIM-22-1-71.PMC3947936.pdf
"Panel „ History of Medical Informatics in Europe “, EFMI STC  2013 “Data and Knowledge for Medical Decision Support”,  Prague, Czech Republic, 2013; Available at: http://stc2013.org/joint-activities/panels –2nd part.",Non-OADS,/arxiv_data1/oa_pdf/79/d6/AIM-22-1-49.PMC3947938.pdf
Available at: http://www.imia.org/ethics.lasso.,Non-OADS,/arxiv_data1/oa_pdf/79/d6/AIM-22-1-49.PMC3947938.pdf
Available at: http://www.hdmi.hr.,Non-OADS,/arxiv_data1/oa_pdf/79/d6/AIM-22-1-49.PMC3947938.pdf
Available at: http://www.amzh.hr/news%20and%20events.html.,Non-OADS,/arxiv_data1/oa_pdf/79/d6/AIM-22-1-49.PMC3947938.pdf
Available at: http://www.action-grid.eu/in - dex.php?url=home.,Non-OADS,/arxiv_data1/oa_pdf/79/d6/AIM-22-1-49.PMC3947938.pdf
Available at: http://www.srce.unizg.hr/homepage/products-services/middleware/aaieduhr/.,Non-OADS,/arxiv_data1/oa_pdf/79/d6/AIM-22-1-49.PMC3947938.pdf
Available at: http://www.hdmi.hr.,Non-OADS,/arxiv_data1/oa_pdf/79/d6/AIM-22-1-49.PMC3947938.pdf
Available at: http://www.hl7.hr.,Non-OADS,/arxiv_data1/oa_pdf/79/d6/AIM-22-1-49.PMC3947938.pdf
http://www.amia.org/pro-grams/working-groups/nursing-informatics/history-project 9.,Non-OADS,/arxiv_data1/oa_pdf/9d/64/AIM-22-1-68.PMC3947943.pdf
Power Point Presentations and other deatails about the Panel can be found at http://stc2013.org/joint-activities/panels  CONFLICT OF INTEREST: NONE DECLARED.,Non-OADS,/arxiv_data1/oa_pdf/69/26/AIM-22-1-6.PMC3947944.pdf
Direct Submission to Repbase Update(JUN-2004) ohttp://www.girinst.org 4(2004).,OADS,/arxiv_data1/oa_pdf/92/74/ncomms4348.PMC3948050.pdf
"Gregory, T. R. Animal Genome Size Database ohttp://www.genomesize.com 4 (2013).",OADS,/arxiv_data1/oa_pdf/92/74/ncomms4348.PMC3948050.pdf
"Hall, A. BioEdit version 5.0.6 ohttp://www.mbio.ncsu.edu/BioEdit/ bioedit.html 4(2004).",OADS,/arxiv_data1/oa_pdf/92/74/ncomms4348.PMC3948050.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/92/74/ncomms4348.PMC3948050.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Gilbert, C. et al.",Non-OADS,/arxiv_data1/oa_pdf/92/74/ncomms4348.PMC3948050.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4348 ARTICLE NATURE COMMUNICATIONS | 5:3348 | DOI: 10.1038/ncomms4348 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/92/74/ncomms4348.PMC3948050.pdf
Analysis of the time-lapse image stacks was carried out using ImageJ v 1.47a (http://rsb.info.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/22/d9/ncomms4369.PMC3948051.pdf
"Differential gene expression was calculated using the BioConductor package limma 49(http://www.bioconductor.org/packages/release/bioc/vignettes/limma/ inst/doc/usersguide.pdf), with default settings.",OADS,/arxiv_data1/oa_pdf/22/d9/ncomms4369.PMC3948051.pdf
Global tuberculosis report http://www.who.int/tb/publications/ global_report/en/index.html (2012).,Non-OADS,/arxiv_data1/oa_pdf/22/d9/ncomms4369.PMC3948051.pdf
"Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: A.K., L.V., H.W.H.G, J.-M.N.",Non-OADS,/arxiv_data1/oa_pdf/22/d9/ncomms4369.PMC3948051.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Koul, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/22/d9/ncomms4369.PMC3948051.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4369 10 NATURE COMMUNICATIONS | 5:3369 | DOI: 10.1038/ncomms4369 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/22/d9/ncomms4369.PMC3948051.pdf
Supplementary Information accompanies this paper at http://www.nature.com/nature communications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/4b/88/ncomms4360.PMC3948052.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Abe, G. et al.",Non-OADS,/arxiv_data1/oa_pdf/4b/88/ncomms4360.PMC3948052.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4360 ARTICLE NATURE COMMUNICATIONS | 5:3360 | DOI: 10.1038/ncomms4360 | www.nature.com/naturecommunications 7 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/4b/88/ncomms4360.PMC3948052.pdf
BACs with a low repeat content according to RepeatMasker (http://www.repeatmasker.org/) analysiswere assembled into contigs spanning the physical map of Spirodela polyrhiza .,OADS,/arxiv_data1/oa_pdf/dd/b2/ncomms4311.PMC3948053.pdf
Assembly check .The so called ‘assembly checker’ is based on sequence content assessment by masking one sequence set with another via the programme vmatch (http://www.vmatch.de).,Non-OADS,/arxiv_data1/oa_pdf/dd/b2/ncomms4311.PMC3948053.pdf
The programme tallmyer41from the programme suite genome tools (http://genometools.org/) was used to calculate the frequency of each 16-mer in the respective genome assembliesand other sequence sets.,OADS,/arxiv_data1/oa_pdf/dd/b2/ncomms4311.PMC3948053.pdf
"Transposons and rRNA genes were annotated by the wublast version of RepeatMasker-open-3-3-0 (http://www.repeatmasker.org) against the mipsREdat (REdat_v9.3, 387 Mb, 56,169 entries).",OADS,/arxiv_data1/oa_pdf/dd/b2/ncomms4311.PMC3948053.pdf
A more detailed insight into the annotation structure was achieved with the integrative genome viewer (http://www.broadinstitute.org/igv/) by deﬁning custo- mized tracks for the different element types and kmer values in combination with special colour codes and display options.Synteny .Analysis of genome duplications were based on all-against-all blastp comparisons between non-redundant gene sets of the respective species ( E-value cutoff Eo10–10).,OADS,/arxiv_data1/oa_pdf/dd/b2/ncomms4311.PMC3948053.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/dd/b2/ncomms4311.PMC3948053.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/How to cite this article: Wang, W. et al.",Non-OADS,/arxiv_data1/oa_pdf/dd/b2/ncomms4311.PMC3948053.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4311 ARTICLE NATURE COMMUNICATIONS | 5:3311 | DOI: 10.1038/ncomms4311 | www.nature.com/naturecommunications 13 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/dd/b2/ncomms4311.PMC3948053.pdf
"The microarray data have been deposited in Gene ExpressionOmnibus (GEO, http://www.ncbi.nlm.nih.gov/geo) with GEO Series accessionnumber GSE54243.",OADS,/arxiv_data1/oa_pdf/45/93/ncomms4357.PMC3948059.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/45/93/ncomms4357.PMC3948059.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Chen, C. et al.",Non-OADS,/arxiv_data1/oa_pdf/45/93/ncomms4357.PMC3948059.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4357 ARTICLE NATURE COMMUNICATIONS | 5:3357 | DOI: 10.1038/ncomms4357 | www.nature.com/naturecommunications 11 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/45/93/ncomms4357.PMC3948059.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Ideguchi, T. et al.",Non-OADS,/arxiv_data1/oa_pdf/eb/4b/ncomms4375.PMC3948060.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4375 8 NATURE COMMUNICATIONS | 5:3375 | DOI: 10.1038/ncomms4375 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/eb/4b/ncomms4375.PMC3948060.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4269 | DOI: 10.1038/srep04269 10",Non-OADS,/arxiv_data1/oa_pdf/28/51/srep04269.PMC3948069.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e7/f4/srep04328.PMC3948070.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4328 | DOI: 10.1038/srep04328 7",Non-OADS,/arxiv_data1/oa_pdf/e7/f4/srep04328.PMC3948070.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fb/02/srep04288.PMC3948072.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4288 | DOI: 10.1038/srep04288 9",Non-OADS,/arxiv_data1/oa_pdf/fb/02/srep04288.PMC3948072.pdf
"The sampling at Grenoble Les Fresnes is maintained within a French national programme of the Laboratoire Central de Surveillance de la Qualite ´de l Air (LCSQA, http://www.lcsqa.org/) for the monitoring of the impact of biomass burning in urbanenvironment.",Non-OADS,/arxiv_data1/oa_pdf/5a/54/ncomms4335.PMC3948073.pdf
"This programme is directed by O. Favez (Institut National de l’Envir- onnement Industriel et des Risques (INERIS); http://www.ineris.fr/), and sampling is performed by the people from Air Rho ˆne-Alpes (http://www.air-rhonealpes.fr).",Non-OADS,/arxiv_data1/oa_pdf/5a/54/ncomms4335.PMC3948073.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Nozie `re, B. et al.",Non-OADS,/arxiv_data1/oa_pdf/5a/54/ncomms4335.PMC3948073.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4335 ARTICLE NATURE COMMUNICATIONS | 5:3335 | DOI: 10.1038/ncomms4335 | www.nature.com/naturecommunications 7 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/5a/54/ncomms4335.PMC3948073.pdf
"F.C.-L. designed theexperiments, interpreted the data and wrote the paper.Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.",Non-OADS,/arxiv_data1/oa_pdf/50/21/ncomms4347.PMC3948078.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: A´lvarez-Quilo ´n, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/50/21/ncomms4347.PMC3948078.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4347 10 NATURE COMMUNICATIONS | 5:3347 | DOI: 10.1038/ncomms4347 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/50/21/ncomms4347.PMC3948078.pdf
"The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribut ion-NonCommercial- ShareAlike licence /http://creativecommons.org/licenses/by-nc-sa/3.0/ S. The written permission of Cambridge University Press must be obtained for commercial re-use.Correspondence and reprint requests to: Margaret Nampijja, Department of Psychology, Lancaster University, Fylde College, Lancaster LA1 4YF, UK.",Non-OADS,/arxiv_data1/oa_pdf/a8/28/S1355617712000768a.PMC3948080.pdf
"See: http://creativecommons.org/ licenses/by/3.0/ REFERENCES 1 Feest TG, Riad HN, Collins CH, et al .",Non-OADS,/arxiv_data1/oa_pdf/7a/d6/medethics-2012-100992.PMC3948088.pdf
2010. http://www.ics.ac.uk/intensive_care_professional/standards_and_ guidelines/dcd (accessed 20 July 2012).,Non-OADS,/arxiv_data1/oa_pdf/7a/d6/medethics-2012-100992.PMC3948088.pdf
2000. http://www.bristol-inquiry.org.uk (accessed 20 July 2012).,Non-OADS,/arxiv_data1/oa_pdf/7a/d6/medethics-2012-100992.PMC3948088.pdf
2001. http://www.rclinquiry.org.uk (accessed 20 July 2012).,Non-OADS,/arxiv_data1/oa_pdf/7a/d6/medethics-2012-100992.PMC3948088.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/60/70/srep04325.PMC3948090.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4325 | DOI: 10.1038/srep04325 5",Non-OADS,/arxiv_data1/oa_pdf/60/70/srep04325.PMC3948090.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Cerebral blood ﬂow during dynamic exercise M Hiura et al 396 Journal of Cerebral Blood Flow & Metabolism (2014), 389 – 396 &2014 ISCBFM",Non-OADS,/arxiv_data1/oa_pdf/dd/77/jcbfm2013220a.PMC3948124.pdf
"Amnis Corp 2011, web https://amnis.com/docu- ments/brochures/FSBrochure Final.pdf.",Non-OADS,/arxiv_data1/oa_pdf/bd/d1/leu2013255a.PMC3948156.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/VSELs: an update MZ Ratajczak et al 484 Leukemia (2014) 473 – 484 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/bd/d1/leu2013255a.PMC3948156.pdf
The position of the loci was compared with resequencing data reported in the 1000 Genomes project (http://www.1000genomes.org/).,OADS,/arxiv_data1/oa_pdf/bb/d6/leu2013330a.PMC3948159.pdf
"In addition, the various polymorphisms found in the UCK1 sequence were not related to its expression level nor with response to AZAtreatment, alternate to what has been demonstrated for DCK.44 We did not explore other possible mechanisms of gene expression regulation, such as miRNA or splicing variants.45However, UCK1 has several regulating miRNAs, (http://www.targetscan.org/) and future studies are warranted, because miRNAs could be helpful tools to modulate sensitivity to AZA.",Non-OADS,/arxiv_data1/oa_pdf/bb/d6/leu2013330a.PMC3948159.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)Biological causes of resistance to azacitidine A Valencia et al 628 Leukemia (2014) 621 – 628 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/bb/d6/leu2013330a.PMC3948159.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)STAT5 serine phosphorylation in leukemia A Berger et al 641 &2014 Macmillan Publishers Limited Leukemia (2014) 629 – 641",Non-OADS,/arxiv_data1/oa_pdf/07/e9/leu2013351a.PMC3948164.pdf
"Jacquard JM, Improved weaving loom exhibited at Paris Industrial Ex - hibition 1801,[ http://en.wikipedia.org/wiki/Jacquard_loom] 4.",Non-OADS,/arxiv_data1/oa_pdf/a3/c8/AIM-22-1-18.PMC3948183.pdf
"Journal of Biomedical Informatics, http://www.journals.el - sevier.com/journal-of-biomedical-informatics.",Non-OADS,/arxiv_data1/oa_pdf/61/fc/AIM-22-1-37.PMC3948184.pdf
"7. International Journal of Medical Informatics, http://www.ijmijournal.com/.",Non-OADS,/arxiv_data1/oa_pdf/61/fc/AIM-22-1-37.PMC3948184.pdf
"Methods of Information in Medicine, http://www.schattau - er.de/en/magazine/subject-areas/journals-a-z/methods.ht - ml.",Non-OADS,/arxiv_data1/oa_pdf/61/fc/AIM-22-1-37.PMC3948184.pdf
"Artificial Intelligence in Medicine, http://www.journals.el - sevier.com/artificial-intelligence-in-medicine/.",Non-OADS,/arxiv_data1/oa_pdf/61/fc/AIM-22-1-37.PMC3948184.pdf
11. http://www.iospress.nl/bookserie/studies-in-health-technol - ogy-and-informatics/.,Non-OADS,/arxiv_data1/oa_pdf/61/fc/AIM-22-1-37.PMC3948184.pdf
15. http://www.ehealthnews.eu/research-and-development/fp6-projects.,Non-OADS,/arxiv_data1/oa_pdf/61/fc/AIM-22-1-37.PMC3948184.pdf
16. http://www.ehealthnews.eu/research-and-development/fp7-projects.,Non-OADS,/arxiv_data1/oa_pdf/61/fc/AIM-22-1-37.PMC3948184.pdf
28. http://www.ifip.org/images/stories/ifip/public/Archive/50thanni/Jubbook.pdf .,Non-OADS,/arxiv_data1/oa_pdf/61/fc/AIM-22-1-37.PMC3948184.pdf
54. http://ec.europa.eu/information_society/doc/qualif/health/COM_2004_0356_F_EN_ACTE.pdf.,Non-OADS,/arxiv_data1/oa_pdf/61/fc/AIM-22-1-37.PMC3948184.pdf
66. http://ec.europa.eu/digital-agenda/en/news/ehealth-action- plan-2012-2020-innovative-healthcare-21st-century.,Non-OADS,/arxiv_data1/oa_pdf/61/fc/AIM-22-1-37.PMC3948184.pdf
69. http://www.loc.gov/aba/.,OADS,/arxiv_data1/oa_pdf/61/fc/AIM-22-1-37.PMC3948184.pdf
70. http://infohistory.rutgers.edu/mediawiki/index.php/.,Non-OADS,/arxiv_data1/oa_pdf/61/fc/AIM-22-1-37.PMC3948184.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseOctober 2013 |  80  | e51304 | Page 1 of 7Video Article The Encapsulation of Cell-free Transcription and Translation Machinery in Vesicles for the Construction of Cellular Mimics Amy C. Spencer1, Paola Torre1, Sheref S. Mansy1 1Centre for Integrative Biology, University of Trento Correspondence to: Sheref S. Mansy at mansy@science.unitn.it URL: http://www.jove.com/video/51304 DOI: doi:10.3791/51304 Keywords: Bioengineering, Issue 80, synthetic biology, minimal cell, protocell, artificial cell, cell-free, in vitro  transcription-translation, liposome, vesicle Date Published: 10/21/2013 Citation: Spencer, A.C., Torre, P., Mansy, S.S.",Non-OADS,/arxiv_data1/oa_pdf/0e/2f/jove-80-51304.PMC3948186.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51304/ Introduction Cell-free, in vitro  transcription-translation reactions and the generation of vesicles from synthetic lipids are nothing new.",Non-OADS,/arxiv_data1/oa_pdf/0e/2f/jove-80-51304.PMC3948186.pdf
"Neuronalcell death was evaluated by propidium iodide (PI) incorporation and PI fluorescenceimages were obtained using a Keyence BV-8000 fluorescence microscope (Tokyo, Japan) at an exposure time of 0.5 s. The PI intensity was estimated using Image J software (http://rsbweb.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/51/1d/srep04329.PMC3948352.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/51/1d/srep04329.PMC3948352.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4329 | DOI: 10.1038/srep04329 11",Non-OADS,/arxiv_data1/oa_pdf/51/1d/srep04329.PMC3948352.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4323 | DOI: 10.1038/srep04323 10",Non-OADS,/arxiv_data1/oa_pdf/1c/8e/srep04323.PMC3948355.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4153 | DOI: 10.1038/srep04153 7,Non-OADS,/arxiv_data1/oa_pdf/6e/04/srep04153.PMC3948356.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4153 | DOI: 10.1038/srep04153 8",Non-OADS,/arxiv_data1/oa_pdf/6e/04/srep04153.PMC3948356.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/91/cia-9-403.PMC3948360.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 403–410Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  403OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5424 9The perspectives of older women with chronic  neck pain on perceived effects of qigong   and exercise therapy on aging: a qualitative  interview study Christine holmberg1,2 Julia rappenecker1 Julia J Karner1 Claudia M Witt1,3 1Institute for social Medicine,   epidemiology, and health economics,   2Berlin school of Public health,   Charité – Universitätsmedizin  Berlin, Berlin, germany; 3Center  for Complementary and Integrative  Medicine, University hospital Zurich,   Zurich, switzerland Correspondence: Christine holmberg   Institute for social Medicine,  epidemiology, and health economics,  Charité Universitätsmedizin Berlin,   57 luisenstrasse, Berlin 10117, germany   Tel +49 30 450 529 192   Fax +49 30 450 529 917   email christine.holmberg@charite.d eAbstract:  Chronic pain is prevalent in elderly populations.",Non-OADS,/arxiv_data1/oa_pdf/9c/91/cia-9-403.PMC3948360.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/9c/91/cia-9-403.PMC3948360.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/91/cia-9-403.PMC3948360.pdf
Available at: http://www.dor.kaiser.org/exter - nal/DORExternal/research_report/collen_tribute.aspx.,Non-OADS,/arxiv_data1/oa_pdf/6d/8d/AIM-22-1-4.PMC3948361.pdf
"Avail - able at: http://xnet.kp.org/ncal/tpmgawards/collen/about.html; Accessed January 07, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6d/8d/AIM-22-1-4.PMC3948361.pdf
"Avail - able at: http://xnet.kp.org/ncal/tpmgawards/collen/about.html; Accessed January 07, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6d/8d/AIM-22-1-4.PMC3948361.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/eb/90/ncomms4325.PMC3948375.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Wattanakit, C. et al.",Non-OADS,/arxiv_data1/oa_pdf/eb/90/ncomms4325.PMC3948375.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4325 8 NATURE COMMUNICATIONS | 5:3325 | DOI: 10.1038/ncomms4325 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/eb/90/ncomms4325.PMC3948375.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/9a/d0/ncomms4304.PMC3948393.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Keller, D. P. et al.",Non-OADS,/arxiv_data1/oa_pdf/9a/d0/ncomms4304.PMC3948393.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4304 ARTICLE NATURE COMMUNICATIONS | 5:3304 | DOI: 10.1038/ncomms4304 | www.nature.com/naturecommunications 11 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/9a/d0/ncomms4304.PMC3948393.pdf
"Tel: 82-2-6299-2571, Fax: 82-2-6299-2585, E-mail: jyh623@cau.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 February 66(2): 105-111  http://dx.doi.org/10.4097/kjae.2014.66.2.105",Non-OADS,/arxiv_data1/oa_pdf/32/92/kjae-66-105.PMC3948436.pdf
"Tel: 82-2-2650-5285, Fax: 82-2-2655-2924, E-mail: ankyj@ewha.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 February 66(2): 112-119  http://dx.doi.org/10.4097/kjae.2014.66.2.112",Non-OADS,/arxiv_data1/oa_pdf/60/b5/kjae-66-112.PMC3948437.pdf
"Tel: 82-51-990-6283, Fax: 82-51-990-6283, E-mail: uamyfriends@hanmail.net     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 February 66(2): 120-126  http://dx.doi.org/10.4097/kjae.2014.66.2.120",Non-OADS,/arxiv_data1/oa_pdf/41/f2/kjae-66-120.PMC3948438.pdf
"seoul.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 February 66(2): 127-130  http://dx.doi.org/10.4097/kjae.2014.66.2.127",Non-OADS,/arxiv_data1/oa_pdf/f2/7f/kjae-66-127.PMC3948439.pdf
"Tel: 82-2-3410-0356, Fax: 82-2-3410-0361, E-mail: anesthe@ skku.edu     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 February 66(2): 131-135  http://dx.doi.org/10.4097/kjae.2014.66.2.131",Non-OADS,/arxiv_data1/oa_pdf/3b/1d/kjae-66-131.PMC3948440.pdf
"Tel: 82-31-249-7212, Fax: 82-31-258-4212, E-mail: cjwooo@catholic.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CCKorean J Anesthesiol 2014 February 66(2): 136-142  http://dx.doi.org/10.4097/kjae.2014.66.2.136",Non-OADS,/arxiv_data1/oa_pdf/09/3b/kjae-66-136.PMC3948441.pdf
"Tel: 82-53-650-4502, Fax: 82-53-650-4517, E-mail: anessy73@cu.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CCKorean J Anesthesiol 2014 February 66(2): 143-152  http://dx.doi.org/10.4097/kjae.2014.66.2.143",Non-OADS,/arxiv_data1/oa_pdf/68/7c/kjae-66-143.PMC3948442.pdf
"In a retrospective  analysis that focused on complications in patients who were  administered dantrolene for malignant hyperthermia from 1987  Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 February 66(2): 153-156  http://dx.doi.org/10.4097/kjae.2014.66.2.153 Case Report",Non-OADS,/arxiv_data1/oa_pdf/4d/a5/kjae-66-153.PMC3948443.pdf
"Case Report A 54-year-old male, 165.8 cm in height, weighing 55.6 kg was  scheduled for PPPD and video-assisted thoracic surgery (V ATS)  due to a previously diagnosed duodenal cancer and a 1.1 cm- Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 February 66(2): 157-159  http://dx.doi.org/10.4097/kjae.2014.66.2.157 Case Report",Non-OADS,/arxiv_data1/oa_pdf/42/fc/kjae-66-157.PMC3948444.pdf
"Previous medical history revealed rheumatic involvement of  Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 February 66(2): 160-163  http://dx.doi.org/10.4097/kjae.2014.66.2.160 Case Report",Non-OADS,/arxiv_data1/oa_pdf/65/cd/kjae-66-160.PMC3948445.pdf
"Adequate  anticoagulation both during CPB and during weaning from CPB  Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 February 66(2): 164-168  http://dx.doi.org/10.4097/kjae.2014.66.2.164 Case Report",Non-OADS,/arxiv_data1/oa_pdf/ac/74/kjae-66-164.PMC3948446.pdf
"Her visual analogue scale (VAS) score for pain was 8  Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 February 66(2): 169-172  http://dx.doi.org/10.4097/kjae.2014.66.2.169 Case Report",OADS,/arxiv_data1/oa_pdf/3f/61/kjae-66-169.PMC3948447.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 February 66(2): 93-94  http://dx.doi.org/10.4097/kjae.2014.66.2.93 Editorial",Non-OADS,/arxiv_data1/oa_pdf/32/f8/kjae-66-93.PMC3948448.pdf
"Tel: 82-32-890-3937, Fax: 82-32-890-3968, E-mail: jhs@inha.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 February 66(2): 95-98  http://dx.doi.org/10.4097/kjae.2014.66.2.95",Non-OADS,/arxiv_data1/oa_pdf/00/44/kjae-66-95.PMC3948449.pdf
"Tel: 82-54-770-8317, Fax: 82-54-770-8500, E-mail: sujink100@hanmail.net     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 February 66(2): 99-104  http://dx.doi.org/10.4097/kjae.2014.66.2.99",Non-OADS,/arxiv_data1/oa_pdf/e3/8b/kjae-66-99.PMC3948450.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004495).,Non-OADS,/arxiv_data1/oa_pdf/35/c4/bmjopen-2013-004495.PMC3948451.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004222).,Non-OADS,/arxiv_data1/oa_pdf/13/8b/bmjopen-2013-004222.PMC3948452.pdf
"Report to the GMC, August 2012. http://www.gmc-uk.org/The_ Impact_of_the_Working_Time_Regulations_on_Medical_Education_ and_Training___Literature_Review.pdf_51155615.pdf 2.",Non-OADS,/arxiv_data1/oa_pdf/13/8b/bmjopen-2013-004222.PMC3948452.pdf
http://www.medsoconline.org/ 48.,Non-OADS,/arxiv_data1/oa_pdf/13/8b/bmjopen-2013-004222.PMC3948452.pdf
"Final report to the hpc, 2011. http://www.hpc-uk.org/assets/documents/10003771Professionalisminhealthcareprofessionals.pdf 51.",Non-OADS,/arxiv_data1/oa_pdf/13/8b/bmjopen-2013-004222.PMC3948452.pdf
"Luxembourg: Publications Office of the European Union, 2012. http://www.eurofound.europa.eu/pubdocs/2011/82/en/1/EF1182EN.pdf 64.",Non-OADS,/arxiv_data1/oa_pdf/13/8b/bmjopen-2013-004222.PMC3948452.pdf
doi:10.1136/bmjopen-2013- 004515 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004515).,Non-OADS,/arxiv_data1/oa_pdf/84/0b/bmjopen-2013-004515.PMC3948453.pdf
Retrieved July 2013. http://www.plainhealthcare.co.uk/our-products/odyssey-range/teleassess 17.,Non-OADS,/arxiv_data1/oa_pdf/84/0b/bmjopen-2013-004515.PMC3948453.pdf
Trials 2013;14:4. http://www.trialsjournal.com/content/ 14/1/4 24.,Non-OADS,/arxiv_data1/oa_pdf/84/0b/bmjopen-2013-004515.PMC3948453.pdf
"Trial registration: http://www.clinicaltrials.gov, NCT01146730.INTRODUCTION Work contributes to ﬁnancial stability and offers a structure to everyday life, possibilities for personal development and social inter-action; all factors that are found to promote good mental health and well-being.",Non-OADS,/arxiv_data1/oa_pdf/55/6d/bmjopen-2013-004321.PMC3948454.pdf
"METHODS Design The At Work and Coping Trial (A WaC) (Trial registration—http://www.clinicaltrials.gov, NCT01146730) is a rando- mised controlled multicentre trial evaluating the effect of work-focused cognitive behavioural therapy and an adapta-tion of individual placement and support on RTW in CMDs.",Non-OADS,/arxiv_data1/oa_pdf/55/6d/bmjopen-2013-004321.PMC3948454.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003759).,Non-OADS,/arxiv_data1/oa_pdf/f4/34/bmjopen-2013-003759.PMC3948455.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004093).,Non-OADS,/arxiv_data1/oa_pdf/15/33/bmjopen-2013-004093.PMC3948456.pdf
19. http://www.uphs.upenn.edu/bugdrug/antibiotic_manual/IUATLD_afb %20microscopy_guide.pdf (accessed 25 Dec).,Non-OADS,/arxiv_data1/oa_pdf/15/33/bmjopen-2013-004093.PMC3948456.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004179).,Non-OADS,/arxiv_data1/oa_pdf/57/e4/bmjopen-2013-004179.PMC3948458.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/57/e4/bmjopen-2013-004179.PMC3948458.pdf
Publicação em 28/04/2009.http://www.ibope.com.br (Acesso em 28 ju.,Non-OADS,/arxiv_data1/oa_pdf/57/e4/bmjopen-2013-004179.PMC3948458.pdf
Disponível em http://www.lipe.com.br .,Non-OADS,/arxiv_data1/oa_pdf/57/e4/bmjopen-2013-004179.PMC3948458.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003715).,Non-OADS,/arxiv_data1/oa_pdf/fa/5e/bmjopen-2013-003715.PMC3948459.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fa/5e/bmjopen-2013-003715.PMC3948459.pdf
http://www.popline.org/node/206889 12.,Non-OADS,/arxiv_data1/oa_pdf/fa/5e/bmjopen-2013-003715.PMC3948459.pdf
The Balanced Counseling Strategy Plus: a toolkit for family planning service providers working in High HIV/STI prevalence settings http://www.popcouncil.org/publications/books/2012_BalancedCounselingStrategyPLUS.asp2012 13.,Non-OADS,/arxiv_data1/oa_pdf/fa/5e/bmjopen-2013-003715.PMC3948459.pdf
http://www.cdc.gov/ reproductivehealth/ProductsPubs/PFA_support/ 14.,Non-OADS,/arxiv_data1/oa_pdf/fa/5e/bmjopen-2013-003715.PMC3948459.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2013- 004595).,Non-OADS,/arxiv_data1/oa_pdf/4a/4b/bmjopen-2013-004595.PMC3948460.pdf
"Registration details: http://www.clinicaltrials.gov (NCT01624896).INTRODUCTION China, a country with a rapidly rising preva- lence of cardiovascular disease,1–3is con- comitantly expanding access to advanced cardiovascular procedures.",Non-OADS,/arxiv_data1/oa_pdf/4a/4b/bmjopen-2013-004595.PMC3948460.pdf
The study is regis-tered at http://www.clinicaltrials.gov (NCT01624896).,Non-OADS,/arxiv_data1/oa_pdf/4a/4b/bmjopen-2013-004595.PMC3948460.pdf
The study is registered at http://www.clinicaltrials.gov (NCT01624896).,Non-OADS,/arxiv_data1/oa_pdf/4a/4b/bmjopen-2013-004595.PMC3948460.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ 8 Li J, Dharmarajan K, Li X, et al.BMJ Open 2014; 4:e004595.",Non-OADS,/arxiv_data1/oa_pdf/4a/4b/bmjopen-2013-004595.PMC3948460.pdf
http://www.cmt.com.cn/detail/39179.html(accessed 17 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/4a/4b/bmjopen-2013-004595.PMC3948460.pdf
Regulation about cardiovascular interventional techniques 2007. http://www.moh.gov.cn/mohbgt/pw10712/200804/18725.shtml (accessed 17Sep 2013).18.,Non-OADS,/arxiv_data1/oa_pdf/4a/4b/bmjopen-2013-004595.PMC3948460.pdf
http://www.stats.gov.cn/tjsj/ndsj/2010/indexeh.htm(accessed 17 Sep 2013).,OADS,/arxiv_data1/oa_pdf/4a/4b/bmjopen-2013-004595.PMC3948460.pdf
http://www.moh.gov.cn/cmsresources/mohbgt/cmsrsdocument/doc6535.pdf (accessed 17 Sep 2013).,OADS,/arxiv_data1/oa_pdf/4a/4b/bmjopen-2013-004595.PMC3948460.pdf
https://www.ncdr.com/WebNCDR/home/metrics-and-measures (accessed 17 Sep 2013).,OADS,/arxiv_data1/oa_pdf/4a/4b/bmjopen-2013-004595.PMC3948460.pdf
AHA annual survey database fiscal year 2011. http://www.ahadataviewer.com/book-cd-products/ aha-survey/ (accessed 17 Sep 2013).,OADS,/arxiv_data1/oa_pdf/4a/4b/bmjopen-2013-004595.PMC3948460.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/11/bhs362.PMC3948488.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/1b/bhs366.PMC3948491.pdf
"Procedure The previously recorded stimuli underwent a further process of pre- emphasis prior to presentation ( http://www.mrc-cbu.cam.ac.uk/ ~rhodri/headphonesim.htm ), in order to optimize auditory quality in the acoustically challenging scanner environment.",Non-OADS,/arxiv_data1/oa_pdf/51/1b/bhs366.PMC3948491.pdf
Stimuli were pre- sented using CAST experimental software ( http://www.mrc-cbu.cam.,OADS,/arxiv_data1/oa_pdf/51/1b/bhs366.PMC3948491.pdf
"To explore further the role of each con-dition in the nonword point effect, we selected the activatedcluster shown in Figure 4Aas a region of interest, within which we examined the activation of the 4 nonword pointconditions using MarsBaR ( http://marsbar.sourceforge.net/ ).",OADS,/arxiv_data1/oa_pdf/51/1b/bhs366.PMC3948491.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/ed/bhs375.PMC3948493.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/9e/ed/bhs375.PMC3948493.pdf
Secondary Leitlinien Sepsis 2010. http://www.sepsis-gesellschaft.de/cgi-bin/WebObjects/DsgCMS.woa/2/wo/2ewkjkZfYnXP78ZyUCxIGM/2.1.MainWrapper.25.1.1.0.3.1.1.3.7.0.0 21.,Non-OADS,/arxiv_data1/oa_pdf/d1/71/bmjopen-2014-004914.PMC3948573.pdf
http://www.ha.org.hk/upload/publication_15/411.pdf (accessed 1 Mar 2013).,Non-OADS,/arxiv_data1/oa_pdf/94/96/bmjopen-2013-003903.PMC3948574.pdf
http://www.statistics.gov.hk/pub/B10100032012AN12B0100.pdf (accessed 1 Mar 2013).,OADS,/arxiv_data1/oa_pdf/94/96/bmjopen-2013-003903.PMC3948574.pdf
2012. http://www.statistics.gov.hk/pub/ B1120015052012XXXXB0100.pdf (accessed 29 Nov 2013).,OADS,/arxiv_data1/oa_pdf/94/96/bmjopen-2013-003903.PMC3948574.pdf
http://www.statistics.gov.hk/pub/B10100032011AN11B0100.pdf (accessed 1 Mar 2013).,OADS,/arxiv_data1/oa_pdf/94/96/bmjopen-2013-003903.PMC3948574.pdf
2012. http://stats.oecd.org/index.aspx?queryid=30165 (accessed25 Feb 2014) 17.,OADS,/arxiv_data1/oa_pdf/94/96/bmjopen-2013-003903.PMC3948574.pdf
2010. http://www.ha.org.hk/haho/ho/pred/ga_PSS_2010_ES_ENG.pdf (accessed 25 Feb 2014) 22.,Non-OADS,/arxiv_data1/oa_pdf/94/96/bmjopen-2013-003903.PMC3948574.pdf
http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdf (accessed 12 Feb 2014).,OADS,/arxiv_data1/oa_pdf/f4/4b/bmjopen-2013-004546.PMC3948575.pdf
http://www.bapen.org.uk/ screening-for-malnutrition/must/must-toolkit/the-must-itself (accessed12 Feb 2014).,Non-OADS,/arxiv_data1/oa_pdf/f4/4b/bmjopen-2013-004546.PMC3948575.pdf
http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf (accessed 12 Feb 2014).,OADS,/arxiv_data1/oa_pdf/f4/4b/bmjopen-2013-004546.PMC3948575.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2013- 004571).,Non-OADS,/arxiv_data1/oa_pdf/60/20/bmjopen-2013-004571.PMC3948576.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004216).,Non-OADS,/arxiv_data1/oa_pdf/d3/2f/bmjopen-2013-004216.PMC3948577.pdf
"Statistical analysis A meta-analysis using the weighted mean difference in the C/D ratios of olanzapine or clozapine betweensmokers and non-smokers was performed using the Review Manager (RevMan) V.5.1 for Windows softwareprogram (Cochrane Collaboration, http://www.cc-ims.",OADS,/arxiv_data1/oa_pdf/d3/2f/bmjopen-2013-004216.PMC3948577.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004379).,Non-OADS,/arxiv_data1/oa_pdf/f1/81/bmjopen-2013-004379.PMC3948578.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004439).,Non-OADS,/arxiv_data1/oa_pdf/d0/76/bmjopen-2013-004439.PMC3948579.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d0/76/bmjopen-2013-004439.PMC3948579.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004384).,Non-OADS,/arxiv_data1/oa_pdf/77/80/bmjopen-2013-004384.PMC3948580.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2013-004282).,Non-OADS,/arxiv_data1/oa_pdf/69/68/bmjopen-2013-004282.PMC3948581.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-004972).,Non-OADS,/arxiv_data1/oa_pdf/89/3e/bmjopen-2014-004972.PMC3948582.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-004842).,Non-OADS,/arxiv_data1/oa_pdf/4d/15/bmjopen-2014-004842.PMC3948633.pdf
http://clinicaltrials.gov/show/NCT00427388.,Non-OADS,/arxiv_data1/oa_pdf/4d/15/bmjopen-2014-004842.PMC3948633.pdf
"http://support.sas.com/documentation/cdl/en/etsug/60372/ HTML/default/viewer.htm#etsug_autoreg_sect024.htm, 2014 (accessed 16 Jan 2014).",OADS,/arxiv_data1/oa_pdf/4d/15/bmjopen-2014-004842.PMC3948633.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2013- 003978).,Non-OADS,/arxiv_data1/oa_pdf/cc/3e/bmjopen-2013-003978.PMC3948634.pdf
"2009. http://www.prisma-statement.org/statement.htm 10 Zheng H, Barnett AG, Merollini K, et al.BMJ Open 2014; 4:e003978.",Non-OADS,/arxiv_data1/oa_pdf/cc/3e/bmjopen-2013-003978.PMC3948634.pdf
http://www.nice.org.uk/page.aspx?o=299970 (accessed 16 May 2010).,Non-OADS,/arxiv_data1/oa_pdf/cc/3e/bmjopen-2013-003978.PMC3948634.pdf
2011. http://www.nicedsu.org.uk (accessed 7 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/cc/3e/bmjopen-2013-003978.PMC3948634.pdf
2011. http://www.nicedsu.org.uk (accessed 7 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/cc/3e/bmjopen-2013-003978.PMC3948634.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004177).,Non-OADS,/arxiv_data1/oa_pdf/94/a9/bmjopen-2013-004177.PMC3948636.pdf
National report on human exposure to environmental chemicals (Centers for Disease Control and Prevention) 2009. http://www.cdc.gov/exposurereport (accessed 18 Feb 2012) 38.,Non-OADS,/arxiv_data1/oa_pdf/94/a9/bmjopen-2013-004177.PMC3948636.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2013- 004107).,Non-OADS,/arxiv_data1/oa_pdf/b8/a6/bmjopen-2013-004107.PMC3948637.pdf
http://www.phc.ox.ac.uk/ 13.,Non-OADS,/arxiv_data1/oa_pdf/b8/a6/bmjopen-2013-004107.PMC3948637.pdf
About The Cochrane Collaboration (Cochrane ReviewGroups (CRGs)) 2012. http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/TOBACCO/sect0.html 14.,Non-OADS,/arxiv_data1/oa_pdf/b8/a6/bmjopen-2013-004107.PMC3948637.pdf
About The Cochrane Collaboration(Cochrane Review Groups (CRGs)) 2007. http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/ENDOC/frame.html 15.,OADS,/arxiv_data1/oa_pdf/b8/a6/bmjopen-2013-004107.PMC3948637.pdf
"The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org 16.",OADS,/arxiv_data1/oa_pdf/b8/a6/bmjopen-2013-004107.PMC3948637.pdf
"A: The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org 17.",OADS,/arxiv_data1/oa_pdf/b8/a6/bmjopen-2013-004107.PMC3948637.pdf
http://clinicaltrials.gov/show/NCT01387425 25.,Non-OADS,/arxiv_data1/oa_pdf/b8/a6/bmjopen-2013-004107.PMC3948637.pdf
http://www.controlled-trials.com/ISRCTN34551140 27.,Non-OADS,/arxiv_data1/oa_pdf/b8/a6/bmjopen-2013-004107.PMC3948637.pdf
To view please visit the journal http://dx.doi.org/ 10.1136/bmjopen-2013-003434.,Non-OADS,/arxiv_data1/oa_pdf/53/a2/bmjopen-2013-003434.PMC3948638.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/53/a2/bmjopen-2013-003434.PMC3948638.pdf
2008; http://ai.fmcsa.dot.gov/CarrierResearchResults/CarrierResearchContent.asp?p=4 5.,OADS,/arxiv_data1/oa_pdf/53/a2/bmjopen-2013-003434.PMC3948638.pdf
http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed 4 Nov 2012).,Non-OADS,/arxiv_data1/oa_pdf/53/a2/bmjopen-2013-003434.PMC3948638.pdf
The National Institute for Health and Care Excellence (NICE) http://www.nice.org.uk/aboutnice/howwework/devnicetech/guidetothemethodsoftechnologyappraisal.jsp (accessed 1 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/53/a2/bmjopen-2013-003434.PMC3948638.pdf
doi:10.1136/ bmjopen-2013-004244 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004244).,Non-OADS,/arxiv_data1/oa_pdf/44/b6/bmjopen-2013-004244.PMC3948639.pdf
http://goo.gl/8Lzfk (accessed 4 Jun 2013).,Non-OADS,/arxiv_data1/oa_pdf/44/b6/bmjopen-2013-004244.PMC3948639.pdf
http://goo.gl/jlBXf (accessed 4 Jun 2013).,OADS,/arxiv_data1/oa_pdf/44/b6/bmjopen-2013-004244.PMC3948639.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004355).,Non-OADS,/arxiv_data1/oa_pdf/cf/65/bmjopen-2013-004355.PMC3948640.pdf
Available from: http://www.cap.org,Non-OADS,/arxiv_data1/oa_pdf/e2/54/main.PMC3948655.pdf
Available from: http://tabnet.datasus.gov.br/cgi/deftohtm.,OADS,/arxiv_data1/oa_pdf/d0/99/main.PMC3948660.pdf
Available from: http://portalsaude.saude.gov.br/portalsaude/noticia/5494/162/triagem-neonatal-alcanca-83-de-cobertura-nacional.html 18.,Non-OADS,/arxiv_data1/oa_pdf/d0/99/main.PMC3948660.pdf
Available from: http://clinicaltrials.gov/show/NCT01532856 16.,Non-OADS,/arxiv_data1/oa_pdf/1b/0c/main.PMC3948661.pdf
Available from: http://clinicaltrials.gov/show/NCT01532856 17.,Non-OADS,/arxiv_data1/oa_pdf/1b/0c/main.PMC3948661.pdf
Available from: http://snp500cancer.nci.nih.gov.,OADS,/arxiv_data1/oa_pdf/6b/08/main.PMC3948663.pdf
Available from: http://www.ibge.gov.br/home/estatistica/populacao/condicaodevida/indicadoresminimos/sinteseindicsociais2006/indic_sociais2006.pdf 11.,OADS,/arxiv_data1/oa_pdf/26/1e/main.PMC3948666.pdf
Available from: http://apps.who.int/iris/bitstream/10665/42682/1/9241545992.pdf  7 .,OADS,/arxiv_data1/oa_pdf/21/75/main.PMC3948667.pdf
2013 [cited 2012 Nov 29] Available from: http://www.nccn.org/professionals/physician_gls/pdf/cml.pdf 26.,Non-OADS,/arxiv_data1/oa_pdf/21/75/main.PMC3948667.pdf
"ISSN 2234-3806 • eISSN 2234-3814  104  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.104 Ann Lab Med 2014;34:104-110 http://dx.doi.org/10.3343/alm.2014.34.2.104Original Article Clinical Chemistry Assessment of the Trueness and Inter-Laboratory  Precision of Routine Uric Acid Assays Using 4 Frozen  Pooled Serum Samples Measured by the Japan Society  of Clinical Chemistry’s HPLC Method Yaping Jiang, Ph.D.1, Ou Liu, M.S.2, and Guobing Xu, M.S.1 Department of Clinical Laboratory1, Peking University First Hospital; Department of Clinical Laboratory2, Tsinghua University First Hospital, Beijng, China Background:  Reference procedures are required for evaluating the accuracy of routine  analytical systems for uric acid (UA).",Non-OADS,/arxiv_data1/oa_pdf/30/30/alm-34-104.PMC3948822.pdf
Trueness for routine uric acid assays http://dx.doi.org/10.3343/alm.2014.34.2.104 www.annlabmed.org  105Numerous methods have been reported for the measurement of  UA in human serum.,OADS,/arxiv_data1/oa_pdf/30/30/alm-34-104.PMC3948822.pdf
"Trueness for routine uric acid assays 106  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.104prepared with Milli-Q (18.2 MΩ cm) water and filtered through  0.2-μm filters from Sartorius AG (Goettingen, Germany).",OADS,/arxiv_data1/oa_pdf/30/30/alm-34-104.PMC3948822.pdf
Trueness for routine uric acid assays http://dx.doi.org/10.3343/alm.2014.34.2.104 www.annlabmed.org  107ing to ISO Guide 35 [22].,Non-OADS,/arxiv_data1/oa_pdf/30/30/alm-34-104.PMC3948822.pdf
Trueness for routine uric acid assays 108  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.1043.,OADS,/arxiv_data1/oa_pdf/30/30/alm-34-104.PMC3948822.pdf
Trueness for routine uric acid assays http://dx.doi.org/10.3343/alm.2014.34.2.104 www.annlabmed.org  109time affected the results calculated by peak height but not those  calculated by peak area.,OADS,/arxiv_data1/oa_pdf/30/30/alm-34-104.PMC3948822.pdf
Trueness for routine uric acid assays 110  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.104HPLC method in China.,Non-OADS,/arxiv_data1/oa_pdf/30/30/alm-34-104.PMC3948822.pdf
http://ci.nii.ac.jp/naid/110004299689.,Non-OADS,/arxiv_data1/oa_pdf/30/30/alm-34-104.PMC3948822.pdf
https://www-s.nist.gov/ srmors/view_cert.cfm?srm=909B (Updated on Aug 2011).,OADS,/arxiv_data1/oa_pdf/30/30/alm-34-104.PMC3948822.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2014.34.2.111 www.annlabmed.org  111 Ann Lab Med 2014;34:111-117 http://dx.doi.org/10.3343/alm.2014.34.2.111Original Article Clinical Microbiology Performance of Kiestra Total Laboratory Automation  Combined with MS in Clinical Microbiology Practice Nico T. Mutters, M.D.1,2, Caspar J. Hodiamont, M.D.2, Menno D. de Jong, M.D.2, Hendri P. J. Overmeijer, B.A.Sc.2,  Mandy van den Boogaard, B.A.Sc.2, and Caroline E.Visser, M.D.2 Department of Infectious Diseases1, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg, Germany; Academic Medical Centre2,  Department of Medical Microbiology, University of Amsterdam, Amsterdam, the Netherlands Background:  Microbiological laboratories seek technologically innovative solutions to cope  with large numbers of samples and limited personnel and financial resources.",Non-OADS,/arxiv_data1/oa_pdf/1a/94/alm-34-111.PMC3948823.pdf
"Performance of Kiestra TLA with MS 112  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.111Kiestra B.V., Drachten, the Netherlands).",OADS,/arxiv_data1/oa_pdf/1a/94/alm-34-111.PMC3948823.pdf
Performance of Kiestra TLA with MS http://dx.doi.org/10.3343/alm.2014.34.2.111 www.annlabmed.org  1133.,OADS,/arxiv_data1/oa_pdf/1a/94/alm-34-111.PMC3948823.pdf
"Performance of Kiestra TLA with MS 114  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.111ing, acridine orange staining, or by culturing.",Non-OADS,/arxiv_data1/oa_pdf/1a/94/alm-34-111.PMC3948823.pdf
Performance of Kiestra TLA with MS http://dx.doi.org/10.3343/alm.2014.34.2.111 www.annlabmed.org  1154.,OADS,/arxiv_data1/oa_pdf/1a/94/alm-34-111.PMC3948823.pdf
"Performance of Kiestra TLA with MS 116  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.111negative (91.5-99%) bacteria [16, 17].",OADS,/arxiv_data1/oa_pdf/1a/94/alm-34-111.PMC3948823.pdf
Performance of Kiestra TLA with MS http://dx.doi.org/10.3343/alm.2014.34.2.111 www.annlabmed.org  1174.,OADS,/arxiv_data1/oa_pdf/1a/94/alm-34-111.PMC3948823.pdf
"ISSN 2234-3806 • eISSN 2234-3814  118  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.118 Ann Lab Med 2014;34:118-126 http://dx.doi.org/10.3343/alm.2014.34.2.118Original Article Diagnostic Immunology Development of Enzyme-Linked Immunosorbent  Assays Using 2 Truncated ORF2 Proteins for Detection  of IgG Antibodies Against Hepatitis E Virus Reza Taherkhani, Ph.D.1,2, Manoochehr Makvandi, Ph.D.1,2, and Fatemeh Farshadpour, Ph.D.1,2  Health Research Institute1, Infectious and Tropical Disease Research Center, Ahvaz Jundishapur University of Medical Scien, Ahvaz; Department of Medical  Virology2, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran Background:  Without appropriate culture systems for hepatitis E virus (HEV), sufficient  natural viral proteins are difficult to generate for use in serological tests.",Non-OADS,/arxiv_data1/oa_pdf/20/db/alm-34-118.PMC3948824.pdf
"ELISAs using 2 truncated forms of HEV ORF2 protein http://dx.doi.org/10.3343/alm.2014.34.2.118 www.annlabmed.org  119may cause serious consequences in pregnant women and pa - tients with chronic liver disease [2, 7].",Non-OADS,/arxiv_data1/oa_pdf/20/db/alm-34-118.PMC3948824.pdf
ELISAs using 2 truncated forms of HEV ORF2 protein 120  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.118(New England BioLab).,Non-OADS,/arxiv_data1/oa_pdf/20/db/alm-34-118.PMC3948824.pdf
ELISAs using 2 truncated forms of HEV ORF2 protein http://dx.doi.org/10.3343/alm.2014.34.2.118 www.annlabmed.org  121of 2% casein hydrolysate and 1% bovine serum albumin (BSA)  in PBS at 37°C for 1 hr.,Non-OADS,/arxiv_data1/oa_pdf/20/db/alm-34-118.PMC3948824.pdf
ELISAs using 2 truncated forms of HEV ORF2 protein 122  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.118 Fig.,Non-OADS,/arxiv_data1/oa_pdf/20/db/alm-34-118.PMC3948824.pdf
ELISAs using 2 truncated forms of HEV ORF2 protein http://dx.doi.org/10.3343/alm.2014.34.2.118 www.annlabmed.org  1232.,Non-OADS,/arxiv_data1/oa_pdf/20/db/alm-34-118.PMC3948824.pdf
ELISAs using 2 truncated forms of HEV ORF2 protein 124  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.118BSA in PBS.,OADS,/arxiv_data1/oa_pdf/20/db/alm-34-118.PMC3948824.pdf
ELISAs using 2 truncated forms of HEV ORF2 protein http://dx.doi.org/10.3343/alm.2014.34.2.118 www.annlabmed.org  125Table 1.,Non-OADS,/arxiv_data1/oa_pdf/20/db/alm-34-118.PMC3948824.pdf
"ELISAs using 2 truncated forms of HEV ORF2 protein 126  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.118search Center of Ahvaz Jundishapur University of Medical Sci - ences, Ahvaz, Iran.",OADS,/arxiv_data1/oa_pdf/20/db/alm-34-118.PMC3948824.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2014.34.2.127 www.annlabmed.org  127 Ann Lab Med 2014;34:127-133 http://dx.doi.org/10.3343/alm.2014.34.2.127Original Article Diagnostic Genetics Clinical Validation of AdvanSure GenoBlot Assay as  Primary Screening and Test of Cure for Human  Papillomavirus Infection Jimin Kahng, M.D.1, Eun-Jee Oh, M.D.1, Hae Nam Lee, M.D.2, Dae Woo Lee, M.D.2, and Yonggoo Kim, M.D.1 Departments of Laboratory Medicine1 and Gynecology2, College of Medicine, The Catholic University of Korea, Seoul, Korea Background:  Clinical specificity and sensitivity are essential factors in the adoption of a hu - man papillomavirus (HPV) test as a primary screening tool and test of cure after treatment  of cervical cancer and precancerous lesions (High-Risk-Lesion).",Non-OADS,/arxiv_data1/oa_pdf/9a/62/alm-34-127.PMC3948825.pdf
"GenoBlot as screening and test of cure for HPV 128  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.127types –including 26, 53, 69, 70, 73, and 82 that are gradually  being classified as HR types [13, 14] –than genotyping systems  currently available on the market; however, it has not yet been  clinically validated.",Non-OADS,/arxiv_data1/oa_pdf/9a/62/alm-34-127.PMC3948825.pdf
GenoBlot as screening and test of cure for HPV http://dx.doi.org/10.3343/alm.2014.34.2.127 www.annlabmed.org  129extension step was performed for each PCR at 72 °C for 5 min.,Non-OADS,/arxiv_data1/oa_pdf/9a/62/alm-34-127.PMC3948825.pdf
GenoBlot as screening and test of cure for HPV 130  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.1273.,Non-OADS,/arxiv_data1/oa_pdf/9a/62/alm-34-127.PMC3948825.pdf
GenoBlot as screening and test of cure for HPV http://dx.doi.org/10.3343/alm.2014.34.2.127 www.annlabmed.org  131low-up specimens were collected.,OADS,/arxiv_data1/oa_pdf/9a/62/alm-34-127.PMC3948825.pdf
"GenoBlot as screening and test of cure for HPV 132  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.127The positive rates of individual genotypes were relatively higher  in GenoBlot than in HPVDNAChip, with exceptions for geno - types 51 and 56, for which HPVDNAChip showed higher posi - tive rates than GenoBlot.",Non-OADS,/arxiv_data1/oa_pdf/9a/62/alm-34-127.PMC3948825.pdf
GenoBlot as screening and test of cure for HPV http://dx.doi.org/10.3343/alm.2014.34.2.127 www.annlabmed.org  133fection or re-infection.,Non-OADS,/arxiv_data1/oa_pdf/9a/62/alm-34-127.PMC3948825.pdf
"ISSN 2234-3806 • eISSN 2234-3814  134  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.134 Ann Lab Med 2014;34:134-138 http://dx.doi.org/10.3343/alm.2014.34.2.134Original Article Diagnostic Genetics Identification of a De Novo  Heterozygous Missense  FLNB  Mutation in Lethal Atelosteogenesis Type I by  Exome Sequencing Ga Won Jeon, M.D.1,*, Mi-Na Lee, M.D.2,*, Ji Mi Jung, M.D.1, Seong Yeon Hong, M.D.3, Young Nam Kim, M.D.4,  Jong Beom Sin, M.D.1, and Chang-Seok Ki, M.D.2 Department of Pediatrics1, Inje University College of Medicine, Busan Paik Hospital, Busan; Department of Laboratory Medicine and Genetics2, Samsung  Medical Center, Sungkyunkwan University School of Medicine, Seoul; Department of Obstetrics and Gynecology3, Catholic University of Daegu, Daegu  Catholic University Medical Center, Daegu; Department of Obstetrics and Gynecology4, Inje University College of Medicine, Busan Paik Hospital, Busan, Korea Background:  Atelosteogenesis type I (AO-I) is a rare lethal skeletal dysplastic disorder  characterized by severe short-limbed dwarfism and dislocated hips, knees, and elbows.",Non-OADS,/arxiv_data1/oa_pdf/ef/01/alm-34-134.PMC3948826.pdf
Exome sequencing for atelosteogenesis type I http://dx.doi.org/10.3343/alm.2014.34.2.134 www.annlabmed.org  135skeletal dysplasias [9].,Non-OADS,/arxiv_data1/oa_pdf/ef/01/alm-34-134.PMC3948826.pdf
These variants  were annotated by ANNOVAR (version 2011 Jun 18) [15] to fil - ter SNPs reported in the dbSNP database (build 135) [16] and  the 1000 Genomes Project (http://1000genomes.org).,OADS,/arxiv_data1/oa_pdf/ef/01/alm-34-134.PMC3948826.pdf
Polyphen-2 (http://genetics.bwh.harvard.edu/pph2/) and  SIFT (Sorting Intolerant From Tolerant) (http://sift.jcvi.org/) were  used to predict the consequences of the missense variants on  protein function.,OADS,/arxiv_data1/oa_pdf/ef/01/alm-34-134.PMC3948826.pdf
Exome sequencing for atelosteogenesis type I 136  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.134severely shortened and distally hypoplastic.,Non-OADS,/arxiv_data1/oa_pdf/ef/01/alm-34-134.PMC3948826.pdf
"Exome sequencing for atelosteogenesis type I http://dx.doi.org/10.3343/alm.2014.34.2.134 www.annlabmed.org  137nantly found in the brain and blood vessels, FlnB in bones, and  FlnC in muscles.",OADS,/arxiv_data1/oa_pdf/ef/01/alm-34-134.PMC3948826.pdf
Exome sequencing for atelosteogenesis type I 138  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.1345.,Non-OADS,/arxiv_data1/oa_pdf/ef/01/alm-34-134.PMC3948826.pdf
"http://www.genetests.org (Accessed on Apr 30, 2013).",OADS,/arxiv_data1/oa_pdf/ef/01/alm-34-134.PMC3948826.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2014.34.2.139 www.annlabmed.org  139 Ann Lab Med 2014;34:139-144 http://dx.doi.org/10.3343/alm.2014.34.2.139Brief Communications Clinical Microbiology Antimicrobial Resistance Patterns and Integron  Carriage of Escherichia coli  Isolates Causing  Community-Acquired Infections in Turkey Aysegul Copur-Cicek, M.D.1, Osman Birol Ozgumus, Ph.D.1, Aysegul Saral, M.S.2, and Cemal Sandalli, Ph.D.3 Department of Medical Microbiology1, Faculty of Medicine, Recep Tayyip Erdo ğan University, Rize; Department of Biology2, Faculty of Arts & Sciences, Artvin  Coruh University, Artvin; Department of Biology3, Faculty of Arts & Sciences, Recep Tayyip Erdo ğan University, Rize, Turkey We aimed to observe antimicrobial resistance patterns and integron carriage of Esche - richia coli  isolates causing community-acquired infections.",Non-OADS,/arxiv_data1/oa_pdf/c2/60/alm-34-139.PMC3948827.pdf
"Integron carriage of E. coli  isolates 140  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.139out using both conventional methods and Vitek2 compact sys - tem (bioMerieux, Durham, NC, USA) according to the manufac - turers’ instructions.",OADS,/arxiv_data1/oa_pdf/c2/60/alm-34-139.PMC3948827.pdf
Integron carriage of E. coli  isolates http://dx.doi.org/10.3343/alm.2014.34.2.139 www.annlabmed.org  141Table 1.,Non-OADS,/arxiv_data1/oa_pdf/c2/60/alm-34-139.PMC3948827.pdf
Integron carriage of E. coli  isolates 142  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.139Table 1.,Non-OADS,/arxiv_data1/oa_pdf/c2/60/alm-34-139.PMC3948827.pdf
Integron carriage of E. coli  isolates http://dx.doi.org/10.3343/alm.2014.34.2.139 www.annlabmed.org  143Fig.,OADS,/arxiv_data1/oa_pdf/c2/60/alm-34-139.PMC3948827.pdf
Integron carriage of E. coli  isolates 144  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.1396.,OADS,/arxiv_data1/oa_pdf/c2/60/alm-34-139.PMC3948827.pdf
8. http://www.ncbi.nlm.nih.gov/BLAST.,Non-OADS,/arxiv_data1/oa_pdf/c2/60/alm-34-139.PMC3948827.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2014.34.2.145 www.annlabmed.org  145 Ann Lab Med 2014;34:145-147 http://dx.doi.org/10.3343/alm.2014.34.2.145Brief Communications Clinical Microbiology Prevalence of Human Astrovirus in Patients with Acute  Gastroenteritis Heejin Ham, M.S.1, Seah Oh, M.S.1, Jungim Jang, Ph.D.1, Sukju Jo, M.S.1, Sungmin Choi, M.S.1, and Sonil Pak, Ph.D.2  Department of Microbiology1, Seoul Metropolitan Government Research Institute of Public Health and Environment, Gwacheon; College of Veterinary  Medicine2, Kangwon National University, Chuncheon, Korea The prevalence of human astroviruses was tested in patients with acute gastroenteritis by  using conventional duplex reverse transcription (RT)-PCR and electrophoresis.",OADS,/arxiv_data1/oa_pdf/9e/e3/alm-34-145.PMC3948828.pdf
"Astrovirus prevalence in gastroenteritis patients 146  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.145of Public Health and Environment, where they were stored at  -70°C until further analysis.",Non-OADS,/arxiv_data1/oa_pdf/9e/e3/alm-34-145.PMC3948828.pdf
Astrovirus prevalence in gastroenteritis patients http://dx.doi.org/10.3343/alm.2014.34.2.145 www.annlabmed.org  147decreased in older individuals (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/9e/e3/alm-34-145.PMC3948828.pdf
Report of SIHE  2004;40:290-300. http://health.seoul.go.kr/healthlab/1623?sc=bd_ title&pageno=1&bc_no=108&sv=astrovirus (Updated on Feb 2013).,OADS,/arxiv_data1/oa_pdf/9e/e3/alm-34-145.PMC3948828.pdf
"Enternet Korea, Yearly  Report 2012;43-49. http://www.cdc.go.kr/CDC/notice/CdcKrInfo0301.",Non-OADS,/arxiv_data1/oa_pdf/9e/e3/alm-34-145.PMC3948828.pdf
"ISSN 2234-3806 • eISSN 2234-3814  148  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.148 Ann Lab Med 2014;34:148-151 http://dx.doi.org/10.3343/alm.2014.34.2.148Letter to the Editor  Diagnostic Hematology A Rare Case of Acute Leukemic Presentation of Blastic  Plasmacytoid Dendritic Cell Neoplasm without  Cutaneous Lesions Shinae Yu, M.D.1,*, Min-Jung Kwon, M.D.1,*, Kyungeun Kim, M.D.2, Dong-Hoe Koo, M.D.3, Hee-Yeon Woo, M.D.1,  and Hyosoon Park, M.D.1 Departments of Laboratory Medicine1, Pathology2, and Internal Medicine3, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine,   Seoul, Korea Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare  hematological malignancy with a clinically aggressive phenotype  arising from CD4/CD56-expressing plasmacytoid dendritic cell  precursors [1].",Non-OADS,/arxiv_data1/oa_pdf/22/c5/alm-34-148.PMC3948829.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/c5/alm-34-148.PMC3948829.pdf
BPDCN without cutaneous lesions http://dx.doi.org/10.3343/alm.2014.34.2.148 www.annlabmed.org  149medium-sized cells together with effacement of the normal LN  architecture.,Non-OADS,/arxiv_data1/oa_pdf/22/c5/alm-34-148.PMC3948829.pdf
BPDCN without cutaneous lesions 150  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.148and had a ki-67 labeling index of 60%.,OADS,/arxiv_data1/oa_pdf/22/c5/alm-34-148.PMC3948829.pdf
BPDCN without cutaneous lesions http://dx.doi.org/10.3343/alm.2014.34.2.148 www.annlabmed.org  151patients was inhomogeneous and often not optimal [11].,Non-OADS,/arxiv_data1/oa_pdf/22/c5/alm-34-148.PMC3948829.pdf
"ISSN 2234-3806 • eISSN 2234-3814  152  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.152 Ann Lab Med 2014;34:152-154 http://dx.doi.org/10.3343/alm.2014.34.2.152Letter to the Editor  Diagnostic Hematology A Case of Acute Promyelocytic Leukemia Concomitant  with Plasma Cell Myeloma Jinsook Lim, M.D.1, Gye Cheol Kwon, M.D.1, Sun Hoe Koo, M.D.1, Ik Chan Song, M.D.2, and Jimyung Kim, M.D.1 Departments of Laboratory Medicine1 and Internal Medicine2, Chungnam National University Hospital, Daejeon, Korea Dear Editor AML is a myeloid clonal malignancy characterized by the accu - mulation of abnormal immature myeloid cells in the bone mar - row.",Non-OADS,/arxiv_data1/oa_pdf/69/ca/alm-34-152.PMC3948830.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/ca/alm-34-152.PMC3948830.pdf
"Co-occurrence of APL and plasma cell myeloma http://dx.doi.org/10.3343/alm.2014.34.2.152 www.annlabmed.org  153ric analysis demonstrated blastic cells expressing CD13, CD33,  and cytoplasmic MPO, but not HLA-DR, CD34, or CD15, consis - tent with the characteristics of APL.",OADS,/arxiv_data1/oa_pdf/69/ca/alm-34-152.PMC3948830.pdf
Co-occurrence of APL and plasma cell myeloma 154  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.152cidentally without previous chemotherapy.,Non-OADS,/arxiv_data1/oa_pdf/69/ca/alm-34-152.PMC3948830.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2014.34.2.155 www.annlabmed.org  155 Ann Lab Med 2014;34:155-158 http://dx.doi.org/10.3343/alm.2014.34.2.155Letter to the Editor  Diagnostic Hematology  Therapy-Related Acute Megakaryoblastic Leukemia in  a Lung Cancer Patient Jung Joo Moon, M.D., Myung-Hyun Nam, M.D., Chae Seung Lim, M.D., Chang Kyu Lee, M.D., Yunjung Cho, M.D.,   and Soo-Young Yoon, M.D.",Non-OADS,/arxiv_data1/oa_pdf/4c/1d/alm-34-155.PMC3948831.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/1d/alm-34-155.PMC3948831.pdf
"Therapy-related AMKL 156  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.155reticular chromatin, one to three inconspicuous nucleoli, baso - philic agranular cytoplasm, and frequently formed pseudopod.",Non-OADS,/arxiv_data1/oa_pdf/4c/1d/alm-34-155.PMC3948831.pdf
"Therapy-related AMKL http://dx.doi.org/10.3343/alm.2014.34.2.155 www.annlabmed.org  157versely, there were relatively more granulocytes, but these also  showed dysplastic features such as megaloblastoid change, hy - posegmentation, and cytoplasmic hypogranularity.",Non-OADS,/arxiv_data1/oa_pdf/4c/1d/alm-34-155.PMC3948831.pdf
Therapy-related AMKL 158  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.155AMKL without any evidence of preceding myelodysplasia.,Non-OADS,/arxiv_data1/oa_pdf/4c/1d/alm-34-155.PMC3948831.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2014.34.2.159 www.annlabmed.org  159 Ann Lab Med 2014;34:159-162 http://dx.doi.org/10.3343/alm.2014.34.2.159Letter to the Editor  Diagnostic Hematology A Novel Hemizygous I418S Mutation in the ALAS2   Gene in a Young Korean Man with X-Linked  Sideroblastic Anemia Soo Young Moon, M.D.1, In-Jae Jun, B.S.1, Ji-Eun Kim, M.S.1, Seung Jun Lee, M.D.1, Hyun Kyung Kim, M.D.1,  and Sung-Soo Yoon, M.D.2 Departments of Laboratory Medicine1 and Internal Medicine2, Seoul National University College of Medicine, Seoul, Korea Dear Editor, Sideroblastic anemia is a heterogeneous disorder that is charac - terized by increased  serum iron and ferritin levels, high number  of hypochromic red blood cells (RBCs), and ineffective erythro - poiesis with ringed sideroblasts in the bone marrow (BM) [1].",Non-OADS,/arxiv_data1/oa_pdf/48/a0/alm-34-159.PMC3948832.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/a0/alm-34-159.PMC3948832.pdf
"Hemizygous I418S mutation in ALAS2 160  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.159ropoietic changes, including nuclear budding and internuclear  bridging (Fig.",Non-OADS,/arxiv_data1/oa_pdf/48/a0/alm-34-159.PMC3948832.pdf
"We used the SIFT (http:// sift.jcvi.org/www/SIFT_enst_submit.html), Align GVGD (http:// agvgd.iarc.fr/), and Polyphen-2 (http://genetics.bwh.harvard.",OADS,/arxiv_data1/oa_pdf/48/a0/alm-34-159.PMC3948832.pdf
Hemizygous I418S mutation in ALAS2 http://dx.doi.org/10.3343/alm.2014.34.2.159 www.annlabmed.org  161several clinically distinctive forms of inherited sideroblastic ane - mia have been elucidated.,Non-OADS,/arxiv_data1/oa_pdf/48/a0/alm-34-159.PMC3948832.pdf
Hemizygous I418S mutation in ALAS2 162  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.15913.,Non-OADS,/arxiv_data1/oa_pdf/48/a0/alm-34-159.PMC3948832.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2014.34.2.163 www.annlabmed.org  163 Ann Lab Med 2014;34:163-165 http://dx.doi.org/10.3343/alm.2014.34.2.163Letter to the Editor  Diagnostic Hematology A Case of Residual Non-Small Cell Lung Cancer Cells  Coexisting With Newly Developed Small Cell Lung  Cancer Cells in Ascitic Fluid after Chemotherapy for  Non-Small Cell Lung Cancer Sang Hyuk Park, M.D.1, Hyun-Sook Chi, M.D.2, Young Jin Kim, M.D.3, Young-Uk Cho, M.D.2, Seongsoo Jang, M.D.2,  Chan-Jeoung Park, M.D.2, and Sang-We Kim, M.D.4  Department of Laboratory Medicine1, Pusan National University School of Medicine, Pusan National University Hospital, Busan; Department of Laboratory  Medicine2, University of Ulsan College of Medicine and Asan Medical Center, Seoul; Department of Laboratory Medicine3, Kyung Hee University School of  Medicine, Seoul; Department of Oncology4, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea Dear editor, Synchronous primary lung cancer occurs in only 0.5% of pa - tients with lung cancer, and coexistence of non-small cell lung  cancer (NSCLC) and small-cell lung cancer (SCLC) has been  reported in a very small fraction of lung cancer cases [1, 2].",Non-OADS,/arxiv_data1/oa_pdf/ae/a5/alm-34-163.PMC3948833.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/a5/alm-34-163.PMC3948833.pdf
NSCLC coexisting with SCLC cells in ascitic fluid 164  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.163Fig.,OADS,/arxiv_data1/oa_pdf/ae/a5/alm-34-163.PMC3948833.pdf
NSCLC coexisting with SCLC cells in ascitic fluid http://dx.doi.org/10.3343/alm.2014.34.2.163 www.annlabmed.org  165in the right middle and lower lobes.,Non-OADS,/arxiv_data1/oa_pdf/ae/a5/alm-34-163.PMC3948833.pdf
"ISSN 2234-3806 • eISSN 2234-3814  166  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.166 Ann Lab Med 2014;34:166-169 http://dx.doi.org/10.3343/alm.2014.34.2.166Letter to the Editor  Diagnostic Hematology Acute Lymphoblastic Leukemia with Mature B-Cell  Phenotype and t(9;11;11)(p22;q23;p11.2): A Case  Study and Literature Review  Borahm Kim, M.D.1, Seung-Tae Lee, M.D.1, Hee-Jin Kim, M.D.1, Soo-Hyun Lee, M.D.2, Keon HeeYoo, M.D.2,   Hong Hoe Koo, M.D.2, and Sun Hee Kim, M.D.1 Departments of Laboratory Medicine and Genetics1 and Pediatrics2, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Patients with infantile ALL are fundamentally different from adult  patients in that infants have a worse prognosis, which is attrib - uted to the increased relative incidence of MLL gene rearrange - ments [1, 2].",Non-OADS,/arxiv_data1/oa_pdf/da/7a/alm-34-166.PMC3948834.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/7a/alm-34-166.PMC3948834.pdf
Mature B-ALL with t(9;11;11) http://dx.doi.org/10.3343/alm.2014.34.2.166 www.annlabmed.org  167(Fig.,Non-OADS,/arxiv_data1/oa_pdf/da/7a/alm-34-166.PMC3948834.pdf
Mature B-ALL with t(9;11;11) 168  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.166Table 1.,Non-OADS,/arxiv_data1/oa_pdf/da/7a/alm-34-166.PMC3948834.pdf
"Mature B-ALL with t(9;11;11) http://dx.doi.org/10.3343/alm.2014.34.2.166 www.annlabmed.org  169B-ALL), while others showed CR with no evidence of relapse.",Non-OADS,/arxiv_data1/oa_pdf/da/7a/alm-34-166.PMC3948834.pdf
"ISSN 2234-3806 • eISSN 2234-3814  170  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.170 Ann Lab Med 2014;34:170-173 http://dx.doi.org/10.3343/alm.2014.34.2.170Letter to the Editor  Diagnostic Hematology Pyrosequencing as a Fast and Reliable Method in  Detecting the MYD88  p.L265P Mutation in Decalcified  Formalin-Fixed and Paraffin-Embedded Tissues Niklas Gebauer, M.D., Veronica Bernard, Ph.D., Claudia Röhner, M.D., Manuela Krokowski, M.D., Hartmut Merz, M.D.,  Alfred C. Feller, M.D., and Christoph Thorns, M.D.",Non-OADS,/arxiv_data1/oa_pdf/18/49/alm-34-170.PMC3948835.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/49/alm-34-170.PMC3948835.pdf
"Pyrosequencing of the MYD88  p.L265P mutation http://dx.doi.org/10.3343/alm.2014.34.2.170 www.annlabmed.org  171were designed and synthesized (Tib Molbiol, Berlin, Germany) as  follows: MYD88 -265-forward: 5 ’-GAATGTGTGCCAGGGGTACTT;  MYD88 -265-reverse: 5 ’-Bioteg-TCAGGATGCTGGGGAACTA;  MYD88 -265-sequencing-forward: 5 ’-CCCATCAGAAGCGAC.",Non-OADS,/arxiv_data1/oa_pdf/18/49/alm-34-170.PMC3948835.pdf
Pyrosequencing of the MYD88  p.L265P mutation 172  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.170Table 1.,Non-OADS,/arxiv_data1/oa_pdf/18/49/alm-34-170.PMC3948835.pdf
Pyrosequencing of the MYD88  p.L265P mutation http://dx.doi.org/10.3343/alm.2014.34.2.170 www.annlabmed.org  173mutation.,Non-OADS,/arxiv_data1/oa_pdf/18/49/alm-34-170.PMC3948835.pdf
"ISSN 2234-3806 • eISSN 2234-3814  174  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.174 Ann Lab Med 2014;34:174-176 http://dx.doi.org/10.3343/alm.2014.34.2.174Letter to the Editor  Clinical Microbiology Discrepant Satellitism for Identification of  Granulicatella adiacens  Isolates Young Rae Koh, M.D., Jongyoun Yi, M.D., Hyung Hoi Kim, M.D., Chulhun L. Chang, M.D., and Shine Young Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/e9/8b/alm-34-174.PMC3948836.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/8b/alm-34-174.PMC3948836.pdf
"Satellitism of Granulicatella adiacens http://dx.doi.org/10.3343/alm.2014.34.2.174 www.annlabmed.org  175(Applied Biosystems, Foster City, CA, USA).",OADS,/arxiv_data1/oa_pdf/e9/8b/alm-34-174.PMC3948836.pdf
The resulting sequence was compared with sequences in  GenBank (http://www.ncbi.nlm.nih.gov).,OADS,/arxiv_data1/oa_pdf/e9/8b/alm-34-174.PMC3948836.pdf
Satellitism of Granulicatella adiacens 176  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.174pleomorphic cocci are revealed in pairs and short chains that  fail to grow in subculture.,Non-OADS,/arxiv_data1/oa_pdf/e9/8b/alm-34-174.PMC3948836.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2014.34.2.177 www.annlabmed.org  177 Ann Lab   2014;34:177-179 http://dx.doi.org/10.3343/alm.2014.34.2.177Letter to the Editor  Clinical Microbiology The First Case of Eggerthella lenta  Bacteremia in Korea Hwa Jeen Lee, M.D.1, Sung Kuk Hong, M.D.1, Woo Suk Choi, M.D.2, and Eui-Chong Kim, M.D.1 Departments of Laboratory Medicine1 and Urology2, Seoul National University Hospital, Seoul, Korea Eggerthella lenta , previously Eubacterium lentum , is a non-mo - tile, non-spore-forming anaerobic gram-positive bacillus.",Non-OADS,/arxiv_data1/oa_pdf/d1/10/alm-34-177.PMC3948837.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/10/alm-34-177.PMC3948837.pdf
Eggerthella lenta  bacteremia 178  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.177GenBank sequence NR_074377.1 ( Eggerthella lenta ) and  96.8% identity match with GenBank sequence AY321958.1  (Eggerthella sinensis ).,OADS,/arxiv_data1/oa_pdf/d1/10/alm-34-177.PMC3948837.pdf
"Eggerthella lenta  bacteremia http://dx.doi.org/10.3343/alm.2014.34.2.177 www.annlabmed.org  179elevated CRP levels, and decreased leukocyte count and gastro - intestinal tract malignancy as a predisposing factor for E. lenta   bacteremia.",Non-OADS,/arxiv_data1/oa_pdf/d1/10/alm-34-177.PMC3948837.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2014.34.2.85 www.annlabmed.org  85Ann Lab Med 2014;34:85-91 http://dx.doi.org/10.3343/alm.2014.34.2.85Original Article Diagnostic Hematology Changes in Plasma Levels of Natural Anticoagulants in  Disseminated Intravascular Coagulation: High  Prognostic Value of Antithrombin and Protein C in  Patients with Underlying Sepsis or Severe Infection Qute Choi, M.D.1, Ki Ho Hong, M.D.1,3, Ji-Eun Kim, M.S.1,2, and Hyun Kyung Kim, M.D.1,2 Department of Laboratory Medicine1, Cancer Research Institute2, Seoul National University College of Medicine; Department of Laboratory Medicine3, Seoul  Medical Center, Seoul, Korea Background:  Dysfunctional natural anticoagulant systems enhance intravascular fibrin for - mation in disseminated intravascular coagulation (DIC), and plasma levels of natural anti - coagulants can be used in the diagnosis and prognosis of DIC.",OADS,/arxiv_data1/oa_pdf/16/24/alm-34-85.PMC3948838.pdf
"Antithrombin and protein C in DIC  86  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.85ulants can restore dysfunctional anticoagulant systems, recombi - nant anticoagulant proteins including antithrombin and activated  protein C have been investigated for the treatment of DIC [2].",Non-OADS,/arxiv_data1/oa_pdf/16/24/alm-34-85.PMC3948838.pdf
Antithrombin and protein C in DIC  http://dx.doi.org/10.3343/alm.2014.34.2.85 www.annlabmed.org  87RESULTS 1.,OADS,/arxiv_data1/oa_pdf/16/24/alm-34-85.PMC3948838.pdf
"Antithrombin and protein C in DIC  88  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.85also significantly lower in patients with overt-DIC (51.9±29.8,  36.7±25.3) than in patients without overt-DIC (84.9±26.7,  80.8±37.6) ( P<0.001).",Non-OADS,/arxiv_data1/oa_pdf/16/24/alm-34-85.PMC3948838.pdf
Antithrombin and protein C in DIC  http://dx.doi.org/10.3343/alm.2014.34.2.85 www.annlabmed.org  89compared to those with high antithrombin levels (>63%) ( P<  0.001) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/16/24/alm-34-85.PMC3948838.pdf
"Antithrombin and protein C in DIC  90  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.85ease group, the hazard ratio of D-dimer was highest (21.15;  95% CI, 2.90-154.42) and that of antithrombin was also high  (5.54; 95% CI, 1.34-22.95).",OADS,/arxiv_data1/oa_pdf/16/24/alm-34-85.PMC3948838.pdf
Antithrombin and protein C in DIC  http://dx.doi.org/10.3343/alm.2014.34.2.85 www.annlabmed.org  91ported.,Non-OADS,/arxiv_data1/oa_pdf/16/24/alm-34-85.PMC3948838.pdf
"ISSN 2234-3806 • eISSN 2234-3814  92  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.92 Ann Lab Med 2014;34:92-97 http://dx.doi.org/10.3343/alm.2014.34.2.92Original Article Diagnostic Hematology Novel Markers of Early Neutrophilic and Monocytic  Engraftment after Hematopoietic Stem Cell  Transplantation Jimin Kahng, M.D.1, Seung-Ah Yahng, M.D.2, Jae Wook Lee, M.D.3, Yonggoo Kim, M.D.1, Myungshin Kim, M.D.1,  Eun-Jee Oh, M.D.1, Yeon-Joon Park, M.D.1, Jong Wook Lee, M.D.2, Bin Cho, M.D.3, and Kyungja Han, M.D.1 Departments of Laboratory Medicine1, Hematology2, and Pediatrics3, College of Medicine, The Catholic University of Korea, Seoul, Korea Background:  Numerous studies tried to find new markers that after hematopoietic stem  cell transplantation predict engraftment earlier than the conventional marker, absolute neu - trophil count (ANC >500/µL).",Non-OADS,/arxiv_data1/oa_pdf/0d/c1/alm-34-92.PMC3948839.pdf
"Early post-HSCT engraftment markers http://dx.doi.org/10.3343/alm.2014.34.2.92 www.annlabmed.org  93 Some automated hematology analyzers have recently started  to offer new parameters, enabled by data fusion software, that  make accurate complete blood count (CBC) with differentials  (CBC-diff) possible in severe leukopenic samples.",Non-OADS,/arxiv_data1/oa_pdf/0d/c1/alm-34-92.PMC3948839.pdf
"Early post-HSCT engraftment markers 94  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.921)   Establishing predictive cutoff values for the proposed markers of  neutrophilic and monocytic engraftment Each parameter cutoff value was established as follows: 1) from  the engraftment cases, a value that predicted engraftment days  earlier than, or at least on the same day as ANC; and 2) the  value was not found in the failure cases.",OADS,/arxiv_data1/oa_pdf/0d/c1/alm-34-92.PMC3948839.pdf
"Early post-HSCT engraftment markers http://dx.doi.org/10.3343/alm.2014.34.2.92 www.annlabmed.org  95ers and their significant engraftment patterns established, we  then set the cutoff values as follows: NEUTRO at MNV >185  and MNC <150, and MONO at MMV >190 and MMC <130.",OADS,/arxiv_data1/oa_pdf/0d/c1/alm-34-92.PMC3948839.pdf
Early post-HSCT engraftment markers 96  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.923.,Non-OADS,/arxiv_data1/oa_pdf/0d/c1/alm-34-92.PMC3948839.pdf
"Early post-HSCT engraftment markers http://dx.doi.org/10.3343/alm.2014.34.2.92 www.annlabmed.org  97population data, it is recommended that each laboratory adjust  the parameter values according to the characteristic pattern af - ter HSCT.",Non-OADS,/arxiv_data1/oa_pdf/0d/c1/alm-34-92.PMC3948839.pdf
"ISSN 2234-3806 • eISSN 2234-3814  98  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.98 Ann Lab Med 2014;34:98-103 http://dx.doi.org/10.3343/alm.2014.34.2.98Original Article Clinical Chemistry Mean Platelet Volume and Vitamin D Level Medine Cumhur Cure, M.D.1, Erkan Cure, M.D.2, Suleyman Yuce, M.D.2, TarkanYazici, M.D.1, Inanc Karakoyun, M.D.3,   and Hasan Efe, M.D.1 Departments of Biochemistry1 and Internal Medicine2, University of Recep Tayyip Erdogan, Rize; Department of Biochemistry3, Izmir Public Health  Laboratory, Izmir, Turkey Background:  Vitamin D deficiency and a high mean platelet volume (MPV) are related to  cardiovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/39/12/alm-34-98.PMC3948840.pdf
"MPV and vitamin D http://dx.doi.org/10.3343/alm.2014.34.2.98 www.annlabmed.org  99plementation restores immune function and decreases cyto - kines levels [17], elevated cytokine levels lead to increased MPV  [4, 18].",Non-OADS,/arxiv_data1/oa_pdf/39/12/alm-34-98.PMC3948840.pdf
"MPV and vitamin D 100  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.98tients with a vitamin D level of <20 ng/mL was significantly  higher than that in patients with a vitamin D level of >20 ng/mL  (7.9±1.0 fL vs. 7.5±1.1 fL, P=0.003).",OADS,/arxiv_data1/oa_pdf/39/12/alm-34-98.PMC3948840.pdf
MPV and vitamin D http://dx.doi.org/10.3343/alm.2014.34.2.98 www.annlabmed.org  101ng/mL indicates an increased cardiac risk.,Non-OADS,/arxiv_data1/oa_pdf/39/12/alm-34-98.PMC3948840.pdf
MPV and vitamin D 102  www.annlabmed.org http://dx.doi.org/10.3343/alm.2014.34.2.98[40].,OADS,/arxiv_data1/oa_pdf/39/12/alm-34-98.PMC3948840.pdf
"MPV and vitamin D http://dx.doi.org/10.3343/alm.2014.34.2.98 www.annlabmed.org  103man JA, et al.",OADS,/arxiv_data1/oa_pdf/39/12/alm-34-98.PMC3948840.pdf
"Among them, this article re - views 6 clinical articles that were published in major medical  journals; one of each article regarding risk factors, phenotype,  assessment, exacerbation, management and prognosis of pa -REVIEW http://dx.doi.org/10.4046/trd.2014.76.2.53 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;76:53-58 53Address for correspondence: Yu-Il Kim, M.D., Ph.D. Division of Pulmonology, Department of Internal Medicine, Chonnam  National University Hospital, 42 Jebong-ro, Dong-gu, Gwangju 501-757,  Korea Phone:  82-62-220-6296, Fax: 82-62-225-8578 E-mail: kyionly@chonnam.ac.kr Received:  Oct. 14, 2013 Revised:  Oct. 21, 2013 Accepted:  Oct. 28, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/00/c4/trd-76-53.PMC3948852.pdf
COPD review of 2013 http://dx.doi.org/10.4046/trd.2014.76.2.53  55 www.e-trd.orgAssessment GOLD 2011 disease severity classification in COPD - Gene: a prospective cohort study.,Non-OADS,/arxiv_data1/oa_pdf/00/c4/trd-76-53.PMC3948852.pdf
COPD review of 2013 http://dx.doi.org/10.4046/trd.2014.76.2.53  57 www.e-trd.orgPrognosis Long-term natural history of chronic obstructive pul - monary disease: severe exacerbations and mortality.,Non-OADS,/arxiv_data1/oa_pdf/00/c4/trd-76-53.PMC3948852.pdf
"DNA ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2014.76.2.59 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;76:59-65 59Address for correspondence: Young Kil Park, Ph.D. Korean Institute of Tuberculosis, 168-5 Osongsangmyung 4 ro, Osong- up, Cheongwon 363-954, Korea Phone:  82-43-249-4960, Fax: 82-43-249-4965 E-mail: ypark7@empas.com Received:  Oct. 10, 2013 Revised:  Nov. 4, 2013 Accepted:  Nov. 7, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/f8/c9/trd-76-59.PMC3948853.pdf
VNTR typing of Korean M. tuberculosis  isolates http://dx.doi.org/10.4046/trd.2014.76.2.59  61 www.e-trd.orgthe epidemiological information of the strains from the PHCs  and each person who had the clustered strain by documents  and telephone calls.,Non-OADS,/arxiv_data1/oa_pdf/f8/c9/trd-76-59.PMC3948853.pdf
"VNTR typing of Korean M. tuberculosis  isolates http://dx.doi.org/10.4046/trd.2014.76.2.59  63 www.e-trd.org3336, 3820, 4120, 2372, 4348, and 3155) were needed to be  equivalent to the discriminatory power of the 32 VNTR loci  (data not shown).",Non-OADS,/arxiv_data1/oa_pdf/f8/c9/trd-76-59.PMC3948853.pdf
VNTR typing of Korean M. tuberculosis  isolates http://dx.doi.org/10.4046/trd.2014.76.2.59  65 www.e-trd.orgvariable-number tandem repeat typing of Mycobacterium  tuberculosis .,Non-OADS,/arxiv_data1/oa_pdf/f8/c9/trd-76-59.PMC3948853.pdf
"All rights reserved.ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2014.76.2.66 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;76:66-74 66Address for correspondence: Miok Kim, M.D., Ph.D. Department of Internal Medicine, Jeju National University Hospital, 15  Aran 13-gil, Jeju 690-767, Korea Phone:  82-64-717-1614, Fax: 82-64-717-1131 E-mail: miohkim@hanmail.net Received:  Nov. 20, 2012 Revised:  Jan. 20, 2014 Accepted:  Jan. 29, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/22/56/trd-76-66.PMC3948854.pdf
HCAP among hospitalized patients http://dx.doi.org/10.4046/trd.2014.76.2.66  67 www.e-trd.orgSociety (ATS) and the Infectious Disease Society of America  (IDSA) published the first guidelines for managing adults with  HCAP2.,Non-OADS,/arxiv_data1/oa_pdf/22/56/trd-76-66.PMC3948854.pdf
"HCAP among hospitalized patients http://dx.doi.org/10.4046/trd.2014.76.2.66  69 www.e-trd.orgwith CAP) were excluded, and there were no 30-day mortali - ties among these patients.",Non-OADS,/arxiv_data1/oa_pdf/22/56/trd-76-66.PMC3948854.pdf
HCAP among hospitalized patients http://dx.doi.org/10.4046/trd.2014.76.2.66  71 www.e-trd.orgTable 4.,Non-OADS,/arxiv_data1/oa_pdf/22/56/trd-76-66.PMC3948854.pdf
"HCAP among hospitalized patients http://dx.doi.org/10.4046/trd.2014.76.2.66  73 www.e-trd.orgCAP group, yet fewer than 10% of the Pseudomonas pneumo - nia cases occurred in the HCAP group.",Non-OADS,/arxiv_data1/oa_pdf/22/56/trd-76-66.PMC3948854.pdf
"All rights reserved.CASE REPORThttp://dx.doi.org/10.4046/trd.2014.76.2.75 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;76:75-79 75Address for correspondence: Kyung Soo Chung, M.D.",Non-OADS,/arxiv_data1/oa_pdf/a8/82/trd-76-75.PMC3948855.pdf
"Division of Pulmonology, Department of Internal Medicine, Yonsei  University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120- 752, Korea Phone:  82-2-2228-2270, Fax: 82-2-393-6884 E-mail:  chungks@yuhs.ac Received:  Aug. 13, 2013 Revised:  Sep. 2, 2013 Accepted:  Sep. 23, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/a8/82/trd-76-75.PMC3948855.pdf
HP associated with TCE http://dx.doi.org/10.4046/trd.2014.76.2.75  77 www.e-trd.orgnormal limits.,Non-OADS,/arxiv_data1/oa_pdf/a8/82/trd-76-75.PMC3948855.pdf
HP associated with TCE http://dx.doi.org/10.4046/trd.2014.76.2.75  79 www.e-trd.orgsensitized8.,Non-OADS,/arxiv_data1/oa_pdf/a8/82/trd-76-75.PMC3948855.pdf
"In the  United States, the most common AIDS-related opportunistic  infections recorded were Pneumocystis carinii pneumonia ,  Mycobacterium avium  complex disease and esophageal can -CASE REPORThttp://dx.doi.org/10.4046/trd.2014.76.2.80 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;76:80-83 80Address for correspondence: Hee Jung Yoon, M.D., Ph.D. Division of Infectious Diseases, Department of Internal Medicine, Eulji  University Hospital, Eulji University School of Medicine, 95 Dunsanseo- ro, Seo-gu, Daejeon 302-799, Korea Phone:   82-42-611-3096, Fax: 82-42-611-3853 E-mail: yhj822@medimail.co.kr Received:  Aug. 20, 2013 Revised:  Sep. 6, 2013 Accepted:  Sep. 26, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/80/ff/trd-76-80.PMC3948856.pdf
Invasive pneumococcal disease http://dx.doi.org/10.4046/trd.2014.76.2.80  81 www.e-trd.orgheadache for 2 weeks.,Non-OADS,/arxiv_data1/oa_pdf/80/ff/trd-76-80.PMC3948856.pdf
"Invasive pneumococcal disease http://dx.doi.org/10.4046/trd.2014.76.2.80  83 www.e-trd.org82% to 100%, specificity 75% to 96%)8.",Non-OADS,/arxiv_data1/oa_pdf/80/ff/trd-76-80.PMC3948856.pdf
"As with other pandemic influenza strains, an additive effect CASE REPORThttp://dx.doi.org/10.4046/trd.2014.76.2.84 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;76:84-87 84Address for correspondence: Sang Hoon Han, M.D, Ph.D. Department of Internal Medicine, Yonsei University College of Medicine,  50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea Phone:  82-2-2228-1991, Fax: 82-2-393-6884 E-mail: shhan74@yuhs.ac Received:  Aug. 31, 2013 Revised:  Sep. 27, 2013 Accepted:  Oct. 14, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/64/3b/trd-76-84.PMC3948857.pdf
"H1N1 and tuberculosis co-infection http://dx.doi.org/10.4046/trd.2014.76.2.84  85 www.e-trd.orgformed, and pH1N1 infection was confirmed on hospital day  (HOD) 2.",Non-OADS,/arxiv_data1/oa_pdf/64/3b/trd-76-84.PMC3948857.pdf
"H1N1 and tuberculosis co-infection http://dx.doi.org/10.4046/trd.2014.76.2.84  87 www.e-trd.orgcount, 2 patients were lymphopenic.",Non-OADS,/arxiv_data1/oa_pdf/64/3b/trd-76-84.PMC3948857.pdf
Available from: http://www.who.int/tb/publica - tions/global_report/en/.,OADS,/arxiv_data1/oa_pdf/64/3b/trd-76-84.PMC3948857.pdf
"When this ab - normal budding occurs during early gestation, the cysts tend CASE REPORThttp://dx.doi.org/10.4046/trd.2014.76.2.88 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;76:88-92 88Address for correspondence: Seung Won Ra, M.D.",Non-OADS,/arxiv_data1/oa_pdf/d9/c3/trd-76-88.PMC3948858.pdf
"Department of Internal Medicine, Ulsan University Hospital, University  of Ulsan College of Medicine, 877 Bangeojinsunhwan-doro, Dong-gu,  Ulsan 682-714, Korea Phone:  82-52-250-7029, Fax: 82-52-250-7048 E-mail: docra@docra.pe.kr Received:  Oct. 11, 2013 Revised:  Oct. 14, 2013 Accepted:  Oct. 21, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/d9/c3/trd-76-88.PMC3948858.pdf
Non-infected and infected bronchogenic cyst http://dx.doi.org/10.4046/trd.2014.76.2.88  89 www.e-trd.orgmogeneous echoic lesion with fine particles on US.,Non-OADS,/arxiv_data1/oa_pdf/d9/c3/trd-76-88.PMC3948858.pdf
Non-infected and infected bronchogenic cyst http://dx.doi.org/10.4046/trd.2014.76.2.88  91 www.e-trd.orgof a bronchogenic cyst7-10.,Non-OADS,/arxiv_data1/oa_pdf/d9/c3/trd-76-88.PMC3948858.pdf
DICOM Standard Committee (2011) Part 10: Media Storage and File Format for Media Interchange (PS 3.10-2011) in DICOM Standard.Available via http://medical.nema.org/Dicom/2011/11_10pu.pdf .,Non-OADS,/arxiv_data1/oa_pdf/51/66/13244_2013_Article_296.PMC3948904.pdf
Availableviahttp://medical.nema.org/Dicom/2011/11_11pu.pdf .,Non-OADS,/arxiv_data1/oa_pdf/51/66/13244_2013_Article_296.PMC3948904.pdf
Available via http://medical.nema.org/Dicom/2011/11_ 12pu.pdf .,Non-OADS,/arxiv_data1/oa_pdf/51/66/13244_2013_Article_296.PMC3948904.pdf
Available via http://www.ihe.net/ .,Non-OADS,/arxiv_data1/oa_pdf/51/66/13244_2013_Article_296.PMC3948904.pdf
Available via http://www.ihe.net/Technical_Framework/ upload/IHE_RAD_TF_V ol1.pdf .,OADS,/arxiv_data1/oa_pdf/51/66/13244_2013_Article_296.PMC3948904.pdf
Available via http://wiki.ihe.net/index.php?title=Cross-enterprise_ Document_Sharing_for_Imaging .,Non-OADS,/arxiv_data1/oa_pdf/51/66/13244_2013_Article_296.PMC3948904.pdf
Available from:  http://www.aidsdatahub.org/dmdocuments/NACO_Annual_   Report_2011_12.pdf [Last cited on 2013 May 27].,OADS,/arxiv_data1/oa_pdf/7b/92/NMJ-54-365.PMC3948956.pdf
Available from http://www.en.wikipedia.org/wiki/Radiation_ protection.,OADS,/arxiv_data1/oa_pdf/d6/26/NMJ-54-386.PMC3948960.pdf
"Available  from http://www.icrp.org/docs/Radiological protection in fluoroscopically guided procedures performed outside the  imaging depa, pdf.",Non-OADS,/arxiv_data1/oa_pdf/d6/26/NMJ-54-386.PMC3948960.pdf
Available from: http://www.docstoc.com/ docs/35860270/film-reject-rate-in-selected-diagnostic-x-ray- facilities-in-tanzania.,Non-OADS,/arxiv_data1/oa_pdf/d6/26/NMJ-54-386.PMC3948960.pdf
Available from: http://www.e-radiography.net/radtech/Dose_ ae/dose.htm.,Non-OADS,/arxiv_data1/oa_pdf/d6/26/NMJ-54-386.PMC3948960.pdf
Available from: http://web.archive.org/web/20110519235026/;  http://www.population.gov.ng/files/nationafinal.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e3/ef/NMJ-54-392.PMC3948961.pdf
Available from: http://www.newsecuritybeat.,Non-OADS,/arxiv_data1/oa_pdf/98/b1/NMJ-54-398.PMC3948962.pdf
http://www.sicklecellfoundation.,Non-OADS,/arxiv_data1/oa_pdf/d9/bf/NMJ-54-408.PMC3948964.pdf
Available  from: http://apps.who.int/gb/ebwha/pdf_files/WHA59/ A59_9-en.pdf [Last Accessed on 2011 June].,OADS,/arxiv_data1/oa_pdf/d9/bf/NMJ-54-408.PMC3948964.pdf
"1: 1-7, February 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.1.1 ▣ORIGINAL ARTICLE Seroprevalence of Plasmodium vivax in the Republic of  Korea (2003-2005) using Indirect Fluorescent Antibody Test Tong-Soo Kim1,†, Yoon-Joong Kang2,†, Won-Ja Lee3, Byoung-Kuk Na4, Sung-Ung Moon5, Seok Ho Cha6,   Sung-Keun Lee7, Yun-Kyu Park1, Jhang-Ho Pak8, Pyo Yun Cho1, Youngjoo Sohn9,*, Hyeong-Woo Lee10,* 1Department of Parasitology, College of Medicine, Inha University, Incheon 405-751, Korea; 2Department of Biomedical Science, Jungwon  University, Goesan, Chungbuk 367-805, Korea; 3Division of Malaria and Parasitic Diseases, National Institute of Health, Osong 363-951, Korea;  4Department of Parasitology and Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju 660-751, Korea;  5Department of International Medicine, Seoul National University, Bundang Hospital, Seongnam 463-707, Korea; 6Department of Biomedical  Technology, Inha University School of Medicine, Incheon 400-712, Korea; 7Department of Pharmacology, Inha University School of Medicine,  Incheon 400-712, Korea; 8Asan Institute for Life Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul 138-736, Korea;  9Department of Anatomy, College of Korean Medicine, Institute of Korean Medicine, Kyung Hee University, Seoul 130-701, Korea;   10Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, Florida 32610, USA Abstract:  Plasmodium vivax reemerged in the Republic of Korea (ROK) in 1993, and is likely to continue to affect public  health.",Non-OADS,/arxiv_data1/oa_pdf/f6/82/kjp-52-1.PMC3948985.pdf
"© 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/82/kjp-52-1.PMC3948985.pdf
"1: 105-109, February 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.1.105 ▣BRIEF COMMUNICATION Evolution of Genetic Polymorphisms of Plasmodium  falciparum Merozoite Surface Protein (PfMSP) in Thailand Jiraporn Kuesap1, Wanna Chaijaroenkul1, Kanchanok Ketprathum1, Puntanat Tattiyapong1,   Kesara Na-Bangchang2,* 1Faculty of Allied Health Sciences, 2Chulabhorn International College of Medicine, Thammasat University, Pathumthani, 12121, Thailand Abstract:  Plasmodium falciparum malaria is a major public health problem in Thailand due to the emergence of multidrug  resistance.",Non-OADS,/arxiv_data1/oa_pdf/08/3b/kjp-52-105.PMC3948986.pdf
"*Corresponding author (kesaratmu@yahoo.com) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/3b/kjp-52-105.PMC3948986.pdf
"1: 111-115, February 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.1.111 ▣BRIEF COMMUNICATION Effects of Some Pesticides on Development of   Ascaris suum Eggs Yong-Man Yu1,†, Jin-Won Kim2,†, Won-Seok Na2, Young-Nam Youn1, In-Wook Choi3, Young-Ha Lee3,*  1Department of Applied Biology, College of Agriculture and Life Sciences, Chungnam National University, Daejeon 305-764, Korea;   2Department of Environmental Horticulture, The University of Seoul, Seoul 130-743, Korea;   3Department of Infection Biology, Chungnam National University School of Medicine, Daejeon 301-131, Korea Abstract:  To evaluate the effects of pesticides to parasite eggs, Ascaris suum eggs were incubated with 5 different pesti - cides (1:1,500-1:2,000 dilutions of 2% emamectin benzoate, 5% spinetoram, 5% indoxacarb, 1% deltamethrin, and 5%  flufenoxuron; all v/v) at 20ºC for 6 weeks, and microscopically evaluated the egg survival and development on a weekly basis.",Non-OADS,/arxiv_data1/oa_pdf/77/39/kjp-52-111.PMC3948987.pdf
"*Corresponding author (yhalee@cnu.ac.kr) †Yong-Man Yu and Jin-Won Kim equally contributed as the first author © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/39/kjp-52-111.PMC3948987.pdf
"1: 117-120, February 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.1.117 ▣BRIEF COMMUNICATION Partial Purification and Properties of a Cysteine   Protease from Citrus Red Mite Panonychus citri Seong Chul Hong1, Kyu-Hee Her2, Heung-Up Kim3, Jaechun Lee3, Sang Pyo Lee4, Young-Bae Chung5,* Departments of 1Preventive Medicine and The Environmental Health Center, 2Surgery, 3Internal Medicine, and 5Parasitology, Jeju National University  School of Medicine, Jeju 690-767, Korea; 4Department of Internal Medicine, Gachon University Gil Medical Center, Incheon 406-799, Korea Abstract:  Several studies have reported that the citrus red mites Panonychus citri were an important allergen of citrus-cul - tivating farmers in Jeju Island.",Non-OADS,/arxiv_data1/oa_pdf/05/91/kjp-52-117.PMC3948988.pdf
"*Corresponding author (ybchung@jejunu.ac.kr) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/91/kjp-52-117.PMC3948988.pdf
"1: 21-26, February 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.1.21 ▣ORIGINAL ARTICLE Expression of Translationally Controlled Tumor Protein  (TCTP) Gene of Dirofilaria immitis Guided by  Transcriptomic Screening  Yan Fu1,†, Jingchao Lan2,†, Xuhang Wu1, Deying Yang1, Zhihe Zhang2, Huaming Nie1, Rong Hou2,   Runhui Zhang1, Wanpeng Zheng1, Yue Xie1, Ning Yan1, Zhi Yang2, Chengdong Wang2, Li Luo2, Li Liu2,   Xiaobin Gu1, Shuxian Wang1, Xuerong Peng3, Guangyou Yang1,*  1Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural University, Ya’an 625014, China;   2The Sichuan Key Laboratory for Conservation Biology on Endangered Wildlife, Developing Toward a State Key Laboratory for China,   Chengdu Research Base of Giant Panda Breeding, Chengdu, Sichuan 610081, China;   3Department of Chemistry, College of Life and Basic Science, Sichuan Agricultural University, Ya’an 625014, China Abstract:  Dirofilaria immitis (heartworm) infections affect domestic dogs, cats, and various wild mammals with increasing  incidence in temperate and tropical areas.",Non-OADS,/arxiv_data1/oa_pdf/ad/d6/kjp-52-21.PMC3948989.pdf
"© 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/d6/kjp-52-21.PMC3948989.pdf
ncbi.nlm.nih.gov/projects/gorf/) and the BLAST network serv- er of the NCBI (http://blast.ncbi.nlm.nih.gov/Blast.cgi) were  used to analyse open reading frames (ORF) of the nucleotide  sequence and deduced amino acid sequences to determine  similarities with previously reported sequences in GenBank.,OADS,/arxiv_data1/oa_pdf/ad/d6/kjp-52-21.PMC3948989.pdf
Signal PV4.0 at the Center of Biological Sequence Analysis (http://www.cbs.dtu.dk/services/SignalP/) was employed to predict the signal sequence.,OADS,/arxiv_data1/oa_pdf/ad/d6/kjp-52-21.PMC3948989.pdf
"1: 27-33, February 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.1.27 ▣ORIGINAL ARTICLE Mucosal Immune Responses of Mice Experimentally  Infected with Pygidiopsis summa   (Trematoda: Heterophyidae) Jong-Yil Chai1, Young-Jin Park1, Jae-Hwan Park1,†, Bong-Kwang Jung1, Eun-Hee Shin1,2,* 1Department of Parasitology and Tropical Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea; 2Seoul National University  Bundang Hospital, Seongnam 463-707, Korea  Abstract:  Mucosal immune responses against Pygidiopsis summa (Trematoda: Heterophyidae) infection were studied in  ICR mice.",OADS,/arxiv_data1/oa_pdf/a8/18/kjp-52-27.PMC3948990.pdf
"© 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/18/kjp-52-27.PMC3948990.pdf
"1: 35-40, February 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.1.35 ▣ORIGINAL ARTICLE Zoonotic Trematode Metacercariae in Fish from   Phnom Penh and Pursat, Cambodia Jong-Yil Chai1, Woon-Mok Sohn2,*, Byoung-Kuk Na2, Tai-Soon Yong3, Keeseon S. Eom4, Cheong-Ha Yoon5,   Eui-Hyug Hoang5, Hoo-Gn Jeoung5, Duong Socheat6 1Department of Parasitology and Tropical Medicine, Seoul National University College of Medicine, and Institute of Endemic Diseases, Seoul National  University Medical Research Center, Seoul 110-799, Korea; 2Department of Parasitology and Tropical Medicine, and Institute of Health Sciences,  Gyeongsang National University School of Medicine, Jinju 660-751, Korea; 3Department of Environmental Medical Biology and Institute of Tropical  Medicine, Yonsei University College of Medicine, Seoul 120-752, Korea; 4Department of Parasitology and Medical Research Institute, Chungbuk  National University College of Medicine, Cheongju 360-763, Korea; 5Korea Association of Health Promotion, Seoul 157-704, Korea;   6National Malaria Center for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia Abstract:  A survey was performed to investigate the infection status of freshwater fish with zoonotic trematode metacer - cariae in Phnom Penh and Pursat Province, Cambodia.",Non-OADS,/arxiv_data1/oa_pdf/23/be/kjp-52-35.PMC3948991.pdf
"*Corresponding author (wmsohn@gnu.ac.kr) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/23/be/kjp-52-35.PMC3948991.pdf
"1: 41-46, February 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.1.41 ▣ORIGINAL ARTICLE Diagnostic Efficacy of a Recombinant Cysteine Protease  of Spirometra erinacei Larvae for Serodiagnosis of  Sparganosis S.M.",Non-OADS,/arxiv_data1/oa_pdf/55/4e/kjp-52-41.PMC3948992.pdf
"*Corresponding author (mhchoi@snu.ac.kr) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/4e/kjp-52-41.PMC3948992.pdf
"1: 47-49, February 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.1.47 ▣ORIGINAL ARTICLE Higher Seroprevalence of Hepatitis B Virus Antigen in  Patients with Cystic Hydatid Disease than in Patients  Referred to Internal Medicine Clinics in Turkey  Bilge Gültepe1, Ahmet Cumhur Dülger2, İlhami Gültepe3, Sevdegul Karadas4,*, Senar Ebinç2, Ramazan Esen5 1Division of Microbiology, 2Division of Gastroenterology, 4Emergency Medicine, 5Division of Hematology, Yuzuncu Yil University, School of Medicine,  65100 Zeve Kampus, Turkey; 3Van Lokman Hekim Hospital, Division of internal Medicine; Turkey Abstract:  Turkey remains an intermediate area for prevalence of hepatitis B virus (HBV) surface antigenemia.",Non-OADS,/arxiv_data1/oa_pdf/16/b4/kjp-52-47.PMC3948993.pdf
"*Corresponding author (sevdegulkaradas@yahoo.com.tr) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/b4/kjp-52-47.PMC3948993.pdf
"1: 51-56, February 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.1.51 ▣ORIGINAL ARTICLE Prevalence of Helminthic Infections among Inhabitants of  Lao PDR Keeseon S. Eom1, Tai-Soon Yong2, Woon-Mok Sohn3, Jong-Yil Chai4, Duk-Young Min5, Han-Jong Rim6,   Hyeong-Kyu Jeon1,*, Virasack Banouvong7, Bounnaloth Insisiengmay8, Bounlay Phommasack8  1Department of Parasitology and Medical Research Institute, Chungbuk National University School of Medicine, Cheongju 361-763, Korea;  2Department of Environmental Medical Biology and Institute of Tropical Medicine, Yonsei University College of Medicine, Seoul 120-752, Korea;  3Department of Parasitology and Institute of Health Sciences, Gyeongsang National University College of Medicine, Chinju 660-751, Korea;  4Department of Parasitology and Tropical Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea; 5Department of  Microbiology and Immunology, Eulji University College of Medicine, Daejeon 301-746, Korea; 6Department of Parasitology, Korea University College  of Medicine, Seoul 130-705, Korea; 7Malaria Center, Provincial Health Department, Luang Prabang, Lao PDR; 8Department of Communicable  Disease Control, Ministry of Health, Lao PDR Abstract:  The prevalence of helminthic infections was surveyed on a total of 6,178 residents (males 2,549 and females  3,629) in 102 villages of 9 provinces in Lao PDR between 2007 and 2011 under the project of Korea-Laos Collaborative  Project for Control of Foodborne Trematode Infections in Lao PDR.",OADS,/arxiv_data1/oa_pdf/92/44/kjp-52-51.PMC3948994.pdf
"*Corresponding author (jeonhk@chungbuk.ac.kr) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/44/kjp-52-51.PMC3948994.pdf
"1: 57-62, February 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.1.57 ▣ORIGINAL ARTICLE Seasonal Abundance of Culicoides (Diptera:  Ceratopogonidae) Collected by Mosquito Magnet®   in Northern Gyeonggi-do (Province), Korea Heung Chul Kim1, Glenn A. Bellis2, Myung-Soon Kim3, Terry A. Klein4, Sung-Tae Chong1, Jee-Yong Park3,* 15th Medical Detachment, 168th Multifunctional Medical Battalion, 65th Medical Brigade, Unit 15247, APO AP 96205-5247, USA; 2Department of  Agriculture, Fisheries and Forestry, Northern Australia Quarantine Strategy (NAQS), PO Box 37846, Winnellie, Northern Territory 0821, Australia;  3Foreign Animal Disease Division, Animal and Plant Quarantine Agency, Anyang 430-757, Korea; 4Public Health Command Region-Pacific, Camp  Zama, Japan, Address: 65th Medical Brigade, Unit 15281, APO AP 96205-5281, USA Abstract:  Biting midges (Culicoides: Ceratopogonidae) were collected by Mosquito Magnet® traps at the Neutral Nations  Supervisory Commission (NNSC) camp and Daeseongdong village inside the demilitarized zone (DMZ) and near the mili - tary demarcation line (MDL) separating North and South Korea and at Warrior Base (US Army training site) and Tongilchon  3 km south of the DMZ in northern Gyeonggi Province, Republic of Korea (ROK), from May-October 2010-2012, to deter - mine their seasonal distributions.",Non-OADS,/arxiv_data1/oa_pdf/6e/59/kjp-52-57.PMC3948995.pdf
"*Corresponding author (parkjyyunesy@korea.kr)  © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/59/kjp-52-57.PMC3948995.pdf
"1: 63-67, February 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.1.63 ▣ORIGINAL ARTICLE A New Species of Chigger Mite (Acari: Trombiculidae)   from Rodents in Southwest China  Tian-Guang Ren1,2, Xian-Guo Guo1,2,*, Dao-Chao Jin1,*, Dian Wu2, Quinn E. Fletcher3 1Institute of Entomology, Guizhou University (The Provincial Key Laboratory for Agricultural Pest Management of Mountainous Region),   Guiyang 550025, P .",Non-OADS,/arxiv_data1/oa_pdf/da/a4/kjp-52-63.PMC3948996.pdf
"*Corresponding authors (xianguoguo@yahoo.com; daochaojin@126.com) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/a4/kjp-52-63.PMC3948996.pdf
"1: 69-73, February 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.1.69 ▣CASE REPORT Intramuscular Sparganosis in the Gastrocnemius Muscle:  A Case Report Jeung Il Kim1, Tae Wan Kim1, Sung Min Hong1, Tae Yong Moon2, In Sook Lee2, Kyung Un Choi3, Hak Sun Yu4,5,* 1Department of Orthopedic Surgery, 2Department of Radiology, Medical Research Institute, Pusan National University Hospital, Busan 602-739,  Korea; 3Department of Pathology, 4Department of Parasitology, School of Medicine, 5Immunoregulatory Therapeutics Group in Brain Busan 21  Project, Pusan National University, Yangsan 626-870, Korea  Abstract:  Sparganosis is a parasitic infection caused by the plerocercoid tapeworm larva of the genus Spirometra.",Non-OADS,/arxiv_data1/oa_pdf/01/89/kjp-52-69.PMC3948997.pdf
"*Corresponding author (hsyu@pusan.ac.kr) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/89/kjp-52-69.PMC3948997.pdf
"1: 75-78, February 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.1.75 ▣CASE REPORT Recurred Sparganosis 1 Year after Surgical Removal of a  Sparganum in a Korean Woman  Young-Il Lee1, Min Seo2, Hyun-Woo Park3,* 1Department of Anatomy, 2Department of Parasitology, 3Department of Orthopedic Surgery, College of Medicine, Dankook University,   Cheonan 330-714, Korea Abstract:  Sparganosis, an infection due to the plerocercoid of Spirometra erinacei, are found worldwide but the majority  of cases occur in East Asia including Korea.",Non-OADS,/arxiv_data1/oa_pdf/bd/f2/kjp-52-75.PMC3948998.pdf
"*Corresponding author (m3artist@hanmail.net) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bd/f2/kjp-52-75.PMC3948998.pdf
"1: 79-83, February 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.1.79 ▣CASE REPORT Four Cases of Taenia saginata Infection with an   Analysis of COX1 Gene Jaeeun Cho1,†, Bong-Kwang Jung1,†, Hyemi Lim1, Min-Jae Kim1,2, Thanapon Yooyen3, Dongmin Lee4,   Keeseon S. Eom4, Eun-Hee Shin1,5, Jong-Yil Chai1,* 1Department of Parasitology and Tropical Medicine, 2Department of Internal Medicine, Seoul National University College of Medicine,   Seoul 110-799, Korea; 3Department of Biology, Faculty of Science, Thaksin University, Phatthalung 93110, Thailand; 4Department of Parasitology,  Medical Research Institute and Parasite Resource Bank, Chungbuk National University School of Medicine, Cheongju 361-763, Korea; 5Seoul  National University Bundang Hospital, Seongnam 463-707, Korea  Abstract:  Human taeniases had been not uncommon in the Republic of Korea (=Korea) until the 1980s.",Non-OADS,/arxiv_data1/oa_pdf/3e/c9/kjp-52-79.PMC3948999.pdf
"© 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/c9/kjp-52-79.PMC3948999.pdf
"1: 85-87, February 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.1.85 ▣CASE REPORT Heavy Hymenolepis nana Infection Possibly Through  Organic Foods: Report of a Case  Bong Jin Kim1, Kyung Seob Song2, Hyun-Hee Kong3, Hee-Jae Cha4, Meesun Ock4,* 1Department of Internal Medicine, On Hospital, Busan 614-883, Korea; 2Department of Physiology, College of Medicine, Kosin University,   Busan 602-703, Korea; 3Department of Parasitology, College of Medicine, Dong-A University, Busan 602-714, Korea;   4Department of Parasitology and Genetics, College of Medicine, Kosin University, Busan 602-703, Korea  Abstract:  We encountered a patient with heavy Hymenolepis nana infection.",Non-OADS,/arxiv_data1/oa_pdf/37/ce/kjp-52-85.PMC3949000.pdf
"*Corresponding author (sunnyock@kosin.ac.kr) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/ce/kjp-52-85.PMC3949000.pdf
"1: 89-92, February 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.1.89 ▣CASE REPORT First Report of Myiasis Caused by Cochliomyia  hominivorax (Diptera: Calliphoridae) in a Diabetic Foot  Ulcer Patient in Argentina María Sofía Olea1, Néstor Centeno2, Cecilia Adriana Veggiani Aybar1, Eugenia Silvana Ortega1,   Guillermina Begoña Galante1, Luis Olea3, María Julia Dantur Juri1,4,* 1Instituto Superior de Entomología “Dr.",Non-OADS,/arxiv_data1/oa_pdf/91/26/kjp-52-89.PMC3949001.pdf
"*Corresponding author (juliadantur@yahoo.com.ar) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/26/kjp-52-89.PMC3949001.pdf
"1: 9-19, February 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.1.9 ▣ORIGINAL ARTICLE Occurrence and Molecular Identification of Anisakis  Dujardin, 1845 from Marine Fish in Southern Makassar  Strait, Indonesia  Hilal Anshary1,*, Sriwulan1, Mark A. Freeman2, Kazuo Ogawa3 1Laboratory of Fish Parasites and Diseases, Department of Fisheries, Faculty of Marine Science and Fisheries, Hasanuddin University,   Makassar, Indonesia; 2Institute of Ocean and Earth Sciences, University of Malaya, Malaysia; 3Meguro Parasitological Museum, Meguro-ku,   Tokyo 153-0064, Japan Abstract:  Anisakis spp.",Non-OADS,/arxiv_data1/oa_pdf/ac/93/kjp-52-9.PMC3949002.pdf
"*Corresponding author (hilalanshary@gmail.com; hilalanshary@unhas.ac.id) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/93/kjp-52-9.PMC3949002.pdf
"1: 93-97, February 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.1.93 ▣BRIEF COMMUNICATION Gene Cloning, Expression and Immunogenicity of the  Protective Antigen Subolesin in Dermacentor silvarum Yonghong Hu1,†, Hua Zeng1,†, Jincheng Zhang2, Duo Wang1, Dongming Li1, Tiantian Zhang1,   Shujie Yang1, Jingze Liu1,* 1Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology of Hebei Province, College of Life Sciences, Hebei Normal University,  Shijiazhuang, 050024, China; 2Shijiazhuang Post and Telecommunication Technical College, Shijiazhuang, 050021, China Abstract:  Subolesin (4D8), the ortholog of insect akirins, is a highly conserved protective antigen and thus has the poten - tial for development of a broad-spectrum vaccine against ticks and mosquitoes.",Non-OADS,/arxiv_data1/oa_pdf/a7/69/kjp-52-93.PMC3949003.pdf
"© 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/69/kjp-52-93.PMC3949003.pdf
"1: 99-103, February 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.1.99 ▣BRIEF COMMUNICATION Whole Mitochondrial Genome Sequence of an Indian  Plasmodium falciparum Field Isolate Suchi Tyagi1, Veena Pande2, Aparup Das1,* 1Evolutionary Genomics and Bioinformatics Laboratory, National Institute of Malaria Research, Sector- 8 Dwarka, New Delhi 110077, India;  2Department of Biotechnology, Kumaun University, Nainital, Uttarakhand 263001, India Abstract:  Mitochondrial genome sequence of malaria parasites has served as a potential marker for inferring evolutionary  history of the Plasmodium genus.",Non-OADS,/arxiv_data1/oa_pdf/fa/cb/kjp-52-99.PMC3949004.pdf
"© 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/cb/kjp-52-99.PMC3949004.pdf
http://www.ema.europa.eu/ema/index.jsp?,Non-OADS,/arxiv_data1/oa_pdf/64/b4/10549_2014_Article_2879.PMC3949011.pdf
http://www.celltrion.com/en/C OMPANY/notice_view.asp?idx= 348&code=ennews .,OADS,/arxiv_data1/oa_pdf/64/b4/10549_2014_Article_2879.PMC3949011.pdf
"2000 Feb 29—Identiﬁer NCT01084876, Demonstrate efﬁcacy and safety of metastatic breast cancer (COMPARE); 9 March 2010. http://clinicaltrials.gov/ct2/show/ NCT01084876 .",Non-OADS,/arxiv_data1/oa_pdf/64/b4/10549_2014_Article_2879.PMC3949011.pdf
Biocon may launch Roche’s Herceptin biosim- ilar version by March 2014. http://drugdiscovery.pharmaceutical- business-review.com/news/biocon-may-launch-roches-herceptin-biosimilar-version-by-March-2014-220813 .,Non-OADS,/arxiv_data1/oa_pdf/64/b4/10549_2014_Article_2879.PMC3949011.pdf
"2000 Feb 29—Identiﬁer NCT01764022, Asafety and efﬁcacy study of BCD-022 with paclitaxel comparedto herceptin with paclitaxel in HER2-positive metastatic breast cancer patients; 7 January 2013. http://clinicaltrials.gov/ct2/show/ NCT01764022 .",Non-OADS,/arxiv_data1/oa_pdf/64/b4/10549_2014_Article_2879.PMC3949011.pdf
"2000 Feb 29—Identiﬁer NCT01901146, Efﬁcacy and Safety Study of ABP 980 Compared With Trast- uzumab in Subjects With HER2 Positive Early Breast Cancer(Lilac); 20 May 2013. http://clinicaltrials.gov/ct2/show/NCT0 1901146 .",Non-OADS,/arxiv_data1/oa_pdf/64/b4/10549_2014_Article_2879.PMC3949011.pdf
http://www.ema.europa.eu/ema/index.jsp?curl= pages/medicines/human/medicines/002576/human_med_001682.,Non-OADS,/arxiv_data1/oa_pdf/64/b4/10549_2014_Article_2879.PMC3949011.pdf
http://www.ema.europa.eu/ema/index.jsp?curl= pages/medicines/human/medicines/002778/human_med_001677.,Non-OADS,/arxiv_data1/oa_pdf/64/b4/10549_2014_Article_2879.PMC3949011.pdf
Lancet 376(9735):91–102.Available at: http://www.ncbi.nlm.nih.gov/pubmed/20570343 .,Non-OADS,/arxiv_data1/oa_pdf/05/6c/10549_2014_Article_2881.PMC3949013.pdf
Available at: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/05/6c/10549_2014_Article_2881.PMC3949013.pdf
Available at: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/05/6c/10549_2014_Article_2881.PMC3949013.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/ 6992972 .,Non-OADS,/arxiv_data1/oa_pdf/05/6c/10549_2014_Article_2881.PMC3949013.pdf
"http://dx.doi.org/10.1016/j.redox.2014.01.004Abbreviations: ECAR, extracellular acidi ﬁcation rate; iNOS, inducible nitric oxide synthase; MTEC, mouse tracheal epithelial cell; OCR, oxygen consumption rate;TCA, tricarboxylic acid ☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium,provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/a0/f5/main.PMC3949089.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/66/main.PMC3949090.pdf
434Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.01.010 2213-2317 &2014 The Authors.,OADS,/arxiv_data1/oa_pdf/c9/66/main.PMC3949090.pdf
"This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).Abbreviations: BH4, tetrahydrobiopterin; CRP, C-reactive protein; COX, cyclo-oxygenase; ER, endoplasmic reticulum; ERO1, endoplasmic reticulum oxidoreducti n 1; EV, extracellular vesicles; FX1, factor XI; GPI, glycoprotein 1; GPX, glutathione peroxidase; GRX, glutaredoxin; GSH, glutathione; MIRNA, microRNA; MPO, myeloperoxidase; NO, nitric oxide; NOS, nitric oxide synthase; NOX, NADPH oxidase; O 2d/C0, superoxide anion radical; ONOO-, peroxynitrite; PDI, protein disulphide isomerase; Prx, peroxiredoxin; RNS, reactive nitrogen species; ROS, reactive nitrogen species; Trx, thioredoxin; VWF, von Willebrand factor; XO, xanthine oxidase nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/c9/66/main.PMC3949090.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/bb/main.PMC3949091.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/bb/main.PMC3949091.pdf
"http://dx.doi.org/10.1016/j.redox.2013.12.030☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/a9/bb/main.PMC3949091.pdf
Supporting information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2013.12.030 .,OADS,/arxiv_data1/oa_pdf/a9/bb/main.PMC3949091.pdf
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org /licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/27/main.PMC3949092.pdf
His visionary idea was that the pathological thickeningContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.02.002 2213-2317 &2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/35/27/main.PMC3949092.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/27/main.PMC3949092.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/61/main.PMC3949093.pdf
"Although the mechanism of AMD is not fully understood, it is well known that AMD affects different cell types in the retina with a broadContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.01.023 2213-2317 &2014 The Authors.",OADS,/arxiv_data1/oa_pdf/ae/61/main.PMC3949093.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: AhR, aryl hydrocarbon receptor; AMD, age related macular degeneration; AP-1, activator protein 1; APE1, apurinic endonuclease 1/redoxfactor-1; ApoE, apolipoprotein E; CBF/NF-Y/YY1, CCAAT binding factor/nuclearfactor-Y/Yin Yang 1; CECs, choroidal endothelial cells; CNV, choroidal neovascu-larization; DCFH-DA, dichlorodihydro ﬂuorescin diacetate; DMSO, dimethylsulph- oxide; Fluc, ﬁreﬂy luciferase; HIF-1 α, hypoxia inducible factor-1 α; HSF1, heat-shock factor 1; I κB-α, inhibitory NF- κB-α; MCP-1, monocyte chemoattractant protein-1; MTF1, metal regulatory transcription factor 1; NF- κB, nuclear factor- κB; Nox, NADPH oxidase; Nrf, nuclear factor erythroid-2-related factor; oxLDL, oxidizedlow density lipoprotein; redox, reduction/oxidation; Rluc, renilla luciferase; RNV,retinal neovascularization; ROS, reactive oxygen species; RPE, retinal pigmentepithelium; RVECs, retinal vascular endothelial cells; SA- β-gal, senescence asso- ciated β-gal; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophor- esis; TUNEL, TdT mediated dUTP- ﬂuorescein nick end-labeling; VEGF, vascular endothelial growth factor nCorresponding author at: Department of Ophthalmology, Henry Ford Health System, 1 Ford Place 5D, Detroit, MI, United States.",Non-OADS,/arxiv_data1/oa_pdf/ae/61/main.PMC3949093.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/ee/main.PMC3949094.pdf
"Recent studies show that selenocysteine in the C-terminal redox center rendersmitochondrial TR insensitive to inactivation from oxidants [6],Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.01.021 2213-2317 &2014 The Authors.",OADS,/arxiv_data1/oa_pdf/07/ee/main.PMC3949094.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/ee/main.PMC3949094.pdf
Supporting information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2014.01.021 .,OADS,/arxiv_data1/oa_pdf/07/ee/main.PMC3949094.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/3c/main.PMC3949095.pdf
"In contrast, the impact of vitamin DContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.01.024 2213-2317 &2014 The Authors.",OADS,/arxiv_data1/oa_pdf/86/3c/main.PMC3949095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/3c/main.PMC3949095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2013.12.017 2213-2317 &2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/88/40/main.PMC3949096.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: GMP, good manufacturing practice; CNS, central nervous system; SAH, subarachnoid hemorrhage; I/R, ischemia reperfusion; AT, ataxia telangiectas ia; ALS, amyotrophic laterial sclerosis; NOX4, NADPH oxidase, isoform 4; E 1/2, Half-wave metal-centered reduction potential; SOD, superoxide dismutase; NHE, normal hydrogen electrode; SOD, superoxide dismutase; ONOO/C0, peroxynitrite; O 2/C0, superoxide; NO, nitric oxide; CO 3/C0, carbonate radical; HO 2/C0, monodeprotonated hydrogen peroxide; ClO/C0, hypochlorite; GS/C0, monodeprotonated glutathione; MnP, Mn porphyrin; MnTnHex-2-PyP5þ, Mn(III) meso -tetrakis( N-(n-hexyl)pyridinium-2-yl)porphyrin (AEOL10113); MnTE-2-PyP5þ, Mn(III) meso -tetrakis( N-ethylpyridinium-2-yl)porphyrin (AEOL10113); MnTnBuOE-2-PyP5þ, Mn(III) meso -tetrakis( N-(n-butoxyethyl)pyridi- nium-2-yl)porphyrin; MnTDE-2-ImP5þ, Mn(III) tetrakis[ N,N0-diethylimidazolium-2-yl)porphyrin, AEOL10150; HIF-1 α, hypoxia inducible factor-1; NF- κB, nuclear factor κB; AP-1, activator protein-1; SP-1, speci ﬁcity protein-1; TGF- β1, one of the 3 members of the TGF- βtransforming growth factor- βfamily; TF, transcription factor; Nrf-2, nuclear factor-erythroid-derived 2-like 2; VEGF, vascular endothelial growth factor; PTEN, phosphoinositide 3-phosphatase; MCAO, middle cerebral arte ry occlusion; 8-OHdG, 8-hydroxy-20-deoxyguanosine; PI3K, phosphatidylinositide 3-kinase; AKT, protein kinase B (PKB), a serine/threonine-speci ﬁc protein kinase; mTOR, mammalian target of rapamycin (mTOR), a serine/threonine protein kinase; ETC, mitochondrial electron transport chain; BBB, blood brain barrier ☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which p ermits non- commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/88/40/main.PMC3949096.pdf
"Leong, I. Spasojevic, SOD Therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways, Antioxide Redox Signal (2013) , http://dx.doi.org/10.1089/ars.2012.5147 .",OADS,/arxiv_data1/oa_pdf/88/40/main.PMC3949096.pdf
"(2013) , http://dx.doi.org/10.1515/irm-2013-0004 .",Non-OADS,/arxiv_data1/oa_pdf/88/40/main.PMC3949096.pdf
"Reboucas, L. Benov, Simple biological systems for assessing the activity of superoxide dismutase mimics, Antioxide Redox Signal (2013) , http://dx.doi.org/10.1089/ars.2013.5576 .",OADS,/arxiv_data1/oa_pdf/88/40/main.PMC3949096.pdf
"(2013) , http://dx.doi.org/10.1074/jbc.M113.511642 .",Non-OADS,/arxiv_data1/oa_pdf/88/40/main.PMC3949096.pdf
"Piganelli, Effects of metallopor- phyrins on reducing in ﬂammation and autoimmunity, Antioxide Redox Signal (2013) , http://dx.doi.org/10.1089/ars.2013.5257 .",Non-OADS,/arxiv_data1/oa_pdf/88/40/main.PMC3949096.pdf
"Piganelli, Mn porphyrin regulation of aerobic glycolysis: implications on the activation ofdiabetogenic immune cells, Antioxide Redox Signal (2013) , http://dx.doi.org/ 10.1089/ars.2012.5167 .",Non-OADS,/arxiv_data1/oa_pdf/88/40/main.PMC3949096.pdf
"http://dx.doi.org/10.1016/j.redox.2013.12.016Abbreviations: ADAMST, a disintegrin and metalloproteinase with a thrombospondin type 1 motif; AGE, advanced glycation end products; E, from embryonic day; EGFR, epidermal growth factor receptor; ERK, extracellular-signal regulated kinase; F3NK, fructosamine 3-phosphokinase; FKHRL1, forkhead tran scription factor; HMGB1, high-mobility-group-protein B1; HNE, 4-hydroxy- trans- 2-nonenal; Jak1/2, Janus kinase 1/2; LDL, low density lipoprotein; HDL, high density lipoprotein; MDA, malondialdehyde; MEKK, mitogen-activated protein/ERK kinase kinases; MnSOD, manganese superoxide dismutase; Nf- κB, nuclear factor-light-chain-enhancer of activated B; PIK3, phosphoinositol 3 kinase; RAGE, receptor of AGEs; RCC, reactive carbonyl compounds; S100B, S100 calcium binding protein B; SIRt1, NADþ-dependent deacetylase and survival factor 1; SR-A, scavenger receptor class A; Stat 1/2, signal transducers and activators of transcription 1/2; VSMC, vascular smooth mus cle cells ☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which p ermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/77/fa/main.PMC3949097.pdf
http://dx.doi.org/10.1155/2010/917108 .,Non-OADS,/arxiv_data1/oa_pdf/77/fa/main.PMC3949097.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/1a/main.PMC3949099.pdf
Measurements at the single-cell level allow robust statistical analysis and provide a wayContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2013.12.020 2213-2317 &2014 The Authors.,OADS,/arxiv_data1/oa_pdf/0a/1a/main.PMC3949099.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/1a/main.PMC3949099.pdf
"Commercial automated tools such as IMSTAR Path ﬁnder (www.imstarsa.com ) are also available, and have been used in comet assay studies [20] (for a list of commercial comet assay analysis software, see http://www.cometassay.com ) but, they are expensive and provide no possibilities for examining and modifying the under- lying image processing algorithm.",Non-OADS,/arxiv_data1/oa_pdf/0a/1a/main.PMC3949099.pdf
Supporting information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2013.12.020 .,OADS,/arxiv_data1/oa_pdf/0a/1a/main.PMC3949099.pdf
"1840 (2) (2014) 794 –800, (Epub 2013 Apr 22, http://dx.doi.org/10.1016/j.bbagen.2013.04.022 ).",Non-OADS,/arxiv_data1/oa_pdf/0a/1a/main.PMC3949099.pdf
"26 (2004) 249 –261, http://dx.doi.org/ 10.1385/MB:26:3:249 .",Non-OADS,/arxiv_data1/oa_pdf/0a/1a/main.PMC3949099.pdf
"Available: 〈http://autocomet.com/ 〉, Accessed: 5.10.12.",Non-OADS,/arxiv_data1/oa_pdf/0a/1a/main.PMC3949099.pdf
"749 (1-2) (2012) 70 –75,http://dx.doi.org/10.1016/j.mrgentox.2012.07.003 .",OADS,/arxiv_data1/oa_pdf/0a/1a/main.PMC3949099.pdf
Novel SNPs that have been success-fully genotyped and validated were submitted to dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP/) under the sub- mission handle OICR_HUDSON.,OADS,/arxiv_data1/oa_pdf/9a/03/ijc0134-2330.PMC3949167.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b5/68/srep04342.PMC3949245.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4342 | DOI: 10.1038/srep04342 8",Non-OADS,/arxiv_data1/oa_pdf/b5/68/srep04342.PMC3949245.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c2/fc/srep04337.PMC3949246.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4337 | DOI: 10.1038/srep04337 7",Non-OADS,/arxiv_data1/oa_pdf/c2/fc/srep04337.PMC3949246.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4346 | DOI: 10.1038/srep04346 5",Non-OADS,/arxiv_data1/oa_pdf/4a/c8/srep04346.PMC3949247.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/54/c1/srep04344.PMC3949248.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4344 | DOI: 10.1038/srep04344 9",Non-OADS,/arxiv_data1/oa_pdf/54/c1/srep04344.PMC3949248.pdf
The 16S rDNA V3–V5 region was amplified with bar-coded primers and sequenced by the Human Genome Sequencing Center at Baylor College of Medicine using protocols developed for the Human Microbiome Project (http://www.hmpdacc.org/tools_protocols/tools_protocols.php) as described 17.,OADS,/arxiv_data1/oa_pdf/9a/a5/srep04345.PMC3949250.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9a/a5/srep04345.PMC3949250.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4345 | DOI: 10.1038/srep04345 7",Non-OADS,/arxiv_data1/oa_pdf/9a/a5/srep04345.PMC3949250.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b3/54/srep04341.PMC3949251.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 Figure 7 |Distribution of sand weights at various heights in the shifting sand area and the gravel paving area above the Mogao Grottoes during the great dust storm of June 2, 2011.",Non-OADS,/arxiv_data1/oa_pdf/b3/54/srep04341.PMC3949251.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/25/22/srep04316.PMC3949285.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4316 | DOI: 10.1038/srep04316 6",Non-OADS,/arxiv_data1/oa_pdf/25/22/srep04316.PMC3949285.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/53/6f/srep04348.PMC3949293.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4348 | DOI: 10.1038/srep04348 6",Non-OADS,/arxiv_data1/oa_pdf/53/6f/srep04348.PMC3949293.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4336 | DOI: 10.1038/srep04336 7",Non-OADS,/arxiv_data1/oa_pdf/e2/40/srep04336.PMC3949294.pdf
Glycans were analyzed on the basis of their elution positions and measured in glucose units then compared to reference values in NIBRT’s ‘‘GlycoBase v3.0’’database available at http://glycobase.nibrt.ie) for structure assignment.,OADS,/arxiv_data1/oa_pdf/a1/d2/srep04347.PMC3949295.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a1/d2/srep04347.PMC3949295.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4347 | DOI: 10.1038/srep04347 10",Non-OADS,/arxiv_data1/oa_pdf/a1/d2/srep04347.PMC3949295.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4338 | DOI: 10.1038/srep04338 7",Non-OADS,/arxiv_data1/oa_pdf/ac/f7/srep04338.PMC3949296.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4340 | DOI: 10.1038/srep04340 5",Non-OADS,/arxiv_data1/oa_pdf/05/cc/srep04340.PMC3949297.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4335 | DOI: 10.1038/srep04335 8",Non-OADS,/arxiv_data1/oa_pdf/a7/91/srep04335.PMC3949298.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4333 | DOI: 10.1038/srep04333 7",Non-OADS,/arxiv_data1/oa_pdf/19/57/srep04333.PMC3949302.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/,Non-OADS,/arxiv_data1/oa_pdf/86/4f/thoraxjnl119347.PMC3949324.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs297/en  [Last accessed on 2013].,Non-OADS,/arxiv_data1/oa_pdf/01/a7/ABR-3-38.PMC3949327.pdf
Available from: http://www.sedemen.org.,Non-OADS,/arxiv_data1/oa_pdf/7f/7a/ABR-3-50.PMC3949336.pdf
Available from: http://www.asid.net.au.,Non-OADS,/arxiv_data1/oa_pdf/7f/7a/ABR-3-50.PMC3949336.pdf
"3) When the disease holding period is long The longer the patient has the disease, the less responsive EDITORIALhttp://dx.doi.org/10.5125/jkaoms.2014.40.1.1 pISSN 2234-7550 ·eISSN 2234-5930",Non-OADS,/arxiv_data1/oa_pdf/31/c6/jkaoms-40-1.PMC3949487.pdf
"Therefore,	use	of	any	CASE REPORT Su-Gwan Kim Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun  University, 309, Pilmun-daero, Dong-gu, Gwangju 501-759, Korea TEL: +82-62-220-3819   FAX: +82-62-228-7316 E-mail: sgckim@chosun.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2014 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/24/2c/jkaoms-40-37.PMC3949488.pdf
http://dx.doi.org/10.5125/jkaoms.2014.40.1.37 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/24/2c/jkaoms-40-37.PMC3949488.pdf
"To overcome this  limitation, ND via modified face-lift or the retroauricular ap-CASE REPORT Woong Nam Department of Oral and Maxillofacial Surgery, College of  Dentistry, Yonsei  University, 50, Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea TEL: +82-2-2228-2971   FAX: +82-2-2227-8022 E-mail: omsnam@yuhs.ac    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2014 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/4e/34/jkaoms-40-27.PMC3949489.pdf
"http://dx.doi.org/10.5125/jkaoms.2014.40.1.27 pISSN 2234-7550 ·eISSN 2234-5930 This work was supported by the Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the  Ministry of Education, Science and Technology (2009-0094027).",OADS,/arxiv_data1/oa_pdf/4e/34/jkaoms-40-27.PMC3949489.pdf
"Introduction Over the recent decades, neurosensory impairment of tri- geminal nerve associated with dental implant surgery, which  has become a major medico-legal issue, has been continu- ously increased1 and its incidence is reported to be from 6.5% ORIGINAL ARTICLE Jong-Ho Lee Department of Oral and Maxillofacial Surgery, School of Dentistry, Seoul  National University, 101, Daehak-ro, Jongno-gu, Seoul 110-768, Korea  TEL: +82-2-2072-2630   FAX: +82-2-766-4948 E-mail: leejongh@snu.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2014 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/76/e1/jkaoms-40-3.PMC3949490.pdf
"http://dx.doi.org/10.5125/jkaoms.2014.40.1.3 pISSN 2234-7550 ·eISSN 2234-5930 This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of  Korea (A101578).",Non-OADS,/arxiv_data1/oa_pdf/76/e1/jkaoms-40-3.PMC3949490.pdf
"When  performing BSSO, it is crucial to control the lingual split  because it may result in an unfavorable fracture or inferior  ORIGINAL ARTICLE Yong Deok Kim Department of Oral and Maxillofacial Surgery, School of Dentistry, Pusan  National University, 49, Busandaehak-ro, Mulgeum-eup, Yangsan 626-870,  Korea TEL: +82-55-360-5116   FAX: +82-55-360-5104 E-mail: ydkimdds@pusan.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2014 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/e5/da/jkaoms-40-11.PMC3949491.pdf
"http://dx.doi.org/10.5125/jkaoms.2014.40.1.11 pISSN 2234-7550 ·eISSN 2234-5930 This study was supported by Clinical Research Grant, Pusan National University Dental Hospital.",Non-OADS,/arxiv_data1/oa_pdf/e5/da/jkaoms-40-11.PMC3949491.pdf
"This	 type	includes	symptoms	such	as	foreign	body	sensation,	pain	 referred	to	the	ear,	and	dysphagia.CASE REPORT Joo-Young Ohe Department of Oral and Maxillofacial Surgery, Kyung Hee University Dental  Hospital, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 130-701, Korea TEL: +82-2-958-9360   FAX: +82-2-966-4572 E-mail: ojyoung81@hanmail.net    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2014 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/d4/a8/jkaoms-40-43.PMC3949492.pdf
http://dx.doi.org/10.5125/jkaoms.2014.40.1.43 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/d4/a8/jkaoms-40-43.PMC3949492.pdf
"Especially	in	the	case	of	mild	facial	asymmetry	with	a	mi- nor	lateral	deviation	of	the	mandible,	unilateral	sagittal	split	CASE REPORT Sang-Hoon Kang Department of Oral and Maxillofacial Surgery, National Health Insurance  Service Ilsan Hospital, 100, Ilsan-ro, Ilsandong-gu, Goyang 410-719, Korea TEL: +82-31-900-0267   FAX: +82-31-900-0343 E-mail: omfs1ksh@hanmail.net    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2014 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/11/d2/jkaoms-40-32.PMC3949493.pdf
http://dx.doi.org/10.5125/jkaoms.2014.40.1.32 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/11/d2/jkaoms-40-32.PMC3949493.pdf
"The frequency of  fracture around the mandibular region is higher than that of CLINICAL ANALYSIS Joo-Young Ohe Department of Oral and Maxillofacial Surgery, Kyung Hee University Dental  Hospital, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 130-701, Korea TEL: +82-2-958-9360   FAX: +82-2-966-4572 E-mail: ojyoung81@hanmail.net    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2014 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/8f/46/jkaoms-40-21.PMC3949494.pdf
http://dx.doi.org/10.5125/jkaoms.2014.40.1.21 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/8f/46/jkaoms-40-21.PMC3949494.pdf
"Sinus lift is generally performed prior CLINICAL ANALYSIS Su-Gwan Kim Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun  University, 309, Pilmun-daero, Dong-gu, Gwangju 501-759, Korea TEL: +82-62-220-3819   FAX: +82-62-228-7316 E-mail: sgckim@chosun.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2014 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/f1/bf/jkaoms-40-17.PMC3949495.pdf
http://dx.doi.org/10.5125/jkaoms.2014.40.1.17 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/f1/bf/jkaoms-40-17.PMC3949495.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/4d/det445.PMC3949497.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/99/deu027.PMC3949499.pdf
"Retrieved from http://www.theage.com.au/victoria/ sperm-donor-privacy-not-protected-20130202-2drh6.html , consulted 4.2.13.",Non-OADS,/arxiv_data1/oa_pdf/ed/99/deu027.PMC3949499.pdf
http://dx.doi.org/10.1016/j.rmcr.2013.04.002Respiratory Medicine Case Reports 9 (2013) 38 e41 Open access under CC BY-NC-ND license .,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC3949545.pdf
http://dx.doi.org/10.1016/j.rmcr.2013.04.004Respiratory Medicine Case Reports 9 (2013) 27 e29 Open access under CC BY-NC-ND license .,Non-OADS,/arxiv_data1/oa_pdf/c1/09/main.PMC3949546.pdf
The Journal of Rheumatology 2013. http://dx.doi.org/10.3899/jrheum.121043 [epub ahead of print].P.,Non-OADS,/arxiv_data1/oa_pdf/c1/09/main.PMC3949546.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/44/57/cia-9-395.PMC3949547.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 395–402Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  395OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5666 2effects of weight loss and exercise on trunk  muscle composition in older women Alice s ryan Aruna selina harduarsingh- Permaul Baltimore Veterans Affairs Medical  Center; gerontology and geriatric  Medicine, school of Medicine,   University of Maryland; Baltimore  geriatric research education and  Clinical Center (greCC), and  research and Development service,   VA Maryland health Care system,   Baltimore, MD, UsA Correspondence: Alice s ryan   Division of gerontology and geriatric  Medicine, BT/18/gr, 10 n greene st,   Baltimore Veterans Affairs Medical  Center, Baltimore, MD 21201, UsA   Tel +1 410 605 7185   Fax +1 410 605 7913   email aryan@grecc.umaryland.ed uBackground:  Aging and obesity increase the risk for mobility limitations in women.",Non-OADS,/arxiv_data1/oa_pdf/44/57/cia-9-395.PMC3949547.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/44/57/cia-9-395.PMC3949547.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/57/cia-9-395.PMC3949547.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c2/df/amep-5-061.PMC3949548.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2014:5 61–64Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  61Short rEPortopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/ 10.2147/AMEP .S4878 9triangular model integrating clinical teaching   and assessment Adel Abdelaziz1,2 Emad Koshak3 1Medical Education Development  Unit, Faculty of Medicine, Al Baha  University, Al Baha, Saudi Arabia;   2Medical Education Department,   Faculty of Medicine, Suez Canal  University, Egypt; 3Dean and Internal  Medicine Department, Faculty of  Medicine, Al Baha University, Al Baha,   Saudi Arabia Correspondence: Adel Abdelaziz   Medical Education Development Unit,  Faculty of Medicine, Al Baha University,  Po Box 1988, Al Baha, Saudi Arabia   tel +96 65 5524 2678   Fax +966 7724 7272   Email doctoradel5@yahoo.co mAbstract : Structuring clinical teaching is a challenge facing medical education curriculum  designers.",Non-OADS,/arxiv_data1/oa_pdf/c2/df/amep-5-061.PMC3949548.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/c2/df/amep-5-061.PMC3949548.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/df/amep-5-061.PMC3949548.pdf
http://dx.doi.org/10.1016/j.rmcr.2013.03.006Respiratory Medicine Case Reports 9 (2013) 11 e14 Open access under CC BY-NC-ND license .,Non-OADS,/arxiv_data1/oa_pdf/8f/1e/main.PMC3949549.pdf
http://dx.doi.org/10.1016/j.rmcr.2013.03.005Respiratory Medicine Case Reports 9 (2013) 18 e20 Open access under CC BY-NC-ND license .,Non-OADS,/arxiv_data1/oa_pdf/d6/2f/main.PMC3949550.pdf
http://dx.doi.org/10.1016/j.rmcr.2013.04.003Respiratory Medicine Case Reports 9 (2013) 34 e37 Open access under CC BY-NC-ND license .,Non-OADS,/arxiv_data1/oa_pdf/ee/d3/main.PMC3949551.pdf
http://dx.doi.org/10.1016/j.rmcr.2013.05.001Respiratory Medicine Case Reports 9 (2013) 30 e33 Open access under CC BY-NC-ND license .,Non-OADS,/arxiv_data1/oa_pdf/03/ba/main.PMC3949552.pdf
http://dx.doi.org/10.1016/j.rmcr.2013.03.002Respiratory Medicine Case Reports 9 (2013) 4 e7 Open access under CC BY-NC-ND license .,Non-OADS,/arxiv_data1/oa_pdf/a0/85/main.PMC3949553.pdf
Available from: http://www.hc-sc.gc.ca/dhp-mps/alt_formats/pdf/medeff/advisories-avis/prof/ 2012/volibris_hpc-cps-eng.pdf ; 2012.A.,OADS,/arxiv_data1/oa_pdf/a0/85/main.PMC3949553.pdf
http://dx.doi.org/10.1016/j.rmcr.2013.03.004Respiratory Medicine Case Reports 9 (2013) 15 e17 Open access under CC BY-NC-ND license .,Non-OADS,/arxiv_data1/oa_pdf/1a/91/main.PMC3949554.pdf
http://dx.doi.org/10.1016/j.rmcr.2013.02.002Respiratory Medicine Case Reports 9 (2013) 8 e10 Open access under CC BY-NC-ND license .,Non-OADS,/arxiv_data1/oa_pdf/15/84/main.PMC3949555.pdf
http://dx.doi.org/10.1016/j.rmcr.2013.03.001Respiratory Medicine Case Reports 9 (2013) 1 e3 Open access under CC BY-NC-ND license .,Non-OADS,/arxiv_data1/oa_pdf/cc/73/main.PMC3949556.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9b/a9/cmar-6-093.PMC3949557.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCancer Management and Research 2014:6 93–103Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  93Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S5221 7Proactive strategies for regorafenib in metastatic  colorectal cancer: implications for optimal   patient management Gazala Khan1 Rebecca A Moss2 Fadi Braiteh3,4 Marc Saltzman5 1Department of Hematology and  Oncology, Henry Ford Hospital,   Detroit, M i, USA; 2Rutgers Cancer  institute of New Jersey, Rutgers, The  State University of New Jersey, New  Brunswick, NJ, USA; 3US Oncology  Research, Las vegas, N v, USA;   4Comprehensive Cancer Centers  of Nevada, Las vegas, N v, USA;   5innovative Medical Research of South  Florida, inc, Aventura, FL, USA Correspondence: Gazala Khan   Henry Ford Hospital, 2799 west   Grand Boulevard, Pallister Place   T-139, Detroit, Mi, 48202, USA   Tel +1 313 916 1784   Fax +1 313 916 1266   email gkhan1@hfhs.or gAbstract:  Regorafenib is a broad-spectrum oral multikinase inhibitor that targets several   angiogenic, oncogenic, and stromal receptor tyrosine kinases that support the tumor  microenvironment.",Non-OADS,/arxiv_data1/oa_pdf/9b/a9/cmar-6-093.PMC3949557.pdf
Available  from: http://clinicaltrial.gov/show/NCT01103323.,Non-OADS,/arxiv_data1/oa_pdf/9b/a9/cmar-6-093.PMC3949557.pdf
Available  from: http://labeling.bayerhealthcare.com/html/products/pi/Stivarga_ PI.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9b/a9/cmar-6-093.PMC3949557.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/9b/a9/cmar-6-093.PMC3949557.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/a9/cmar-6-093.PMC3949557.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2010/021923s008s009lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9b/a9/cmar-6-093.PMC3949557.pdf
Available from: http://clinicaltrial.gov/show/ NCT01298570.,Non-OADS,/arxiv_data1/oa_pdf/9b/a9/cmar-6-093.PMC3949557.pdf
Avail - able from: http://clinicaltrial.gov/show/NCT01538680.,Non-OADS,/arxiv_data1/oa_pdf/9b/a9/cmar-6-093.PMC3949557.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/07/b0/cpaa-6-043.PMC3949558.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Pharmacology: Advances and Applications 2014:6 43–50Clinical Pharmacology: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  43OriginAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S5062 6Population pharmacokinetics of olprinone   in healthy male volunteers Takayuki Kunisawa1 hidefumi Kasai2 Makoto suda2 Manabu Y oshimura3 Ami sugawara3 Yuki izumi3 Takafumi iida3 Atsushi Kurosawa3 hiroshi iwasaki3 1surgical Operation Department,   Asahikawa Medical University  hospital, hokkaido, Japan; 2Clinical  study Management Division, Bell  Medical solutions inc, T okyo, Japan;   3Department of Anesthesiology and  Critical Care Medicine, Asahikawa  Medical University, hokkaido, Japan Correspondence: Takayuki Kunisawa   Department of Anesthesiology   and Critical Care Medicine,   Asahikawa Medical University,   2-1-1-1 Midorigaoka-higashi, Asahikawa,   hokkaido 078-8510, Japan   Tel +81 166 68 2583   Fax +81 166 68 2589   email taka.kunisawa@nifty.ne.j pBackground : Olprinone decreases the cardiac preload and/or afterload because of its  vasodilatory effect and increases myocardial contractility by inhibiting phosphodiesterase III.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/cpaa-6-043.PMC3949558.pdf
Available from: http://www.fda.gov/downloads/Drugs/ GuidanceComplian ceRegulatoryInformation/Guidances/UCM072137.,Non-OADS,/arxiv_data1/oa_pdf/07/b0/cpaa-6-043.PMC3949558.pdf
"Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-pharmacology-advances-and-applications-journa lClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/cpaa-6-043.PMC3949558.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/07/b0/cpaa-6-043.PMC3949558.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a0/63/cmar-6-119.PMC3949559.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCancer Management and Research 2014:6 119–134Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  119ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/CMAR.S5737 8Multiple neoplasms, single primaries,   and patient survival Magid h amer Department of Medicine, st Rita’s  Medical Center, lima, Oh, Usa Correspondence : Magid h amer   st Rita’s Medical Center,   825 West Market street, suite 203,   lima, Oh 45805, Usa   Tel +1 614 499 0296   Fax +1 614 448 4499   email magidamer@email.co mBackground:  Multiple primary neoplasms in surviving cancer patients are relatively common,  with an increasing incidence.",Non-OADS,/arxiv_data1/oa_pdf/a0/63/cmar-6-119.PMC3949559.pdf
"Patients with  simultaneous bilateral paired organ cancers such as breast,  lung, or renal, were considered to have a single primary if  their cancers had the same histologic diagnosis.The primary tumor site was defined according to the  International Classification of Diseases Tenth  Revision  (ICD-10)6 (http://apps.who.int/classifications/icd10/ browse/2010/e n).",Non-OADS,/arxiv_data1/oa_pdf/a0/63/cmar-6-119.PMC3949559.pdf
"Cancer Management and Research 2014:6submit your manuscript | www.dovepress.co m Dove press Dove press 121Multiple neoplasms, single primaries, and survival Administration, 2009 ( http://www.ssa.gov/oact/STATS/ table4c6.htm l).",Non-OADS,/arxiv_data1/oa_pdf/a0/63/cmar-6-119.PMC3949559.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/a0/63/cmar-6-119.PMC3949559.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/63/cmar-6-119.PMC3949559.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/07/7d/cmar-6-105.PMC3949560.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCancer Management and Research 2014:6 105–117Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  105Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CMAR.S3238 0Fertility preservation during cancer   treatment: clinical guidelines Kenny A Rodriguez- wallberg1,2 Kutluk Oktay3,4 1Karolinska institutet, Department  of Clinical Science, intervention and  Technology, Division of Obstetrics  and Gynecology, 2Reproductive  Medicine, Karolinska University  Hospital Huddinge, Stockholm,   Sweden; 3innovation institute for  Fertility Preservation, Rye and New  Y ork, 4Department of Obstetrics  and Gynecology, New York Medical  College, valhalla, NY, USA Correspondence: Kenny A Rodriguez- wallberg   Reproductive Medicine, Karolinska  University Hospital Huddinge,  Novumhuset Plan 4, Se-141 86  Stockholm, Sweden   email kenny.rodriguez-wallberg@ karolinska.s e    Kutluk Oktay   innovation institute for Fertility  Preservation, 139 e 23rd St,   New York, NY 10010, USA   email koktay@fertilitypreservation.or gAbstract:  The majority of children, adolescents, and young adults diagnosed with cancer today  will become long-term survivors.",Non-OADS,/arxiv_data1/oa_pdf/07/7d/cmar-6-105.PMC3949560.pdf
Available from: http://www.socialstyrelsen.se/Lists/ Artikelkatalog /Attachments/18919/2012-12-19.pdf .,Non-OADS,/arxiv_data1/oa_pdf/07/7d/cmar-6-105.PMC3949560.pdf
Available from: http://eco.iarc.fr/EUCAN /.,Non-OADS,/arxiv_data1/oa_pdf/07/7d/cmar-6-105.PMC3949560.pdf
Available from:  http://www.sign.ac.uk/pdf/sign132.pdf .,Non-OADS,/arxiv_data1/oa_pdf/07/7d/cmar-6-105.PMC3949560.pdf
Available from: http://www.ukccs.org /.,Non-OADS,/arxiv_data1/oa_pdf/07/7d/cmar-6-105.PMC3949560.pdf
Available from: http://seer.cancer.gov/archive/ csr/1975_2007 /.,Non-OADS,/arxiv_data1/oa_pdf/07/7d/cmar-6-105.PMC3949560.pdf
Available from: http://www.cancer.org.au.,Non-OADS,/arxiv_data1/oa_pdf/07/7d/cmar-6-105.PMC3949560.pdf
Available from:  http://www.asrm.org.,Non-OADS,/arxiv_data1/oa_pdf/07/7d/cmar-6-105.PMC3949560.pdf
Available  from: http://www.isfp-fertility.org.,Non-OADS,/arxiv_data1/oa_pdf/07/7d/cmar-6-105.PMC3949560.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/07/7d/cmar-6-105.PMC3949560.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/07/7d/cmar-6-105.PMC3949560.pdf
http://dx.doi.org/10.1016/j.rmcr.2013.04.001Respiratory Medicine Case Reports 9 (2013) 21 e26 Open access under CC BY-NC-ND license .,Non-OADS,/arxiv_data1/oa_pdf/d7/6e/main.PMC3949561.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/b9/f1/JEM_20131804.PMC3949563.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/b9/f1/JEM_20131804.PMC3949563.pdf
"http://dx.doi.org/10.1182/   blood-2003-01-031 8 Bhattacharya, D., A. Czechowicz, A.G. Ooi, D.J.",Non-OADS,/arxiv_data1/oa_pdf/b9/f1/JEM_20131804.PMC3949563.pdf
"http://dx.doi.org/10.1038/nature1188 5 Dorie, M.J., M.A.",OADS,/arxiv_data1/oa_pdf/b9/f1/JEM_20131804.PMC3949563.pdf
"http://dx.doi.org/10.1016/j.stem.2007.05.01 5 Dykstra, B., S. Olthof, J. Schreuder, M. Ritsema, and G. de Haan.",OADS,/arxiv_data1/oa_pdf/b9/f1/JEM_20131804.PMC3949563.pdf
"http://dx.doi.org/10   .1084/jem.2011149 0 Ema, H., K. Sudo, J. Seita, A. Matsubara, Y. Morita, M. Osawa, K. Takatsu, S.  Takaki, and H. Nakauchi.",OADS,/arxiv_data1/oa_pdf/b9/f1/JEM_20131804.PMC3949563.pdf
"http://dx.doi.org/10.1016/j.devcel.2005.03.01 9 Gerrits, A., B. Dykstra, O.J.",OADS,/arxiv_data1/oa_pdf/b9/f1/JEM_20131804.PMC3949563.pdf
"115:2610– 2618. http://dx.doi.org/10.1182/blood-2009-06-22975 7 Goodman, J.W., and G.S.",Non-OADS,/arxiv_data1/oa_pdf/b9/f1/JEM_20131804.PMC3949563.pdf
"http://dx.doi.org/10.1038/nature1192 6 Kiel, M.J., O.H.",OADS,/arxiv_data1/oa_pdf/b9/f1/JEM_20131804.PMC3949563.pdf
"http://dx.doi.org/10.1016/j.cell.2005.05.02 6 Körbling, M., P .",OADS,/arxiv_data1/oa_pdf/b9/f1/JEM_20131804.PMC3949563.pdf
"http://dx.doi.org/10.1093/   bioinformatics/btp55 4 Lapid, K., C. Glait-Santar, S. Gur-Cohen, J. Canaani, O. Kollet, and T. Lapidot.",Non-OADS,/arxiv_data1/oa_pdf/b9/f1/JEM_20131804.PMC3949563.pdf
"http://dx.doi.org/10.1182/blood-2004-11-428 2Lo Celso, C., and D.T.",OADS,/arxiv_data1/oa_pdf/b9/f1/JEM_20131804.PMC3949563.pdf
"http://dx.doi.org/10.1242/jcs.07411 2 Mazurier, F ., M. Doedens, O.I.",OADS,/arxiv_data1/oa_pdf/b9/f1/JEM_20131804.PMC3949563.pdf
http://dx.doi.org/10.1046/j.1365-2141.2003.04107.,Non-OADS,/arxiv_data1/oa_pdf/b9/f1/JEM_20131804.PMC3949563.pdf
"http://dx.doi.org/10.1016/j.cell.2008.01.02 5 Pozotrigo, M., N. Adel, H. Landau, A. Lesokhin, N. Lendvai, D.J.",OADS,/arxiv_data1/oa_pdf/b9/f1/JEM_20131804.PMC3949563.pdf
"http://dx.doi.org/10   .1038/bmt.2012.28 1 Ramos, C.A., Y. Zheng, I. Colombowala, and M.A.",OADS,/arxiv_data1/oa_pdf/b9/f1/JEM_20131804.PMC3949563.pdf
"http://dx.doi.org/10.1182/blood-2013-01-48113 5 Warren, S., R.N.",Non-OADS,/arxiv_data1/oa_pdf/b9/f1/JEM_20131804.PMC3949563.pdf
"http://dx.doi.org/10.1126/science.106408 1 Xing, Z., M.A.",OADS,/arxiv_data1/oa_pdf/b9/f1/JEM_20131804.PMC3949563.pdf
http://dx.doi.org/10.1182/blood-   2005-12-01027 2,Non-OADS,/arxiv_data1/oa_pdf/b9/f1/JEM_20131804.PMC3949563.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi.org/10   .1212/WNL.42.3.63 1 Bancher, C., H. Braak, P. Fischer, and K.A.",OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi   .org/10.1016/0304-3940(93)90590- H Bero, A.W., P. Yan, J.H.",OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi.org/10.1038/nn.280 1 Braak, H., and E. Braak.",OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi.org/10   .1016/0197-4580(95)00021- 6 Castellano, J.M., J. Kim, F.R.",OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi.org/10.1016/j.nbd.2012.05.02 1 Cirrito, J.R., K.A.",OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi.org/10.1016/j.neuron.2005.10.02 8 Cirrito, J.R., J.-E. Kang, J. Lee, F.R.",OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
http://dx.doi.org/10.1016/j.neuron.2008.02.00 3EEG recording.,OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi.org/10.1038/ncb190 1 de Calignon, A., M. Polydoro, M. Suárez-Calvet, C. William, D.H. Adamowicz,  K.J.",Non-OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi.org/10.1016/j.neuron.2011   .11.03 3 Eckermann, K., M.-M. Mocanu, I. Khlistunova, J. Biernat, A. Nissen, A.  Hofmann, K. Schönig, H. Bujard, A. Haemisch, E. Mandelkow, et al.",OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"282:31755– 31765. http://dx.doi.org/10.1074/jbc.M70528220 0 Frost, B., R.L.",OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"284:12845– 12852. http://dx.doi.org/10.1074/jbc.M80875920 0 Guo, J.L., and V.M.-Y.",OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi.org/10.1074/jbc.M110.20929 6 Harris, J.A., A. Koyama, S. Maeda, K. Ho, N. Devidze, D.B.",OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi.org/10.1371/journal.pone.004588 1 Hochgräfe, K., and E.-M. Mandelkow.",Non-OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi.org/10.1007/s12035-012-8379- 1 Iba, M., J.L.",Non-OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2642-12.201 3 Jack, C.R.",Non-OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi.org/10.1016/S1474-4422(12)70291- 0 Karch, C.M., A.T. Jeng, and A.M. Goate.",OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi.org/10.1074/jbc.M112.38064 2 Kfoury, N., B.B.",OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi.org/10.1074/jbc.M112   .34607 2 Lee, H.-J., S. Patel, and S.-J.",OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi.org/10.1371/journal.pone.003130 2 Luk, K.C., V .",Non-OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi.org/10.1126/science.122715 7 Maia, L.F., S.A. Kaeser, J. Reichwald, M. Hruscha, P. Martus, M. Staufenbiel,  and M. Jucker.",OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi.org/10.1111/   ejn.1222 9 Pooler, A.M., E.C.",OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi.org/10.1038/embor.2013.1 5 Price, J.C., S. Guan, A. Burlingame, S.B.",OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi.org/10.1007/s00401-012-0987- 3 Verges, D.K., J.L.",Non-OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
"http://dx.doi   .org/10.1523/JNEUROSCI.0607-11.201 1 Yamada, K., J.R. Cirrito, F .R.",OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
http://dx.doi.org/10.1523/   JNEUROSCI.2569-11.201 1,Non-OADS,/arxiv_data1/oa_pdf/6b/40/JEM_20131685.PMC3949564.pdf
This article is distributed under the terms of an Attri - bution–Noncommercial–Share Alike–No Mirror Sites license for the first six  months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1016/j.ccr.2012.02.00 7 Dessein, R., M. Gironella, C. Vignal, L. Peyrin ­Biroulet, H. Sokol, T .",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1007/978­1­61779­185­7_ 7 Du, P ., W .A.",Non-OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10   .1093/bioinformatics/btn22 4 Edgar, R.C.",Non-OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1093/   bioinformatics/btq46 1 Faith, D.P ., and A.M. Baker.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1086/51623 7 Fiske, W .H., D. Threadgill, and R.J. Coffey.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"315:583– 601. http://dx.doi.org/10.1016/j.yexcr.2008.10.04 3 Galán, J.E., J.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1038/   357588a 0 Garcia, M.R., L. Ledgerwood, Y .",Non-OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1172/JCI4162 8 Giannoukos, G., D.M.",Non-OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1186/gb ­2012­13­3­r23 Hamilton, J.P ., G. Xie, J.­P .",Non-OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1152/   ajpgi.00027.200 7 Hartman, A.L., D.M.",Non-OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10   .1146/annurev­immunol­020711­07493 7 Huang, C.S., M.J. O’brien, S. Yang, and F .A.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1111/j.1572­ 0241.2004.40131. x Ivanov, I.I., K. Atarashi, N. Manel, E.L. Brodie, T. Shima, U. Karaoz, D. Wei,  K.C.",Non-OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1016/j.cell.2009.09.03 3 Kehl­Fie, T.E., S. Chitayat, M.I.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1126/science.122482 0 Bates, J.M., E. Mittge, J. Kuhlman, K.N.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1038/nmeth.227 6 Bongers, G., D. Maussang, L.R.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1053/j.gastro.2012.05.03 4 Bruewer, M., A. Luegering, T. Kucharzik, C.A.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1038/nmeth.f.30 3 Caporaso, J.G., C.L.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
http://dx.doi.org/10.1038/ismej.2012.,Non-OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"148:1258– 1270. http://dx.doi.org/10.1016/j.cell.2012.01.03 5 Daley, J.M., A.A. Thomay, M.D.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
http://dx.doi.org/10.1189/jlb.040724 7,Non-OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1038/nrc361 0 Sekirov, I., N.M. Tam, M. Jogova, M.L.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"76:4726– 4736. http://dx.doi.org/10.1128/IAI.00319­0 8 Shibata, K., H. Yamada, H. Hara, K. Kishihara, and Y .",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi   .org/10.1152/ajpcell.00274.200 7 Smyth, G.K. 2004.",Non-OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"Sci  Rep. 1:170. http://dx.doi.org/10.1038/srep0017 0 Suzuki, M., G. Raab, M.A.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1074/jbc.272.50.3173 0 Tamura, A., Y .",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/   10.1053/j.gastro.2007.11.04 0 Trapnell, C., L. Pachter, and S.L.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi   .org/10.1093/bioinformatics/btp12 0 Ubeda, C., Y .",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1172/JCI4391 8 Untergasser, A., H. Nijveen, X. Rao, T .",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1093/nar/gkm30 6 van Ampting, M.T.J., L.M.P .",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1128/IAI.06165­1 1 von Rosenvinge, E.C., Y .",Non-OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1038/ismej.2013.3 3 W ang, Y ., S. Devkota, M.W .",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1371/journal.pone.001360 7 Willing, B.P ., S.L.",Non-OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1038/nrmicro253 6 Wu, S., K.J.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1038/nm.201 5Lei, Z., T. Maeda, A. Tamura, T. Nakamura, Y .",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/   10.1016/j.ydbio.2012.07.00 5 Lin, S.M., P .",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1093/nar/gkm107 5 Lioni, M., P .",Non-OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10   .2353/ajpath.2007.06034 3 Louis, E., C. Ribbens, A. Godon, D. Franchimont, D. De Groote, N. Hardy,  J. Boniver, J. Belaiche, and M. Malaise.",Non-OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
http://dx.doi.org/10.1046/j.1365­2249.2000.01227.,Non-OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1038/ismej.2010.13 3 Mantovani, A., M.A.",Non-OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1038/nri302 4 McColl, K.E.L.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1056/NEJMcp100111 0 McDonald, D., M.N.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10   .1038/ismej.2011.13 9 Merritt, M.E., and J.R. Donaldson.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1099/jmm.0.014092­ 0 Na, X., D. Zhao, H.W .",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1053/j.gastro.2005   .01.05 3 Nagano, Y ., K. Itoh, and K. Honda.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi   .org/10.1016/j.coi.2012.05.00 7 Noffsinger, A.E.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1146/ annurev.pathol.4.110807.09231 7 Pizarro­Cerdá, J., and P .",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1016/j.cell.2006.02.01 2 Plottel, C.S., and M.J. Blaser.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1016/j.chom.2011.10.00 3 Ridlon, J.M., D.­J.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
"http://dx.doi.org/10.1093/   bioinformatics/btp61 6 Sartor, R.B.",OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
http://dx.doi.org/10.1053/j.gastro.2007   .11.05 9,Non-OADS,/arxiv_data1/oa_pdf/44/5c/JEM_20131587.PMC3949565.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
Online supplemental material is available at http://www.jem   .org/cgi/content/full/jem.20130604/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
http://dx.doi.org/10   .1111/j.1365-2567.2011.03456.,Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
http://dx.doi.org/10.1016/j.immuni.2012.02.01 2Gene expression analysis.,OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
E-MEXP-3820 (https://www.ebi.ac.uk/   arrayexpress/experiments/E-MEXP-3820/).,OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1016/S0092-   8674(00)81299- 4 Hock, M., M. Vaeth, R. Rudolf, A.K.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.2337/db06-005 8 Johnston, R.J., A.C. Poholek, D. DiToro, I. Yusuf, D. Eto, B. Barnett, A.L.",Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1126/science.117587 0 Johnston, R.J., Y.S.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1084/jem.2011117 4 Josefowicz, S.Z., L.F .",Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1146/annurev.immunol.25.022106.14162 3 Klein-Hessling, S., M.K.",Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1074/ jbc  .M80592920 0 Koch, M.A., G. Tucker-Heard, N.R.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1038/ni.173 1 Kroenke, M.A., D. Eto, M. Locci, M. Cho, T. Davidson, E.K.",Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.10.00 8 Lahl, K., C. Loddenkemper, C. Drouin, J. Freyer, J. Arnason, G. Eberl, A.  Hamann, H. Wagner, J. Huehn, and T. Sparwasser.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1084/jem.2006185 2 Lee, P.P., D.R.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1016/   S1074-7613(01)00227- 8 Li, H., Y.Y.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1046/j.1440-   1711.1998.00709. x Bauquet, A.T., H. Jin, A.M. Paterson, M. Mitsdoerffer, I.C.",Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi   .org/10.1038/ni.169 0 Bhattacharyya, S., J. Deb, A.K.",Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1084/jem.2010094 5 Bodor, J., T. Bopp, M. Vaeth, M. Klein, E. Serfling, T. Hünig, C. Becker,  H. Schild, and E. Schmitt.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/   10.1002/eji.20114157 8 Bollig, N., A. Brüstle, K. Kellner, W. Ackermann, E. Abass, H. Raifer,  B. Camara, C. Brendel, G. Giel, E. Bothur, et al.",Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1093/intimm/dxn04 4 Bonelli, M., J.S.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1136/ard.2009.11713 5 Bopp, T., C. Becker, M. Klein, S. Klein-Hessling, A. Palmetshofer, E. Serfling,  V. Heib, M. Becker, J. Kubach, S. Schmitt, et al.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1084/   jem.2006212 9 Chaudhry, A., D. Rudra, P. Treuting, R.M.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1038/nm.242 6 Chuvpilo, S., E. Jankevics, D. Tyrsin, A. Akimzhanov, D. Moroz, M.K.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"12:304– 311. http://dx.doi.org/10.1038/ni.200 6 Cretney, E., A. Kallies, and S.L.",Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"29:621– 663. http://dx.doi.org/10.1146/annurev-immunol-031210-10140 0 Farrow, M.A., E.Y.",Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1074/jbc.M110.15437 7 Hill, J.A., M. Feuerer, K. T ash, S. Haxhinasto, J. Perez, R. Melamed, D. Mathis, and  C. Benoist.",Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
http://dx.doi.org/10.1016/j.immuni.2007.09.01 0,OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1016/j.yexcr.2008.09.00 8 Serfling, E., F. Berberich-Siebelt, S. Chuvpilo, E. Jankevics, S. Klein- Hessling, T. Twardzik, and A. Avots.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1016/S0167-4889(00)00082- 3 Serfling, E., A. Avots, S. Klein-Hessling, R. Rudolf, M. Vaeth, and F.  Berberich-Siebelt.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"10:16. http://dx.doi.org/   10.1186/1478-811X-10-1 6 Shaffer, A.L., K.I.",Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/   10.1016/S1074-7613(02)00335- 7 Simpson, N., P.A.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1002/   art.2503 2 Vaeth, M., T. Gogishvili, T. Bopp, M. Klein, F. Berberich-Siebelt, S.  Gattenloehner, A. Avots, T. Sparwasser, N. Grebe, E. Schmitt, et al.",Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"24:2423– 2443. http://dx.doi.org/10.1128/MCB.24.6.2423-2443.200 4 Wing, K., Y. Onishi, P. Prieto-Martin, T. Yamaguchi, M. Miyara, Z. Fehervari,  T. Nomura, and S. Sakaguchi.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1126/   science.116006 2 Wolf, I., V. Pevzner, E. Kaiser, G. Bernhardt, E. Claudio, U. Siebenlist,  R. Förster, and M. Lipp.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"273:28831– 28836. http://dx.doi.org/10.1074/jbc.273.44.2883 1 Wollenberg, I., A. Agua-Doce, A. Hernández, C. Almeida, V.G.",Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.4049/jimmunol.110132 8 Yu, D., S. Rao, L.M.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.07.00 2 Zheng, Y., S.Z.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1038/nm.242 5 Liu, X., X. Yan, B. Zhong, R.I. Nurieva, A. Wang, X. Wang, N. Martin- Orozco, Y. Wang, S.H.",Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1084/jem.2012021 9 Ma, C.S., E.K.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1084/jem.2012099 4 McCaffrey, P.G., P.K.",Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1093/nar/22.11.213 4 Müller, M.R., and A. Rao.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/   10.1038/nri281 8 Nayak, A., J. Glöckner-Pagel, M. Vaeth, J.E.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1074/jbc.M90046520 0 Oestreich, K.J., S.E.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"13:405– 411. http://dx.doi.org/10.1038/ni.224 2 Peng, S.L., A.J.",Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1016/S1074-7613(01)00085- 1 Qiao, B., J. Wu, Y .W .",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1093/   rheumatology/keh65 6 Ranger, A.M., M.R.",Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80465- 3 Rasheed, A.U., H.P.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1002/eji.20063613 6 Rengarajan, J., K.A.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1084/jem.2001112 8 Rengarajan, J., B. Tang, and L.H.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1038/ni74 4 Sage, P.T., L.M.",Non-OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10.1038/ni.249 6 Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
"http://dx.doi.org/10   .1016/j.cell.2008.05.00 9 Schmidt, D., A. Nayak, J.E.",OADS,/arxiv_data1/oa_pdf/48/07/JEM_20130604.PMC3949566.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1038/nri139 1 ar-Rushdi, A., K. Nishikura, J. Erikson, R. Watt, G. Rovera, and C.M.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1016/S0140-6736(00)04046- 0 Beutler, B.",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"4:498.  http://dx.doi.org/10.1038/nri140 1 Bouillet, P ., D. Metcalf, D.C. Huang, D.M.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1126/science   .286.5445.173 5 Braggio, E., J.J. Keats, X. Leleu, S. Van Wier, V.H.",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"44:1375– 1381. http://dx.doi.org/10.1016/j.humpath.2012.10.02 6 Coornaert, B., M. Baens, K. Heyninck, T. Bekaert, M. Haegman, J. Staal,   L. Sun, Z.J.",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10   .1038/ni156 1 Cory, S. 1995.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1146/annurev.iy   .13.040195.00250 1 Cyster, J.G., S.B.",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1038/371389a 0 Deane, J.A., P. Pisitkun, R.S.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1016/j.immuni.2007.09.00 9 Egle, A., A.W .",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1182/   blood-2003-07-246 9 Ewald, S.E., B.L.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1038/ng.2007.2 7 Powers, J.P., S. Li, J.C. Jaen, J. Liu, N.P.",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1016/j.bmcl.2006.03.02 0 Puente, X.S., M. Pinyol, V. Quesada, L. Conde, G.R.",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1038/nature1011 3 Rebeaud, F., S. Hailfinger, A. Posevitz-Fejfar, M. Tapernoux, R. Moser, D.  Rueda, O. Gaide, M. Guzzardi, E.M. Iancu, N. Rufer, et al.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1038/ni156 8 Rossi, D., S. Deaglio, D. Dominguez-Sola, S. Rasi, T. Vaisitti, C. Agostinelli, V .",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1182/blood-   2011-06-35916 6 Rui, L., R. Schmitz, M. Ceribelli, and L.M.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10   .1038/ni.209 4 Schüler, F., L. Dölken, C. Hirt, T. Kiefer, T. Berg, G. Fusch, K. Weitmann,  W. Hoffmann, C. Fusch, S. Janz, et al.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1002/ijc.2395 8 Shaffer, A.L., A. Rosenwald, and L.M.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"2:920– 932. http://dx.doi.org/10.1038/nri95 3 Shen, Y., J. Iqbal, J.Z.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1182/blood-2004-01-024 3 Subramanian, S., K. Tus, Q.Z.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1038/ni129 7 Thomson, W., A. Barton, X. Ke, S. Eyre, A. Hinks, J. Bowes, R. Donn, D.  Symmons, S. Hider, I.N.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1038/ng.2007.3 2 Tokunaga, F ., H. Nishimasu, R. Ishitani, E. Goto, T. Noguchi, K. Mio, K.  Kamei, A. Ma, K. Iwai, and O. Nureki.",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1038/emboj.2012   .241 Treon, S.P., L. Xu, G. Yang, Y. Zhou, X. Liu, Y. Cao, P. Sheehy, R.J.  Manning, C.J.",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1056/NEJMoa120071 0 Trøen, G., A. Warsame, and J. Delabie.",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1126/science.387443 0 Vaux, D.L., S. Cory, and J.M.",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1038/335440a 0 Verhelst, K., I. Carpentier, M. Kreike, L. Meloni, L. Verstrepen, T. Kensche,  I. Dikic, and R. Beyaert.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1038/emboj.2012.24 0 Wang, L., M.S.",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/   10.1038/nature0740 5 Goodnow, C.C.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1016/j.cell.2007.06.03 3 Goodnow , C.C., and P .",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1038/334676a 0 Graham, R.R., C. Cotsapas, L. Davies, R. Hackett, C.J.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1038/ng.20 0 Harhaj, E.W ., and V .M.",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
http://dx.doi.org/10.1111/j.1600- 065X.2012.01100.,Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/   10.1038/3504712 3 Iqbal, J., V .T.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10   .1200/JCO.2005.03.426 4 Jeelall, Y.S., J.Q.",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1084/jem.2011274 4 Kim, Y .M., M.M.",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1038/nature0672 6 Krieg, A.M. 2002.",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1038/416603 a Lenz, G., R.E.",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1126/science.115362 9 Mercurio, F ., H. Zhu, B.W .",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1126/scienc e.278   .5339.86 0 Morin, R.D., M. Mendez-Lago, A.J.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1038/nature1035 1 Ngo, V.N., R.M.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1038/nature0967 1 Pasqualucci, L., V. Trifonov, G. Fabbri, J. Ma, D. Rossi, A. Chiarenza, V.A.",Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1038/ng.89 2 Pisitkun, P., J.A.",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1056/   NEJMoa110901 6 Woodland, R.T., M.R.",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1016/   j.smim.2006.06.00 1 Wotherspoon, A.C., C. Doglioni, T.C.",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
"http://dx.doi.org/10.1016/   0140-6736(93)91409- F Xu, L., Z.R.",OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
http://dx.doi.org/10.1182/blood-2012-09-45435 5,Non-OADS,/arxiv_data1/oa_pdf/e7/92/JEM_20131424.PMC3949567.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"285:7045– 7055. http://dx.doi.org/10.1074/jbc.M109.07927 7 Bachmaier, K., S. Toya, X. Gao, T. Triantafillou, S. Garrean, G.Y.",Non-OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1038/nm160 7 Bauernfeind, F., E. Bartok, A. Rieger, L. Franchi, G. Núñez, and V.  Hornung.",Non-OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.4049/jimmunol.110061 3 Brown, J.H., D.P .",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
http://dx.doi.org/10.1161/01.RES.0000216039.75913.9 evectors.,Non-OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi   .org/10.1016/j.cardiores.2005.06.02 1 Chen, Z., W .D.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1038/nsmb88 8 Chiasson, C.M., K.B.",Non-OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi   .org/10.1091/mbc.E08-07-073 5 Clement, H.W ., J.F .",Non-OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1007/   s00702-009-0327- 5 Cole, P.A., K. Shen, Y. Qiao, and D. Wang.",Non-OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"40:148– 160. http://dx.doi.org/10.1080/0891693060118352 2 Dejana, E., F. Orsenigo, and M.G.",Non-OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1242/jcs.01789 7 Diebold, I., T. Djordjevic, A. Petry, A. Hatzelmann, H. T enor, J. Hess, and A. Görlach.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1161/CIRCRESAHA   .109.19659 2 Frey, R.S., M. Ushio-Fukai, and A.B.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1089/   ars.2008.222 0 Fridovich, I.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1146/annurev.bi.64.070195   .00052 5 Gandhirajan, R.K., S. Meng, H.C. Chandramoorthy, K. Mallilankaraman, S.  Mancarella, H. Gao, R. Razmpour, X.F .",Non-OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1038/ncb148 6 Gavard, J., V .",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.10.01 9 Giannoni, E., F .",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"25:6391– 6403. http://dx.doi.org/10.1128/MCB.25.15.6391-6403.200 5 Giniatullin, A.R., and R.A. Giniatullin.",Non-OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1113/jphysiol.2003.05069 0 Gong, H., B. Shen, P .",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1126/science.117477 9 Hatanaka, K., M. Simons, and M. Murakami.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1152/ajpheart.00650.201 0 Holinstat, M., D. Mehta, T. Kozasa, R.D.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1074/jbc.M30390020 0 Huang, K., Y .H.",Non-OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1016/j.jmb.2009.01.01 2 Indra, A.K., X. Warot, J. Brocard, J.M.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1093/nar/27.22.432 4 Kaplan, D.D., T.E.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi   .org/10.1074/jbc.M10612120 0 Kelly, P ., P .J.",Non-OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1021/bi700235 f Khoa, N.D., M. Postow, J. Danielsson, and B.N.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1124/mol.105.01685 7 Kim, M.P ., S.I.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1007/   s00441-008-0682- 9 Klages, B., U. Brandt, M.I.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1083/jcb.144.4.74 5 Komarova, Y ., and A.B.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"72:463– 493. http://dx.doi.org/10.1146/annurev-physiol-021909-13583 3 Komarova, Y .A., D. Mehta, and A.B.",Non-OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/   10.1126/stke.4122007re 8 Korhonen, H., B. Fisslthaler, A. Moers, A. Wirth, D. Habermehl, T .",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi   .org/10.1016/0304-3959(94)00254- C Li, Q., N.Y .",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10   .1089/ars.2008.240 7 Meigs, T.E., M. Fedor-Chaiken, D.D.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10   .1074/jbc.M20198420 0 Meigs, T.E., J. Juneja, C.T.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1074/ jbc.M50044520 0 Mirza, M.K., Y .",Non-OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1084/jem.2009185 7 Nishida, M., Y. Maruyama, R. Tanaka, K. Kontani, T. Nagao, and H. Kurose.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1038/3504412 0 Offermanns, S., V .",Non-OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1126/science.275.5299.53 3 Okada, M., S. Nada, Y .",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"3:1208.  http://dx.doi.org/10.1038/ncomms219 9 Potter, M.D., S. Barbero, and D.A.",Non-OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1074/jbc.M50556820 0 Rhee, S.G. 2006.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1126/science.113048 1 Roskoski, R. Jr. 2005.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi   .org/10.1016/j.bbrc.2005.03.01 2 Salmeen, A., and D. Barford.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1089/ars.2005.7.56 0 Shan, D., L. Chen, D. Wang, Y .C.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1016/j.devcel   .2006.03.01 4 Shi, G.X., K. Harrison, S.B.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1016/   j.devcel.2013.04.00 8 Su, T., X. Li, N. Liu, S. Pan, J. Lu, J. Yang, and Z. Zhang.",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1074/jbc.M109.07284 3 Vandenbroucke St Amant, E., M. Tauseef, S.M.",Non-OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10   .1161/CIRCRESAHA.112.26965 4 Wind, S., K. Beuerlein, T. Eucker, H. Müller, P .",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
http://dx.doi.org/10.1111/j.1476-5381.2010.00920.,Non-OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10   .1016/j.devcel.2005.06.00 6 Xiao, K., D.F .",OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
"http://dx.doi.org/10.1083/jcb.20030600 1 Y u, W ., S. Beaudry , H. Negoro, I. Boucher, M. Tran, T .",Non-OADS,/arxiv_data1/oa_pdf/07/db/JEM_20131190.PMC3949568.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1084/jem.2010012 4 Barber, D.L., E.J.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi   .org/10.1038/nature0444 4 Beresford, G.W ., and J.M.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1038/8981 0 Blattman, J.N., R. Antia, D.J.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1084/jem.2000102 1 Brahmer, J.R., C.G.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1200/JCO   .2009.26.760 9 Brahmer, J.R., S.S. T ykodi, L.Q.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1056/NEJMoa120069 4 Brown, K.E., G.J.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1016/j.coi.2010.03.00 7 Choi, N.M., and J.M.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1371/journal.pone.003755 4 Cretney, E., A. Xin, W .",Non-OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1038/ni.200 6 Day, C.L., D.E.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1038/   nature0511 5 Fourcade, J., Z.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"207:2175– 2186. http://dx.doi.org/10.1084/jem.2010063 7 Gong, D., and T.R.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/   10.1038/2120 8 Johnston, R.J., A.C. Poholek, D. DiT oro, I. Y usuf, D. Eto, B. Barnett, A.L.",Non-OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1126/science.117587 0 Kallies, A., A. Xin, G.T.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1016/   j.immuni.2009.06.02 1 Kao, C., K.J.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
Online supplemental material is  available at http://www.jem.org/cgi/content/full/jem.20130208/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1016/   S1074-7613(03)00267- X Shin, H., S.D.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.06.01 9 Shin, H.M., V .N.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1016/j.immuni.2013.08.03 2 T opalian, S.L., C.G.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1016/j.coi.2011.12.00 9 T opalian, S.L., F .S.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10   .1056/NEJMoa120069 0 Turner, C.A.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"80:11398– 11403. http://dx.doi.org/10.1128/JVI.01177-0 6 Velu, V ., S. Kannanganat, C. Ibegbu, L. Chennareddi, F .",Non-OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1128/JVI.00024-0 7 Wei, Q., W .K.",Non-OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1074/jbc.M50049120 0 Wherry, E.J., S.J.",Non-OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1016/j.immuni   .2007.09.00 6 Y oon, H., and J.M.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.4049/jimmunol.100007 9 Y oon, H.S., C.D.",Non-OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.4049/jimmunol.110337 1 Y oungblood, B., K.J.",Non-OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1016/   j.immuni.2011.06.01 5 Y u, J., C. Angelin-Duclos, J. Greenwood, J. Liao, and K. Calame.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10   .1128/MCB.20.7.2592-2603.200 0 Zajac, A.J., J.N.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
188:2205– 2213. http://dx.doi.org/10.1084/jem.188.12.220 5receptor PD-1 and sustains virus-specific CD8+ T cell responses during  chronic infection.,Non-OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1038/   ni.204 6 Kersh, E.N.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1016/j.cell.2007.02.00 5 Lafon, M., F .",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi   .org/10.1084/jem.2008052 6 Murali-Krishna, K., J.D.",Non-OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1016/S1074-7613(00) 80470- 7 Oestreich, K.J., H. Y oon, R. Ahmed, and J.M.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1016/   j.molimm.2007.07.03 8 Pircher, H., K. Bürki, R. Lang, H. Hengartner, and R.M.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1038/342559a 0 Radziewicz, H., C.C.",Non-OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi   .org/10.1128/JVI.02021-0 6 Rutishauser, R.L., G.A.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.05.01 4 Samoylenko, A., U. Roth, K. Jungermann, and T. Kietzmann.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
"http://dx.doi.org/10   .1016/S1074-7613(02)00335- 7 Shapiro-Shelef, M., K.I.",OADS,/arxiv_data1/oa_pdf/56/22/JEM_20130208.PMC3949569.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
Online supplemental material is  available at http://www.jem.org/cgi/content/full/jem.20130785/DC1.,Non-OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"3:296.  http://dx.doi.org/10.3389/fimmu.2012.0029 6 Berney, T., R.D.",Non-OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.4049/jimmunol.110102 7 Josefowicz, S.Z., L.F .",Non-OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1146/annurev.immunol.25.022106.14162 3 Katz, J.D., B. Wang, K. Haskins, C. Benoist, and D. Mathis.",Non-OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"74:1089– 1100. http://dx.doi.org/10.1016/0092-8674(93)90730- E Kurts, C., W .R.",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1084/jem   .184.3.92 3 Lu, Y ., J. Suzuki, M. Guillioli, O. Umland, and Z. Chen.",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
http://dx.doi.org/10.1111/j.1365-2567.2011.03466.,Non-OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1182/blood-2012-04-42142 0 Mandl, J.N., R. Liou, F .",Non-OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"20:509– 516. http://dx.doi.org/10.1016/S1074-7613(04)00111- 6 Mempel, T.R., M.J. Pittet, K. Khazaie, W .",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1016/j.immuni.2006.04.01 5 Miska, J., E. Bas, P .",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1002/eji.20124259 0 Mukhopadhaya, A., T. Hanafusa, I. Jarchum, Y .G.",Non-OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1084/jem.194.5.62 9 Onishi, Y ., Z. Fehervari, T. Yamaguchi, and S. Sakaguchi.",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10   .1038/ni.264 9 Read, S., V .",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"192:295– 302. http://dx.doi.org/10.1084/jem.192.2.29 5 Ricordi, C., P .E.",Non-OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10   .1097/00007890-200101150-0002 0 Cano, D.A., I.C.",Non-OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10   .1038/nrendo.2011.14 8 Chen, Z., A.E.",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1084/jem.2005140 9 Chen, Z., J. Stockton, D. Mathis, and C. Benoist.",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1038/nm.255 6 Dor, Y ., J.",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1038/nature0252 0 Driver, J.P ., F .",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.2337/db09-111 6 Ermann, J., V .",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10   .2337/db11-051 6 Feuerer, M., Y .",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10   .1016/j.immuni.2009.08.02 3 Fife, B.T., K.E.",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1038/ni.179 0 Germain, R.N., E.A.",Non-OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1126/science.122106 3 Hadjantonakis, A.K., S. Macmaster, and A. Nagy .",Non-OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"2:11. http://dx.doi.org/10   .1186/1472-6750-2-1 1 Hagness, M., K. Henjum, J. Landskron, K.W .",Non-OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.4049/   jimmunol.110136 7 Hahn, S., R. Gehri, and P .",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
http://dx.doi   .org/10.1111/j.1600-065X.1995.tb00684.,Non-OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10   .1152/ajpendo.00365.200 5 Hogquist, K.A., S.C. Jameson, W .R.",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
http://dx.doi.org/10.1016/0092-8674(94)90169- 4,OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1093/intimm/10.12.196 9 Tang, Q., J.Y .",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1038/ni128 9 Tarbell, K.V ., L. Petit, X. Zuo, P .",Non-OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1084/jem.2006163 1 T eft, W .A., M.G.",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi   .org/10.1146/annurev.immunol.24.021605.09053 5 Thornton, A.M., and E.M. Shevach.",Non-OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi   .org/10.1084/jem.188.2.28 7 Tisch, R., and B. Wang.",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10   .1016/S0065-2776(08)00805- 5 Tite, J.P ., and C.A.",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1002/eji.183014100 4 Tsai, S., P .",Non-OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi   .org/10.4049/jimmunol.130016 8 Turley, S., L. Poirot, M. Hattori, C. Benoist, and D. Mathis.",Non-OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi   .org/10.1084/jem.2003096 6 Wan, Y .Y ., and R.A. Flavell.",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10   .1126/science.116006 2 Yi, P ., J.S.",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi   .org/10.1016/j.cell.2013.04.00 8 Zhang, N., B. Schröppel, G. Lal, C. Jakubzick, X. Mao, D. Chen, N. Yin, R.  Jessberger, J.C. Ochando, Y .",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi   .org/10.1172/JCI6193 1 Samy, E.T., L.A. Parker, C.P .",Non-OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1084/jem.2004103 3 Schneider, H., J. Downey, A. Smith, B.H.",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi   .org/10.1126/science.113107 8 Sherry, N.A., J.A.",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/   10.2337/db05-103 4 Shevach, E.M. 2006.",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1016/j.immuni.2006.08.00 3 Shevach, E.M. 2008.",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"322:202– 203. http://dx.doi.org/10.1126/science.116487 2 Shevach, E.M. 2011.",Non-OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1016/B978-0-12-387827-4.00004- 8 Speier, S., D. Nyqvist, O. Cabrera, J. Y u, R.D.",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi   .org/10.1038/nm170 1 Speier, S., D. Nyqvist, M. Köhler, A. Caicedo, I.B.",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1038/ni.184 4 Surh, C.D., and J. Sprent.",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1016/j.immuni.2008.11.00 2 Tadokoro, C.E., G. Shakhar, S. Shen, Y .",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
"http://dx.doi.org/10.1084/jem.2005078 3 Takahashi, T., Y .",OADS,/arxiv_data1/oa_pdf/2a/d0/JEM_20130785.PMC3949570.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/55/1e/JEM_20131125.PMC3949571.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/55/1e/JEM_20131125.PMC3949571.pdf
"http://dx.doi.org/   10.1074/jbc.270.15.897 6 Al-Lamki, R.S., J.R. Bradley, and J.S.",Non-OADS,/arxiv_data1/oa_pdf/55/1e/JEM_20131125.PMC3949571.pdf
"http://dx.doi.org/10.1097/   TP .0b013e3181891d8 b Cook-Mills, J.M., M.E.",OADS,/arxiv_data1/oa_pdf/55/1e/JEM_20131125.PMC3949571.pdf
"http://dx.doi.org/10.1089/ars.2010.352 2 Fritsche-Guenther, R., F. Witzel, A. Sieber, R. Herr, N. Schmidt, S. Braun,  T. Brummer, C. Sers, and N. Blüthgen.",OADS,/arxiv_data1/oa_pdf/55/1e/JEM_20131125.PMC3949571.pdf
"7:489. http://dx.doi.org/10.1038/msb.2011.2 7 Jacinto, E., V. Facchinetti, D. Liu, N. Soto, S. Wei, S.Y.",Non-OADS,/arxiv_data1/oa_pdf/55/1e/JEM_20131125.PMC3949571.pdf
"http://dx.doi.org/10.1016/j.cell.2006.08.03 3 Koch, A.E., J.C. Burrows, G.K. Haines, T.M.",OADS,/arxiv_data1/oa_pdf/55/1e/JEM_20131125.PMC3949571.pdf
"http://dx.doi.org/10.1016/j.cell.2012   .03.01 7 Lechleitner, S., J. Gille, D.R.",OADS,/arxiv_data1/oa_pdf/55/1e/JEM_20131125.PMC3949571.pdf
"http://dx.doi   .org/10.1084/jem.187.12.202 3 Madge, L.A., and J.S.",OADS,/arxiv_data1/oa_pdf/55/1e/JEM_20131125.PMC3949571.pdf
"http://dx.doi.org/10.1006/exmp.2001   .2368 Manes, T.D., J.S.",OADS,/arxiv_data1/oa_pdf/55/1e/JEM_20131125.PMC3949571.pdf
"http://dx.doi.org/10.1097/01.tp.0000231356.57576.8 2 O’Brien, K.D., M.D.",Non-OADS,/arxiv_data1/oa_pdf/55/1e/JEM_20131125.PMC3949571.pdf
"http://dx.doi.org/10.1038/   nri217 1 Ren, B., Y .",OADS,/arxiv_data1/oa_pdf/55/1e/JEM_20131125.PMC3949571.pdf
"http://dx.doi.org/10.1172/JCI3983 7Roberts, P .J., and C.J.",OADS,/arxiv_data1/oa_pdf/55/1e/JEM_20131125.PMC3949571.pdf
"http://dx.doi.org/10.1038/sj.onc.121042 2 Sarbassov, D.D., S.M.",Non-OADS,/arxiv_data1/oa_pdf/55/1e/JEM_20131125.PMC3949571.pdf
"http://dx.doi.org/10.1161/   CIRCRESAHA.112.27031 4 Tellides, G., and J.S.",Non-OADS,/arxiv_data1/oa_pdf/55/1e/JEM_20131125.PMC3949571.pdf
"http://dx.doi.org/10.1161/01.RES   .0000258861.72279.2 9 Tsoyi, K., H.J.",OADS,/arxiv_data1/oa_pdf/55/1e/JEM_20131125.PMC3949571.pdf
"http://dx.doi.org/10.1016/   j.atherosclerosis.2010.07.06 1 Wang, C., T. Yi, L. Qin, R.A. Maldonado, U.H.",OADS,/arxiv_data1/oa_pdf/55/1e/JEM_20131125.PMC3949571.pdf
"http://dx.doi.org/10.1172/JCI6620 4 Xu, X.S., C. Vanderziel, C.F .",Non-OADS,/arxiv_data1/oa_pdf/55/1e/JEM_20131125.PMC3949571.pdf
http://dx.doi.org/   10.1074/jbc.273.50.3323 0,Non-OADS,/arxiv_data1/oa_pdf/55/1e/JEM_20131125.PMC3949571.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1084/jem.2008124 2 Cyster, J.G., and S.R.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1146/annurev-immunol-020711-07501 1 Dai, M., P .",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1093/nar/gni17 9 Doisne, J.-M., L. Bartholin, K.-P .",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1084/jem.2009012 7 Fathman, J.W ., D. Bhattacharya, M.A.",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi   .org/10.1182/blood-2011-04-34891 2 Finotto, S., M.F .",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1126/science.106554 4 Freud, A.G., B. Becknell, S. Roychowdhury, H.C. Mao, A.K.",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/   10.1016/j.immuni.2005.01.01 3 Gascoyne, D.M., E. Long, H. Veiga-Fernandes, J. de Boer, O. Williams, B. Seddon,  M. Coles, D. Kioussis, and H.J.M.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1038/ni.178 7 Gasteiger, G., S. Hemmers, P .D.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1084/jem.2012257 1 Germanov, E., L. Veinotte, R. Cullen, E. Chamberlain, E.C.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1016/j.immuni.2011.11.01 6 Grégoire, C., L. Chasson, C. Luci, E. T omasello, F .",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
http://dx.doi.org/10.1111/j.1600-065X.2007.00563.,Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1126/scisignal.200160 8 Hao, Z., and K. Rajewsky.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"194:1151– 1164. http://dx.doi.org/10.1084/jem.194.8.115 1 Hayakawa, Y ., and M.J. Smyth.",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1093/bioinformatics/18.suppl_1.S9 6 Huntington, N.D., H. Tabarias, K. Fairfax, J. Brady, Y .",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1038/ni126 8 Irizarry, R.A., B.M.",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1093/nar/gng01 5(Bolstad et al., 2003).",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
Online supplemental material is available at http://www.jem.org/   cgi/content/full/jem.20131560/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/   10.1038/ni.193 0 Arbonés, M.L., D.C. Ord, K. Ley, H. Ratech, C. Maynard-Curry, G. Otten, D.J.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1016/1074-7613(94)90076- 0 Arnold, S.J., J. Sugnaseelan, M. Groszer, S. Srinivas, and E.J.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1002/dvg.2056 2 Bolstad, B.M., R.A. Irizarry, M. Astrand, and T.P .",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/   10.1093/bioinformatics/19.2.18 5 Carlson, C.M., B.T.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"442:299– 302. http://dx.doi.org/10.1038/nature0488 2 Carotta, S., S.H.M.",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1182/blood-2010-11-31895 6 Chiossone, L., J. Chaix, N. Fuseri, C. Roth, E. Vivier, and T. Walzer.",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1182/blood-2008-10-18717 9 Colucci, F ., M.A.",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10   .1038/nri108 8 Cruz-Guilloty, F ., M.E.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi   .org/10.1016/j.immuni.2012.09.00 8 Ramirez, K., K.J.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.04.00 6 Rankin, L.C., J.R. Groom, M. Chopin, M.J. Herold, J.A.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1016/S1074-7613(03)00294- 2 Savage, A.K., M.G.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi   .org/10.1016/j.immuni.2008.07.01 1 Schoenborn, J.R., and C.B.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1084/jem.2012209 7 Silver, J.D., M.E.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1093/biostatistics/   kxn04 2 Soderquest, K., N. Powell, C. Luci, N. van Rooijen, A. Hidalgo, F .",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1182/blood-2010-10-31226 4 Spits, H., D. Artis, M. Colonna, A. Diefenbach, J.P .",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1038/nri336 5 Stewart, C.A., T. Walzer, S.H.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1182/blood-2004-08-326 2 Talloen, W ., D.-A.",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1093/bioinformatics/btm47 8 T erme, M., E. Ullrich, L. Aymeric, K. Meinhardt, J.D.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-11-337 9 Thomas, S.Y ., S.T.",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi   .org/10.1084/jem.2010263 0 T ownsend, M.J., A.S. Weinmann, J.L.",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1128/   MCB.20.11.4106-4114.200 0 Kamizono, S., G.S.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1084/jem.2009217 6 Kennedy , M.K., M. Glaccum, S.N.",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1084/jem.191.5.77 1 Kim, C.H., B. Johnston, and E.C.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1182/blood-2001-12-019 6 Kim, S., K. Iizuka, H.-S.P .",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1038/ni79 6 Klose, C.S.N., E.A.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1038/   nature1181 3 Kovalovsky, D., O.U.",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/   10.1038/ni.164 1 Lai, C.B., and D.L.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1074/jbc.M111.30693 6 Laouar, Y ., F .S.",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1038/ni119 7 Lazarevic, V ., and L.H.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1038/ni.205 9 Mayol, K., V .",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1182/blood-2011-06-36257 4 Paust, S., H.S.",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1038/ni.195 3 Peng, H., X. Jiang, Y .",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1172/JCI6638 1 Peschon, J.J., P .J.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi   .org/10.1084/jem.180.5.195 5 Pettitt, S.J., Q. Liang, X.Y .",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1038/nmeth.134 2 Pihlgren, M., P .M.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
http://dx.doi.org/10.1084/jem.184.6.214 1,Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1016/S1074-7613(04)00076- 7 Verbist, K.C., and K.D.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi   .org/10.1016/j.cyto.2012.05.02 0 Vivier, E., E. T omasello, M. Baratin, T. Walzer, and S. Ugolini.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10   .1038/ni158 2 Vonarbourg, C., A. Mortha, V .L.",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1016/j.immuni.2010.10.01 7 Vosshenrich, C.A.J., M.E.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1038/ni139 5 Wagner, N., J. Löhler, T.F .",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1002/(SICI)1521-4141(199811)28:11<3832::AID-   IMMU3832>3.0.CO;2- J Wald, O., I.D.",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1073/   pnas.060969210 4 Walzer, T., L. Chiossone, J. Chaix, A. Calver, C. Carozzo, L. Garrigue-Antar,  Y .",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1038/   ni152 3 Weinreich, M.A., O.A.",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi   .org/10.1038/ni.189 8 Y okota, Y ., A. Mansouri, S. Mori, S. Sugawara, S. Adachi, S. Nishikawa, and  P .",OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
"http://dx.doi.org/10.1038/1781 2 Zhu, J., D. Jankovic, A.J.",Non-OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
http://dx.doi   .org/10.1016/j.immuni.2012.09.00 7,OADS,/arxiv_data1/oa_pdf/00/05/JEM_20131560.PMC3949572.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six  months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10.1074/jbc   .M00485220 0 Bunch, T.A., Y. Grinblat, and L.S.",OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10   .1093/nar/16.3.104 3 Caraux, A., B. Klein, B. Paiva, C. Bret, A. Schmitz, G.M.",Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi   .org/10.3324/haematol.2009.01868 9 Catalán, D., O. Aravena, F .",Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10.1186/ar298 5 Christensen, S.R., M. Kashgarian, L. Alexopoulou, R.A. Flavell, S. Akira, and  M.J. Shlomchik.",Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10.1042/   BJ2010032 3 Davidson, W .F ., H.C. Morse III, S.O.",Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/   10.1158/0008-5472.CAN-05-135 3 Elchebly, M., P .",Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
http://dx.doi   .org/10.1111/j.1600-065X.2009.00782.,Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10.1124/pr.109.002006 Flint, A.J., T .",Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10.1016/0092-8674(92)90190- N Frangioni, J.V ., A. Oda, M. Smith, E.W .",OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10.1074/jbc.M10135420 0 Gross, J.A., S.R.",OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10   .1136/ard.2010.13846 1 Arias-Romero, L.E., S. Saha, O. Villamar-Cruz, S.-C. Yip, S.P .",Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10   .1038/nm143 5 Bentires-Alj, M., and B.G.",OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"67:2420– 2424. http://dx.doi.org/10.1158/0008-5472.CAN-06-461 0 Bjorge, J.D., A. Pang, and D.J.",OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10.1146/annurev.immunol.23   .021704.11564 7 Pao, L.I., K.-P .",Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/   10.1016/j.immuni.2007.04.01 6 Raingeaud, J., A.J.",OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"10:1057– 1069. http://dx.doi.org/10.1016/S1097-2765(02)00739- 6 Sack, U., K. Conrad, E. Csernok, I. Frank, F .",Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10.1111/j.1749-6632   .2009.04735. x Schiemann, B., J.L.",Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10.1126/science.106196 4 Seyfert, V .L., S. McMahon, W .",OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10.1016/j.bmcl   .2007.03.00 1 Shultz, L.D., and M.C.",OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10.1146/annurev.immunol.26.021607   .09041 8 Viglianti, G.A., C.M.",Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10.1016/S1074-   7613(03)00323- 6 Xie, L., S.-Y .",OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"42:12792–   12804. http://dx.doi.org/10.1021/bi035238 p Xu, H., H. An, J. Hou, C. Han, P .",Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10 .1016/j   .molimm.2008.05.00 6 Yanaba, K., J.D.",OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10.1111/j.1600-065X   .2008.00646.x Zheng, Y ., S. Gallucci, J.P .",Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10.1016/S1074-7613(01)00183- 2 Heinonen, K.M., N. Dubé, A. Bourdeau, W .S.",OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/   10.1073/pnas.060594410 3 Julien, S.G., N. Dubé, M. Read, J. Penney, M. Paquet, Y .",Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
http://dx.doi.org/10.1111/ j.1600-065X.2008.00748.,Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10.1084/jem.2005063 0 Lin, Q., J.R. Gu, T.W.",OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/   10.1182/blood-2008-03-14872 6 Mackay, F ., S.A. Woodcock, P .",Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10.1084/jem.190.11.169 7 Matsushita, T., M. Fujimoto, M. Hasegawa, Y .",OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/10.1038/   nature0295 5 Mei, H.E., D. Frölich, C. Giesecke, C. Loddenkemper, K. Reiter, S. Schmidt, E.  Feist, C. Daridon, H.-P .",OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
"http://dx.doi.org/   10.1182/blood-2010-01-26653 6 Myers, M.P., J.N.",Non-OADS,/arxiv_data1/oa_pdf/6e/d8/JEM_20131196.PMC3949573.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six  months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"After six  months it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"48:1513–   1516. http://dx.doi.org/10.1002/1097-0142(19811001)48:7<1513::AID-   CNCR2820480705>3.0.CO;2- Q Luo, J., N.L.",Non-OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi   .org/10.1038/nature1174 3 Matsuoka, S., B.A.",OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/10.1126/   science.114032 1 Murphy, J.M., A.L.",OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/10.1021/jm400457 y Nomme, J., J.M.",OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/10   .1248/bpb.19.138 2 Radu, C.G., C.J.",OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/10.1038/nm172 4 Reichard, P .",OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/10.1146/ annurev.bi.57.070188.00202 5 Schoppy, D.W ., R.L.",Non-OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/10.1172/JCI5892 8 Schwarzenberg, J., C.G.",OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/10.1007/s00259-010-1666- z Shields, A.F ., J.R. Grierson, B.M.",Non-OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/10.1038/333 7 Shu, C.J., D.O.",Non-OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/10.2967/jnumed.109.07336 1 Stella, V .J., and Q.",OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi   .org/10.1038/nprot.2009.2 8 T oy , G., W .R.",OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/10   .1038/nrd350 4the inventors of 18F-L-FAC and analogs, which were patented by the University of  California and have been licensed to Sofie Biosciences.",Non-OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"209:2215– 2228. http://dx.doi.org/10.1084/jem.2012106 1 Bartek, J., M. Mistrik, and J. Bartkova.",OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/10.1038/nsmb.222 0 Boulos, N., H.L.",Non-OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/10   .1182/blood-2010-08-30126 7 Chiuten, D.F ., P .H.",Non-OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"877:3831– 3840. http://dx.doi.org/10.1016/j.jchromb.2009.09.03 0 Csapo, Z., G. Keszler, G. Safrany, T. Spasokoukotskaja, I. Talianidis, M. Staub,  and M. Sasvari-Szekely.",OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/10   .1016/S0006-2952(03)00182- 5 Datta, N.S., D.S.",OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/10.1038/nature0933 9 Fong, P .C., D.S.",OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/10.1056/NEJMoa090021 2 Hanahan, D., and R.A. Weinberg.",OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/10.1016/j.cell.2011.02.01 3 Hastak, K., R.K. Paul, M.K.",OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/10.1126/science.121859 5 Jordheim, L.P ., E. Cros, M.H.",OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/   10.1158/1078-0432.CCR-04-050 6 Kamphorst, J.J., J.",OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/10.1021/   ac202220 b Kufe, D.W ., P .",Non-OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/10.1085/jgp.8.6.51 9 Williams, R.T., M.F .",OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
"http://dx.doi.org/   10.1093/nar/gks70 7 Y u, X.-C., M. Miranda, Z. Liu, S. Patel, N. Nguyen, K. Carson, Q. Liu, and  J.C. Swaffield.",OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
http://dx.doi.org/10.1177/108705710935360 4,Non-OADS,/arxiv_data1/oa_pdf/a2/10/JEM_20131738.PMC3949575.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"After six months it  is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1021/pr100346 7 Bitoun, E., A. Micheloni, L. Lamant, C. Bonnart, A. Tartaglia­Polcini, C.  Cobbold, T. Al Saati, F .",Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1093/hmg/ddg24 7 Boniface, K., F.X.",Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1172/JCI4144 0 Brattsand, M., and T. Egelrud.",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1074/jbc.274.42.3003 3 Brattsand, M., K. Stefansson, C. Lundh, Y .",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"13:549– 561. http://dx.doi.org/10.1517/14712598.2013.75870 8 Hansson, L., A. Bäckman, A. Ny, M. Edlund, E. Ekholm, B. Ekstrand  Hammarström, J. Törnell, P. Wallbrandt, H. Wennbo, and T. Egelrud.",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
http://dx.doi.org/10.1046/j.0022­202x.2001.01684.,Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
http://dx.doi.org/   10.1111/j.1525­1470.1996.tb01202.,Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1093/   hmg/ddi03 0 Homey, B., and A. Zlotnik.",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1016/S0952­7915(99)00028­ X Horikawa, T., T. Nakayama, I. Hikita, H. Yamada, R. Fujisawa, T. Bito,  S. Harada, A. Fukunaga, D. Chantry, P.W.",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"14:767– 773. http://dx.doi.org/10.1093/intimm/dxf04 4 Hoste, E., P .",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1038/jid   .2011.15 3 Hovnanian, A.",Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi   .org/10.1007/s00441­013­1558­ 1 Judge, M.R., G. Morgan, and J.I.",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
http://dx.doi.org/10.1111/j.1365­2133.1994.tb04971.,Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1038/jid.2011.26 2 Komatsu, N., K. Saijoh, N. Otsuki, T. Kishi, I.P .",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1016/   j.cca.2006.10.00 9 Lee, E.B., K.W .",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
http://dx.doi.org/10   .1111/j.1399­3038.2009.00919.,Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1038/sj.onc.120550 2 Mills, K.H., L.S.",Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1001/archderm.1958   .0156010005900 9 Nograles, K.E., L.C.",Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1111/j.0022­202X.2004   .23547. x Briot, A., C. Deraison, M. Lacroix, C. Bonnart, A. Robin, C. Besson, P.  Dubus, and A. Hovnanian.",Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1084/jem.2008224 2 Carroll, J.M., and L.B.",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
http://dx.doi.org/10.1111/j.0022­202X.2004.22512.,Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1038/7597 7 Comel, M. 1949.",Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1159/00025729 0 de Veer, S.J., J.E.",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1515/bc­2011­25 0 de V eer, S.J., S.S. Ukolova, C.A.",Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1038/ncb159 7 Deraison, C., C. Bonnart, F .",Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1091/ mbc.E07 ­02­0124 Descargues, P ., C. Deraison, C. Bonnart, M. Kreft, M. Kishibe, A. Ishida­ Yamamoto, P .",Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/   10.1038/sj.jid.570028 4 Ekholm, I.E., M. Brattsand, and T. Egelrud.",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1046/j.1523 ­ 1747.2000.00820. x Fortugno, P ., A. Bresciani, C. Paolini, C. Pazzagli, M. El Hachem, M. D’Alessio,  and G. Zambruno.",Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10   .1038/jid.2011.17 4 Frateschi, S., E. Camerer, G. Crisante, S. Rieser, M. Membrez, R.P .",Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
http://dx.doi.org/10.1111/j.1365­2133.2005.06884.,Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1146/annurev­pathol­011811­13244 8 Renner, E.D., D. Hartl, S. Rylaarsdam, M.L.",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10   .1016/j.jaci.2009.06.00 9 Roth, W., J. Deussing, V.A.",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1096/fj.99­0970co m Sakabe, J., M. Yamamoto, S. Hirakawa, A. Motoyama, I. Ohta, K. Tatsuno,  T. Ito, K. Kabashima, T. Hibino, and Y. Tokura.",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10   .1038/ng.62 9 Soumelis, V., P.A.",Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1038/nrm91 0 Stefansson, K., M. Brattsand, A. Ny, B. Glas, and T. Egelrud.",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1515/BC.2006.09 5 Stefansson, K., M. Brattsand, D. Roosterman, C. Kempkes, G. Bocheva,  M. Steinhoff, and T. Egelrud.",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1038/sj.jid.570096 5 Steinhoff, M., U. Neisius, A. Ikoma, M. Fartasch, G. Heyer, P .S.",Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
http://dx.doi.org/10.1046/ j.1525­1470.1999.99005.,Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1016/j.jaci.2013.04.04 6 Sun, J.D., and K.G.",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
http://dx.doi.org/   10.1111/j.1365­4632.2005.02637.,Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"285:372– 377. http://dx.doi.org/10.1007/BF0037183 9 Tsuda, T., M. Tohyama, K. Yamasaki, Y. Shirakata, Y. Yahata, S.  Tokumaru, K. Sayama, and K. Hashimoto.",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi.org/10.1016/S0923 ­  1811(02)00138 ­X Yamasaki, K., J. Schauber, A. Coda, H. Lin, R.A. Dorschner, N.M.  Schechter, C. Bonnart, P .",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
"http://dx.doi   .org/10.1096/fj.06­6075co m Yang, T., D. Liang, P.J.",OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
http://dx.doi.org/10.1101/gad.123210 4,Non-OADS,/arxiv_data1/oa_pdf/00/73/JEM_20131797.PMC3949577.pdf
This article is distributed under the terms of an Attribution–Noncommercial–Share  Alike–No Mirror Sites license for the first six months after the publication date  (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"After six months it is available under a Cre - ative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported  license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1084/jem.2007071 9 Berg, L.J., L.D.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1146/annurev.immunol.22   .012703.10474 3 Bettelli, E., Y.",Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1038/nature0475 3 Bonnet, M., M. Loosveld, B. Montpellier, J.M.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1182/blood-2011-02-33684 2 Boomer, J.S., and J.M.",Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1101/ cshperspect.a00243 6 Boyman, O., and J. Sprent.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.4049/jimmunol.110301 5 Chaudhry, A., and A.Y.",Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1172/JCI5717 5 Chi, H. 2012.",Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi   .org/10.1016/j.cell.2011.07.03 3 Delgoffe, G.M., T.P .",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.04.01 4 Ferrara, T.J., C. Mueller, N. Sahu, A. Ben-Jebria, and A. August.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1016/j.jaci.2005.12.133 0 Finkelstein, L.D., Y. Shimizu, and P.L.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10   .1038/nri288 8 Finlay, D.K., E. Rosenzweig, L.V.",Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"209:2441– 2453. http://dx.doi.org/10.1084/jem.2011260 7 Gomez-Rodriguez, J., N. Sahu, R. Handon, T.S.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10   .1016/j.immuni.2009.07.00 9 Gomez-Rodriguez, J., Z.J.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1084/jem.2009199 9 Guy, C.S., K.M.",Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1038/ni.253 8Signaling Technology), phospho-STAT5 (BD), and PTEN (BD), CD4+   T cells were fixed with 4% PFA and permeabilized with methanol at 20 C.  Cells were stained with the indicated phospho-antibodies for 60 min in the  dark at 4°C.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1111/imr.1202 9 Battaglia, M., A. Stabilini, and M.G.",Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"105:4743– 4748. http://dx.doi.org/10.1182/blood-2004-10-393 2 Bensinger, S.J., P.T.",Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1084/   jem.179.2.58 9 Saito, K., K.F.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1016/S1074-7613(03)00297- 8 Salmond, R.J., J. Emery, K. Okkenhaug, and R. Zamoyska.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.4049/jimmunol.090229 4 Sauer, S., L. Bruno, A. Hertweck, D. Finlay, M. Leleu, M. Spivakov, Z.A.",Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1016/S1074-7613(03)00304- 2 Seder, R.A., W .E.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1084/jem   .176.4.109 1 Shi, L.Z., R. Wang, G. Huang, P. Vogel, G. Neale, D.R.",Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1084/jem.2011027 8 Sinclair, L.V., J. Rolf, E. Emslie, Y.B.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1038/ni.255 6 Singleton, K.L., M. Gosh, R.D.",Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1126/scisignal.200182 1 Song, M.S., L. Salmena, and P .P .",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1038/ni89 5 Turner, M.S., L.P. Kane, and P.A.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.4049/jimmunol.090145 9 van der Windt, G.J., and E.L. Pearce.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
http://dx.doi.org/10.1111/j.1600-065X.2012.01150.,Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1038/nrd368 3 Wang, R., C.P.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10   .1016/j.immuni.2011.09.02 1 Xu, X., L. Ye, K. Araki, and R. Ahmed.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10   .1016/j.smim.2012.12.00 5 Yamane, H., and W.E.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1111/imr.1203 2 Zhu, J., and W.E.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
http://dx.doi.org/10.1111/j.1600-065X.2010.00951.,Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1084/jem.2007147 7 Hedrick, S.M., R. Hess Michelini, A.L.",Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1038/nri327 8 Josefowicz, S.Z., L.F. Lu, and A.Y.",Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"30:531– 564. http://dx.doi.org/10.1146/annurev.immunol.25.022106.14162 3 Kang, J., S.J.",Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1189/jlb.120785 1 Kim, J.M., and A. Rudensky.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
212:86– 98. http://dx.doi.org/10.1111/j.0105-2896.2006.00426.,Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/   10.1016/j.intimp.2007.08.02 7 Kretschmer, K., I. Apostolou, D. Hawiger, K. Khazaie, M.C.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1016/j.immuni.2007.02.00 9 Lee, I.H., W.P.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi   .org/10.1084/jem.190.9.126 3 Li, C.R., and L.J.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"38:13– 25. http://dx.doi.org/10.1016/j.immuni.2013.01.00 4 Liao, X.C., and D.R.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1016/1074-7613(95)90065- 9 Liu, H., S. Yao, S.M.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi   .org/10.1146/annurev-immunol-032712-09595 6 Michalek, R.D., V.A.",Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.4049/jimmunol.100361 3 Michel, F., G. Attal-Bonnefoy, G. Mangino, S. Mise-Omata, and O.   Acuto.",Non-OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10   .1016/S1074-7613(01)00244- 8 Miskov-Zivanov, N., M.S.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/   10.1126/scisignal.200421 7 Nie, Z., G. Hu, G. Wei, K. Cui, A. Yamane, W. Resch, R. Wang, D.R.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
"http://dx.doi.org/10.1016/j.cell.2012.08.03 3 Olive, V., M.J. Bennett, J.C. Walker, C. Ma, I. Jiang, C. Cordon-Cardo,  Q.J.",OADS,/arxiv_data1/oa_pdf/df/da/JEM_20131459.PMC3949578.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"After six months it is   available under a Creative Commons License (Attribution–Noncommercial–Share   Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0 /).D.",Non-OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
Online sup - plemental material is available at http://www.jem.org/cgi/content/full/jem   .20130968/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.1093/hmg/ddr20 6 Aletaha, D., T. Neogi, A.J.",OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/   10.1136/ard.2010.13846 1 Bajtner, E., K.S.",OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.1186/ar180 0 Bella, J., M. Eaton, B. Brodsky, and H.M. Berman.",Non-OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.1126/science.769569 9 Brand, D.D., K.A.",OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.1038/nprot   .2007.17 3 Brunsberg, U., K. Gustafsson, L. Jansson, E. Michaëlsson, L. Ahrlund- Richter, S. Pettersson, R. Mattsson, and R. Holmdahl.",OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.1002/   eji.183024073 6 Buck, D., E. Albrecht, M. Aslam, A. Goris, N. Hauenstein, A. Jochim, S.  Cepok, V. Grummel, B. Dubois, A. Berthele, et al.",Non-OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.1002/ana.2374 9 Burkhardt, H., T .",Non-OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.1002/art.1047 2 Cao, D., Ia.",Non-OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.4049/jimmunol.110137 8 Collaborative Computational Project, Number 4.",Non-OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
http://dx.doi.org/10.1107/S090744499400311 2suspension was transferred into carbenicillin-containing terrific broth (TB) me - dium and cultured at 37°C.,Non-OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.1002/art.3465 8 Fujii, K., M. Tsuji, A. Kitamura, and K. Murota.",OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.1007/BF0018271 0 Glanville, J., T.C.",Non-OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.1002/art.178029031 4 Holmdahl, R., L. Jansson, A. Larsson, and R. Jonsson.",OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
http://dx.doi.org/10   .1111/j.1365-3083.1990.tb02754.,Non-OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.1016/0022-1759(95)00203- 0 Klaczkowska, D., B. Raposo, and K.S.",OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
http://dx.doi.org/10.1111/j.1365-3083.2010.02479.,Non-OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.1107/   S002188989200994 4 Leslie, A.G.W., and H.R.",Non-OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
http://dx.doi.org/10.1046/j.1365-2567.2001.01267.,Non-OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.1136/ard.2006.06478 2 Nandakumar, K.S., and R. Holmdahl.",OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.1016/j.jim.2005.06.01 7 Nandakumar, K.S., L. Svensson, and R. Holmdahl.",OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.1016/S0002-9440(10)63542- 0 Nandakumar, K.S., A.K.B.",OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.1136/ard.2011.15173 8 Olee, T., P.M. Yang, K.A.",OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.1172/JCI11527 7 Stuart, J.M., and F.J. Dixon.",OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.1084/   jem.158.2.37 8 Svensson, L., J. Jirholt, R. Holmdahl, and L. Jansson.",OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.1046/j.1365-2249   .1998.00529. x Vencovský, J., E. Zd’árský, S.P.",OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"http://dx.doi.org/10.1093/rheumatology/   41.4.40 1 Wooley, P.H., H.S.",Non-OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
http://dx.doi.org/10.1084/jem.154.3.68 8,Non-OADS,/arxiv_data1/oa_pdf/97/4a/JEM_20130968.PMC3949579.pdf
"Summary of SSR markers within three QTL regions chromo- someCTF QTL MarkerMarker   positionaNo.of  alleles  7 qCTF7 RM20875 1,274,622 2 RM3196 2,044,280 2 RM5752 2,567,873 3 RM20973 2,769,995 2 RM5711* 3,142,204 6 RM21030 3,501,880 4 RM21052 3,770,907 3 RM21076 4,028,130 2 RM21078 4,028,526 2  8 qCTF8 RM22674* 8,497,626 2 RM22679 8,580,100 3 RM22684 8,806,201 3 RM22780 10,798,150 2 12 qCTF12 RM3331 23,494,445 2 RM28580 24,324,781 5 RM28669* 25,556,822 3 RM28678 25,736,191 3 RM1227 27,338,885 3 RM28825 27,466,213 2 a Position of marker based on location of the start of SSR repeat in  IRGSP build 1.0 in RAP-DB (http://rapdb.dna.affrc.go.jp).",Non-OADS,/arxiv_data1/oa_pdf/15/2d/63_483.PMC3949585.pdf
"http://www.saskcanola.com/research/breeding.php?detail=65 Food and Agriculture Organization of the United Nations, FAOSTAT|©  FAO Statistics Division 2013|28 February 2013. http://faostat3.fao.org/home/index.",Non-OADS,/arxiv_data1/oa_pdf/ec/8e/63_495.PMC3949587.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/07/c9/ijgm-7-143.PMC3949694.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 143–148International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  143ExpErt OpInIO nopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/IJGM.S5317 0Management of opioid addiction   with buprenorphine: French history   and current management pierre poloméni1 raymund Schwan2,3 1Department of Addictology,   paris Seine Saint Denis University  Hospital, A p-Hp, Site rené Muret  Sevran, France; 2Care Center for  the treatment and prevention of  Addictions (CSA pA), nancy University  Hospital, 3General psychiatric  Division for the Greater nancy  Urban Community, psychotherapeutic  Center of nancy, Laxou, France Correspondence: pierre poloméni   Department of Addictology, paris   Seine Saint Denis University Hospital,   Ap-Hp, CHU rené Muret – avenue du  Dr Schaeffner – 93270 Sevran, France   tel +33 1 4152 5999   Fax +33 1 4152 5820   Email pierre.polomeni@rmb.aphp.f rAbstract:  The way in which opioid addiction is managed in France is unique, as it is based on  the prescription of buprenorphine by general practitioners and is dispensed by retail pharmacies.",Non-OADS,/arxiv_data1/oa_pdf/07/c9/ijgm-7-143.PMC3949694.pdf
"Available from: http://www.ofdt.fr/BDD/publications/ docs/dcc2012.pd f. Accessed June 25, 2013.",Non-OADS,/arxiv_data1/oa_pdf/07/c9/ijgm-7-143.PMC3949694.pdf
Available from: http://www.has-sante.fr/portail/upload/docs/ application/pdf/TSO_court.pdf.,Non-OADS,/arxiv_data1/oa_pdf/07/c9/ijgm-7-143.PMC3949694.pdf
Available from: http://www.ofdt.fr/BDD_len/seristat/00003.,Non-OADS,/arxiv_data1/oa_pdf/07/c9/ijgm-7-143.PMC3949694.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/07/c9/ijgm-7-143.PMC3949694.pdf
"Available from: http://ansm.sante.fr/var/ansm_site/storage/original/ application/b275587447c30549b123fe6c29f4c76b.pd f. Accessed  June 25, 2013.",OADS,/arxiv_data1/oa_pdf/07/c9/ijgm-7-143.PMC3949694.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/07/c9/ijgm-7-143.PMC3949694.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/07/c9/ijgm-7-143.PMC3949694.pdf
Available from: http://radar.boisestate.edu/pdfs/TIP43%281%29.,OADS,/arxiv_data1/oa_pdf/07/c9/ijgm-7-143.PMC3949694.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6c/a3/jbm-5-031.PMC3949695.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Blood Medicine 2014:5 31–36Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  31Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S5794 4Applying spatial epidemiology to hematological   disease using R: a guide for hematologists   and oncologists Kei Kohno1 Hiroto Narimatsu2 Katsumi Otani2 Ri Sho2 Y osuke Shiono1 ikuko Suzuki1 Yuichi Kato1 Akira Fukao2 Takeo Kato1 1Department of Neurology,   Hematology, Metabolism,   endocrinology, and Diabetology,   Yamagata University School of  Medicine, 2Department of Public  Health, Yamagata University Graduate  School of Medicine, Yamagata, Japan Correspondence: Hiroto Narimatsu   Department of Public Health, Yamagata  University Graduate School of Medicine,  2-2-2 iida-nishi, Yamagata,   990-9585, Japan   Tel +81 02 3628 5260   Fax +81 02 3628 5261   email hiroto-narimatsu@umin.or gAbstract:  “Spatial statistics” is an academic field that deals with the statistical analysis of spatial  data, and has been applied to econometrics and various other policy fields.",Non-OADS,/arxiv_data1/oa_pdf/6c/a3/jbm-5-031.PMC3949695.pdf
"http://qgis.osgeo.org ),5 and environments have  been set up for clinicians to allow them to conduct spatial epidemiological research.",Non-OADS,/arxiv_data1/oa_pdf/6c/a3/jbm-5-031.PMC3949695.pdf
"The age-adjusted disease incidence was used; in Figure  1, it  was calculated using the 1985 model population of Japan10  and the 2008 model population of Y amagata Prefecture.11  This dataset was saved as a “ csv file” (“blood.csv” in this  review).Preparing for the analysis:   second step These are the instructions that were used for the analysis: •	Go to the Excel Save menu •	Save your worksheet file as a “csv file” (“blood.csv”) in  R work directory (the work directory can be set using the  preference menu of R) •	Close Excel •	Start R by double clicking on the desktop icon •	R shows the symbol, then expects input commands •	Select “Packages” from the main menu, select “Install  package(s)”, choose a CRAN (Comprehensive R Archi  ve  Network; http://cran.r-project.org ) site, and select the  “spdep” and “DCluster” packages to download and install.",OADS,/arxiv_data1/oa_pdf/6c/a3/jbm-5-031.PMC3949695.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/6c/a3/jbm-5-031.PMC3949695.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/a3/jbm-5-031.PMC3949695.pdf
"Available from: http://www.r-project.or g. Accessed February 12, 2013.",Non-OADS,/arxiv_data1/oa_pdf/6c/a3/jbm-5-031.PMC3949695.pdf
Available from: http://www.niph.go.jp/soshiki/gijutsu/download/index.,Non-OADS,/arxiv_data1/oa_pdf/6c/a3/jbm-5-031.PMC3949695.pdf
"Available from: http://www.qgis.or g. Accessed February 12, 2013.",Non-OADS,/arxiv_data1/oa_pdf/6c/a3/jbm-5-031.PMC3949695.pdf
"Available from: http://web.sfc.keio.ac.jp/ ∼maunz/wiki/ index.php?%B6%F5%B4%D6%A5%C7%A1%BC%A5%BF%A4% CE%C5%FD%B7%D7%CA%AC%C0%C F. Accessed February 20,  2013.",OADS,/arxiv_data1/oa_pdf/6c/a3/jbm-5-031.PMC3949695.pdf
Available from: http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/suii06/ fuhyo.html .,Non-OADS,/arxiv_data1/oa_pdf/6c/a3/jbm-5-031.PMC3949695.pdf
Available from:  http://www.pref.yamagata.jp/ou/kikakushinko/020052/tokei/jinkel.,Non-OADS,/arxiv_data1/oa_pdf/6c/a3/jbm-5-031.PMC3949695.pdf
Available from: https://http://www.pref.yamagata.jp/kenfuku/kenko/ gan/7090005gantouroku.html .,Non-OADS,/arxiv_data1/oa_pdf/6c/a3/jbm-5-031.PMC3949695.pdf
Available from: http://nlftp.mlit.go.jp/ ksj/.,Non-OADS,/arxiv_data1/oa_pdf/6c/a3/jbm-5-031.PMC3949695.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/a3/dmso-7-085.PMC3949696.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 85–94Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  85Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S4889 6Optimal management of type 2 diabetes   in patients with increased risk of hypoglycemia Morgan Anderson1 Jason Powell2 Kendall M Campbell3 James R Taylor2 1North Florida/South Georgia  veterans Health System, Malcom  Randall vAMC, 2University of Florida,  College of Pharmacy, Gainesville,  3The Center for Underrepresented  Minorities in Academic Medicine,   The Florida State University College  of Medicine Tallahassee, FL, USA Correspondence: James R Taylor   University of Florida, College of   Pharmacy, 1225 Center Drive   HPNP Bulding, Room 3309   Gainesville, FL 32610, USA   Tel +1 352 273 6239   Fax +1 352 273 6242   email jtaylor@cop.ufl.ed uAbstract : With the number of individuals diagnosed with type 2 diabetes on the rise, it has  become more important to ensure these patients are effectively treated.",Non-OADS,/arxiv_data1/oa_pdf/56/a3/dmso-7-085.PMC3949696.pdf
Available from:  http://www.diabetes.org/diabetes-basics/statistics /.,Non-OADS,/arxiv_data1/oa_pdf/56/a3/dmso-7-085.PMC3949696.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/56/a3/dmso-7-085.PMC3949696.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/a3/dmso-7-085.PMC3949696.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/3a/ijgm-7-149.PMC3949697.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 149–158International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  149OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S4583 9Potential pathway of anti-inflammatory effect   by new Zealand honeys Victoria T omblin1 lynnette r Ferguson1 Dug Yeo han1 Pamela Murray1 ralf schlothauer2 1Discipline of nutrition, Faculty of  Medical and health sciences, The  University of auckland, auckland,  new Zealand; 2comvita new  Zealand  ltd, Paengaroa, new Zealand correspondence: lynnette r Ferguson;  Dug Yeo han   Discipline of nutrition, Faculty of Medical  and health sciences, The University of  auckland, Private Bag 92019, auckland  1142, new Zealand   email l.ferguson@auckland.ac.n z;  dy.han@auckland.ac.n zAbstract:  The role of honey in wound healing continues to attract worldwide attention.",Non-OADS,/arxiv_data1/oa_pdf/20/3a/ijgm-7-149.PMC3949697.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/20/3a/ijgm-7-149.PMC3949697.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/3a/ijgm-7-149.PMC3949697.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/55/09/idr-7-041.PMC3949698.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInfection and Drug Resistance 2014:7 41–56Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  41RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S3624 7Approaches to hepatitis C treatment   and cure using NS5A inhibitors James J Kohler1,2 James H Nettles1,2 Franck Amblard1,2 Selwyn J Hurwitz1,2 Leda Bassit1,2 Richard A Stanton1 Maryam ehteshami1 Raymond F Schinazi1,2 1Center for AIDS Research and  Department of Pediatrics, emory  University School of Medicine, Atlanta,   GA, USA; 2Atlanta veterans Affairs  Medical Center, Decatur, GA, USA Correspondence: Raymond F Schinazi   Laboratory of Biochemical Pharmacology,   Department of Pediatrics, emory   University, Health Sciences Research   Building, Room e-418, 1760 Haygood   Drive, Atlanta, GA 30322, USA   Tel +1 404 727 1414   Fax +1 404 727 1330   email rschina@emory.ed uAbstract:  Recent progress in the understanding of hepatitis C virus (HCV) biology and the  availability of in vitro models to study its replication have facilitated the development of direct- acting antiviral agents (DAAs) that target specific steps in the viral replication cycle.",Non-OADS,/arxiv_data1/oa_pdf/55/09/idr-7-041.PMC3949698.pdf
Available from: http://investors.gilead.com/phoenix.,Non-OADS,/arxiv_data1/oa_pdf/55/09/idr-7-041.PMC3949698.pdf
Available from: http://investors.gilead.com/phoenix.,Non-OADS,/arxiv_data1/oa_pdf/55/09/idr-7-041.PMC3949698.pdf
Available from: http://investors.vrtx.com/releasedetail.,Non-OADS,/arxiv_data1/oa_pdf/55/09/idr-7-041.PMC3949698.pdf
Available from: http://clinicaltrials.gov/ ct2/show/NCT0185876 6.,Non-OADS,/arxiv_data1/oa_pdf/55/09/idr-7-041.PMC3949698.pdf
Available from: http://clinicaltrials.gov/ct2/show/ NCT0149783 4.,Non-OADS,/arxiv_data1/oa_pdf/55/09/idr-7-041.PMC3949698.pdf
Available  from: http://clinicaltrials.gov/ct2/show/NCT0176828 6.,Non-OADS,/arxiv_data1/oa_pdf/55/09/idr-7-041.PMC3949698.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/55/09/idr-7-041.PMC3949698.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/55/09/idr-7-041.PMC3949698.pdf
Avail - able from: http://clinicaltrials.gov/ct2/show/NCT0153297 3.,Non-OADS,/arxiv_data1/oa_pdf/55/09/idr-7-041.PMC3949698.pdf
"Available from:  http://www.abbott.com/news-media/press-releases/abbott-presents- promising-phase-2b-interferonfree-hepatitis-c-results-at-2012-liver- meeting.ht m. Accessed June 27, 2013.",Non-OADS,/arxiv_data1/oa_pdf/55/09/idr-7-041.PMC3949698.pdf
"Available  from: http://www.clinicaltrialfacts.com/hepatitis-c-chronic/effect-of- omeprazole-and-ritonavir-on-gs-115217/summar y. Accessed October  13, 2013.",Non-OADS,/arxiv_data1/oa_pdf/55/09/idr-7-041.PMC3949698.pdf
Available from: http://investorshub.advfn.com/ boards/read_msg.aspx?message_i d=49610323.,Non-OADS,/arxiv_data1/oa_pdf/55/09/idr-7-041.PMC3949698.pdf
"Available from: http://www.bms.com/research/ investigational/hepatitis/Pages/DCV -BMS-790052.asp x. Accessed  October 13, 2013.",Non-OADS,/arxiv_data1/oa_pdf/55/09/idr-7-041.PMC3949698.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/79/3a/dmso-7-095.PMC3949699.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 95–105Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  95Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S3645 5Diabetes and sexual dysfunction: current  perspectives Maria ida Maiorino1 Giuseppe Bellastella1 Katherine esposito2 1Department of Medical, Surgical,   Neurological, Metabolic and Geriatric  Sciences, Second University of Naples,   Naples, italy; 2Department of Clinical  and experimental Medicine, Second  University of Naples, Naples, italy Correspondence: Katherine esposito   endocrinology and Metabolic Diseases  Unit, University Hospital at Second  University of Naples, Piazza L Miraglia   no 2, 80138 Napoli, italy   Tel +39 081 566 5031   Fax +39 081 566 5054   email katherine.esposito@unina2.i tAbstract:  Diabetes mellitus is one of the most common chronic diseases in nearly all countries.",Non-OADS,/arxiv_data1/oa_pdf/79/3a/dmso-7-095.PMC3949699.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/79/3a/dmso-7-095.PMC3949699.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/79/3a/dmso-7-095.PMC3949699.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/eb/79/ijn-9-1167.PMC3949700.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 1167–1174International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1167OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S5857 1Facile method for the synthesis of silver  nanoparticles using 3-hydrazino-isatin derivatives in  aqueous methanol and their antibacterial activity ayman el-Faham1,2 ahmed a elzatahry1,3 Zeid a al-Othman1 elsayed ahmed elsayed4,5 1Department of chemistry, college  of science, King saud University,   riyadh, saudi arabia; 2Department  of chemistry, Faculty of science,   alexandria University, Ibrahimia,   alexandria, egypt; 3Polymer Materials  research Department, advanced  T echnology and New Materials  research Institute, city of scientific  research and T echnology applications,   New Borg el-arab city, alexandria,   egypt; 4Bioproducts research chair,   Zoology Department, Faculty of  science, King saud University, saudi  arabia; 5Natural and Microbial  Products Department, National  research centre, Dokki, cairo, egypt correspondence: ayman el-Faham   Department of chemistry, college of   science, King saud University, PO Box   2455, 11451 riyadh, saudi arabia   Tel +966 11 467 3195   Fax +966 11 467 5992   email aymanel_faham@hotmail.co m;  aelfaham@ksu.edu.s aIntroduction:  A new method for preparation of silver nanoparticles (AgNPs) based on using  hydrazino-isatin derivatives in an aqueous methanol reaction medium is reported here.",Non-OADS,/arxiv_data1/oa_pdf/eb/79/ijn-9-1167.PMC3949700.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/eb/79/ijn-9-1167.PMC3949700.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/79/ijn-9-1167.PMC3949700.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/82/f3/ijn-9-1185.PMC3949701.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine  2014: 9 1185–1198International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1185OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5551 4effects of titania nanotubes with or without  bovine serum albumin loaded on human   gingival fibroblasts Xiangning liu1,* Xiaosong Zhou2,* shaobing li3 renfa lai1 Zhiying Zhou1 Ye Zhang1 lei Zhou3 1The First affiliated hospital of Jinan  University, guangzhou, 2chemistry  science and T echnology school,   Zhanjiang Normal University,   Zhanjiang, 3guangdong Provincial  stomatological hospital, southern  Medical University, guangzhou,   People’s republic of china *These authors contributed equally to  this work correspondence: lei Zhou   guangdong Provincial stomatological  hospital, southern Medical University,  No 366 Jiangnan avenue south,  guangzhou 510280,   People’s republic of china   Tel + 86 020 8423 3801   Fax + 86 020 8443 3177   email zho668@263.ne tAbstract:  Modifying the surface of the transmucosal area is a key research area because this  process positively affects the three functions of implants: attachment to soft tissue, inhibiting bac - terial biofilm adhesion, and the preservation of the crestal bone.",Non-OADS,/arxiv_data1/oa_pdf/82/f3/ijn-9-1185.PMC3949701.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/82/f3/ijn-9-1185.PMC3949701.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/f3/ijn-9-1185.PMC3949701.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/67/aa/ijn-9-1175.PMC3949719.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 1175–1184International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1175OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5506 0Biological activity of lactoferrin-functionalized  biomimetic hydroxyapatite nanocrystals Nunzia Nocerino1 andrea Fulgione1 Marco Iannaccone1 laura T omasetta1 Flora Ianniello1 Francesca Martora1 Marco lelli2 Norberto roveri2 Federico capuano3 rosanna capparelli1 1Department of agriculture special  Biotechnology center Federico II,   ceBIOTec Biotechnology,    University of Naples Federico II,    Naples, 2Department of chemistry,   g ciamician, alma Mater studiorum,   University of Bologna, Bologna,   3Department of Food Inspection IZs   Me, Naples, Italy correspondence: rosanna capparelli   Department of agriculture special  Biotechnology center Federico II,  ceBIOTec Biotechnology, University of  Naples, Federico II, Via Università 100,  Portici 80055, Naples, Italy   Tel +39 08 1253 9274   Fax +39 08 1776 2886   email capparel@unina.i tAbstract:  The emergence of bacterial strains resistant to antibiotics is a general public  health problem.",Non-OADS,/arxiv_data1/oa_pdf/67/aa/ijn-9-1175.PMC3949719.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/67/aa/ijn-9-1175.PMC3949719.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/aa/ijn-9-1175.PMC3949719.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0a/25/ijgm-7-137.PMC3949720.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2014:7 137–141International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  137Case reportopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IJGM.S5150 4pseudomyxoma peritonei: a clinical case   of this poorly understood condition ana Maria de oliveira1 Catarina Graça rodrigues1  alexys Borges2  alexandra Martins1 sofia Loureiro dos santos3 Francisco rocha pires4  João Mascarenhas araújo2  João ramos de Deus1 1Department of Gastroenterology,   2Department of Internal Medicine,   3Department of pathology and  anatomical sciences, 4Department of  surgery, pathology and anatomical  sciences, prof. Doutor Fernando  Fonseca Hospital, amadora, portugal  Correspondence: ana Maria de oliveira   IC 19, 2720-276 amadora, portugal   tel +351 963 867 012   Fax +351 214 345 566   email anaoliveira.fml@gmail.co mBackground:  Pseudomyxoma peritonei is an uncommon condition with an estimated incidence  of one to two per million (worldwide) per year.",Non-OADS,/arxiv_data1/oa_pdf/0a/25/ijgm-7-137.PMC3949720.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/0a/25/ijgm-7-137.PMC3949720.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/25/ijgm-7-137.PMC3949720.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/33/2b/imcrj-7-035.PMC3949721.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Medical Case Reports Journal 2014:7 35–39International Medical Case Reports Journal Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/33/2b/imcrj-7-035.PMC3949721.pdf
"Or use: http://dvpr.es/1hmKuq aDove press submit your manuscript | www.dovepress.co m Dove press  35Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S6005 0Rare case of pneumorrhachis, pneumomediastinum,  pneumothorax, and surgical emphysema secondary  to bronchial asthma parag suresh Mahajan1 Nasser Jassim al  Maslamani1 Nishan K purayil2 1Department of Radiology, 2accident  and emergency Department, al Khor  Hospital, Hamad Medical Corporation,   Doha, Qatar Correspondence: parag suresh Mahajan   Department of Radiology, al Khor  Hospital, Hamad Medical Corporation,  po Box 3050, Doha, Qatar   tel +97 46 634 7694   email mdfrcr@gmail.co mAbstract:  Air localized within the spinal canal is called pneumorrhachis.",Non-OADS,/arxiv_data1/oa_pdf/33/2b/imcrj-7-035.PMC3949721.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/33/2b/imcrj-7-035.PMC3949721.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/33/2b/imcrj-7-035.PMC3949721.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/44/02/ijgm-7-131.PMC3949722.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 131–135International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  131OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S5666 0study of urinary leukotriene e4 levels in children  with acute asthma Ghada saad abd el-Motaleb1 alraohaa ahmed ahmed  abou amer1 Gamal Mohamed elawa2 Mohamed abo alsood abd  elfattah3 1Department of Pediatrics,   2Department of clinical Pathology,   Faculty of Medicine, Benha University,   Benha, Qalyubia, egypt; 3Department  of Pediatrics, Ministry of health  hospital, cairo, egypt correspondence: Ghada saad abd  el-Motaleb   Faculty of Medicine, Benha University,  Farid nada street, Benha, Qalyubia,   13512, egypt   email ghad2a@yahoo.co mObjective:  The goal of this study was to evaluate the impact of urinary leukotriene E4 (ULTE4)  in asthmatic children during acute asthma exacerbation.",Non-OADS,/arxiv_data1/oa_pdf/44/02/ijgm-7-131.PMC3949722.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/44/02/ijgm-7-131.PMC3949722.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/02/ijgm-7-131.PMC3949722.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1c/0b/imcrj-7-031.PMC3949723.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Medical Case Reports Journal 2014:7 31–33International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  31Case RepoRTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/IMCRJ.S5837 7Herpes simplex virus type 2-associated recurrent  aseptic (Mollaret’s) meningitis in genitourinary  medicine clinic: a case report ahmad K abou-Foul Thajunisha M Buhary sedki L Gayed Department of Genitourinary  Medicine, Royal Blackburn Hospital,   east Lancashire Hospitals NHs Trust,   Blackburn, UK Correspondence: sedki L Gayed   Department of Genitourinary Medicine,  east Lancashire Hospitals NHs Trust,   st peter’s Health Centre, Church street,  Burnley, Lancashire, UK, BB11 2DL   T el +44 12 8264 4301   email sedki.gayed@elht.nhs.u kIntroduction:  Cases of idiopathic recurrent benign aseptic meningitis were first described  by Mollaret.",Non-OADS,/arxiv_data1/oa_pdf/1c/0b/imcrj-7-031.PMC3949723.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/1c/0b/imcrj-7-031.PMC3949723.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/0b/imcrj-7-031.PMC3949723.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fc/91/rmhp-7-045.PMC3949730.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpRisk Management and Healthcare Policy 2014:7 45–49Risk Management and Healthcare Policy Dove press submit your manuscript | www.dovepress.co m Dove press  45ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/RMHP .S5725 7Validation of dengue infection severity score surangrat Pongpan1,2 Jayanton Patumanond3 apichart Wisitwong4 chamaiporn Tawichasri5 sirianong namwongprom1,6 1clinical epidemiology Program,   Faculty of Medicine, chiang Mai  University, chiang Mai, Thailand;   2Department of Occupational  Medicine, Phrae Hospital, Phrae,   Thailand; 3clinical epidemiology  Program, Faculty of Medicine,   Thammasat University, Bangkok,   Thailand; 4Department of social  Medicine, sawanpracharak Hospital,   nakorn sawan, Thailand; 5clinical  epidemiology society at chiang Mai,   chiang Mai, Thailand; 6Department of  Radiology, Faculty of Medicine, chiang  Mai University, chiang Mai, Thailand correspondence: sirianong  namwongprom   Department of Radiology, Faculty   of Medicine, chiang Mai University,  chiang Mai 50200, Thailand   Tel +66 53 945 458   Fax +66 53 945 476   email snamwong@med.cmu.ac.t hObjective:  To validate a simple scoring system to classify dengue viral infection severity to  patients in different settings.",Non-OADS,/arxiv_data1/oa_pdf/fc/91/rmhp-7-045.PMC3949730.pdf
"Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/risk-management-and-healthcare-policy-journa lRisk Management and Healthcare Policy is an international, peer- reviewed, open access journal focusing on all aspects of public health,  policy, and preventative measures to promote good health and improve  morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/fc/91/rmhp-7-045.PMC3949730.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/91/rmhp-7-045.PMC3949730.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/fc/91/rmhp-7-045.PMC3949730.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/65/a1/ott-7-395.PMC3949731.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 395–404OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  395Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S3884 6Clinical efficacy and safety of imatinib in the  management of Ph+ chronic myeloid or acute  lymphoblastic leukemia in Chinese patients Yu Zhu Si-Xuan Qian Department of Hematology, The First  Affiliated Hospital of Nanjing Medical  University, Jiangsu Province Hospital,   Nanjing, Jiangsu Province, People’s  Republic of China Correspondence: Si-Xuan Qian   Department of Hematology, The First  Affiliated Hospital of Nanjing Medical  University, Jiangsu Province Hospital,   300 Guangzhou Rd, Nanjing,   People’s Republic of China   Tel +86 25 8378 1120   Fax +86 25 8378 1120   email qiansx@medmail.com.c nAbstract:  Imatinib mesylate is considered the standard first-line systemic treatment for patients  with chronic myeloid leukemia (CML) and functions by targeting BCR-ABL  tyrosine kinases.",Non-OADS,/arxiv_data1/oa_pdf/65/a1/ott-7-395.PMC3949731.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/65/a1/ott-7-395.PMC3949731.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/a1/ott-7-395.PMC3949731.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5e/d6/opth-8-485.PMC3949732.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 485–492Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  485Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5541 3Pneumatic displacement with intravitreal  bevacizumab for massive submacular hemorrhage  due to polypoidal choroidal vasculopathy Masayasu Kitahashi1 Takayuki Baba1 Madoka sakurai1 hirotaka Y okouchi1 Mariko Kubota-Taniai1 Y oshinori Mitamura2 shuichi Yamamoto1 1Department of Ophthalmology and  Visual science, Chiba University  graduate school of Medicine, Chiba,   2institute of health Biosciences,   University of Tokushima graduate  school, T okushima, Japan Correspondence: Masayasu Kitahashi   Department of Ophthalmology and Visual  science, Chiba University graduate  school of Medicine, 1-8-1 inohana,  Chuo-ku, Chiba 260-8670, Japan   Tel +81 43 226 2124   Fax +81 43 227 1810   email k itahashi_m@yahoo.co.j pBackground:  The purpose of this study was to compare the effectiveness of pneumatic  displacement combined with intravitreal bevacizumab (IVB) with that of pneumatic displacement  (PD) alone to treat massive submacular hemorrhage (SMH) secondary to polypoidal choroidal  vasculopathy (PCV).",Non-OADS,/arxiv_data1/oa_pdf/5e/d6/opth-8-485.PMC3949732.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/5e/d6/opth-8-485.PMC3949732.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/d6/opth-8-485.PMC3949732.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/52/nss-6-027.PMC3949750.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNature and Science of Sleep 2014:6 27–36Nature and Science of Sleep Dove press submit your manuscript | www.dovepress.co m Dove press  27OrigiNal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NSS.S5378 9Time rather than sleep appears to enhance   off-line learning and transfer of learning   of an implicit continuous task alham al-Sharman catherine F Siengsukon Department of Physical Therapy and  rehabilitation Science, University of  Kansas Medical center, Kansas city,   KS, USa correspondence: catherine F Siengsukon   University of Kansas Medical center,  3901 rainbow Blvd, Mail Stop 2002,  Kansas city, KS 66160, USa   Tel +1 913 588 6913   Fax +1 913 588 4568   email csiengsukon@kumc.ed uAbstract:  There is increasing evidence that sleep promotes off-line enhancement of a variety  of explicitly learned motor tasks in young adults.",Non-OADS,/arxiv_data1/oa_pdf/e8/52/nss-6-027.PMC3949750.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/e8/52/nss-6-027.PMC3949750.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/52/nss-6-027.PMC3949750.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/aa/93/opth-8-493.PMC3949751.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 493–497Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  493Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5561 5Influence of automated disc margin determination  on stratus OCT optic nerve head measurements andré soares de Camargo luiz alberto soares Melo Jr Flavio eduardo hirai ivan Maynart Tavares Glaucoma Service, Department of  Ophthalmology and Visual sciences,   Federal University of São Paulo,   Paulista Medical School, São Paulo,   Brazil Correspondence : ivan Maynart Tavares   Rua Botucatu, 821, Sao Paulo,   SP, 04023-062, Brazil   T el +55 11 50852010   Fax +55 11 50852004   email im.tavares@unifesp.b rPurpose:  To analyze the influence of manual correction of the automatically determined edge  of the optic nerve head (ONH) in optic disc measurements in cases in which the optical coher - ence tomography did not identify the disc limits correctly.",Non-OADS,/arxiv_data1/oa_pdf/aa/93/opth-8-493.PMC3949751.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/aa/93/opth-8-493.PMC3949751.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/93/opth-8-493.PMC3949751.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/52/8b/ott-7-387.PMC3949752.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 387–393OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  387REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S5887 0The predictive role of pretreatment epidermal  growth factor receptor T790M mutation   on the progression-free survival of tyrosine- kinase inhibitor-treated non-small cell lung   cancer patients: a meta-analysis Ding Ding Y ongfeng Yu Ziming Li Xiaomin Niu Shun Lu Department of Shanghai Lung Cancer  Center, Shanghai Chest Hospital,   Shanghai Jiaotong University, Shanghai,   People’s Republic of China Correspondence: Shun Lu   Department of Shanghai Lung Cancer   Center, Shanghai Chest Hospital,   Shanghai Jiaotong University, 241 Huaihai  West Road, Xuhui District, Shanghai   200030, People’s Republic of China   Tel +86 21 62821990   Fax +86 21 62801109   Email shunl1964@gmail.co mPurpose:  Subclones bearing the epidermal growth factor receptor (EGFR) T790M mutation  concomitant with deletional mutation in exon 19 ( Del19 ) or a point mutation in exon 21 (L858R)  have been reported in non-small cell lung cancer patients before any EGFR tyrosine-kinase  inhibitor (TKI) treatment.",Non-OADS,/arxiv_data1/oa_pdf/52/8b/ott-7-387.PMC3949752.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/52/8b/ott-7-387.PMC3949752.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/8b/ott-7-387.PMC3949752.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/b0/tcrm-10-151.PMC3949753.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 151–163Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  151Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S3351 7Sexual dimorphism of miRNA expression:   a new perspective in understanding the sex   bias of autoimmune diseases Rujuan Dai S Ansar Ahmed Department of Biomedical Sciences  and Pathobiology, virginia-Maryland  Regional College of veterinary  Medicine, virginia T ech, Blacksburg,   vA, USA Correspondence: S Ansar Ahmed   Department of Biomedical Sciences and   Pathology, virginia-Maryland Regional   College of veterinary Medicine, virginia   Tech, 265 Duckpond Dr, vA 24061, USA   Tel +1 540 231 4652   Fax +1 540 231 6033   email ansrahmd@vt.ed uAbstract : Autoimmune diseases encompass a diverse group of diseases which emanate from a  dysregulated immune system that launches a damaging attack on its own tissues.",Non-OADS,/arxiv_data1/oa_pdf/24/b0/tcrm-10-151.PMC3949753.pdf
Available from: http://www.niaid.,Non-OADS,/arxiv_data1/oa_pdf/24/b0/tcrm-10-151.PMC3949753.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/24/b0/tcrm-10-151.PMC3949753.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/b0/tcrm-10-151.PMC3949753.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/94/3a/ott-7-375.PMC3949762.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 375–385OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  375Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S3886 8Development of anaplastic lymphoma kinase  (ALK) inhibitors and molecular diagnosis   in ALK rearrangement-positive lung cancer eiji iwama1,2 isamu Okamoto3 Taishi Harada2 Koichi Takayama2 Y oichi Nakanishi2,3 1Department of Comprehensive  Clinical Oncology, Faculty of Medical  Sciences, Kyushu University, 2Research  institute for Diseases of the Chest,   Graduate School of Medical Sciences,   Kyushu University, 3Center for Clinical  and Translational Research, Kyushu  University Hospital, Fukuoka, Japan Correspondence: isamu Okamoto   Center for Clinical and Translational  Research, Kyushu University Hospital,  3-1-1 Maidashi, Higashi ku,   Fukuoka 812-8582, Japan   T el +81 92 642 5378   Fax +81 92 642 5389   email okamotoi@kokyu.med.kyushu-u.",Non-OADS,/arxiv_data1/oa_pdf/94/3a/ott-7-375.PMC3949762.pdf
Available from: http://clinicaltrials.gov/show/NCT01154140.,Non-OADS,/arxiv_data1/oa_pdf/94/3a/ott-7-375.PMC3949762.pdf
Available from: http://www.clinicaltrials.jp/user/ showCteDetailE.jsp?japicId=JapicCTI-132316.,Non-OADS,/arxiv_data1/oa_pdf/94/3a/ott-7-375.PMC3949762.pdf
Available from: http://clinicaltrials.gov/show/NCT01801111.,Non-OADS,/arxiv_data1/oa_pdf/94/3a/ott-7-375.PMC3949762.pdf
Available from: http://clinicaltrials.gov/show/NCT01828099.,Non-OADS,/arxiv_data1/oa_pdf/94/3a/ott-7-375.PMC3949762.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/94/3a/ott-7-375.PMC3949762.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/94/3a/ott-7-375.PMC3949762.pdf
Available  from: http://clinicaltrials.gov/show/NCT01625234.,Non-OADS,/arxiv_data1/oa_pdf/94/3a/ott-7-375.PMC3949762.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d5/9d/prbm-7-089.PMC3949763.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPsychology Research and Behavior Management 2014:7 89–91Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  89LetteRopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/PRBM.S6145 0Online web-based sun-protective behaviors Nicola Luigi Bragazzi1,2 1School of Public Health, Department  of Health Sciences (DISSAL),   University of Genoa, Via Antonio  Pastore,Genoa, Italy; 2DINOGMI,   Department of Neuroscience,   Rehabilitation, Ophthalmology,   Genetics, Maternal and Child Health,   Section of Psychiatry, University of  Genoa, Genoa, Italy Correspondence: Nicola Luigi Bragazzi   School of Public Health, Department   of Health Sciences (DISSAL),   University of Genoa, Via Antonio   Pastore 1, 16132 Genoa, Italy   tel +39 1 0353 7664   Fax +39 1 0353 7669   email robertobragazzi@gmail.co mDear editor I read with great interest the recently published article by Diao and Lee1 concerning  the sun-protective behaviors in populations at high risk for skin cancer, with a special  emphasis on melanoma.",Non-OADS,/arxiv_data1/oa_pdf/d5/9d/prbm-7-089.PMC3949763.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/d5/9d/prbm-7-089.PMC3949763.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/d5/9d/prbm-7-089.PMC3949763.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c6/81/ndt-10-433.PMC3949764.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 433–438Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  433OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S5937 5Influence of valproate on the required dose of  propofol for anesthesia during electroconvulsive  therapy of bipolar affective disorder patients Gökben Hızlı Sayar Gül Eryılmaz Siban Şemieog ˘lu Eylem Özten Işıl Gög ˘cegöz Gül Uskudar University, Neuropsychiatry  Istanbul Hospital, Istanbul, T urkey Correspondence: Gökben Hızlı Sayar   Department of Psychiatry, Uskudar  University, Neuropsychiatry Istanbul  Hospital, Alemdag Caddesi Site Yolu   No 29, Umraniye, Istanbul, Turkey   Tel +90 216 633 0649   Fax +90 216 634 1250   email gokben.hizlisayar@uskudar.edu.t rBackground:  Propofol is often used as an anesthetic agent for electroconvulsive therapy (ECT).",Non-OADS,/arxiv_data1/oa_pdf/c6/81/ndt-10-433.PMC3949764.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c6/81/ndt-10-433.PMC3949764.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/81/ndt-10-433.PMC3949764.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/e7/dmj-38-1.PMC3950189.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:1-12 Gestational Diabetes Mellitus in Korean Women:  Similarities and Differences from Other Racial/Ethnic  Groups Catherine Kim1,2 Departments of 1Medicine, 2Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor, MI, USA Gestational diabetes mellitus (GDM) reflects defects in insulin secretion in response to the metabolic demands of pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/97/e7/dmj-38-1.PMC3950189.pdf
There is probably some re -Review Epidemiology http://dx.doi.org/10.4093/dmj.2014.38.1.1 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/97/e7/dmj-38-1.PMC3950189.pdf
"2Kim C Diabetes Metab J 2014;38:1-12 http://e-dmj.orggional variation, as ethnic Korean women in the United States  have been noted to have a slightly higher GDM prevalence  (4.7%) in medical center-based reports [8].",Non-OADS,/arxiv_data1/oa_pdf/97/e7/dmj-38-1.PMC3950189.pdf
"3Gestational diabetes mellitus in Korean women Diabetes Metab J 2014;38:1-12 http://e-dmj.orgglucose during pregnancy, probably through insulin secretion,  and consequently, the latter has also been associated with  macrosomia in Europeans [18].",Non-OADS,/arxiv_data1/oa_pdf/97/e7/dmj-38-1.PMC3950189.pdf
4Kim C Diabetes Metab J 2014;38:1-12 http://e-dmj.org[40].,Non-OADS,/arxiv_data1/oa_pdf/97/e7/dmj-38-1.PMC3950189.pdf
"5Gestational diabetes mellitus in Korean women Diabetes Metab J 2014;38:1-12 http://e-dmj.orgincreased risk of future diabetes after a GDM delivery; for ev - ery 1 kg increase in prepregnancy weight, there was a 40% in - crease in odds of developing type 2 diabetes (OR, 1.40; 95%  CI, 1.20 to 1.60).",Non-OADS,/arxiv_data1/oa_pdf/97/e7/dmj-38-1.PMC3950189.pdf
"6Kim C Diabetes Metab J 2014;38:1-12 http://e-dmj.orgbetween lower adiponectin and higher glucose levels is also  present in the first and early second trimester of pregnancy  [66,67] and later in pregnancy [68], independent of BMI.",Non-OADS,/arxiv_data1/oa_pdf/97/e7/dmj-38-1.PMC3950189.pdf
"7Gestational diabetes mellitus in Korean women Diabetes Metab J 2014;38:1-12 http://e-dmj.orgBEHAVIORS AND BEHAVIORAL  INTERVENTION Among non-Korean populations with GDM, which tend to  have a high prevalence of obesity, decreasing postpartum obe - sity can decrease diabetes risk.",Non-OADS,/arxiv_data1/oa_pdf/97/e7/dmj-38-1.PMC3950189.pdf
"8Kim C Diabetes Metab J 2014;38:1-12 http://e-dmj.orgbased data on anthropometrics, dietary habits, and physical  activity as well as glucose tolerance in Korean women could  yield suggestions for GDM prevention and treatment in non- Koreans.",Non-OADS,/arxiv_data1/oa_pdf/97/e7/dmj-38-1.PMC3950189.pdf
"9Gestational diabetes mellitus in Korean women Diabetes Metab J 2014;38:1-12 http://e-dmj.orgMK, Jung HS, Shin HD, Kang HM, Cho NH, Lee IK, Kim SY ,  Han BG, Jang HC, Park KS.",Non-OADS,/arxiv_data1/oa_pdf/97/e7/dmj-38-1.PMC3950189.pdf
10Kim C Diabetes Metab J 2014;38:1-12 http://e-dmj.orgDiabet Med 2011;28:1053-9.,Non-OADS,/arxiv_data1/oa_pdf/97/e7/dmj-38-1.PMC3950189.pdf
"11Gestational diabetes mellitus in Korean women Diabetes Metab J 2014;38:1-12 http://e-dmj.orgdicts postpartum insulin resistance, beta cell dysfunction and  fasting glycaemia.",Non-OADS,/arxiv_data1/oa_pdf/97/e7/dmj-38-1.PMC3950189.pdf
"12Kim C Diabetes Metab J 2014;38:1-12 http://e-dmj.orgRabbia C, Durazzo M, Cassader M, Massobrio M, Pagano G.  Should we consider gestational diabetes a vascular risk factor?",Non-OADS,/arxiv_data1/oa_pdf/97/e7/dmj-38-1.PMC3950189.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/51/dmj-38-13.PMC3950190.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:13-24 The Hijacking of Cellular Signaling and the Diabetes  Epidemic: Mechanisms of Environmental Disruption  of Insulin Action and Glucose Homeostasis Robert M. Sargis Committee on Molecular Metabolism and Nutrition, Kovler Diabetes Center, Section of Endocrinology, Diabetes and Metabolism, Department of Medicine,  University of Chicago, Chicago, IL, USA The burgeoning epidemic of metabolic disease causes significant societal and individual morbidity and threatens the stability of  health care systems around the globe.",Non-OADS,/arxiv_data1/oa_pdf/b1/51/dmj-38-13.PMC3950190.pdf
As such attention has turned to other factors Review Pathophysiology http://dx.doi.org/10.4093/dmj.2014.38.1.13 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/b1/51/dmj-38-13.PMC3950190.pdf
"14Sargis RM Diabetes Metab J 2014;38:13-24 http://e-dmj.orgthat contribute to the development of metabolic disruption,  including the contribution of endocrine disrupting chemicals  (EDCs).",Non-OADS,/arxiv_data1/oa_pdf/b1/51/dmj-38-13.PMC3950190.pdf
"15Environmental disruption of insulin signaling Diabetes Metab J 2014;38:13-24 http://e-dmj.orgtial role in T2DM, EDCs that module β-cell function may also  play a role in type 1 diabetes mellitus (T1DM), which patho - physiologically results from β-cell destruction/dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/b1/51/dmj-38-13.PMC3950190.pdf
16Sargis RM Diabetes Metab J 2014;38:13-24 http://e-dmj.orgdevelopment of diabetes.,Non-OADS,/arxiv_data1/oa_pdf/b1/51/dmj-38-13.PMC3950190.pdf
"17Environmental disruption of insulin signaling Diabetes Metab J 2014;38:13-24 http://e-dmj.orgto attenuate signaling through IRS-1, including TCDD [67],  DEHP [75], and particulate matter [74].",Non-OADS,/arxiv_data1/oa_pdf/b1/51/dmj-38-13.PMC3950190.pdf
18Sargis RM Diabetes Metab J 2014;38:13-24 http://e-dmj.orgP ATHW AYS OF METABOLIC DISRUPTION The potential mechanisms by which EDCs modulate insulin  production and action are myriad.,Non-OADS,/arxiv_data1/oa_pdf/b1/51/dmj-38-13.PMC3950190.pdf
"19Environmental disruption of insulin signaling Diabetes Metab J 2014;38:13-24 http://e-dmj.orgcal studies linking EDCs with alterations in glucose metabo - lism, there remain several important challenges to establish  causality in human populations.",Non-OADS,/arxiv_data1/oa_pdf/b1/51/dmj-38-13.PMC3950190.pdf
20Sargis RM Diabetes Metab J 2014;38:13-24 http://e-dmj.orgCONFLICTS OF INTEREST  No potential conflict of interest relevant to this article was re - ported.,Non-OADS,/arxiv_data1/oa_pdf/b1/51/dmj-38-13.PMC3950190.pdf
Available  from: http://www.idf.org/diabetesatlas (updated 2013 Nov 15).,Non-OADS,/arxiv_data1/oa_pdf/b1/51/dmj-38-13.PMC3950190.pdf
21Environmental disruption of insulin signaling Diabetes Metab J 2014;38:13-24 http://e-dmj.orgpatic energy metabolism via species-specific PPARalpha-de - pendent mechanisms.,Non-OADS,/arxiv_data1/oa_pdf/b1/51/dmj-38-13.PMC3950190.pdf
"22Sargis RM Diabetes Metab J 2014;38:13-24 http://e-dmj.orgA, Muhammed SJ, Salehi A, Gustafsson JA, Quesada I, Nadal  A.",Non-OADS,/arxiv_data1/oa_pdf/b1/51/dmj-38-13.PMC3950190.pdf
23Environmental disruption of insulin signaling Diabetes Metab J 2014;38:13-24 http://e-dmj.org63.,Non-OADS,/arxiv_data1/oa_pdf/b1/51/dmj-38-13.PMC3950190.pdf
24Sargis RM Diabetes Metab J 2014;38:13-24 http://e-dmj.org209-14.,Non-OADS,/arxiv_data1/oa_pdf/b1/51/dmj-38-13.PMC3950190.pdf
Epub  2013 Jun 14. http://dx.doi.org/ 10.1002/jat.2898.,OADS,/arxiv_data1/oa_pdf/b1/51/dmj-38-13.PMC3950190.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/05/dmj-38-25.PMC3950191.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:25-31 Current Status of Diabetic Peripheral Neuropathy in  Korea: Report of a Hospital-Based Study of Type 2  Diabetic Patients in Korea by the Diabetic Neuropathy  Study Group of the Korean Diabetes Association Jong Chul Won1,*, Sang Soo Kim2,*, Kyung Soo Ko1, Bong-Yun Cha3 1Department of Internal Medicine, Cardiovascular and Metabolic Disease Centre, Inje University College of Medicine, Seoul,  2Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan,  3Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea Diabetic peripheral neuropathy (DPN) is the most common complication associated with diabetes.",Non-OADS,/arxiv_data1/oa_pdf/48/05/dmj-38-25.PMC3950191.pdf
DPN leads to a number of impair - ments and functional limitations including foot ulceration and  subsequent lower-extremity amputation [8]; in Korea between Review Complications http://dx.doi.org/10.4093/dmj.2014.38.1.25 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/48/05/dmj-38-25.PMC3950191.pdf
"Diabetes Metab J 2014;38:25-31 http://e-dmj.org2000 and 2002, 44.8% of foot amputee patients had diabetes  [9].",Non-OADS,/arxiv_data1/oa_pdf/48/05/dmj-38-25.PMC3950191.pdf
"27Current status of DPN in Korea Diabetes Metab J 2014;38:25-31 http://e-dmj.orgassociated with DPN include older age, being female, a longer  diabetes duration, lower hemoglobin A1c (HbA1c) level, the  presence of retinopathy, a history of cerebrovascular accident,  or peripheral arterial disease, the presence of hypertension or  dyslipidemia, treatment with an oral hypoglycemic agent or  insulin, and a history of foot ulcers (Fig.",Non-OADS,/arxiv_data1/oa_pdf/48/05/dmj-38-25.PMC3950191.pdf
"Diabetes Metab J 2014;38:25-31 http://e-dmj.orgtreatments, and in line with international and Korean guide - lines, anticonvulsant, and tricyclic antidepressant drugs were  commonly prescribed for symptomatic management [28,29].",Non-OADS,/arxiv_data1/oa_pdf/48/05/dmj-38-25.PMC3950191.pdf
29Current status of DPN in Korea Diabetes Metab J 2014;38:25-31 http://e-dmj.orgCONCLUSIONS The present review provides detailed estimates of the preva - lence of DPN in patients with T2DM in Korea as well as the  clinical characteristics of this disease.,Non-OADS,/arxiv_data1/oa_pdf/48/05/dmj-38-25.PMC3950191.pdf
"Diabetes Metab J 2014;38:25-31 http://e-dmj.orgACKNOWLEDGMENTS This study was supported by the Priority Research Centers  Program through the National Research Foundation of Korea  (NRF) funded by the Ministry of Education, Science, and  Technology (2010-0020224), and by the Inje Research and  Scholarship Foundation in 2012 (J.C.W .",Non-OADS,/arxiv_data1/oa_pdf/48/05/dmj-38-25.PMC3950191.pdf
Epub 2013 Dec 25.  http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/05/dmj-38-25.PMC3950191.pdf
31Current status of DPN in Korea Diabetes Metab J 2014;38:25-31 http://e-dmj.org21.,Non-OADS,/arxiv_data1/oa_pdf/48/05/dmj-38-25.PMC3950191.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/4b/dmj-38-32.PMC3950192.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:32-34 Statin for the Primary Prevention of Cardiovascular  Disease in Patients with Diabetes Mellitus Bo Kyung Koo1,2 1Department of Internal Medicine, Boramae Medical Center, Seoul National University College of Medicine, Seoul,  2Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea Corresponding author: Bo Kyung Koo Department of Internal Medicine, Boramae Medical Center,   Seoul National University College of Medicine, 20 Boramae-ro 5-gil,  Dongjak-gu, Seoul 156-707, Korea E-mail: bokyungkoomd@gmail.comStain is commonly used in subjects with diabetes for both pri - mary and secondary prevention of cardiovascular diseases  (CVDs) [1,2].",Non-OADS,/arxiv_data1/oa_pdf/1f/4b/dmj-38-32.PMC3950192.pdf
How -Editorial Clinical Care/Education http://dx.doi.org/10.4093/dmj.2014.38.1.32 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/1f/4b/dmj-38-32.PMC3950192.pdf
"33Diabetes mellitus and stain Diabetes Metab J 2014;38:32-34 http://e-dmj.orgever, considering that statin therapy is not for reducing LDL-C  itself but for reducing CVD risk, their results should be inter - preted carefully to make the decision whether statin should be  continued or not.",Non-OADS,/arxiv_data1/oa_pdf/1f/4b/dmj-38-32.PMC3950192.pdf
Epub 2013 Nov 7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/4b/dmj-38-32.PMC3950192.pdf
34Koo BK Diabetes Metab J 2014;38:32-34 http://e-dmj.orgmen and women with elevated C-reactive protein.,Non-OADS,/arxiv_data1/oa_pdf/1f/4b/dmj-38-32.PMC3950192.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/03/dmj-38-35.PMC3950193.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:35-43 Prevalence, Awareness, and Management of Obesity in  Korea: Data from the Korea National Health and  Nutrition Examination Survey (1998–2011) Chul Sik Kim1, Seung-Hyun Ko2, Hyuk-Sang Kwon2, Nan Hee Kim3, Jae Hyeon Kim4, Soo Lim5, Sung Hee Choi5,   Kee-Ho Song6, Jong Chul Won7, Dae Jung Kim8, Bong-Yun Cha2, on behalf of the Taskforce Team of Diabetes Fact Sheet of the  Korean Diabetes Association 1 Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of  Medicine, Anyang,  2Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul,  3Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul,  4Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul,  5Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul,  6Department of Internal Medicine, Konkuk University School of Medicine, Seoul,  7Department of Internal Medicine, Mitochondrial Research Group, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul,  8Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea Background:  Obesity is a risk factor for diabetes and several cardiovascular diseases.",Non-OADS,/arxiv_data1/oa_pdf/c0/03/dmj-38-35.PMC3950193.pdf
"Keywords:  Diabetes mellitus; Korea; Obesity; Prevalence Corresponding authors:   Bong-Yun Cha  Division of Endocrinology and Metabolism, Department of Internal  Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea College  of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea E-mail: bycha@catholic.ac.kr Chul Sik Kim Division of Endocrinology and Metabolism, Department of Internal  Medicine, Hallym University Sacred Heart Hospital, Hallym University  College of Medicine, 22 Gwanpyeong-ro 170 beon-gil, Dongan-gu,   Anyang 431-796, Korea E-mail: ironeat@hallym.ac.kr Received: Oct. 7, 2013; Accepted: Nov. 18, 2013Original Article Epidemiology http://dx.doi.org/10.4093/dmj.2014.38.1.35 pISSN 2233-6079 · eISSN 2233-6087 INTRODUCTION Obesity is a chronic disease that is causally related to serious medical illnesses, whose worldwide prevalence has increased  dramatically over the last several decades [1].",Non-OADS,/arxiv_data1/oa_pdf/c0/03/dmj-38-35.PMC3950193.pdf
"Diabetes Metab J 2014;38:35-43 http://e-dmj.orgcial, and cultural changes, including an accelerated pace of nu - trition transition that may result in a greatly increased burden  of chronic diseases, such as obesity [2].",Non-OADS,/arxiv_data1/oa_pdf/c0/03/dmj-38-35.PMC3950193.pdf
37Obesity in Korea Diabetes Metab J 2014;38:35-43 http://e-dmj.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/c0/03/dmj-38-35.PMC3950193.pdf
"Diabetes Metab J 2014;38:35-43 http://e-dmj.orgsuch as for fasting more than 24 hours, skipping meal, use of  self-purchased antiobesity drugs, use of prescribed antiobesity  drugs, taking Korean traditional herbal medication, taking  health functional food, and one food diet were all attempted  by less than 5% of the subjects.Trends in prevalence, awareness, and management of  obesity, 1998 to 2011  A total of 8,117, 5,826, 5,500, 3,025, 6,756, 7,506, 6,255, and  6,155 responses were available for analysis from the KNHANES  in the 1998, 2001, 2005, 2007, 2008, 2009, 2010, and 2011, re - spectively.",Non-OADS,/arxiv_data1/oa_pdf/c0/03/dmj-38-35.PMC3950193.pdf
"39Obesity in Korea Diabetes Metab J 2014;38:35-43 http://e-dmj.orgpared to 1998, it has remained steady since 2005.",Non-OADS,/arxiv_data1/oa_pdf/c0/03/dmj-38-35.PMC3950193.pdf
"Diabetes Metab J 2014;38:35-43 http://e-dmj.org In nondiabetic subjects, subjective awareness for mild obe - sity showed an increasing tendency throughout 2001 to 2011,  but subjects who considered their body sizes to be very obese gradually decreased since 2007 (Fig.",Non-OADS,/arxiv_data1/oa_pdf/c0/03/dmj-38-35.PMC3950193.pdf
41Obesity in Korea Diabetes Metab J 2014;38:35-43 http://e-dmj.orgness for mild or severe obesity showed a decreasing trend from  2007 instead (Fig.,Non-OADS,/arxiv_data1/oa_pdf/c0/03/dmj-38-35.PMC3950193.pdf
Diabetes Metab J 2014;38:35-43 http://e-dmj.orgwere doing exercises and reducing food intake in both nondia - betic and diabetic subjects.,Non-OADS,/arxiv_data1/oa_pdf/c0/03/dmj-38-35.PMC3950193.pdf
"43Obesity in Korea Diabetes Metab J 2014;38:35-43 http://e-dmj.orgdeaths associated with underweight, overweight, and obesity.",Non-OADS,/arxiv_data1/oa_pdf/c0/03/dmj-38-35.PMC3950193.pdf
Available from: http://www.kostat.go.kr (updated 2013  Sep 5).,Non-OADS,/arxiv_data1/oa_pdf/c0/03/dmj-38-35.PMC3950193.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/3b/dmj-38-44.PMC3950194.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:44-50 Plasma Glucose Regulation and Mortality in Korea:   A Pooled Analysis of Three Community-Based Cohort  Studies Nan Hee Kim1, Dong-Jun Kim2, Seok Won Park3, Jee-Y oung Oh4, Joong-Y eol Park5, Chol Shin6, Hong Kyu Lee7,   Y ongsoo Park8, on behalf of the Committee on the Epidemiology of Diabetes Mellitus, Korean Diabetes Association 1 Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine,  Ansan,  2Department of Internal Medicine, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang,  3Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, 4Division of Endocrinology and Metabolism, Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, 5Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Ulsan College of Medicine, Seoul,  6Institute of Human Genomic Study, Korea University Ansan Hospital, Korea University College of Medicine, Ansan,  7Department of Internal Medicine, Eulji University School of Medicine, Seoul,  8 Division of Endocrinology and Metabolism, Department of Internal Medicine and Bioengineering, Hanyang University Seoul Hospital, Hanyang University  College of Medicine, Seoul, Korea Background:  Although diabetes is a well-known risk factor for death, its impact on cancer death is not clearly understood.",Non-OADS,/arxiv_data1/oa_pdf/e8/3b/dmj-38-44.PMC3950194.pdf
Diabetes-related mortality data was not included Original Article Epidemiology http://dx.doi.org/10.4093/dmj.2014.38.1.44 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/e8/3b/dmj-38-44.PMC3950194.pdf
"45Glucose and mortality Diabetes Metab J 2014;38:44-50 http://e-dmj.orgamong major leading causes of death in 1983 in South Korea,  but in 2011, they ranked as the fourth leading cause of natural  death, following malignancy, cerebrovascular disease, and car - diovascular disease (CVD) [2].",Non-OADS,/arxiv_data1/oa_pdf/e8/3b/dmj-38-44.PMC3950194.pdf
Diabetes Metab J 2014;38:44-50 http://e-dmj.orgL) with or without IFG was defined by the 2003 ADA criteria  [16].,Non-OADS,/arxiv_data1/oa_pdf/e8/3b/dmj-38-44.PMC3950194.pdf
"47Glucose and mortality Diabetes Metab J 2014;38:44-50 http://e-dmj.orgFPG or 2hPG criteria than in their normal counterparts, where - as it did not increase in the IFG or IGT groups compared to  those with NGR I (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/e8/3b/dmj-38-44.PMC3950194.pdf
Diabetes Metab J 2014;38:44-50 http://e-dmj.orgabetes nor prediabetes was associated with CVD death.,Non-OADS,/arxiv_data1/oa_pdf/e8/3b/dmj-38-44.PMC3950194.pdf
"49Glucose and mortality Diabetes Metab J 2014;38:44-50 http://e-dmj.org The present study also demonstrated that cancer death did  not significantly increase in subjects with stage 2 IFG (HR, 1.54;  95% CI, 0.88 to 2.68) or IGT (HR, 1.43; 95% CI, 0.88 to 2.35)  when compared to subjects with NGR II.",Non-OADS,/arxiv_data1/oa_pdf/e8/3b/dmj-38-44.PMC3950194.pdf
Available  from: http://www.index.go.kr (updated 2012 Sep 13).,Non-OADS,/arxiv_data1/oa_pdf/e8/3b/dmj-38-44.PMC3950194.pdf
Diabetes Metab J 2014;38:44-50 http://e-dmj.orgAmerican Diabetes Association diagnostic criteria.,Non-OADS,/arxiv_data1/oa_pdf/e8/3b/dmj-38-44.PMC3950194.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/c0/dmj-38-51.PMC3950195.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:51-57 Higher Prevalence and Awareness, but Lower Control  Rate of Hypertension in Patients with Diabetes than  General Population: The Fifth Korean National Health  and Nutrition Examination Survey in 2011 Seung-Hyun Ko1, Hyuk-Sang Kwon1, Dae Jung Kim2, Jae Hyeon Kim3, Nan Hee Kim4, Chul Sik Kim5, Kee-Ho Song6,  Jong Chul Won7, Soo Lim8, Sung Hee Choi8, Kyungdo Han9, Y ong-Moon Park10,11, Bong-Yun Cha1,  on behalf of the Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association 1Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, 2Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon,  3Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 4Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, 5 Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of  Medicine, Anyang,  6Department of Internal Medicine, Konkuk University School of Medicine, Seoul,  7Department of Internal Medicine, Mitochondrial Research Group, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, 8Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, 9Departments of Biostatistics, 10Preventive Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea;  11Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA Background:  We investigated the prevalence, awareness, treatment, and control rate of hypertension in Korean adults with diabetes  using nationally representative data.",Non-OADS,/arxiv_data1/oa_pdf/fb/c0/dmj-38-51.PMC3950195.pdf
"Keywords:  Blood pressure; Diabetes mellitus; Hypertension; Korea National Health and Nutrition Examination Survey  Corresponding authors:  Y ong-Moon Park Department of Preventive Medicine, The Catholic University of Korea College  of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea;   Department of Epidemiology and Biostatistics, Arnold School of Public Health,  University of South Carolina, 800 Sumter St, Columbia, SC 29208, USA E-mail: markYMpark@gmail.com Bong-Yun Cha  Division of Endocrinology and Metabolism, Department of Internal  Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea College  of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea E-mail: bycha@catholic.ac.kr Received: Nov. 23, 2013; Accepted: Dec. 22, 2013Original Article Epidemiology http://dx.doi.org/10.4093/dmj.2014.38.1.51 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/fb/c0/dmj-38-51.PMC3950195.pdf
Diabetes Metab J 2014;38:51-57 http://e-dmj.orgINTRODUCTION The treatment of hypertension and achievement of target blood  pressure (BP) in type 2 diabetes is important in cardiovascular  outcomes and mortality [1].,Non-OADS,/arxiv_data1/oa_pdf/fb/c0/dmj-38-51.PMC3950195.pdf
"53Hypertension in patients with diabetes in Korea Diabetes Metab J 2014;38:51-57 http://e-dmj.orgbeen changed from BP <130/80 mm Hg to <140/90 mm Hg  [11], we used the previous target BP goal (BP <130/80 mm Hg)  in this analysis for comparison with previously published data.",Non-OADS,/arxiv_data1/oa_pdf/fb/c0/dmj-38-51.PMC3950195.pdf
Diabetes Metab J 2014;38:51-57 http://e-dmj.orglevel was highest in the new-DM group ( P=0.0006).,Non-OADS,/arxiv_data1/oa_pdf/fb/c0/dmj-38-51.PMC3950195.pdf
"55Hypertension in patients with diabetes in Korea Diabetes Metab J 2014;38:51-57 http://e-dmj.orgof hypertension in the 50 years and older age group, the rate  was less than half in the 30 to 49 years age group in patients  with diabetes (Fig.",Non-OADS,/arxiv_data1/oa_pdf/fb/c0/dmj-38-51.PMC3950195.pdf
"Diabetes Metab J 2014;38:51-57 http://e-dmj.orgthis change in prevalence of diabetes, the prevalence of hyper - tension in diabetic subjects was also increased from 51.7% in  2008 (KNHANES-IV) to 54.6% in 2011.",Non-OADS,/arxiv_data1/oa_pdf/fb/c0/dmj-38-51.PMC3950195.pdf
57Hypertension in patients with diabetes in Korea Diabetes Metab J 2014;38:51-57 http://e-dmj.orgcomes in people with diabetes mellitus: results of the HOPE  study and MICRO-HOPE substudy.,Non-OADS,/arxiv_data1/oa_pdf/fb/c0/dmj-38-51.PMC3950195.pdf
Available from: http://www.idf.org/ (updated  2013 Nov 21).,Non-OADS,/arxiv_data1/oa_pdf/fb/c0/dmj-38-51.PMC3950195.pdf
Avail - able from: http://knhanes.cdc.go.kr/ (updated 2013 Nov 21).,Non-OADS,/arxiv_data1/oa_pdf/fb/c0/dmj-38-51.PMC3950195.pdf
Available from: http://kostat.go.kr/ (up - dated 2013 Nov 21).,Non-OADS,/arxiv_data1/oa_pdf/fb/c0/dmj-38-51.PMC3950195.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/2d/dmj-38-58.PMC3950196.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:58-63 Assessment of the Association between Mean  Hemoglobin A1c Levels for 5 Y ears and Coronary  Artery Disease by Coronary Angiography in  Nondiabetic Patients Jae-Joon Kim1, Ji-Hoon Kang1, Ja-Jun Goo1, Kyoung-Nyoun Kim1, Ja-Y oung Lee1, Mi-kyung Kim2, Tae Ik Kim1 1Department of Internal Medicine, Maryknoll Medical Center, Busan,   2Department of Internal Medicine, Inje University College of Medicine, Busan, Korea Background:  The effects of glucose on cardiovascular events or mortality in nondiabetic patients has been recently reported.",Non-OADS,/arxiv_data1/oa_pdf/60/2d/dmj-38-58.PMC3950196.pdf
Original Article Complications http://dx.doi.org/10.4093/dmj.2014.38.1.58 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/60/2d/dmj-38-58.PMC3950196.pdf
"59Mean HbA1c and coronary artery disease in nondiabetic patients  Diabetes Metab J 2014;38:58-63 http://e-dmj.orgPrevious studies that were conducted mainly focused on the  HbA1c levels, but it failed to yield comprehensive results re - garding the effect of chronic changes of vessels, induced by  atherosclerosis, on the glucose level.",Non-OADS,/arxiv_data1/oa_pdf/60/2d/dmj-38-58.PMC3950196.pdf
Diabetes Metab J 2014;38:58-63 http://e-dmj.org5.71%±0.40%; P=0.049) (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/60/2d/dmj-38-58.PMC3950196.pdf
61Mean HbA1c and coronary artery disease in nondiabetic patients  Diabetes Metab J 2014;38:58-63 http://e-dmj.orgDISCUSSION Our study showed that higher mean HbA1c levels for 5 years  might be related to CAD even in nondiabetic subjects.,Non-OADS,/arxiv_data1/oa_pdf/60/2d/dmj-38-58.PMC3950196.pdf
"Diabetes Metab J 2014;38:58-63 http://e-dmj.orgsuch knowledge, our results which demonstrate the correla - tion between HbA1c and CAD but not with fasting glucose  may be consistent to the previous findings in other studies.",Non-OADS,/arxiv_data1/oa_pdf/60/2d/dmj-38-58.PMC3950196.pdf
63Mean HbA1c and coronary artery disease in nondiabetic patients  Diabetes Metab J 2014;38:58-63 http://e-dmj.orgmia a risk factor for cardiovascular disease?,Non-OADS,/arxiv_data1/oa_pdf/60/2d/dmj-38-58.PMC3950196.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/b4/dmj-38-64.PMC3950197.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:64-73 Statin Discontinuation after Achieving a Target Low  Density Lipoprotein Cholesterol Level in Type 2  Diabetic Patients without Cardiovascular Disease:   A Randomized Controlled Study Seung-Hwan Lee1,2, Hyuk-Sang Kwon1,3, Y ong-Moon Park4, Seung-Hyun Ko1,2, Y oon-Hee Choi1,5, Kun-Ho Y oon1,5,   Yu-Bae Ahn1,2 1Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul,  2 Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine,  Suwon,  3 Division of Endocrinology and Metabolism, Department of Internal Medicine, Y eouido St. Mary’s Hospital, The Catholic University of Korea College of  Medicine, Seoul,  4Department of Preventive Medicine, The Catholic University of Korea College of Medicine, Seoul,  5 Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea College of  Medicine, Seoul, Korea Background:  This study investigated the rate of relapse of dyslipidemia and the factors which could predict relapse following a  short-term statin discontinuation after achieving a target low density lipoprotein cholesterol (LDL-C) level in type 2 diabetic pa - tients without cardiovascular disease (CVD).",Non-OADS,/arxiv_data1/oa_pdf/cc/b4/dmj-38-64.PMC3950197.pdf
"Based on these evidenc - es, recent guidelines now recommend stricter control of lipid Original Article Clinical Care/Education http://dx.doi.org/10.4093/dmj.2014.38.1.64 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/cc/b4/dmj-38-64.PMC3950197.pdf
65Statin discontinuation in type 2 diabetic patients Diabetes Metab J 2014;38:64-73 http://e-dmj.orglevels.,Non-OADS,/arxiv_data1/oa_pdf/cc/b4/dmj-38-64.PMC3950197.pdf
"Diabetes Metab J 2014;38:64-73 http://e-dmj.orgmeasured using a selective inhibition method (Daiichi, Tokyo,  Japan), and LDL-C levels were measured using a direct enzy - matic assay (Daiichi).",Non-OADS,/arxiv_data1/oa_pdf/cc/b4/dmj-38-64.PMC3950197.pdf
67Statin discontinuation in type 2 diabetic patients Diabetes Metab J 2014;38:64-73 http://e-dmj.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/cc/b4/dmj-38-64.PMC3950197.pdf
Diabetes Metab J 2014;38:64-73 http://e-dmj.orghigher in the relapse group.,Non-OADS,/arxiv_data1/oa_pdf/cc/b4/dmj-38-64.PMC3950197.pdf
69Statin discontinuation in type 2 diabetic patients Diabetes Metab J 2014;38:64-73 http://e-dmj.orgportant factors associated with a relapse of dyslipidemia.,Non-OADS,/arxiv_data1/oa_pdf/cc/b4/dmj-38-64.PMC3950197.pdf
Diabetes Metab J 2014;38:64-73 http://e-dmj.org30-day follow-up period.,Non-OADS,/arxiv_data1/oa_pdf/cc/b4/dmj-38-64.PMC3950197.pdf
"71Statin discontinuation in type 2 diabetic patients Diabetes Metab J 2014;38:64-73 http://e-dmj.orgplaque stabilization, and anti-inflammatory and antioxidant  effects [17].",Non-OADS,/arxiv_data1/oa_pdf/cc/b4/dmj-38-64.PMC3950197.pdf
Diabetes Metab J 2014;38:64-73 http://e-dmj.orgREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/cc/b4/dmj-38-64.PMC3950197.pdf
"73Statin discontinuation in type 2 diabetic patients Diabetes Metab J 2014;38:64-73 http://e-dmj.orgDeMicco DA, Barter P , Cannon CP , Sabatine MS, Braunwald  E, Kastelein JJ, de Lemos JA, Blazing MA, Pedersen TR, Tik - kanen MJ, Sattar N, Ray KK.",Non-OADS,/arxiv_data1/oa_pdf/cc/b4/dmj-38-64.PMC3950197.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/08/dmj-38-74.PMC3950198.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:74-80 Women Are Diagnosed with Type 2 Diabetes at Higher  Body Mass Indices and Older Ages than Men: Korea  National Health and Nutrition Examination Survey  2007–2010 Su Kyoung Kwon Department of Endocrinology and Metabolism, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea Background:  Many epidemiologic studies have shown that women with type 2 diabetes have an increased risk of developing car - diovascular disease compared with men with diabetes.",Non-OADS,/arxiv_data1/oa_pdf/0f/08/dmj-38-74.PMC3950198.pdf
"However,  this gender difference in CVD risk is lessened in diabetic groups  [12-14], and there have been several studies demonstrating that  the relative risk of CVD in type 2 diabetes is greater in women Original Article Obesity and Metabolic Syndrome http://dx.doi.org/10.4093/dmj.2014.38.1.74 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/0f/08/dmj-38-74.PMC3950198.pdf
"75Gender differences of adiposity at the diagnosis of diabetes Diabetes Metab J 2014;38:74-80 http://e-dmj.orgthan men [15,16].",Non-OADS,/arxiv_data1/oa_pdf/0f/08/dmj-38-74.PMC3950198.pdf
76Kwon SK Diabetes Metab J 2014;38:74-80 http://e-dmj.org Blood samples were drawn in the fasting state after a mini - mum 8-hour fast.,Non-OADS,/arxiv_data1/oa_pdf/0f/08/dmj-38-74.PMC3950198.pdf
"77Gender differences of adiposity at the diagnosis of diabetes Diabetes Metab J 2014;38:74-80 http://e-dmj.orgP=0.002) in women and 29.015-0.072×age (year) (95% CI,  -0.105 to 0.039; P<0.001) in men according to linear regres - sion analysis.",OADS,/arxiv_data1/oa_pdf/0f/08/dmj-38-74.PMC3950198.pdf
"78Kwon SK Diabetes Metab J 2014;38:74-80 http://e-dmj.orga steeper inverse relationship in women than in men (-0.18 [95%  CI, -0.18 to -0.17] in women; -0.12 [95% CI, -0.13 to -0.12] in  men) [23].",Non-OADS,/arxiv_data1/oa_pdf/0f/08/dmj-38-74.PMC3950198.pdf
"79Gender differences of adiposity at the diagnosis of diabetes Diabetes Metab J 2014;38:74-80 http://e-dmj.orgaffect the results, but the trends in those groups are consistent  with other age groups, and the results are not expected to  change by adding more subjects.",Non-OADS,/arxiv_data1/oa_pdf/0f/08/dmj-38-74.PMC3950198.pdf
80Kwon SK Diabetes Metab J 2014;38:74-80 http://e-dmj.orgwith diabetes and established coronary heart disease.,Non-OADS,/arxiv_data1/oa_pdf/0f/08/dmj-38-74.PMC3950198.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/cf/dmj-38-81.PMC3950199.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:81-82 Predicting Mortality of Critically Ill Patients by Blood  Glucose Levels ( Diabetes Metab J  2013;37:385‐90) Byung Sam Park, Ji Sung Y oon Department of Internal Medicine, Y eungnam University College of Medicine, Daegu, Korea Corresponding author: Ji Sung Y oon Department of Internal Medicine, Y eungnam University College of Medicine,  170 Hyeonchung-ro, Nam-gu, Daegu 705-717, Korea E-mail: jsyoon9@ynu.ac.krWe appreciate your interests and comments on our study,  “Predicting mortality of critically ill patients by blood glucose  levels” which was published in Diabetes & Metabolism Journal   2013;37:385‐90 [1].",Non-OADS,/arxiv_data1/oa_pdf/e0/cf/dmj-38-81.PMC3950199.pdf
Predicting mor -Response   http://dx.doi.org/10.4093/dmj.2014.38.1.81 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/e0/cf/dmj-38-81.PMC3950199.pdf
Diabetes Metab J 2014;38:81-82 http://e-dmj.orgtality of critically ill patients by blood glucose levels.,Non-OADS,/arxiv_data1/oa_pdf/e0/cf/dmj-38-81.PMC3950199.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/ff/dmj-38-83.PMC3950200.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:83-84 Subclinical Hypothyroidism Is Independently  Associated with Microalbuminuria in a Cohort of  Prediabetic Egyptian Adults   (Diabetes Metab J  2013;37:450-7) In-Kyung Jeong Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea Corresponding author: In-Kyung Jeong Department of Endocrinology and Metabolism, Kyung Hee University  School of Medicine, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-701,  Korea E-mail: jik1016@dreamwiz.comDear Editor ,  It was with great interest that I read the article entitled “Sub - clinical hypothyroidism is independently associated with mi - croalbuminuria in a cohort of prediabetic Egyptian adults” by  El-Eshmawy et al.",Non-OADS,/arxiv_data1/oa_pdf/b2/ff/dmj-38-83.PMC3950200.pdf
[7] demonstrated the Letter http://dx.doi.org/10.4093/dmj.2014.38.1.83 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/b2/ff/dmj-38-83.PMC3950200.pdf
"84Jeong I-K Diabetes Metab J 2014;38:83-84 http://e-dmj.orgassociation between SCH and diabetic retinopathy, but not  with nephropathy.",Non-OADS,/arxiv_data1/oa_pdf/b2/ff/dmj-38-83.PMC3950200.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/1a/dmj-38-85.PMC3950201.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:85-86 Subclinical Hypothyroidism Is Independently  Associated with Microalbuminuria in a Cohort of  Prediabetic Egyptian Adults   (Diabetes Metab J  2013;37:450-7) Mervat M. El-Eshmawy1, Hala A. Abd El-Hafez1, Walaa Othman El Shabrawy2, Ibrahim A. Abdel Aal2 Departments of 1Internal Medicine, 2Clinical Pathology, Specialized Medical Hospital, Mansoura University Faculty of Medicine, Mansoura, Egypt Corresponding author: Mervat M. El-Eshmawy Department of Internal Medicine, Specialized Medical Hospital, Mansoura  University Faculty of Medicine, Elgomhoria St., Mansoura 35516, Egypt E-mail: mervat2040@yahoo.comWe sincerely appreciate the interest and comments regarding  our study, “Subclinical hypothyroidism is independently asso - ciated with microalbuminuria in a cohort of prediabetic Egyp - tian adults” which was published in Diabetes & Metabolism  Journal 2013;37:450-7 .",Non-OADS,/arxiv_data1/oa_pdf/e1/1a/dmj-38-85.PMC3950201.pdf
CONFLICTS OF INTEREST No potential conflict of interest relevant to this article was re - ported.Response http://dx.doi.org/10.4093/dmj.2014.38.1.85 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/e1/1a/dmj-38-85.PMC3950201.pdf
Diabetes Metab J 2014;38:85-86 http://e-dmj.orgREFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/e1/1a/dmj-38-85.PMC3950201.pdf
"ReviewISSN 1738-5997(Print) • ISSN 2092-9935(Online) Electrolyte Blood Press 11:41-45, 2013  http://dx.doi.org/10.5049/EBP.2013.11.2.41 Copyright © 2013 The Korean Society of Electrolyte MetabolismRecent Update of Renin-angiotensin-aldosterone  System in the Pathogenesis of Hypertension Ju-Young Moon, M.D.",Non-OADS,/arxiv_data1/oa_pdf/6c/19/ebp-11-41.PMC3950224.pdf
"Electrolyte Blood Press 11:41-45, 2013 • http://dx.doi.org/10.5049/EBP.2013.11.2.41 43 Copyright © 2013 The Korean Society of Electrolyte Metabolismbility to bind renin leading to readily undergo a transition  to angiotensin release and increase blood pressure in pre-eclampsia, which is a serious hypertensive complica-tion of pregnancy 7).",Non-OADS,/arxiv_data1/oa_pdf/6c/19/ebp-11-41.PMC3950224.pdf
"Electrolyte Blood Press 11:41-45, 2013 • http://dx.doi.org/10.5049/EBP.2013.11.2.41 45 Copyright © 2013 The Korean Society of Electrolyte Metabolismdiscovery of ACE2 and Ang-(1-7) has modified the way  in which the RAAS is viewed from a purely deleterious system in cardiovascular disease to an useful system to protect target organs.",Non-OADS,/arxiv_data1/oa_pdf/6c/19/ebp-11-41.PMC3950224.pdf
"ReviewISSN 1738-5997(Print) • ISSN 2092-9935(Online) Electrolyte Blood Press 11:46-52, 2013  http://dx.doi.org/10.5049/EBP.2013.11.2.46 Copyright © 2013 The Korean Society of Electrolyte MetabolismObesity Associated Hypertension: New Insights into  Mechanism Young Sun Kang, M.D.",Non-OADS,/arxiv_data1/oa_pdf/03/7c/ebp-11-46.PMC3950225.pdf
"Electrolyte Blood Press 11:46-52, 2013 • http://dx.doi.org/10.5049/EBP.2013.11.2.46 47 Copyright © 2013 The Korean Society of Electrolyte Metabolism Fig.",Non-OADS,/arxiv_data1/oa_pdf/03/7c/ebp-11-46.PMC3950225.pdf
"Electrolyte Blood Press 11:46-52, 2013 • http://dx.doi.org/10.5049/EBP.2013.11.2.46 49 Copyright © 2013 The Korean Society of Electrolyte Metabolism Fig.",Non-OADS,/arxiv_data1/oa_pdf/03/7c/ebp-11-46.PMC3950225.pdf
"Electrolyte Blood Press 11:46-52, 2013 • http://dx.doi.org/10.5049/EBP.2013.11.2.46 51 Copyright © 2013 The Korean Society of Electrolyte Metabolismkines.",Non-OADS,/arxiv_data1/oa_pdf/03/7c/ebp-11-46.PMC3950225.pdf
"Case ReportISSN 1738-5997(Print) • ISSN 2092-9935(Online) Electrolyte Blood Press 11:53-55, 2013  http://dx.doi.org/10.5049/EBP.2013.11.2.53 Copyright © 2013 The Korean Society of Electrolyte MetabolismSevere Hypernatremia by Excessive Bamboo Salt  In g est ion  in  H ealt h y  Y ou n g  W om an Hyun Jun Ju, M.D., Hong Jin Bae, M.D.,  Dae Eun Choi, M.D., Ki Ryang Na, M.D.,  Kang Wook Lee, M.D., Young Tai Shin, M.D.",Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ebp-11-53.PMC3950226.pdf
"Electrolyte Blood Press 11:53-55, 2013 • http://dx.doi.org/10.5049/EBP.2013.11.2.53 55 Copyright © 2013 The Korean Society of Electrolyte MetabolismIn summary, we present here a case of severe hypernat-  remia by excessive bamboo salt ingestion in a healthy young woman with clear consciousness and completely recove- red without any sequalae.",Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ebp-11-53.PMC3950226.pdf
"Case ReportISSN 1738-5997(Print) • ISSN 2092-9935(Online) Electrolyte Blood Press 11:56-59, 2013  http://dx.doi.org/10.5049/EBP.2013.11.2.56 Copyright © 2013 The Korean Society of Electrolyte MetabolismSevere Hyponatremia Associated with the Use o f  Angiotensin II Receptor Blocker/thiazide Combinations Da-Rae Kim, M.D., Joo-Hee Cho, M.D.,  Won-Seok Jang, M.D., Jin-Sug Kim, M.D.,  Kyung-Hwan Jeong, M.D., Tae-Won Lee, M.D.,  Chun-Gyoo Ihm, M.D.",Non-OADS,/arxiv_data1/oa_pdf/8f/23/ebp-11-56.PMC3950227.pdf
"Electrolyte Blood Press 11:56-59, 2013 • http://dx.doi.org/10.5049/EBP.2013.11.2.56 57 Copyright © 2013 The Korean Society of Electrolyte Metabolismdoxomil 40 mg qd, aspirin 100 mg qd, vildagliptin 50 mg  qd and atorvastatin 10 mg qd; the antihypertensive agent was changed to olmesartan/hydrochlorothiazide 20/12.5 mg qd 1 month before presentation.",Non-OADS,/arxiv_data1/oa_pdf/8f/23/ebp-11-56.PMC3950227.pdf
"Electrolyte Blood Press 11:56-59, 2013 • http://dx.doi.org/10.5049/EBP.2013.11.2.56 59 Copyright © 2013 The Korean Society of Electrolyte Metabolismculation.",Non-OADS,/arxiv_data1/oa_pdf/8f/23/ebp-11-56.PMC3950227.pdf
"1 © 2014 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Lung cancer remains the leading cause of cancer-related death  throughout the world.1 Fortunately, outstanding development  in cancer genomics and molecular targeted therapy has allowed  targeted therapy that includes treatment optimization based on molecular testing and target mutation, especially in adenocarci - noma.",Non-OADS,/arxiv_data1/oa_pdf/9a/7d/kjpathol-48-1.PMC3950228.pdf
"Department of Pathology, National Cancer Center,  323 Ilsan-ro, Ilsandong-gu, Goyang 410-769,  Korea Tel: +82-31-920-1746 Fax: +82-31-920-1369 E-mail: gklee@ncc.re.krThe Korean Journal of Pathology  2014; 48: 1-9 http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.1▒ REVIEW ▒",Non-OADS,/arxiv_data1/oa_pdf/9a/7d/kjpathol-48-1.PMC3950228.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.12 • Kim H, et al.",OADS,/arxiv_data1/oa_pdf/9a/7d/kjpathol-48-1.PMC3950228.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.1ALK Testing Guideline • 3 Thus, the CAP-IASLC-AMP guideline does not recommend  ALK testing in lung cancer cases without any adenocarcinoma  component, such as pure squamous cell carcinomas, pure small  cell carcinomas, or large cell carcinomas lacking any IHC evi - dence of adenocarcinoma differentiation.17 Actually, about two-thirds of lung cancer patients present  with advanced stage at the time of diagnosis, and small biopsies  or cytology specimens are the only available samples for diagno - sis and molecular testing.",Non-OADS,/arxiv_data1/oa_pdf/9a/7d/kjpathol-48-1.PMC3950228.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.14 • Kim H, et al.",OADS,/arxiv_data1/oa_pdf/9a/7d/kjpathol-48-1.PMC3950228.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.1ALK Testing Guideline • 5 ies (ALK1, 5A4, and D5F3) that have been studied in depth for  NSCLC.",Non-OADS,/arxiv_data1/oa_pdf/9a/7d/kjpathol-48-1.PMC3950228.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.16 • Kim H, et al.",OADS,/arxiv_data1/oa_pdf/9a/7d/kjpathol-48-1.PMC3950228.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.1ALK Testing Guideline • 7 tional clinicians can be established, ‘reflex molecular testing’ is  recommended to minimize the exhaustion of small biopsy tissue  samples for the necessary molecular tests, and to provide a rapid  determination of the genetic characteristics of NSCLC patients.",Non-OADS,/arxiv_data1/oa_pdf/9a/7d/kjpathol-48-1.PMC3950228.pdf
"There are several accessible  external quality assessment (EQA) programs for the quality as - sessment of molecular testing (e.g., http://lung.eqascheme.org;  http://kras.eqascheme.org; http://www.ukneqas.org.uk; http:// www.emqn.org/emqn/schemes; http://www.quip-ringversuche.",Non-OADS,/arxiv_data1/oa_pdf/9a/7d/kjpathol-48-1.PMC3950228.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.18 • Kim H, et al.",OADS,/arxiv_data1/oa_pdf/9a/7d/kjpathol-48-1.PMC3950228.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.1ALK Testing Guideline • 9 testing in advanced non-small-cell lung cancer.,Non-OADS,/arxiv_data1/oa_pdf/9a/7d/kjpathol-48-1.PMC3950228.pdf
"10 pISSN 1738-1843 eISSN 2092-8920© 2014 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Idiopathic interstitial pneumonia is classified into four cate - gories: usual interstitial pneumonia (UIP), desquamative inter - stitial pneumonia, nonspecific interstitial pneumonia, and acute  interstitial pneumonia.1,2 UIP , which is clinically known as id - iopathic pulmonary fibrosis (IPF), is notorious for its poor prog - nosis, with a median survival of 2.8 to 5 years.3,4 Some studies  have suggested an association between UIP and lung cancer,4-6  but reliable clinical and histological information regarding lung  neoplasms in patients with UIP is scarce due to the rarity of the  simultaneous occurrence of these conditions.",Non-OADS,/arxiv_data1/oa_pdf/02/97/kjpathol-48-10.PMC3950229.pdf
"Department of Pathology, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea Tel: +82-2-3410-2800 Fax: +82-2-3410-0025 E-mail: hanjho@skku.eduThe Korean Journal of Pathology  2014; 48: 10-16 http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.10▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/02/97/kjpathol-48-10.PMC3950229.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.10UIP with Lung Cancer • 11 of lung cancer (e.g., a CFP of zero means UIP and lung cancer  were diagnosed at the same time).",Non-OADS,/arxiv_data1/oa_pdf/02/97/kjpathol-48-10.PMC3950229.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.1012 • Song DH, et al.",OADS,/arxiv_data1/oa_pdf/02/97/kjpathol-48-10.PMC3950229.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.10UIP with Lung Cancer • 13 phages in the air spaces and interstitia.,Non-OADS,/arxiv_data1/oa_pdf/02/97/kjpathol-48-10.PMC3950229.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.1014 • Song DH, et al.",OADS,/arxiv_data1/oa_pdf/02/97/kjpathol-48-10.PMC3950229.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.10UIP with Lung Cancer • 15 mous cell carcinoma antigens in IPF.,Non-OADS,/arxiv_data1/oa_pdf/02/97/kjpathol-48-10.PMC3950229.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.1016 • Song DH, et al.",OADS,/arxiv_data1/oa_pdf/02/97/kjpathol-48-10.PMC3950229.pdf
"17 © 2014 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Phosphatase and tensin homolog on chromosome ten (PTEN)  is a regulator of signaling and plays a crucial role in inducing  apoptosis and regulating cell adhesion, proliferation, migration,  and angiogenesis through interference with the phosphoinosit - ide-3 kinase (PI3K) signaling pathway.1-3 It is known that loss of  PTEN expression plays an important role in tumorigenesis and  is associated with lymph node metastasis, tumor grade, and stage  in several different human malignancies including lung cancer.4-9  Several mechanisms such as genetic mutation, promoter methyl - ation, and post-transcriptional modification, may contribute to  PTEN  inactivation.10 Although mutation of the PTEN  gene is  rare in non-small cell lung cancer (NSCLC),11 the lack of PTEN  protein is a common event in NSCLC, which indicates that epi - genetic mechanisms such as post-transcriptional modification by  microRNA (miRNA) may participate in PTEN  inactivation.",Non-OADS,/arxiv_data1/oa_pdf/cd/15/kjpathol-48-17.PMC3950230.pdf
"Department of Pathology, Dong-A University College  of Medicine, 26 Daesingongwon-ro, Seo-gu,   Busan 602-715, Korea Tel: +82-51-240-2833 Fax: +82-51-243-7396 E-mail: msroh@dau.ac.krThe Korean Journal of Pathology  2014; 48: 17-23 http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.17▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/cd/15/kjpathol-48-17.PMC3950230.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.1718 • Lee HW, et al.",Non-OADS,/arxiv_data1/oa_pdf/cd/15/kjpathol-48-17.PMC3950230.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.17PTEN and miR-21 Expression in Pulmonary NE Tumors • 19 ABI PRISM 7000 Sequence Detection System (Applied Biosys - tems).,OADS,/arxiv_data1/oa_pdf/cd/15/kjpathol-48-17.PMC3950230.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.1720 • Lee HW, et al.",Non-OADS,/arxiv_data1/oa_pdf/cd/15/kjpathol-48-17.PMC3950230.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.17PTEN and miR-21 Expression in Pulmonary NE Tumors • 21 significant difference between AC and SCLC (p =.069 in present  study vs p =.044 in previous study).,Non-OADS,/arxiv_data1/oa_pdf/cd/15/kjpathol-48-17.PMC3950230.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.1722 • Lee HW, et al.",OADS,/arxiv_data1/oa_pdf/cd/15/kjpathol-48-17.PMC3950230.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.17PTEN and miR-21 Expression in Pulmonary NE Tumors • 23 netics of tumours of the lung, pleura, thymus and heart.",OADS,/arxiv_data1/oa_pdf/cd/15/kjpathol-48-17.PMC3950230.pdf
"24 pISSN 1738-1843 eISSN 2092-8920© 2014 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Many studies have reported human papillomavirus (HPV) as  the main cause of cervical cancer.",Non-OADS,/arxiv_data1/oa_pdf/3d/e6/kjpathol-48-24.PMC3950231.pdf
"Key Words:  HPV 52; HPV 58; Cyclin-dependent kinase inhibitor p16; Tumor suppressor protein  p53; Cervical neoplasiaReceived:  September 30, 2013 Revised:  February 7, 2014 Accepted:  February 10, 2014 Corresponding Author Kyung Eun Lee, Ph.D. Department of Clinical Laboratory Science, College  of Health Sciences, Catholic University of Pusan,   57 Oryundae-ro, Geumjeong-gu, Busan 609-757,  Korea Tel: +82-51-510-0562 Fax: +82-51-510-0568 E-mail: kelee@cup.ac.krThe Korean Journal of Pathology  2014; 48: 24-29 http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.24▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/3d/e6/kjpathol-48-24.PMC3950231.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.24HPV 52 and 58 Genotypes • 25 MATERIALS AND METHODS Patients and tissue samples We examined three hundred fifteen cases of liquid-based cy - tology, and all samples were taken with a cervical brush during a  gynecological examination for HPV DNA testing between Jan - uary 2011 and December 2011.",Non-OADS,/arxiv_data1/oa_pdf/3d/e6/kjpathol-48-24.PMC3950231.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.2426 • Kim TE, et al.",OADS,/arxiv_data1/oa_pdf/3d/e6/kjpathol-48-24.PMC3950231.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.24HPV 52 and 58 Genotypes • 27 p16 immunoreactivity also showed negative p53 expression, al - though p16 overexpression was not significantly associated  with the loss of p53 protein (p >.05) (Table 3, Fig.",Non-OADS,/arxiv_data1/oa_pdf/3d/e6/kjpathol-48-24.PMC3950231.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.2428 • Kim TE, et al.",OADS,/arxiv_data1/oa_pdf/3d/e6/kjpathol-48-24.PMC3950231.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.24HPV 52 and 58 Genotypes • 29 residual disease after conization with positive margins.,Non-OADS,/arxiv_data1/oa_pdf/3d/e6/kjpathol-48-24.PMC3950231.pdf
"30 pISSN 1738-1843 eISSN 2092-8920© 2014 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Papillary thyroid carcinoma (PTC) is the most common thy - roid cancer and represents the first most prevalent malignancy  in Korea, especially in Korean women.1 PTC often occurs in  conjunction with Hashimoto’s thyroiditis (HT), which is a  common form of chronic autoimmune thyroid disease and clin - ically characterized by circulating autoantibodies to primary  thyroid antigens including thyroglobulin and thyroid peroxi - dase.2 HT is pathologically characterized by the presence of dif - fuse plasma and lymphocytic cell infiltration, oxyphilic cells,  the formation of lymphoid follicles and reactive germinal cen - ters, and parenchymal atrophy.3 The pathogenesis of PTC coex -isting with HT is uncertain.",Non-OADS,/arxiv_data1/oa_pdf/91/41/kjpathol-48-30.PMC3950232.pdf
"Department of Pathology, Kangdong Sacred Heart  Hospital, Hallym University College of Medicine,  150 Seongan-ro, Gangdong-gu, Seoul 134-701,  Korea Tel : +82-2-2224-2325 Fax: +82-2-2224-2471 E-mail: shinn7064@hanmail.netThe Korean Journal of Pathology  2014; 48: 30-35 http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.30▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/91/41/kjpathol-48-30.PMC3950232.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.30P2X 7 Receptor Expression in Papillary Thyroid Carcinoma • 31 cell survival and growth.,Non-OADS,/arxiv_data1/oa_pdf/91/41/kjpathol-48-30.PMC3950232.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.3032 • Kwon JH, et al.",OADS,/arxiv_data1/oa_pdf/91/41/kjpathol-48-30.PMC3950232.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.30P2X 7 Receptor Expression in Papillary Thyroid Carcinoma • 33 Expression of P2X 7R in PTC with or without HT High P2X 7R expression was significantly associated with an  absence of HT (OR, 5.43; 95% CI, 2.45 to 12; p <.001).",Non-OADS,/arxiv_data1/oa_pdf/91/41/kjpathol-48-30.PMC3950232.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.3034 • Kwon JH, et al.",OADS,/arxiv_data1/oa_pdf/91/41/kjpathol-48-30.PMC3950232.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.30P2X 7 Receptor Expression in Papillary Thyroid Carcinoma • 35 predict a favorable tumor behavior such as less tumor multifo - cality, lymphovascular invasion, and extrathyroid extension,  compared to those having PTC without HT.",Non-OADS,/arxiv_data1/oa_pdf/91/41/kjpathol-48-30.PMC3950232.pdf
"36 pISSN 1738-1843 eISSN 2092-8920© 2014 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.The use of molecular pathologic diagnosis for managing can - cer patients has rapidly increased.",Non-OADS,/arxiv_data1/oa_pdf/b6/b4/kjpathol-48-36.PMC3950233.pdf
"Department of Pathology, Seoul National University  Bundang Hospital, 82 Gumi-ro 173beon-gil,  Bundang-gu, Seongnam 463-707, Korea  Tel: +82-31-787-7714 Fax: +82-31-787-4012 E-mail: hye2@snu.ac.krThe Korean Journal of Pathology  2014; 48: 36-42 http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.36▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/b6/b4/kjpathol-48-36.PMC3950233.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.36Effects of Fixation and Storage on Nucleic Acids • 37 also evaluated the effects of duration of fixation, decalcification,  and storage time on the integrity of the nucleic acids.",OADS,/arxiv_data1/oa_pdf/b6/b4/kjpathol-48-36.PMC3950233.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.3638 • Nam SK, et al.",OADS,/arxiv_data1/oa_pdf/b6/b4/kjpathol-48-36.PMC3950233.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.36Effects of Fixation and Storage on Nucleic Acids • 39 to investigate the effects of storage time on DNA preservation.,OADS,/arxiv_data1/oa_pdf/b6/b4/kjpathol-48-36.PMC3950233.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.3640 • Nam SK, et al.",OADS,/arxiv_data1/oa_pdf/b6/b4/kjpathol-48-36.PMC3950233.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.36Effects of Fixation and Storage on Nucleic Acids • 41 In various cancer specimens including papillary thyroid car - cinoma, mucinous adenocarcinoma, as well as some bone and  soft tissue tumor dystrophic calcification, is observed.",Non-OADS,/arxiv_data1/oa_pdf/b6/b4/kjpathol-48-36.PMC3950233.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.3642 • Nam SK, et al.",OADS,/arxiv_data1/oa_pdf/b6/b4/kjpathol-48-36.PMC3950233.pdf
"43 © 2014 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Uterine cervical cancer is the second most common female  malignancy worldwide1 and cervical cancer remains a major  health problem in Korea, although the incidence has shown a  decreasing trend due to the high quality of the national health  project for cervical cancer screening and development of cervical  vaccines.2 Regarding uterine cervical carcinogenesis, human  papillomavirus (HPV) is one of the most important oncogenic  causes in cervical carcinomas.3 HPV is a double-stranded DNA  virus infecting basal epithelial cells of cutaneous or mucosal tis - sues.4 Epidemiologic investigations have clearly established a  causal link between HPV infection and development of cervical  cancer, and recent use of a sensitive molecular method for detec - tion of HPV DNA revealed HPV infection in more than 80%  of squamous intraepithelial lesions.3,5 More than 140 different  HPV genotypes have been identified and sequenced, and ap -proximately 40 HPV genotypes are known to act as oncogenic  genotypes.",Non-OADS,/arxiv_data1/oa_pdf/5f/1d/kjpathol-48-43.PMC3950234.pdf
"Department of Pathology, Gachon University Gil  Medical Center, 21 Namdong-daero 774beon-gil,  Namdong-gu, Incheon 405-760, Korea  Tel: +82-32-460-3865 Fax: +82-32-460-2394 E-mail: hicho@gilhospital.com *Na Rae Kim and Myunghee Kang contributed  equally to this work.The Korean Journal of Pathology  2014; 48: 43-49 http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.43▒ ORIGINAL ARTICLE ▒",Non-OADS,/arxiv_data1/oa_pdf/5f/1d/kjpathol-48-43.PMC3950234.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.4344 • Kim NR, et al.",OADS,/arxiv_data1/oa_pdf/5f/1d/kjpathol-48-43.PMC3950234.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.43Rare and Uncommon HPV Types in Cervical Carcinomas • 45 RESULTS Overall prevalence of rare and uncommon HPV types  relating to the cytologic or histologic diagnosis A total of 447 cases comprised groups 2A, 2B, 3, and unclas - sified HPV genotypes in cases excluding group 1-coinfection  (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/5f/1d/kjpathol-48-43.PMC3950234.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.4346 • Kim NR, et al.",OADS,/arxiv_data1/oa_pdf/5f/1d/kjpathol-48-43.PMC3950234.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.43Rare and Uncommon HPV Types in Cervical Carcinomas • 47 with two types, three types, four types, and more than five types  were 13.3% (421/3,164), 1.9% (59/3,164), 0.4% (14/3,164),  and 0.1% (3/3,164), respectively.",Non-OADS,/arxiv_data1/oa_pdf/5f/1d/kjpathol-48-43.PMC3950234.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.4348 • Kim NR, et al.",OADS,/arxiv_data1/oa_pdf/5f/1d/kjpathol-48-43.PMC3950234.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.43Rare and Uncommon HPV Types in Cervical Carcinomas • 49 intraepithelial lesions.,Non-OADS,/arxiv_data1/oa_pdf/5f/1d/kjpathol-48-43.PMC3950234.pdf
"50 pISSN 1738-1843 eISSN 2092-8920© 2014 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Sertoli cell tumors represent about 1% of all testicular tu - mors.",Non-OADS,/arxiv_data1/oa_pdf/7d/90/kjpathol-48-50.PMC3950235.pdf
"Department of Pathology, Gyeongsang National  University School of Medicine, 15 Jinju-daero  816beon-gil, Jinju 660-751, Korea Tel: +82-55-751-8763 Fax: +82-55-759-7952 E-mail: jongsil25@dreamwiz.comThe Korean Journal of Pathology  2014; 48: 50-53 http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.50▒ CASE STUDY ▒",Non-OADS,/arxiv_data1/oa_pdf/7d/90/kjpathol-48-50.PMC3950235.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.50Large Cell Calcifying Sertoli Cell Tumor of the Testis  • 51 crosis, Reinke crystalloids, or lipofuscin pigment were present,  and the fibrotic stroma appeared benign.",Non-OADS,/arxiv_data1/oa_pdf/7d/90/kjpathol-48-50.PMC3950235.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.5052 • Song DH, et al.",OADS,/arxiv_data1/oa_pdf/7d/90/kjpathol-48-50.PMC3950235.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.50Large Cell Calcifying Sertoli Cell Tumor of the Testis  • 53 probably because of decalcification.,Non-OADS,/arxiv_data1/oa_pdf/7d/90/kjpathol-48-50.PMC3950235.pdf
"54 pISSN 1738-1843 eISSN 2092-8920© 2014 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Primary leiomyoma of the abdominal organs is common in  the uterus and gastrointestinal tract; however, it rarely origi - nates in the liver, and very few cases have been reported.1-9  Moreover, a primary “myxoid” leiomyoma of the liver is ex - tremely rare.",Non-OADS,/arxiv_data1/oa_pdf/70/97/kjpathol-48-54.PMC3950236.pdf
"Department of Pathology, Korea Cancer Center  Hospital, Korea Institute of Radiological and Medical  Sciences, 75 Nowon-ro, Nowon-gu,   Seoul 139-706, Korea Tel: +82-2-970-2545 Fax: +82-2-970-2430 E-mail: sunhoo@kcch.re.krThe Korean Journal of Pathology  2014; 48: 54-57 http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.54▒ CASE STUDY ▒",Non-OADS,/arxiv_data1/oa_pdf/70/97/kjpathol-48-54.PMC3950236.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.54Primary Hepatic Myxoid Leiomyoma • 55 for smooth muscle actin (SMA) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/70/97/kjpathol-48-54.PMC3950236.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.5456 • Choi HS, et al.",OADS,/arxiv_data1/oa_pdf/70/97/kjpathol-48-54.PMC3950236.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.54Primary Hepatic Myxoid Leiomyoma • 57 liver.,Non-OADS,/arxiv_data1/oa_pdf/70/97/kjpathol-48-54.PMC3950236.pdf
"58 pISSN 1738-1843 eISSN 2092-8920© 2014 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Metastasis to the breast from extramammary sites is uncom - mon with fewer than 400 cases reported in the literature ac - cording to one study.1 Carcinoma in the contralateral breast and  malignant melanoma are the most common primary cancers  that metastasize to the breast, followed by lung, prostate, and  stomach cancers.2,3 Metastasis from primary colorectal cancer is  highly unusual and presents at a median age of 54 years.4  We report the first occurrence in our experience of a young,  28-year-old female who presented with a solitary breast lump  from a concurrent colorectal primary tumor.",Non-OADS,/arxiv_data1/oa_pdf/6d/f4/kjpathol-48-58.PMC3950237.pdf
"Specialty Training Registrar, Royal Oldham Hospital,  Rochdale Rd, Oldham, OL1 2JH, UK Tel: +44-7947567907 Fax: +44-1616278745 E-mail: amnahamid@doctors.org.ukThe Korean Journal of Pathology  2014; 48: 58-61 http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.58▒ CASE STUDY ▒",Non-OADS,/arxiv_data1/oa_pdf/6d/f4/kjpathol-48-58.PMC3950237.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.58Primary Sigmoid Adenocarcinoma Metastasis to the Breast • 59 glandular structures with epithelial stratification, and focal  cribriform formations.",Non-OADS,/arxiv_data1/oa_pdf/6d/f4/kjpathol-48-58.PMC3950237.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.5860 • Ahmad A, et al.",Non-OADS,/arxiv_data1/oa_pdf/6d/f4/kjpathol-48-58.PMC3950237.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.58Primary Sigmoid Adenocarcinoma Metastasis to the Breast • 61 prognosis with a survival rate of less than 12 months from the  time of breast tumor diagnosis.5,13 Patient management is com - plex and depends upon multiple factors, including extent of the  primary tumor, lymph node status, distant metastasis, age, and  other comorbidities.",Non-OADS,/arxiv_data1/oa_pdf/6d/f4/kjpathol-48-58.PMC3950237.pdf
"62 pISSN 1738-1843 eISSN 2092-8920© 2014 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Duplications in the alimentary tract are uncommon congeni - tal abnormalities that may occur anywhere from the oral cavity  to the anus, with the ileum being the most common site.1 Ma- lignant change in a duplication is extremely rare.",Non-OADS,/arxiv_data1/oa_pdf/56/8d/kjpathol-48-62.PMC3950238.pdf
"DISCUSSION Duplications are rare congenital anomalies that may occur The Korean Journal of Pathology  2014; 48: 62-65 http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.62▒ BRIEF CASE REPORT ▒ Corresponding Author Hyun Yee Cho, M.D.",Non-OADS,/arxiv_data1/oa_pdf/56/8d/kjpathol-48-62.PMC3950238.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.62Adenocarcinoma Arising in a Colonic Duplication • 63 anywhere along the alimentary tract.1 The most common site of  involvement is the ileum.,Non-OADS,/arxiv_data1/oa_pdf/56/8d/kjpathol-48-62.PMC3950238.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.6264 • Kang M, et al.",OADS,/arxiv_data1/oa_pdf/56/8d/kjpathol-48-62.PMC3950238.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.62Adenocarcinoma Arising in a Colonic Duplication • 65 tion.,Non-OADS,/arxiv_data1/oa_pdf/56/8d/kjpathol-48-62.PMC3950238.pdf
"66 pISSN 1738-1843 eISSN 2092-8920© 2014 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Pulmonary papillary adenoma may be an unusual neoplasm  of the lung.",Non-OADS,/arxiv_data1/oa_pdf/47/1e/kjpathol-48-66.PMC3950239.pdf
"We add a case of papillary adenoma that The Korean Journal of Pathology  2014; 48: 66-68 http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.66▒ BRIEF CASE REPORT ▒ Corresponding Author Joungho Han, M.D.",Non-OADS,/arxiv_data1/oa_pdf/47/1e/kjpathol-48-66.PMC3950239.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.66Pulmonary Papillary Adenoma Mimicking Carcinoid Tumor • 67 occurred in a 68-year-old woman.,Non-OADS,/arxiv_data1/oa_pdf/47/1e/kjpathol-48-66.PMC3950239.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.6668 • Choi IH, et al.",OADS,/arxiv_data1/oa_pdf/47/1e/kjpathol-48-66.PMC3950239.pdf
"69 © 2014 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Fat-forming solitary fibrous tumor (SFT), previously known  as lipomatous hemangiopericytoma, was described as an un - common variant of extrapleural SFT in the 2013 World Health  Organization (WHO) classification of soft tissue tumors.1 Fat- forming SFT is an uncommon, slow-growing neoplasm and is  characterized by the typical histologic features of SFT with a  mature adipocytic component.",Non-OADS,/arxiv_data1/oa_pdf/8d/96/kjpathol-48-69.PMC3950240.pdf
"DISCUSSION A SFT with a lipomatous component was initially termed li - pomatous hemangiopericytoma as an unusual variant of a The Korean Journal of Pathology  2014; 48: 69-72 http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.69▒ BRIEF CASE REPORT ▒ Corresponding Author Kyu Yun Jang, M.D.",Non-OADS,/arxiv_data1/oa_pdf/8d/96/kjpathol-48-69.PMC3950240.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.6970 • Noh SJ, et al.",OADS,/arxiv_data1/oa_pdf/8d/96/kjpathol-48-69.PMC3950240.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.69Malignant Fat-Forming Solitary Fibrous Tumor • 71 cally nonrecurring and nonmetastasizing benign tumors, they  can show malignant histologic features and malignant behav - ior.2-5 Reported cases of malignant fat-forming SFTs revealed  that men and women are equally affected, that the age of pa - tients ranged from 20 to 93 years, and that the maximal size of  a malignant tumor was 20 cm (range, 3.4 to 20 cm).",Non-OADS,/arxiv_data1/oa_pdf/8d/96/kjpathol-48-69.PMC3950240.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.6972 • Noh SJ, et al.",OADS,/arxiv_data1/oa_pdf/8d/96/kjpathol-48-69.PMC3950240.pdf
"73 © 2014 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920The gastrointestinal (GI) tract is the most common site of  primary extranodal lymphomas.",Non-OADS,/arxiv_data1/oa_pdf/ca/cf/kjpathol-48-73.PMC3950241.pdf
"Laboratory tests  showed mild leukocytosis (white blood cell count, 12,540/µL)  with a differential count within normal range, anemia (hemo -The Korean Journal of Pathology  2014; 48: 73-76 http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.73▒ BRIEF CASE REPORT ▒ Corresponding Author Yoon Kyung Jeon, M.D.",Non-OADS,/arxiv_data1/oa_pdf/ca/cf/kjpathol-48-73.PMC3950241.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.7374 • Koh J, et al.",OADS,/arxiv_data1/oa_pdf/ca/cf/kjpathol-48-73.PMC3950241.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.73NK-Cell Enteropathy • 75 pria.,Non-OADS,/arxiv_data1/oa_pdf/ca/cf/kjpathol-48-73.PMC3950241.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.7376 • Koh J, et al.",OADS,/arxiv_data1/oa_pdf/ca/cf/kjpathol-48-73.PMC3950241.pdf
"77 © 2014 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1738-1843 eISSN 2092-8920Microcystic meningioma is an unusual type of meningioma  that has been described under various names including humid,  myxomatous, vacuolated, or arachnoid trabecular cell meningi - oma.1 Histologically, microcystic meningiomas are character - ized by numerous cystic spaces filled with edematous fluid and  intermixed meningothelial cells of stellate or spider shape.",Non-OADS,/arxiv_data1/oa_pdf/11/e1/kjpathol-48-77.PMC3950242.pdf
"The fibrotic area was composed of fibrous nodules and collagen The Korean Journal of Pathology  2014; 48: 77-80 http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.77▒ BRIEF CASE REPORT ▒ Corresponding Author Na Rae Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/11/e1/kjpathol-48-77.PMC3950242.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.7778 • Seok JY, et al.",OADS,/arxiv_data1/oa_pdf/11/e1/kjpathol-48-77.PMC3950242.pdf
http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.77Sclerosing Variant of Microcystic Meningioma • 79 Fig.,Non-OADS,/arxiv_data1/oa_pdf/11/e1/kjpathol-48-77.PMC3950242.pdf
"http://www.koreanjpathol.org http://dx.doi.org/10.4132/KoreanJPathol.2014.48.1.7780 • Seok JY, et al.",OADS,/arxiv_data1/oa_pdf/11/e1/kjpathol-48-77.PMC3950242.pdf
"2014 January;20(1):1-2.  http://dx.doi.org/10.4258/hir.2014.20.1.1 pISSN 2093-3681  •  eISSN 2093-369X  Editorial This	is	an	Open	Access	article	distributed	under	the	terms	of	the	Creative	Com - mons	Attribution	Non-Commercial	License	(http://creativecommons.org/licenses/by- nc/3.0/)	which	permits	unrestricted	non-commercial	use,	distribution,	and	reproduc - tion	in	any	medium,	provided	the	original	work	is	properly	cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/a1/hir-20-1.PMC3950259.pdf
"2 www.e-hir.orgJu Han Kim http://dx.doi.org/10.4258/hir.2014.20.1.1  This issue introduces some of the successful distributed  agents that have been developed by using the open HAP  APIs and providing healthcare services to users by access - ing and analyzing clinical, genomic and lifelog data of their  CCR+.",Non-OADS,/arxiv_data1/oa_pdf/dc/a1/hir-20-1.PMC3950259.pdf
"2014 January;20(1):11-22.  http://dx.doi.org/10.4258/hir.2014.20.1.11 pISSN 2093-3681  •  eISSN 2093-369X  Review Article Submitted: 	December	21,	2013 Accepted: 	January	16,	2014 Corresponding Author  Thomas	Karopka,	Dipl.-Ing.",Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
"Tel:	+49-3834-515303, 	Fax:	+49-3834-515102,	 E-mail:	TKaropka@gmail.com	 This	is	an	Open	Access	article	distributed	under	the	terms	of	the	Creative	Com - mons	Attribution	Non-Commercial	License	(http://creativecommons.org/licenses/by- nc/3.0/)	which	permits	unrestricted	non-commercial	use,	distribution,	and	reproduc - tion	in	any	medium,	provided	the	original	work	is	properly	cited.",Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
12 www.e-hir.orgThomas Karopka et al http://dx.doi.org/10.4258/hir.2014.20.1.1 1Especially in times of financial crisis and austerity the adop - tion of FLOSS principles opens interesting alternatives and  options to tremendously lower total cost of ownership (TCO)  and open the way for a continuous user-driven improvement  process.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
14 www.e-hir.orgThomas Karopka et al http://dx.doi.org/10.4258/hir.2014.20.1.1 1  Vest and Stephens [45] have questioned CIOs of hospitals  in the United States about the use and perception of open  source software health information technology.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
"Resources for Free/Libre Open Source Software (FLOSS) on the Web Name Type URL Region served OpenHealthNews News/resource http://www.openhealthnews.com/ World COSI Open Health Web-portal http://sites.google.com/site/cosihealthit/ World MedFLOSS Web-portal http://www.medfloss.org World FOSS-for-Health Web-portal http://www.foss-for-health.org/portal/ World LinuxMedNews News http://linuxmednews.com/ World Wikipedia List of Open  Source in HCWiki http://en.wikipedia.org/wiki/List_of_open_source_ healthcare_softwareWorld OSEHRA Foundation http://www.osehra.org/ North America/World Open Health Tools Foundation http://www.openhealthtools.org US/World Open Source Health In - formatics in the UKBlog http://www.oshi-uk.com/ UK Open Health Innovation Blog http://opensource.com/health World eHealth Open Source Web-portal http://www.ehealthopensource.org/ UK eHealth Open Source LinkedIn Group http://www.linkedin.com/groups/eHealth-Open- Source-3407265World Open Source Software in  Health CareLinkedIn Group http://www.linkedin.com/groups/Open-Source-Soft - ware-in-Health-1849332 World Fred Trotter Blog http://www.fredtrotter.com/ US/World COSI: Collaboration, Open Solutions & Innovation, FOSS: Free and Open Source Software, HC: health care, OSEHRA: Open  Source Electronic Health Record Agent.",Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
16 www.e-hir.orgThomas Karopka et al http://dx.doi.org/10.4258/hir.2014.20.1.1 1now offers a one-stop shop for anyone interested in medi - cal FLOSS.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
18 www.e-hir.orgThomas Karopka et al http://dx.doi.org/10.4258/hir.2014.20.1.1 1among them the Free Software Foundation award for proj - ects of social benefit in 2011.,OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from: http://www.medfloss.org/.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from:  http://www.open-bio.org/wiki/BOSC.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from: http://www.open-bio.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Avail - able from: http://www.gnu.org/home.en.html.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Avail - able from: http://www.fsf.org.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available  from: http://opensource.org/.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from: http://opensource.org/ licenses/MIT.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from: http://www.eclipse.org/ org/documents/epl-v10.php.,OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from: http://www.mozilla.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from:  https://www.gnu.org/licenses/lgpl.html.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from:  http://www.gnu.org/licenses/agpl-3.0.de.html 16.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
20 www.e-hir.orgThomas Karopka et al http://dx.doi.org/10.4258/hir.2014.20.1.1 12009;78(7):457-72.,OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
http://dx.doi.org/  10.1136/amiajnl-2013-001671.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from:  http://linuxmednews.com/.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from:  http://www.openhealthnews.com.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from: http://www.foss-for- health.org/portal/.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from: http://www.is - fteh.org.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from: http://www.oscon.com/oscon2010/pub - lic/schedule/topic/Health.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from:  http://programming.oreilly.com/2010/03/why-health- care-is-coming-to-t.html.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from: http://www.oscon.com/oscon2011/pub - lic/schedule/topic/Healthcare.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from: http://www.oscon.com/oscon2012/pub - lic/schedule/topic/808.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from: http://www.osehra.org.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from: http://www.imia-medinfo.org/ new2/node/147.,OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from:  http://www.helmholtz-muenchen.de/ibmi/efmi/index.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from: http://www.amia.org/programs/working-groups/ open-source.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available  from: http://en.opensuse.org/openSUSE:Medical_team.,OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from:  http://fedoraproject.org/wiki/SIGs/FedoraMedical.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available  from: http://www.medsphere.com/commercial/openvis - ta-for-the-enterprise.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available  from: https://sites.google.com/site/cosihealthit/.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available  from: http://nhsvista.net.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available  from: http://www.openhealthtools.org/.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
22 www.e-hir.orgThomas Karopka et al http://dx.doi.org/10.4258/hir.2014.20.1.1 1developing countries: OpenMRS: a recipe for successful  collaboration.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from:  http://health.gnu.org/.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from: http://www.tryton.org/.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from:  http://www.gnusolidario.org 83.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from: http://en.wikipedia.org/wiki/ DHIS.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from: http://www.hisp.org/.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from:  http://sourceforge.net/projects/open-clinic/.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from: http://ohie.org/.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
Available from:  http://nhshackday.com.,Non-OADS,/arxiv_data1/oa_pdf/93/a3/hir-20-11.PMC3950260.pdf
"2014 January;20(1):23-29.  http://dx.doi.org/10.4258/hir.2014.20.1.23 pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: 	March	9,	2013 Revised: 	1st,	June	9,	2013; 	2nd,	October 	13,	2013; 	3rd,	November 	29,	2013 Accepted: 	December	3,	2013 Corresponding Author  Hyeoun-Ae	Park,	PhD,	FAAN College 	of	Nursing, 	Seoul 	National 	University, 	103,	Daehak-ro, 	Jong - no-gu, 	Seoul 	1 10-799, 	Korea.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/hir-20-23.PMC3950261.pdf
"Tel:	+82-2-740-8827, 	Fax:	+82-2-766- 1852, 	E-mail: 	hapark@snu.ac.kr This	is	an	Open	Access	article	distributed	under	the	terms	of	the	Creative	Com - mons	Attribution	Non-Commercial	License	(http://creativecommons.org/licenses/by- nc/3.0/)	which	permits	unrestricted	non-commercial	use,	distribution,	and	reproduc - tion	in	any	medium,	provided	the	original	work	is	properly	cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/hir-20-23.PMC3950261.pdf
"24 www.e-hir.orgEunjoo Jeon et al http://dx.doi.org/10.4258/hir.2014.20.1.23students, and patients have been developed and evaluated.",OADS,/arxiv_data1/oa_pdf/7a/92/hir-20-23.PMC3950261.pdf
’ An example query is “http://itunes.apple.,Non-OADS,/arxiv_data1/oa_pdf/7a/92/hir-20-23.PMC3950261.pdf
26 www.e-hir.orgEunjoo Jeon et al http://dx.doi.org/10.4258/hir.2014.20.1.23health-information quality.,OADS,/arxiv_data1/oa_pdf/7a/92/hir-20-23.PMC3950261.pdf
28 www.e-hir.orgEunjoo Jeon et al http://dx.doi.org/10.4258/hir.2014.20.1.23of smartphone health applications could be improved by re - questing that information sources or references be provided  when registering them.,Non-OADS,/arxiv_data1/oa_pdf/7a/92/hir-20-23.PMC3950261.pdf
"2014 January;20(1):3-10.  http://dx.doi.org/10.4258/hir.2014.20.1.3 pISSN 2093-3681  •  eISSN 2093-369X  Review Article Submitted: 	November	6,	2013 Revised: 	January	15,	2014 Accepted: 	January	15,	2014 Corresponding Author  Daniel	Luna,	MD,	MSc Chief 	Information 	Officer, 	Hospital 	Italiano 	de	Buenos 	Aires, 	Pte.",Non-OADS,/arxiv_data1/oa_pdf/f4/a5/hir-20-3.PMC3950262.pdf
"This	is	an	Open	Access	article	distributed	under	the	terms	of	the	Creative	Com - mons	Attribution	Non-Commercial	License	(http://creativecommons.org/licenses/by- nc/3.0/)	which	permits	unrestricted	non-commercial	use,	distribution,	and	reproduc - tion	in	any	medium,	provided	the	original	work	is	properly	cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/a5/hir-20-3.PMC3950262.pdf
"4 www.e-hir.orgDaniel Luna et al http://dx.doi.org/10.4258/hir.2014.20.1.3though success has been achieved in implementing pilots  or isolated programs (mostly in mobile health or local Elec - tronic Medical Records), large sustainable implementations  at a country or regional level are less common [7-10].",Non-OADS,/arxiv_data1/oa_pdf/f4/a5/hir-20-3.PMC3950262.pdf
6 www.e-hir.orgDaniel Luna et al http://dx.doi.org/10.4258/hir.2014.20.1.366th World Assembly [47].,Non-OADS,/arxiv_data1/oa_pdf/f4/a5/hir-20-3.PMC3950262.pdf
8 www.e-hir.orgDaniel Luna et al http://dx.doi.org/10.4258/hir.2014.20.1.3Care in America.,Non-OADS,/arxiv_data1/oa_pdf/f4/a5/hir-20-3.PMC3950262.pdf
Available from: http://www.ceibal.org.,Non-OADS,/arxiv_data1/oa_pdf/f4/a5/hir-20-3.PMC3950262.pdf
Available from: http://www.conectarigual - dad.gob.ar/.,Non-OADS,/arxiv_data1/oa_pdf/f4/a5/hir-20-3.PMC3950262.pdf
Available from:  http://wiki.laptop.org/go/Rwanda.,Non-OADS,/arxiv_data1/oa_pdf/f4/a5/hir-20-3.PMC3950262.pdf
Available from: http://www.postgresql.org/ about/.,Non-OADS,/arxiv_data1/oa_pdf/f4/a5/hir-20-3.PMC3950262.pdf
Available from: http://apps.who.int/gb/ebwha/pdf_files/ EB132/B132_R8-en.pdf.,OADS,/arxiv_data1/oa_pdf/f4/a5/hir-20-3.PMC3950262.pdf
Available from: http://www.amia.org/ programs/global-programs-ghip.,Non-OADS,/arxiv_data1/oa_pdf/f4/a5/hir-20-3.PMC3950262.pdf
10 www.e-hir.orgDaniel Luna et al http://dx.doi.org/10.4258/hir.2014.20.1.3Inform 2013;192:1250.,OADS,/arxiv_data1/oa_pdf/f4/a5/hir-20-3.PMC3950262.pdf
Available from:  http://imia-wg4dev.org/.,Non-OADS,/arxiv_data1/oa_pdf/f4/a5/hir-20-3.PMC3950262.pdf
"2014 January;20(1):30-38.  http://dx.doi.org/10.4258/hir.2014.20.1.30 pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: 	October	31,	2013 Revised: 	January	16,	2014 Accepted: 	January	20,	2014 Corresponding Author  Myonghwa	Park,	PhD College 	of	Nursing, 	Chungnam 	National 	University, 	266	Munhwa- ro,	Jung-gu, 	Daejeon 	301-747, 	Korea.",Non-OADS,/arxiv_data1/oa_pdf/fa/33/hir-20-30.PMC3950263.pdf
"Tel:	+82-42-580-8328, 	Fax:	 +82-42-580-8309,	E-mail:	mhpark@cnu.ac.kr This	is	an	Open	Access	article	distributed	under	the	terms	of	the	Creative	Com - mons	Attribution	Non-Commercial	License	(http://creativecommons.org/licenses/by- nc/3.0/)	which	permits	unrestricted	non-commercial	use,	distribution,	and	reproduc - tion	in	any	medium,	provided	the	original	work	is	properly	cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/33/hir-20-30.PMC3950263.pdf
"32 www.e-hir.orgMyonghwa Park et al http://dx.doi.org/10.4258/hir.2014.20.1.30functional status, leisure & social activity, quality of life, and  living environment (Figure 2).",OADS,/arxiv_data1/oa_pdf/fa/33/hir-20-30.PMC3950263.pdf
34 www.e-hir.orgMyonghwa Park et al http://dx.doi.org/10.4258/hir.2014.20.1.30III.,Non-OADS,/arxiv_data1/oa_pdf/fa/33/hir-20-30.PMC3950263.pdf
"36 www.e-hir.orgMyonghwa Park et al http://dx.doi.org/10.4258/hir.2014.20.1.30dependent variables (regression) and categorical predictor  variables (classification), the C&R Tree builds a classification  and regression tree [15].",OADS,/arxiv_data1/oa_pdf/fa/33/hir-20-30.PMC3950263.pdf
"38 www.e-hir.orgMyonghwa Park et al http://dx.doi.org/10.4258/hir.2014.20.1.30and teeth affect the ability to eat certain foods, nutrient  and dietary intake and nutritional status amongst older  people?",Non-OADS,/arxiv_data1/oa_pdf/fa/33/hir-20-30.PMC3950263.pdf
"2014 January;20(1):39-44.  http://dx.doi.org/10.4258/hir.2014.20.1.39 pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: 	November	15,	2013 Revised: 	1st,	January	21,	2014;	2nd,	January	27,	2014 Accepted: 	January	27,	2014 Corresponding Author  Ju	Han	Kim,	MD,	PhD Seoul 	National 	University 	Biomedical 	Informatics 	(SNUBI), 	Seoul	 National 	University 	College 	of	Medicine, 	103	Daehak-ro, 	Jongno- gu,	Seoul 	110-799, 	Korea.",Non-OADS,/arxiv_data1/oa_pdf/84/d4/hir-20-39.PMC3950264.pdf
"Tel:	+82-2-740-8320, 	Fax:	+82-2-747- 8928,	E-mail:	juhan@snu.ac.kr This	is	an	Open	Access	article	distributed	under	the	terms	of	the	Creative	Com - mons	Attribution	Non-Commercial	License	(http://creativecommons.org/licenses/by- nc/3.0/)	which	permits	unrestricted	non-commercial	use,	distribution,	and	reproduc - tion	in	any	medium,	provided	the	original	work	is	properly	cited.",Non-OADS,/arxiv_data1/oa_pdf/84/d4/hir-20-39.PMC3950264.pdf
40 www.e-hir.orgYu Rang Park et al http://dx.doi.org/10.4258/hir.2014.20.1.39for providing standard personal health record (PHR) con - tents.,Non-OADS,/arxiv_data1/oa_pdf/84/d4/hir-20-39.PMC3950264.pdf
42 www.e-hir.orgYu Rang Park et al http://dx.doi.org/10.4258/hir.2014.20.1.39The QuestionLabel  and Value tags are optional.,Non-OADS,/arxiv_data1/oa_pdf/84/d4/hir-20-39.PMC3950264.pdf
Supplementary Materials Supplementary materials can be found via http://pdf.me - drang.co.kr/Hir/2014/020/Hir020-01-06-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/84/d4/hir-20-39.PMC3950264.pdf
44 www.e-hir.orgYu Rang Park et al http://dx.doi.org/10.4258/hir.2014.20.1.39record pilot with Microsoft HealthVault and Google  Health.,Non-OADS,/arxiv_data1/oa_pdf/84/d4/hir-20-39.PMC3950264.pdf
"2014 January;20(1):45-51.  http://dx.doi.org/10.4258/hir.2014.20.1.45 pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: 	November	21,	2013 Revised: 	January	24,	2014 Accepted: 	January	27,	2014 Corresponding Author  Peom	Park,	PhD Department 	of	Industrial 	Engineering, 	Ajou 	University, 	206	World	 Cup-ro, 	Yeongtong-gu, 	Suwon 	443-749, 	Korea.",Non-OADS,/arxiv_data1/oa_pdf/24/41/hir-20-45.PMC3950265.pdf
"Tel:	+82-31-219- 2426,	Fax:	+82-31-219-1610,	E-mail:	ppark@ajou.ac.kr	 This	is	an	Open	Access	article	distributed	under	the	terms	of	the	Creative	Com - mons	Attribution	Non-Commercial	License	(http://creativecommons.org/licenses/by- nc/3.0/)	which	permits	unrestricted	non-commercial	use,	distribution,	and	reproduc - tion	in	any	medium,	provided	the	original	work	is	properly	cited.",Non-OADS,/arxiv_data1/oa_pdf/24/41/hir-20-45.PMC3950265.pdf
46 www.e-hir.orgDasueran Kim et al http://dx.doi.org/10.4258/hir.2014.20.1.45life rather than effectiveness alone [1-3].,Non-OADS,/arxiv_data1/oa_pdf/24/41/hir-20-45.PMC3950265.pdf
"48 www.e-hir.orgDasueran Kim et al http://dx.doi.org/10.4258/hir.2014.20.1.45portance degree of each function [6,10].",OADS,/arxiv_data1/oa_pdf/24/41/hir-20-45.PMC3950265.pdf
50 www.e-hir.orgDasueran Kim et al http://dx.doi.org/10.4258/hir.2014.20.1.45IV.,OADS,/arxiv_data1/oa_pdf/24/41/hir-20-45.PMC3950265.pdf
"2014 January;20(1):52-60.  http://dx.doi.org/10.4258/hir.2014.20.1.52 pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted:  November 15, 2013 Revised:  January 24, 2014 Accepted:  January 27, 2014 Corresponding Author  Gwan-Su Yi, PhD Department of Bio and Brain Engineering, Korea Advanced Institute  of Science and Technology, 291, Daehak-ro, Yuseong-gu, Daejeon  305-701, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c1/ae/hir-20-52.PMC3950266.pdf
"Tel: +82-42-350-6160, Fax: +82-42-350-6814, E- mail: gsyi@kaist.ac.kr  This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/ae/hir-20-52.PMC3950266.pdf
Construction of Drug Dataset The drug response data was downloaded from the Connec - tivity Map website (http://www.broadinstitute.org/cmap/).,OADS,/arxiv_data1/oa_pdf/c1/ae/hir-20-52.PMC3950266.pdf
54 www.e-hir.orgKihoon Cha et al http://dx.doi.org/10.4258/hir.2014.20.1.52Cheng et al.,OADS,/arxiv_data1/oa_pdf/c1/ae/hir-20-52.PMC3950266.pdf
56 www.e-hir.orgKihoon Cha et al http://dx.doi.org/10.4258/hir.2014.20.1.52as significantly co-expressed gene pairs.,OADS,/arxiv_data1/oa_pdf/c1/ae/hir-20-52.PMC3950266.pdf
"58 www.e-hir.orgKihoon Cha et al http://dx.doi.org/10.4258/hir.2014.20.1.52sion similarity search methods, multiple experiments were  needed to measure co-expression between all pairs of genes  and to perform a t-test for each gene.",OADS,/arxiv_data1/oa_pdf/c1/ae/hir-20-52.PMC3950266.pdf
60 www.e-hir.orgKihoon Cha et al http://dx.doi.org/10.4258/hir.2014.20.1.52in drug response profiles is small.,OADS,/arxiv_data1/oa_pdf/c1/ae/hir-20-52.PMC3950266.pdf
"2014 January;20(1):61-68.  http://dx.doi.org/10.4258/hir.2014.20.1.61 pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: 	November	15,	2013 Revised: 	December	24,	2013 Accepted: 	January	1,	2014 Corresponding Author  Joon-Kyung	Seong,	PhD Department 	of	Biomedical 	Engineering, 	Korea 	University, 	145	 Anam-ro, 	Seongbuk-gu, 	Seoul 	136-701, 	Korea.",Non-OADS,/arxiv_data1/oa_pdf/02/2c/hir-20-61.PMC3950267.pdf
"Tel:	+82-2-940- 2887,	Fax:	+82-2-940-2880,	E-mail:	jkseong@korea.ac.kr	 This	is	an	Open	Access	article	distributed	under	the	terms	of	the	Creative	Com - mons	Attribution	Non-Commercial	License	(http://creativecommons.org/licenses/by- nc/3.0/)	which	permits	unrestricted	non-commercial	use,	distribution,	and	reproduc - tion	in	any	medium,	provided	the	original	work	is	properly	cited.",Non-OADS,/arxiv_data1/oa_pdf/02/2c/hir-20-61.PMC3950267.pdf
62 www.e-hir.orgGa-Young Lee et al http://dx.doi.org/10.4258/hir.2014.20.1.61dementia among the elderly population will reach 1.14 mil - lion by 2030.,Non-OADS,/arxiv_data1/oa_pdf/02/2c/hir-20-61.PMC3950267.pdf
"64 www.e-hir.orgGa-Young Lee et al http://dx.doi.org/10.4258/hir.2014.20.1.61  An input data y from the PCA sub-space is mapped onto  the LDA space as z = WT L y, where the matrix WL is the LDA transformation matrix.",OADS,/arxiv_data1/oa_pdf/02/2c/hir-20-61.PMC3950267.pdf
"66 www.e-hir.orgGa-Young Lee et al http://dx.doi.org/10.4258/hir.2014.20.1.61las, Thickness-ROI, Hippo-Volume, and Hippo-Shape.",OADS,/arxiv_data1/oa_pdf/02/2c/hir-20-61.PMC3950267.pdf
68 www.e-hir.orgGa-Young Lee et al http://dx.doi.org/10.4258/hir.2014.20.1.6125.,OADS,/arxiv_data1/oa_pdf/02/2c/hir-20-61.PMC3950267.pdf
"2014 January;20(1):69-75.  http://dx.doi.org/10.4258/hir.2014.20.1.69 pISSN 2093-3681  •  eISSN 2093-369X  Case Report Submitted: 	November	15,	2013 Revised: 	January	22,	2014 Accepted: 	January	23,	2014 Corresponding Author  Changseok	Bae,	PhD Human 	Computing 	Research 	Section, 	SW	·	Content 	Research 	Labora - tory, 	Electronics 	and	Telecommunications 	Research 	Institute, 	218,	 Gajeong-ro, 	Yuseong-gu, 	Daejeon 	305-700, 	Korea.",Non-OADS,/arxiv_data1/oa_pdf/51/44/hir-20-69.PMC3950268.pdf
"Tel:	+82-42-860- 3816, 	Fax:	+82-42-860-6645, 	E-mail: 	csbae@etri.re.kr This	is	an	Open	Access	article	distributed	under	the	terms	of	the	Creative	Com - mons	Attribution	Non-Commercial	License	(http://creativecommons.org/licenses/by- nc/3.0/)	which	permits	unrestricted	non-commercial	use,	distribution,	and	reproduc - tion	in	any	medium,	provided	the	original	work	is	properly	cited.",Non-OADS,/arxiv_data1/oa_pdf/51/44/hir-20-69.PMC3950268.pdf
70 www.e-hir.orgYongjin Kwon et al http://dx.doi.org/10.4258/hir.2014.20.1.69  Healthcare systems for various purposes have exploited  lifelog data measured by sensors.,OADS,/arxiv_data1/oa_pdf/51/44/hir-20-69.PMC3950268.pdf
72 www.e-hir.orgYongjin Kwon et al http://dx.doi.org/10.4258/hir.2014.20.1.69the frequency domain after a fast Fourier transform [15].,OADS,/arxiv_data1/oa_pdf/51/44/hir-20-69.PMC3950268.pdf
"74 www.e-hir.orgYongjin Kwon et al http://dx.doi.org/10.4258/hir.2014.20.1.69tion to display a graph that shows the patterns for each day,  thus showing the user’s activity patterns and lifestyle during  a week.",OADS,/arxiv_data1/oa_pdf/51/44/hir-20-69.PMC3950268.pdf
"2014 January;20(1):76-78.  http://dx.doi.org/10.4258/hir.2014.20.1.76 pISSN 2093-3681  •  eISSN 2093-369X  Book Review This	is	an	Open	Access	article	distributed	under	the	terms	of	the	Creative	Com - mons	Attribution	Non-Commercial	License	(http://creativecommons.org/licenses/by- nc/3.0/)	which	permits	unrestricted	non-commercial	use,	distribution,	and	reproduc - tion	in	any	medium,	provided	the	original	work	is	properly	cited.",Non-OADS,/arxiv_data1/oa_pdf/77/1b/hir-20-76.PMC3950269.pdf
78 www.e-hir.orgSeewon Ryu http://dx.doi.org/10.4258/hir.2014.20.1.76“Big Data” applications.,Non-OADS,/arxiv_data1/oa_pdf/77/1b/hir-20-76.PMC3950269.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)ROS-JNK-p53 axis confers robust apoptosis Y Shi et al 623 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/aa/7c/cdd2013186a.PMC3950324.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Correspondence should be addressed to L.O.",Non-OADS,/arxiv_data1/oa_pdf/42/c2/nihms554182.PMC3950337.pdf
"Synapse, https://synapse.org/ ; Firehose, http://gdac.broadinstitute.org/ ; GenomeSpace, http://www.genomespace.org/ ; W3C provenance specification, http://www.w3.org/TR/prov-primer/ .",OADS,/arxiv_data1/oa_pdf/42/c2/nihms554182.PMC3950337.pdf
"We invite members of the scientific community to provide feedback ( http://support.sagebase.org/sagebase , access the source code and directly contribute to the software, and suggest additional projects through which to explore a collaborative research paradigm.",Non-OADS,/arxiv_data1/oa_pdf/42/c2/nihms554182.PMC3950337.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/ae/f4/423.PMC3950340.pdf
[Keywords : Argonautes; cellular memory; epigenetics; piRNA] 3Corresponding author E-mail aaa@caltech.edu Article is online at http://www.genesdev.,Non-OADS,/arxiv_data1/oa_pdf/ae/f4/423.PMC3950340.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/42/81/432.PMC3950341.pdf
[Keywords : Hippo signaling; YAP; differentiation; mammary gland; pro- liferation; tumorigenesis] 4Corresponding authors E-mail djpan@jhmi.edu E-mail zahnoci@jhmi.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.233676.113.,Non-OADS,/arxiv_data1/oa_pdf/42/81/432.PMC3950341.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/05/6c/438.PMC3950342.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.233585.113.,Non-OADS,/arxiv_data1/oa_pdf/05/6c/438.PMC3950342.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cs hlp.org/site/misc/ terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/34/fa/451.PMC3950343.pdf
"After six months, it is available under a Cr eative Commons License (Attribution- NonCommercial 3.0 Unporte d), as described at http://creativecommons.org/ licenses/by-nc/3.0/.6Corresponding author E-mail petrinij@mskcc.org Article published online ahead of print.",Non-OADS,/arxiv_data1/oa_pdf/34/fa/451.PMC3950343.pdf
Article and publication date are online at http://www.genesdev.or g/cgi/doi/10.1101/gad.236745.113.,Non-OADS,/arxiv_data1/oa_pdf/34/fa/451.PMC3950343.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/eb/c0/463.PMC3950344.pdf
5Corresponding author E-mail deborah.bourchis@curie.fr Article is online at http://www.genesdev.,Non-OADS,/arxiv_data1/oa_pdf/eb/c0/463.PMC3950344.pdf
"This article, published in Genes &Development ,i s available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/ by-nc/3.0/.19Corresponding author E-mail kwong1@partners.org Article is online at http://www.genesde v.org/cgi/doi/10.",Non-OADS,/arxiv_data1/oa_pdf/51/ea/479.PMC3950345.pdf
Data analysis was con- ducted using R (http://www.r-project.org).,OADS,/arxiv_data1/oa_pdf/51/ea/479.PMC3950345.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/8d/f6/491.PMC3950346.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.234419.113.,Non-OADS,/arxiv_data1/oa_pdf/8d/f6/491.PMC3950346.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/b6/a3/502.PMC3950347.pdf
"After six months, it is available under a Creative Commons License (Attribution- NonCommercial 3.0 Unported), as described at http://creativecommons.org/ licenses/by-nc/3.0/.3These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/b6/a3/502.PMC3950347.pdf
"Present Addresses:4Laboratory on the Mechanism and Regulation of Protein Synthesis, Eunice Kennedy Shriver National Institute of ChildHealth and Human Development, National Institutes of Health, Bethesda, MD 20892, USA;5Immuneering Corporation, One Broadway, 14th floor, Cambridge, MA 02142, USA;6Department of Biotechnology, Shoolini University of Biotechnology and Management Sciences, Solan, Hima- chal Pradesh-173212, India 7Corresponding authors E-mail ahinnebusch@nih.gov E-mail jon.lorsch@nih.gov Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.236547.113.",Non-OADS,/arxiv_data1/oa_pdf/b6/a3/502.PMC3950347.pdf
"This article, published in Genes &Development ,i s available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/ 3.0/.9These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/24/6c/521.PMC3950348.pdf
11Corresponding authors E-mail yokoyama@riken.jpE-mail severik@waksman.rutgers.edu Article is online at http://www.genesdev.,Non-OADS,/arxiv_data1/oa_pdf/24/6c/521.PMC3950348.pdf
Faculty of Intensive Care of the Australian and New Zealand  College of Anaesthetists and Australasian College for Emergency Medicine: Minimum standards for transport of the critically ill. Melbourne: Faculty of Intensive Care of the Australasian and New Zealand College of Anaesthetists and Australian College of Emergency Medicine; 1996. : Available from: http://www.anzca.edu.au/resources/professional-documents/documents/professional-standards/professional-standards-52.html.,Non-OADS,/arxiv_data1/oa_pdf/88/b1/SJA-8-104.PMC3950432.pdf
Available  from: http://www.ukpics.org.uk/documents/PICS_standards.,Non-OADS,/arxiv_data1/oa_pdf/88/b1/SJA-8-104.PMC3950432.pdf
Available from:  http://www.health.vic.gov.au/qualitycouncil/downloads/ interhospital_pt_litreview.pdf.,Non-OADS,/arxiv_data1/oa_pdf/88/b1/SJA-8-104.PMC3950432.pdf
"2001.,:Available from http://www.ahrq.gov/ clinic/ptsafety/index.html.",OADS,/arxiv_data1/oa_pdf/88/b1/SJA-8-104.PMC3950432.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/bb/14/SJA-8-11.PMC3950433.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/90/92/SJA-8-30.PMC3950449.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3y sr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/90/92/SJA-8-30.PMC3950449.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/66/ae/SJA-8-4.PMC3950451.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/54/19/SJA-8-64.PMC3950456.pdf
"Allresearch with avian viruses was conducted under biosafety level 3 contain-ment, including enhancements required by the U.S. Department of Agri-culture and the Select Agent Program ( http://www.cdc.gov/od/ohs /biosfty/bmbl5/bmbl5toc.htm ).",Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
"In addition, normal-ized matrixes and expression values utilized in this study can be found at https://viromics.washington.edu .",Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1016/S0140-6736(13)60903-4 .,OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
15:859 – 865. http://dx.doi.org/10.3201/ eid1506.090072 .,Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1016/S0140-6736(13)61207-6 .,OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1016/S0140-6736(13)61171-X .,OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1016/ S0196-6553(97)90029-8 .,OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
15:432– 439. http://dx.doi.org/10.1016/j.micinf.2013.04.004 .,OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1038/ nature12391 .,Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1126/science.1239844 .,Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
Nature 499: 496 – 499. http://dx.doi.org/10.1038/nature12372 .,Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1016/j.cell.2013.05.034 .,OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1111/j.1462-5822.2007.00900.x .,Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
203: 40 – 48. http://dx.doi.org/10.1093/infdis/jiq018 .,Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1128/JVI.79.15.9470-9479.2005 .,Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1016/ j.jviromet.2011.03.027 .,OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1128/mBio.00165-13 .,Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1371/journal.pone.0013169 .,Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1016/ j.cell.2013.05.052 .,OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1016/j.cell.2013.02.027 .,OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1038/ nature12392 .,Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1038/ emi.2013.30 .,Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
Commun 4:2854. http://dx.doi.org/10.1038/ncomms3854 .Host Response to H7N9 January/February 2014 Volume 5 Issue 1 e01102-13®mbio.asm.org 11,Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1056/ NEJMc0905290 .,OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1001/jama.293.16.2003 .,Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/ 10.1093/jac/dkm307 .,Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1038/cr.2012.165 .,Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1371/ journal.pone.0008713 .,Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
"http://dx.doi.org/10.1016/ j.virusres.2013.02.011 .39.McDermott JE, Shankaran H, Eisfeld AJ, Belisle SE, Neuman G, Li C, McWeeney S, Sabourin C, Kawaoka Y, Katze MG, Waters KM.",OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
5:190. http://dx.doi.org/10.1186/1752-0509-5-190 .,Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1128/JVI.05792-11 .,Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1093/bioinformatics/btm563 .,OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
Cancer 7:54 – 60. http://dx.doi.org/10.1038/nrc2044 .,Non-OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
BMC Genomics 10:22.http://dx.doi.org/10.1186/1471-2164-10-S3-S22 .,OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
http://dx.doi.org/10.1038/nmeth.2212 .Josset et al.,OADS,/arxiv_data1/oa_pdf/2c/cb/mBio.01102-13.PMC3950506.pdf
"Of the 53 expanded loci, 42 were predicted to contain protein-coding genes ( http://www.toxodb.org ).",Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
"bGene identiﬁcations are based on Toxoplasma gondii strain ME49 sequence, v7.0 ( http://www.toxodb.org ).",OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
"bBased on version 8.2 annotation, http://toxodb.org .",OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
"We identiﬁed 65 expanded loci in N. caninum (Liverpool strain; http://www.toxodb.org ), 45 of which contained predicted protein-coding genes.",OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
Raw Affymetrix data ﬁles for each strain were analyzed in R statistical software using the“affy” module ( http://cran.us.r-project.org ).,OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1128/ AEM.00246-12 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1051/parasite/2008153366 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1016/S0304-4017(03)00133-X .,OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
Science 325:484 – 487. http://dx.doi.org/10.1126/science.1177238 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1016/ j.cell.2012.02.039 .,OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1038/ jhg.2011.108 .,OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.4049/jimmunol.0902332 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
Genetics 185:65– 80. http://dx.doi.org/10.1534/genetics.110.114074 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
Cell10:34 – 42. http://dx.doi.org/10.1128/EC.00242-10 .,OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1371/ journal.pbio.0030248 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1016/ j.chom.2008.06.001 .,OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/ 10.1073/pnas.1015980108 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
6:79 – 88. http://dx.doi.org/ 10.1038/nrmicro1800 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1128/IAI.01862-06 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/ 10.1126/science.1133643 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1128/EC.00297-10 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
106:439 – 455. http://dx.doi.org/10.1093/aob/mcq126 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1093/ oxfordjournals.molbev.a026285 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1371/ journal.ppat.1002567 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1126/science.806116 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
21:476 – 481. http://dx.doi.org/10.1016/ j.pt.2005.08.001 .,OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1371/journal.pone.0032123 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1016/S0020-7519(03)00141-3 .,OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
12:656 – 664. http://dx.doi.org/10.1101/gr.229202 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
Diversity of human copy number variation and multicopy genes.Science 330:641– 646. http://dx.doi.org/10.1126/science.1197005 .,OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1128/mBio.00321-12 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1371/ journal.pone.0029998 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
BMCBioinformatics 4:41. http://dx.doi.org/10.1186/1471-2105-4-41 .,OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
BMC Genomics 14: 467. http://dx.doi.org/10.1186/1471-2164-14-467 .,OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1101/gr.097501.109 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1038/ nature05395 .Gene Expansion in T. gondii and Its Relatives January/February 2014 Volume 5 Issue 1 e01003-13®mbio.asm.org 11,OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1084/jem.20100717 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1093/bioinformatics/ btp352 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
http://dx.doi.org/10.1038/nmeth.1923 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
BMC Genomics 11:603. http://dx.doi.org/10.1186/1471-2164-11-603 .,OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
56:52– 64. http://dx.doi.org/10.1080/01621459.1961.10482090 .,Non-OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
BMC Bioinformatics 10:80. http://dx.doi.org/10.1186/1471-2105-10-80 .,OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
Gene 77:61– 68. http://dx.doi.org/10.1016/0378- 1119(89)90359-4 .Adomako-Ankomah et al.,OADS,/arxiv_data1/oa_pdf/ba/bc/mBio.01003-13.PMC3950507.pdf
"Strain G0was obtained from a patient in Uganda participating in the COATtrial ( http://clinicaltrials.gov/ct2/show/nct01075152 ), and strain HC1 was isolated from a patient in the United States.",Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
The C. neoformans var.grubii H99 genome with annotations (2012 release) were downloaded from theBroad Institute ( http://www.broadinstitute.org ) and used as a reference.,OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
The ﬁlter used in GATK was“-stand_callconf 50 -stand_emitconf 10 -dcov 500.” All the SNVs wereannotated using VCFannotator ( http://vcfannotator.sourceforge.net ) rel- ative to the H99 genome.,OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
Reads that contained more than 10% of the bases with phred quality scores below 20 were removed using FASTXtoolkit ( http://hannonlab.cshl.edu/fastx_toolkit ).De novo assembly of the ﬁltered reads was performed by Trinity (44).,OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
RNA-seq data have been made publicly available at GEO ( http://www.ncbi.nlm.nih.gov/geo ) under ac- cession number GSE51573.,OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1097/QAD.0b013e328322ffac .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1371/ journal.pone.0016076 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1128/EC.05273-11 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1007/s11046-011-9512-9 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1128/EC.3.5.1249-1260.2004 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1007/s00294-007- 0147-9 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1371/journal.ppat.1001209 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/ 10.1128/EC.4.1.190-201.2005 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1128/EC.4.8.1420-1433.2005 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1111/ j.1365-2958.2008.06374.x .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1371/ journal.ppat.1002495 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1128/IAI.70.10.5684- 5694.2002 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1371/ journal.pone.0005862 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1371/journal.pone.0019688 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1186/gb-2009-10-3- r25.,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1186/gb-2010- 11-10-r106 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1128/EC.00166-09 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1128/EC.00375-08 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
Cell 117:625– 635. http://dx.doi.org/ 10.1016/j.cell.2004.05.002 .,OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1016/ j.cell.2008.07.046 .,OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1007/ s10059-009-0050-y .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1038/nature02075 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/ 10.1128/IAI.70.9.5246-5255.2002 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1074/ jbc.M109.050666 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1128/AAC.00880-08 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1038/ sj.onc.1201139 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
Nature 430: 35– 44. http://dx.doi.org/ 10.1038/nature02579 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1371/journal.pbio.1001094 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
29:644 – 652. http://dx.doi.org/10.1038/nbt.1883 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1093/ nar/gks804 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1101/ gr.079558.108 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
78: 4213– 4225. http://dx.doi.org/10.1128/IAI.00551-10 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1093/nar/gkr918 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1093/infdis/jit335 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1371/journal.pbio.1001179 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1128/ IAI.74.2.1352-1359.2006 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1046/j.1365- 2958.2003.03281.x .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/ 10.1016/j.fgb.2012.02.001 .,OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1126/science.1159746 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1073/ pnas.97.26.14455 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/ 10.1080/13693780902953886 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
http://dx.doi.org/10.1093/bioinformatics/ btm404 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
43:491– 498. http://dx.doi.org/10.1038/ng.806 .,Non-OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
12:656 – 664. http://dx.doi.org/10.1101/gr.229202 .Chen et al.,OADS,/arxiv_data1/oa_pdf/81/04/mBio.01087-13.PMC3950508.pdf
5:e3.http://dx.doi.org/10.1371/journal.pmed.1000003 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1128/IAI.00403- 06.,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/ 10.1073/pnas.1112729109 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1126/ science.1137195 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
3:35.http://dx.doi.org/10.3389/ fcimb.2013.00035 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1111/mmi.12273 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1111/mmi.12293 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
187:8172– 8180. http://dx.doi.org/ 10.1128/JB.187.23.8172-8180.2005 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1074/jbc.M112.376418 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
189: 8890 – 8900. http://dx.doi.org/10.1128/JB.00972-07 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1128/IAI.00370-08 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/ 10.1006/jmbi.1999.3161 .,OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1002/ (SICI)1097-0290(19980420)58:2/3 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
147:479 – 482. http://dx.doi.org/10.1016/0923-2508(96)84002-2 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
186: 6374 – 6382. http://dx.doi.org/10.1128/JB.186.19.6374- 6382.2004 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1371/journal.ppat.1000303 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1128/IAI.70.7.3665-3672.2002 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
9:178. http://dx.doi.org/10.1186/1471-2180-9-178 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
2:158. http://dx.doi.org/10.3389/fcimb.2012.00158 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1128/IAI.01122-09 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1093/emboj/17.10.2877 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
19:4413– 4419. http://dx.doi.org/10.1093/nar/19.16.4413 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1128/JB.01530-12 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1139/ cjm-2012-0705 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1261/rna.671807 .,OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1016/ j.mib.2007.03.010 .,OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1016/j.mib.2010.01.001 .,OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1101/ sqb.2006.71.016 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
Cell 118:69 – 82. http://dx.doi.org/10.1016/j.cell.2004.06.009 .,OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1111/j.1365-2958.2006.05489.x .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1371/journal.pone.0006213 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1128/IAI.01046-09 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
86: 661– 674. http://dx.doi.org/10.1111/mmi.12011 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
192:4239 – 4245. http://dx.doi.org/10.1128/JB.00504-10 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1111/j.1365-2958.1993.tb01960.x .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1128/JB.00235-06 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1074/mcp.M800187-MCP200 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
11:40. http://dx.doi.org/10.1186/1471-2180-11-40 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1038/nrmicro1478 .,OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/ 10.1093/nar/25.6.1203 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
46:813– 826. http://dx.doi.org/10.1046/j.1365- 2958.2002.03203.x .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/ 10.1053/j.spid.2006.07.002 .,OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1007/978-0-387-72124- 8_16 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/10.1073/ pnas.0601182103 .,Non-OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
http://dx.doi.org/ 10.1128/IAI.01417-12 .Lathem et al.,OADS,/arxiv_data1/oa_pdf/65/f6/mBio.01038-13.PMC3950509.pdf
Lancet 377:849 – 862. http://dx.doi.org/10.1016/S0140-6736(10)60667-8 .,OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1093/infdis/ 147.2.268 .,OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/ 10.1128/JVI.76.24.12463-12472.2002 .GP1 N-Glycans in EBOV Entry and Antibody Evasion January/February 2014 Volume 5 Issue 1 e00862-13®mbio.asm.org 7,OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1038/ nature07082 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1093/infdis/jir295 .,OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/ 10.1128/JVI.02098-06 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1126/ science.287.5458.1664 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/ 10.1006/viro.2001.0899 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
3:41. http://dx.doi.org/10.1186/1743- 422X-3-41 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1128/ JVI.01304-12 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
80:4878 – 4889. http://dx.doi.org/10.1128/ JVI.80.10.4878-4889.2006 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1128/ JVI.02151-09 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1128/JVI.01956-08 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1126/ science.1110656 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
80:4174 – 4178. http://dx.doi.org/10.1128/ JVI.80.8.4174-4178.2006 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1128/JVI.01832-09 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1093/glycob/3.2.97 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
"http://dx.doi.org/10.1038/ emboj.2012.53 .24.Côté M, Misasi J, Ren T, Bruchez A, Lee K, Filone CM, Hensley L, Li Q, Ory D, Chandran K, Cunningham J.",OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1038/nature10380 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1038/ nsmb784 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
86:861– 874. http://dx.doi.org/10.1007/ s00109-008-0350-2 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1126/science.1066371 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1371/journal.ppat.1003232 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1086/514293 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1128/ JVI.78.6.2943-2947.2004 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
76:6841– 6844. http://dx.doi.org/10.1128/ JVI.76.13.6841-6844.2002 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/ 10.1128/MCB.22.14.5173-5181.2002 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/ 10.1016/0014-5793(92)80662-Z .,OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1099/0022-1317-76-2-393 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1002/rcm.4410 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/ 10.1016/j.jbiotec.2012.06.038 .,OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1128/ JVI.01586-06 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
8:11.http://dx.doi.org/ 10.1186/1743-422X-8-11 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1128/JVI.00398-13 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1038/nature10348 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
http://dx.doi.org/10.1128/ JVI.06346-11 .,Non-OADS,/arxiv_data1/oa_pdf/30/6e/mBio.00862-13.PMC3950510.pdf
"http://dx.doi.org/10.1016/0014-4827(71)90223-0 .2.Oh Y, Bi E. 2011.",OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1016/ j.tcb.2010.11.006 .,OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1038/ embor.2011.193 .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/ 10.1111/j.1600-0854.2011.01268.x .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1091/ mbc.E02-01-0013 .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1016/j.mib.2006.10.004 .,OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1083/ jcb.200605081 .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
Cell 5:841– 851. http://dx.doi.org/10.1016/S1097- 2765(00)80324-X .,OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1126/ science.290.5490.341 .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1242/jcs.002931 .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
4:681– 689. http://dx.doi.org/ 10.1016/S1369-5274(01)00269-7 .,OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
4:18.http://dx.doi.org/ 10.1186/1747-1028-4-18 .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1016/S0960- 9822(07)00419-8 .,OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1083/ jcb.138.1.119 .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1242/ jcs.104497 .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
Cell 13:421– 432. http://dx.doi.org/10.1016/ j.devcel.2007.06.011 .,OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
Cell Biol.130:675– 685. http://dx.doi.org/10.1083/jcb.130.3.675 .,OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1016/S0006-291X(03)00907-0 .,OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
23:6672– 6684. http://dx.doi.org/ 10.1128/MCB.23.18.6672-6684.2003 .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1073/ pnas.0508002103 .,OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1128/ MCB.01035-07 .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1016/ S0960-9822(06)00357-5 .,OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1586/eri.11.152 .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1046/j.1365-2958.2001.02459.x .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
71:4045– 4051. http://dx.doi.org/10.1128/ IAI.71.7.4045-4051.2003 .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1038/sj.emboj.7600195 .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
9:595– 601. http://dx.doi.org/10.1016/ j.mib.2006.10.007 .,OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1038/nrmicro2636 .,OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
"http://dx.doi.org/10.1016/ S0955-0674(96)80054-8 .36.Kinoshita E, Kinoshita-Kikuta E, Takiyama K, Koike T. 2006.",OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1016/S1534- 5807(03)00061-3 .,OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1242/ jcs.02820 .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1083/jcb.200307176 .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
15:648 – 653. http://dx.doi.org/10.1016/ j.ceb.2003.09.001 .,OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1111/j.1365-2958.2004.04405.x .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1091/ mbc.E07-09-0876 .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/ 10.1371/journal.pone.0025336 .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1002/1097-0061(20000315)16:4 .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
23:8189 – 8201. http://dx.doi.org/10.1128/MCB.23.22.8189-8201.2003 .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
499:77– 83. http://dx.doi.org/10.1007/ 978-1-60327-151-6_9 .,Non-OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
http://dx.doi.org/10.1002/(SICI)1097-0061(20000115)16:1 .Huang et al.,OADS,/arxiv_data1/oa_pdf/f5/cc/mBio.00915-13.PMC3950511.pdf
"The atomic coordinates and structure factors for unliganded pdH- pBD and the complex of pdHpBD with L-Pro-B and cHyp-B have been deposited in the Protein Data Bank (PDB codes 4E8G, 4J1O, and 4IZG,respectively; http://www.pdb.org ).",OADS,/arxiv_data1/oa_pdf/72/8a/mBio.00933-13.PMC3950512.pdf
